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Abstract. 
Heart rate variability (HRV) is a sensitive, non-invasive measure of cardiac autonomic 
modulation and a known risk factor for cardiac event and death in certain populations. 
The acute effects of exercise are to drastically alter HRV. To a degree, the changes tend 
to reflect the known rearrangement of autonomic control which occurs during exercise. 
Data concerning chronic effects of exercise training on HRV are mixed. However, some 
indication of increases in vagally modulated measures exists. The aim of this thesis was 
to examine the acute and chronic effects of exercise on short-term measures ofHRV in 
healthy subjects and clinical populations. 
Initial investigations assessed the agreement and reliability of different, commercially 
available measurement systems for short-term HRV. The initial literature review 
concluded that data were mixed concerning the reliability of short-term measurement. 
The consequent chapters and papers found that agreement was dependent on the systems 
used and that reliability was fair under only certain physiological conditions. 
Reviewing the literature concerning the chronic effects of exercise on HRV also 
provided mixed results. However, a meta-analysis of these data confirmed a strong, 
highly significant main effect for increased global (SDNN) vagal (HF) measures of 
HRV. This effect was modulated by: subject age, sex and the length of the exercise 
intervention. Empirical work on healthy adults showed that the application of 
recommended HRV measures to exercise ECG data was limited mainly to lower 
intensities. Alternative measurement techniques were also employed with only moderate 
success. 
Prior to this thesis, little was known about the autonomic function of patients with 
peripheral artery disease (PAD). A randomised controlled trial of exercise training in 52 
PAD patients was successfully increasedmaximal walking time in patients on a 
supervised walking program but did not alter any resting HRV measures. However, 
HRV measured during exercise sessions, demonstrated significant increases in global 
and vagally mediated frequency domain measures. 
Changes in HRV in cardiac rehabilitation patients have been examined fairly thoroughly 
in the past but baseline measures are usually made very soon after MI or surgery. This 
study into the effects of eight weeks of cardiac rehabilitation on HRV measures showed 
that measurescould be positively affected in patients with a delayed entry to cardiac 
rehabilitation. Indeed, all expected resting HRV measures increased significantly 
demonstrating increased vagal modulation of heart rate. 
In both PAD and post-MI patients, HF power was found to be a significant predictor of 
improvement in exercise performance. Previously this relationship has only been shown 
in healthy subjects. 
In conclusion, HRV is a significant risk factor in a number of populations. Exercise is 
capable or modifying HRV in certain cases. HRV should, therefore, be viewed as a 
therapeutic target. 
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CHAPTER 1. INTRODUCTION TO THESIS. 
1.1. Introduction. 
1.1.1. History. 
Over twenty years ago, the now seminal paper by Akselrod and colleagues 
(Akselrod et al. 1981) was published in the journal Science. In this paper it was 
stated that. 'Sympathetic and parasympathetic nervous activity make frequency-
specific contributions to the heart rate power spectrum. ' The ability of short-
term measurements to assess cardiac autonomic modulation from an ECG 
recording accurately and non-invasively was realised and a new research tool; 
short-term heart rate variability (HRV) was placed in the public domain. 
1.1.2. The current position of HRV in clinical and scientific 
investigation. 
A search of the PubMed database in April 2005 for 'heart rate variability' 
produced 7933 hits for these MeSH terms. This is evidence for the appeal a non-
invasive and cost effective measure of cardiac autonomic modulation has for 
clinicians and researchers. The applications of HRV measurements range from 
its beginnings in foetal heart rate monitoring, through psychological measures, to 
physiological stressors such as exercise, altitude and space exploration. 
However, where the application of HRV to research has been most abundant and 
arguably most successful, is in diagnosis and monitoring of diseases affecting the 
autonomic nervous system (ANS). 
1.1.3. Current applications of heart rate variability measurements. 
The 1996 Taskforce report on non-invasive electrocardiology (Taskforce 1996) 
made an evidence-based recommendation to the effect that HRV could be 
routinely used for assessment of cardiac autonomic function in patients with 
diabetic autonomic neuropathy and in post-myocardial infarction patients. The 
report also provided a series of recommendations relating to the technical and 
experimental requirements for the recording and analysis of ECG signals for 
determining HRV. Despite this global standard, many published reports fail 
either to provide pertinent information regarding data collection or do not meet 
the required standards set out by the Taskforce. 
In this project, the standards of all recording devices and analysis software were 
in excess of those suggested by the Taskforce. Additionally, all HRV 
measurements were made within the confines of the conditions set out in the 
report. The only exceptions to this were the exploratory measurements made 
under conditions of steady-state exercise. This is not a previously recommended 
use of HRV despite the fact that it has received much attention in the literature. 
Acute changes in HRV reflect shifts in autonomic modulation of the SA node. 
They describe changes in vagal and sympathetic nervous system function well 
under resting conditions, particularly when assessed in the same subjects under 
differing conditions (Pagani et al. 1986). The acute effects of exercise are less 
clear. At low intensities, it appears that changes in HRV reflect vagal 
withdrawal and sympathetic activation. At higher intensities, where there is little 
variation in heart period, data are more mixed (Casadei et ai. 1995). 
Longitudinal studies suggest that changes in some measures of HRV may be 
brought about by chronic exercise training (Davy et ai. 1997), although again the 
data are mixed (Carter et al. 2003). Little information is available concerning the 
effects of chronic exercise training on the acute response (Myslivecek et ai. 
2002). 
1.2. Aim. 
The aim of this thesis was, therefore, to observe acute and chronic changes in 
short-term measures ofHRV in healthy subjects and clinical populations. 
1.3. Structure. 
The Taskforce report gives information on many aspects of HRV but fails to 
provide a sound review of the literature concerning the reliability of HRV 
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measurements. Recognising the importance of reliability when a measurement is 
made longitudinally, chapter two of this thesis was a review of the substantial 
body of literature on this topic. Chapter three assesses the reliability of the 
instruments to be used for data collection within this thesis and the agreement 
between them. Chapter four provides a systematic review of the literature 
surrounding both the acute and chronic responses of HRV measurements to 
exercise and exercise training respectively. In order that definite conclusions can 
be drawn from these data, chapter eight builds on this review by providing a full 
meta-analysis of both cross-sectional differences in selected HRV measures 
between groups based on activity levels and assessed longitudinal adaptations to 
exercise training. 
Chapters five to seven provide laboratory based, empirical data to demonstrate: 
1. Cross sectional differences in HRV measures in healthy subjects of 
differing fitness levels. 
11. The acute effects of exercise on HRV measures. 
111. The ability of modified HRV measures to represent acute autonomic 
adaptation to exercise more accutely. 
The application of the knowledge gained in the first eight chapters to clinical 
populations begins in chapter nine. Where both the standard resting 
measurements discussed previously, and the modified HRV measures developed 
for use during exercise in chapter six, are applied to data collected on peripheral 
artery disease patients. This chapter (nine), assesses the impact of a randomised 
controlled trial of supervised and home based walking exercise on functional 
outcomes and HRV measures in these patients with potentially low initial levels 
of HRV. No previous data concerning the HRV profiles of PAD patients was 
available at the time of this study. 
Chapter 10 also observes change in HRV measures due to exercise intervention 
but this time in post-myocardial infarction and coronary artery disease patients. 
This chapter uses a quasi-experimental design in which volunteers attending a 
cardiovascular rehabilitation programme are studied longitudinally. Data 
concerning changes in HRV programmes were available prior to the start of this 
study. However, these were heterogeneous in nature and often methodologically 
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flawed. Additionally, many studies had utilised 24-hour measurements, taken in 
patients very soon after MI. This study is therefore unique in using short-term 
measurements, made in patients made after the well documented (Bigger et al. 
1992) acute phase ofHRV derangement following myocardial infarction. 
Chapter 11 summarises the findings of this thesis. 
1.4. Notes format of the thesis. 
This thesis is written in the modem style. Each chapter represents a discreet 
piece of work which is linked to the other chapters by a common theme (Figure 
1.1). In some cases (chapters four, five and six) a common methodology and 
population were used. To avoid the reader having to read repeated methodology 
these sections are italicised. References have been placed at the end of each 
chapter. 
1.5. References. 
Akselrod, S., D. Gordon, F. A. Ubel, D. C. Shannon, A. C. Berger and R. J. 
Cohen (1981). "Power spectrum analysis of heart rate fluctuation: a quantitative 
probe of beat-to-beat cardiovascular control." Science 213(4504): 220-222. 
Bigger, J. T., Jr., J. L. Fleiss, R. C. Steinman, L. M. Rolnitzky, R. E. Kleiger and 
J. N. Rottman (1992). "Frequency domain measures of heart period variability 
and mortality after myocardial infarction." Circulation 85( 1): 164-171. 
Carter, J. B., E. W. Banister and A. P. Blaber (2003). "The effect of age and 
gender on heart rate variability after endurance training." Medicine and Science 
in Sports and Exercise 35(8): 1333-1340. 
Casadei, B., S. Cochrane, J. Johnston, J. Conway and P. Sleight (1995). "Pitfalls 
in the interpretation of spectral analysis of the heart rate variability during 
exercise in humans." Acta Physiologica Scandinavia 153(2): 125-131. 
Coats, A. J., S. Adamopoulos, A. Radaelli, A. McCance, T. E. Meyer, L. 
Bernardi, P. L. Soida, P. Davey, O. Ormerod, C. Forfar and et al. (1992). 
"Controlled trial of physical training in chronic heart failure. Exercise 
performance, hemodynamics, ventilation, and autonomic function." Circulation 
85(6): 2119-2131. 
4 
Davy, K. P., W. L. Willis and D. R. Seals (1997). "Influence of exercise training 
on heart rate variability in post-menopausal women with elevated arterial blood 
pressure." Clinical Physiology 17(1): 31-40. 
Myslivecek, P. R., C. A. Brown and L. A. Wolfe (2002). "Effects of physical 
conditioning on cardiac autonomic function in healthy middle-aged women." 
Canadian Journal of Applied Physiology 27(1): 1-18. 
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CHAPTER 2. RELIABILITY OF HEART RATE VARIABILITY 
MEASUREMENTS: A SYSTEMATIC REVIEW OF THE CURRENT 
LITERATURE. 
Abstract 
Heart rate variability (HRV) has been used as a simple, non-invasive technique 
to examine autonomic nervous function. Depressed levels of HRV have been 
shown to be present in a number of pathological conditions including diabetes 
and following myocardial infarction. Reduced HRV has been shown to be a good 
predictor of cardiac events including death in a number of these conditions as 
well as in the elderly and the general population. Within the literature, HRV is 
commonly referred to as a reliable measurement technique. The aim of this 
review was to assess the accuracy of this description based upon a 
comprehensive review of the available data concerning reliability ofHRV. 
From a search of the literature, it was first determined that numerous, published 
studies in this area have utilised statistical analyses other than those 
recommended for the assessment of reliability. By reviewing studies using 
appropriate statistical analyses it was determined that reliability coefficients for 
HRV measures were highly variable. Coefficients of variation ranged from <1 % 
to > 1 00%. Similar variation was found in studies using the intraclass correlation 
coefficient values, and limits of agreement. 
In an attempt to determine reasons for some of the heterogeneity of reliability 
coefficients, several pertinent questions were set. Attempts were then made to 
provide answers to these statements supported by the literature. Briefly, the 
literature lends support to the following statements: 
1. Ambulatory ECG recordings monitoring may be a more reliable HRV 
measurements when compared with those derived from short-term, steady 
state ECG trace. 
11. There seems to be little difference between the reliability coefficients 
reported for either time or frequency domain HRV measures. 
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iii. Clinical populations seem consistently to generate less reliable HRV 
measurements than healthy counterparts. 
IV. Data concerning the effect from test-retest duration on reliability are 
inconsistent. Although some data suggest longer durations may decrease 
reliability other studies show no such effect. 
v. One time domain measure that shows some evidence of being less 
reliable than others is pNN50%. This is especially true in clinical 
populations, and may be due to the often-low values of this specific 
measure. In the frequency domain, reliability of LF and HF power are 
commonly reported concurrently. 
demonstrates inferior reliability. 
In a number of studies LF 
It can be concluded that describing HRV as a reliable measurement technique is 
a gross oversimplification as results of reliability studies are highly 
heterogeneous, and dependent on a number of factors. It is recommended that 
authors report in-house coefficients for HRV measurements used unless 
methodologically similar coefficients have been published previously. Lastly, 
the effects of measurement reliability should be taken into account when deriving 
sample sizes in longitudinal study designs. 
This chapter, in tlUncated fonn has been e-published in the International Journal of Cardiology, see appendix VI. 
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2.1. Aim and Methodology. 
For interindividual differences to be assessed accurately and for intraindividual 
change to be monitored, the method used must also be reliable. Reliability has a 
number of definitions and for a full review of the concept the reader is directed to 
an excellent review article (Atkinson and Nevill 1998). In the case of the 
application of a measurement such as heart rate variability (HRV) the researcher 
or clinician should be interested in how much a measurement taken on an 
individual or group varies when it is repeated. This is akin to absolute reliability 
(Baumgarter 1989), defined as the degree to which repeated measurements vary 
for individuals. 
This review will focus on studies that have assessed the reliability of HRV 
measures. The electronic databases on Medline and Ovid were searched for 
studies using the following terms: heart rate variability, reliability, 
reproducibility. From the references generated by this search strategy a manual 
search was made for further relevant literature. Inclusion criteria were as 
follows: the study was undertaken with the specific aim of assessing the 
reliability ofHRV. Studies were required to have used repeated measurements to 
examine reliability. The investigators were required to have given a 
methodological account of standardised procedures used to control for possible 
confounding variables which may have affected reliability. 
Critical analysis of statistical methods used to assess reliability was undertaken 
and only studies using appropriate statistical analysis, as defined by Atkinson et 
ai. (1998) were included. Twenty-five potential studies were identified. Of 
these, seven studies were rejected for methodological reasons. 
Table 2-2 contains those studies which have examined reliability but are not 
included in the main discussion of the topic due to rejection on methodological 
grounds. Some of these studies still provide insight into HRV reliability, 
therefore some discussion of their findings as well as reasons for rejection can be 
found below. Tables 2-3 and 2-4 give brief descriptions of studies which have 
examined the reliability of HRV measures obtained from ambulatory and ECG 
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recordings respectively. An explanation of the different methodologies used in 
HRV sampling is given below. 
2.2. Introduction to heart rate variability. 
It is commonly perceived that a regular heartbeat is a sign of cardiac health. In 
truth however, the rhythm of a healthy heart is characterised by significant beat-
to-beat variability (Routledge et al. 2002). This heart rate variability (HRV) has 
been used as a simple, non-invasive technique to examine autonomic nervous 
function (Pagani et al. 1986). Depressed levels of HRV have been shown to be 
present in a number of pathological conditions including: heart disease (Bigger et 
al. 1992; Weber et al. 1999), heart failure (Casolo et al. 1989; Scalvini et al. 
1998), diabetes (Malpas and Maling 1990; Ewing et al. 1991; Burger et al. 
1997), hypertension (Konrady et al. 2001), asymptomatic left ventricular 
dysfunction (Scalvini et al. 1998), and following myocardial infarction (Kleiger 
et al. 1987; Bigger et al. 1991; Bigger et al. 1992; Bigger et al. 1992). 
More importantly reduced HRV has been shown to be a good predictor of 
cardiac events including: 
a) death in coronary artery disease (van Boven et al. 1998) 
b) heart failure (Nolan et al. 1998) 
c) stable angina pectoris (Lanza et al. 1997; Forslund et al. 2002) , 
d) following myocardial infraction (Kleiger et al. 1987; Bigger et al. 1993; 
Bigger et al. 1993; Reinhardt et al. 1996; Zuanetti et al. 1996; La Rovere 
et al. 1998; Huikuri et al. 2000; Sosnowski et al. 2002; Filipovic et al. 
2003). 
e) the healthy, elderly population (Tsuji et al. 1994). 
f) the general population (Tsuji et al. 1996). 
As well as these clinical applications, differences in HRV measures have been 
demonstrated cross-sectionally in numerous epidemiological studies. Measures 
of HRV are known to differ significantly according to age (Byrne et al. 1996; 
Stein et al. 1997; Sinnreich et at. 1998; Tulppo et at. 1998; Barnett et al. 1999; 
Kuo et al. 1999; Fukusaki et at. 2000; Kuch et at. 2001), sex (Stein et at. 1997; 
Sinnreich et at. 1998; Barnett et at. 1999; Kuch et at. 2001) and habitual levels of 
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physical activity (Gregoire et ai. 1996; Tulppo et ai. 1998; Migliaro et ai. 2001). 
Recently there are also limited longitudinal data to suggest HRV can be modified 
by increased physical activity (Pardo et ai. 2000; Melanson and Freedson 2001; 
Portier et ai. 2001) although findings are inconsistent (Loimaala et ai. 2000; 
Hedelin et ai. 2001). 
When the major predictors of age and sex are controlled for, numerous other 
factors have been shown to account for some of the variance in HRV. Such 
factors include: body mass index (BMI), height, high-density lipoprotein (HDL) 
levels, plasma insulin levels, smoking, alcohol and caffeine consumption (Byrne 
et ai. 1996; Singh et ai. 1999; Kuch et ai. 2001). 
2.2.1. Analytical Options. 
In the above text, HRV is referred to as a single entity. In fact what is being 
referred to is the cyclical change in sinus rate (the rate of firing of the sinoatrial 
node) over time (Ori et al. 1992). This is a simplistic description a highly 
complex phenomenon. There are two major approaches to the analysis of HRV. 
These are time domain analysis and frequency domain analysis. Time domain 
analysis is the statistical analysis of fluctuations in heart rate based on differences 
between RR intervals over time, usually 24 hours. Frequency domain analysis is 
mathematically more complex and involves the decomposition of the RR interval 
variation data into its frequency components. These are then quantified in terms 
of their relative intensity, termed power. This type of analysis is also known as 
power spectral density analysis because the relative energy content of the time 
series signals of the frequency bands is quantified giving a measure of energy 
distribution over frequency (Ori et ai. 1992). 
In the simplest terms, alterations in heart rate are controlled by the sympathetic 
and parasympathetic branches of the autonomic nervous system (ANS). These 
two branches apply their effect at different frequencies. The parasympathetic 
system appears to influence the high frequency spectrum (HF, 0040 - 0.15 Hz) 
and the sympathetic system appears to influence the low frequency spectrum, 
(LF, 0.04 - 0.15 Hz) although some parasympathetic activity is also detected 
11 
here. Recently there has been much discussion concerning what is represented by 
these two frequency bands (Lanza et at. 1998; Melanson and Freedson 2001), 
particularly the LF band. Empirical evidence suggests that factors other than 
sympathetic nervous activity have significant impact on power in the LF 
spectrum (Chess et at. 1975; Goldsmith et at. 1992; Lombardi et al. 1996; van de 
Borne et al. 1999). 
There is also fluctuation in heart rate at much lower frequencies such as very low 
frequency (VLF, 0.0033-0.04) and ultra low frequency (ULF<0.0033 Hz). The 
physiological explanation of these components is much less well defined. It is 
not the purpose of this paper to give a full account of the various spectra or the 
physiological correlates of each spectra as several excellent reviews on this topic 
already exist (Taskforce 1996; Stein and Kleiger 1999; Routledge et al. 2002). 
Time domain analysis creates a number of measures. Table 2-1 gives brief 
descriptions of time and frequency domain measures recommended for use by 
the Task Force of the European Society of Cardiology and the North American 
Society of Pacing and Electrophysiology (Taskforce 1996). 
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Table 2-1 Time and Frequency domain measures of HRV. 
Abbreviation 
SDNN 
SDANN 
RMSSD 
NNSO (NNSO 
count) 
pNNSO 
SDNN 
HR V triangular 
index 
TINN 
Poincare Plots 
Total Power 
LF 
HF 
LF (nu) 
HF (nu) 
Description 
Time domain measures. 
The standard deviation of all the nOlmal-to-nonnal 
(NN) intervals. 
The standard deviation of the average NN intervals 
calculated over S mins. 
The root of the mean squared differences of 
successive NN intervals. 
The number of successive intervals which differ by 
more than SO ms. 
The proportion of successive intervals which differ 
by more than SO ms derived by dividing NNSO by the 
total number ofNN counts. This may also be 
expressed as a percentage (pNNSO%). 
The standard deviation of all the nonnal-to-nonnal 
(NN) intervals. 
Geometric measures. 
The integral of the density disttibution divided by the 
maximum of the density distribution 
The width of the base of a triangle fitted to the 
histogram of duration of all NN intelvals. 
What the measure represents. 
All the cyclic components responsible for 
variability in the period of the recording. 
All the cyclic components responsible for 
variability during cycles longer than S 
mins. 
Parasympathetic activity. 
Parasympathetic activity. 
Parasympathetic activity. 
All the cyclic components responsible for 
variability in the period of the recording. 
All the cyclic components responsible for 
variability in the period of the recording. 
All the cyclic components responsible for 
vatiability in the period of the recording. 
A scattergram of each NN-intelval of a tachogram All the cyclic components responsible for 
plotted as a function of the previous NN-intelval. variability in the period of the recording. 
Frequency domain measures. 
Vatiation in NN interval below O.ISHz. The lower 
band may be altered depending on duration of 
recording. 
Valiation in NN interval 0.04-0.IS Hz. 
Variation in NN intelval 0.1S-0.40 Hz. 
The proportion of spectral power from 0.04 - 0.4 Hz 
which is in the LF frequency calculated by LF I (TP 
- (ULF+VLF» 
The prop0\1ion of spectral power from 0.04 - 0.4 Hz 
which is in the HF frequency calculated by HF I (TP 
- (ULF+VLF» 
All the cyclic components responsible for 
variability in the period of the recording. 
Sympathetic and parasympathetic activity. 
Parasympathetic activity. 
Sympathetic activity or sympathovagal 
balance. 
Parasympathetic activity or sympathovagal 
balance. 
The above shows that a large number of variables may be produced from a single 
EeG. Although there are correlations between time and frequency domain 
measures, the replacement of one by the other has not been advocated (Taskforce 
1996). 
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2.2.2. Collection Methods. 
There are two general methodologies by which ECG traces for analysis of HRV 
can be obtained. These are 24-hour ambulatory recordings and short (5-15 min) 
resting recordings. Ambulatory recordings can be used to generate all time and 
frequency domain measures of HRV and although time domain analysis can be 
carried out on short-term recordings, these are more suited to analysis via 
spectral methods. The possible measures achieved from short-term recordings are 
limited further by the exclusion of the ULF and depending on recording length, 
the validity of VLF data. As mentioned previously, both methods have been 
shown to have significant clinical application and have been quantitatively 
validated as markers of autonomic function by several authors. 
2.3. Rejection of studies. 
All studies in Table 2-2 have been rejected from this review on statistical 
grounds. Three studies (Hohnloser et ai. 1992; Burger et ai. 1997; Dionne et ai. 
2002) were rejected for their utilisation of the Pearson product moment 
correlation. This statistic merely shows association between two variables and 
does not demonstrate reliability. Bland and Altman (1986) stated that the 
correlation coefficient, and likewise linear regression were totally inappropriate 
as measures of reliability. They stated that pattern recognition and imitation may 
be at work, perpetuating the use of the correlation coefficient. They also 
suggested the idea that referees should be responsible for returning for reanalysis 
papers with such incorrect statistics. Closer examination of a very recent paper 
(Dionne et ai. 2002) published 16 years after the advice of Bland and Altman 
illustrates their point very well. 
Dionne et al. (2002) investigated reliability of HRV in the pre and post-prandial 
state. Looking only at the data for controlled breathing, they reported test-retest 
correlation coefficients for LF of r = 0.99 and r = 0.88 pre and post-prandially. 
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Table 2-2 Studies rejected from review due to inappropriate statistical analysis. 
Author and Subjects. Data Collection and HRV Statistical Values Obtained Parameters. Considered a Reliable Date. ~arameters measured. Analxsis Measure b~ Authors? 
HF, r> 0.74 before and after 
breakfast with normal LF is reliable under Two sets of EeG s recorded for 14 - Pearson breathing but (r<0.58 when controlled breathing Fourteen healthy 16 min, supine with controlled product Dionne et al 
non-obese breathing (12 bpm) in the latter half. moment breathing controlled. conditions. (2002) 
volunteers. Recording repeated after standard correlation LF, r> 0.72 before and after LF is reliable under non-
breakfast 1-2 weeks apart. coefficient. breakfast, with controlled breathing r controlled breathing 
= .99 and .88 before and after conditions 
breakfast. 
Pearson Time domain 0.35 - 0.98, 
Four 24-hour ambulatory EeGs product rMSSD was most reliable. 
Burger et al. Twenty three made. moment Frequency domain 0.61 - 0.93. Yes, they claimed it to be 
(1997) Type 1 diabetics. Time and frequency domain correlation Not significantly different after 3, 6, 9 excellent. 
measures taken at baseline, 3,6 and 9 coefficient. or 12 months. VLF and LF were most 
months. Analysis of reliable. 
variance. 
Seventeen Seven 24 hour ambulatory EeG One way Madias et al patients with Time domain analysis carried out. 
(1996) coronary artery recordings carried out over one analysis of ANOV A P-value not significant. Yes. 
disease month. variance 
No time domain variables were 
Nineteen significantly different (p>0.05). 
Kamalesh et patients with Two consecutive 24-hour ambulatory Repeated In frequency domain analysis there Yes, for both time domain 
al(1994) chronic stable EeG recordings. . measures t- were no significant differences and frequency domain. test. (p>0.05), Total Power was close to 
angina. difference (P=0.09) 
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Vardas et al. 
(1994) 
Gerin et al. 
(1993) 
Hohnloser et 
al. (1992) 
Twenty patients 
with 
unexplained 
syncope. 
Thirty-seven 
healthy 
volunteers. 
Seventeen 
healthy medical 
students, l3 
patients with 
chest pain and 9 
post myocardial 
infarction 
patients. 
Two sets of 2 min intervals just 
before tilt, just after tilt and at the end 
of tilt. repeated 1 - 6 weeks apart. 
Two, controlled 24 hour ambulatory 
ECG recordings taken on consecutive 
days. 
Three 24-hour ambulatory ECG 
recordings carried out on days 1,7 
and 28 of the study. 
Repeated 
measures t-
test. 
Pearson 
product 
moment 
correlation 
coefficient. 
Pearson 
product 
moment 
correlation 
Only frequency domain parameters 
measured. No differences in TP or HF 
from test one to test. Before the end 
of tilt LF measures differed 
significantly. 
Only RMSSD used as measure of 
HRV. Correlation coefficients found 
to be modest (r = 0041) 
For all time domain parameters r = 
0.63 - 0.92. For all frequency 
domain parameters r = 0.79 - 0.88. 
Values similar for all groups and 
between readings at 1, 7 and 28 days. 
Yes, the lack of differences 
between means indicated 
reliability. 
No, modest values reported 
to indicate poor 
reproducibility ofHRV 
measures. 
Yes, both time and 
frequency domain 
measures show good 
reliability independent of 
disease state and time 
between readings. 
* Explanations of statistical tests and abbreviations used can be found in Appendix 1. All abbreviations relating to HRV measures can be found in Table 2-1. 
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Looking at the descriptive statistics it is possible to see that the pre-prandial 
means for LF are very close (test! = 23 345 Hz Eq and test 2 = 23 327 Hz Eq), 
test 1 is within 0.01 % of test 2. However, if the post-prandial LF power 
descriptive data are analysed (test 1 = 22 045 Hz Eq and test 2 = 29 881 Hz Eq); 
it can be seen that tests 1 and 2 differ by 26.3%. On the basis of the strength and 
significance of the correlation coefficients the authors conclude that the LF 
measurements are reproducible. This conclusion is even more alarming when the 
post-prandial LF data under controlled breathing conditions are analysed. This 
test-retest condition had a smaller correlation coefficient (r = 0.57) which was 
close to statistical significance (P = 0.07). However, the mean scores for tests 1 
and 2 demonstrated very well the weakness of this analysis. The mean score for 
test 1 was 26 264 Hz Eq and the mean for test 2 was 10 127 Hz Eq, therefore the 
means score on test 2 is only 38.6% of that on test 1. 
The Pearson product moment correlation was also used by Hohnloser et ai. 
(1992) who reported good reliability of time and frequency domain measures. 
(See Table 2-2). However, over the shorter, 7-day test-retest the percentage 
difference for HRV measures are given. For normal subjects these show poor 
reliability ranging from 10.7 - 23.5% and for patients with chest pain and post 
myocardial infarction patients from 18.4 - 20.2%. 
Burger et ai (1997) correlated time and frequency domain measures of HRV at 
baseline with repeated measures at 6, 9 and 12 months. The majority of 
correlation coefficients were r > 0.75, which was the criteria set by the 
researchers to demonstrate good reliability. In addition, a set of 10 repeated 
measures ANOV As were carried out. The lack of significant variation over time 
due to non-significant P-values was cited as further demonstration of the 
reliability. The reported P-values are not statistically significant (P = 0.88-
0.13). By calculating the effect size (d) for test-retest from 0 - 12 months it can 
be seen that the real differences in the means range from medium (0.5) to large 
(1.76) as classified by Cohen (1982). This is an excellent example of how the 
results of a well-designed study, following 23 subjects over a year can be negated 
by inappropriate statistical analysis. 
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As with the use of ANOV A in the above study, several studies have 
demonstrated how similarity of means or aggregate agreement has been wrongly 
used to assess reliability. This method does not necessarily indicate individual-
subject agreement, which is a pre-requisite for reliability of measurements (Lee 
et al. 1989). Statistically, the repeated measures t-test is often limited in its 
application due to its inability to detect systematic bias. On a more simple level 
the repeated measures t-test simply indicates whether the group means are 
different or not, and whether this difference is significant. Kamalesh et al. (1995) 
simply reported means and standard deviations (log units) for all HRV measures. 
They carried out a repeated measures t-test and reported the t-value assuming a 
non-significant value to show reliability. 
The use of repeated-measures t-tests guards against making errors in the 
interpretaion of correlation coefficients such as those made by Dionne et al. 
(2002). However, it still gives no meaningful measure to assess the reliability of 
sets of scores. It simply states that the scores do or do not differ significantly 
from each other. The significance of a t-value generated in a repeated measures t-
test is dependent on the degrees of freedom (dt). When assessing whether two 
measures are reproducible, by simply analysing whether or not they are 
significantly different from one another, a type 2 error is more likely to be made 
when the df are large. When the df are small the opposite is true. Therefore, a 
significant difference between two means (lack of aggregate agreement) does not 
necessarily indicate lack of individual-subject agreement (Lee et al. 1989). The 
repeated measures t-test should be used in reliability studies only to check for 
systematic bias between the repeated measurements prior to a further statistical 
analysis of agreement between the two methods. 
Madias et al. (1996) investigated the reliability of several HRV methods over 
five tests. Again, correlation coefficients were used. Due to the multiple 
comparisons made, a one-way analysis of variance was also employed to detect 
any differences between the recordings over time. There are several statistical 
problems with the analysis used in this study (Madias et al. 1996). If one were to 
use ANOV A to look at differences over time a repeated measures ANOV A 
should be used. A one-way AN OVA simply looks at the ratio of variance within 
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groups compared to between groups, whereas a repeated-measures ANOVA does 
this for repeated measures on the same individual. This is logically what an 
investigator should be interested in when assessing reliability. 
Additionally, when ANOV A is used to assess reliability the same problems exist 
as when a repeated measures t-test is employed. No statistic is created to tell the 
researcher that the method used is reproducible, only that the test scores do not 
significantly differ. An additional problem is the use of the F statistic generated 
as an indicator of significance. This statistic depends on the variance within each 
set of test scores. If the spread of scores within groups is wide, the F statistic will 
be reduced, leading to an increased likelihood of a type 1 error being made when 
a reliability study is being conducted. A wide range of scores is often reported in 
the literature for HRV data when the test group is heterogeneous for variables 
such as age and gender (Reardon and Malik 1996; Sinnreich et al. 1998; Barnett 
et al. 1999; Kuo et al. 1999; Singh et al. 1999; Fukusaki et al. 2000; Fagard 
2001) and disease state (Van Hoogenhuyze et al. 1991; Hohnloser et al. 1992; 
Bigger et al. 1995; Nolan et al. 1996; Ziegler et al. 1999). In these cases the use 
of ANOV A to assess reliability is even more limited than when the groups are 
homogenous. 
The following questions then remain: 
a) What are the correct methods that should be used to assess reliability? 
b) When correct analysis is used, how reliable are the currently available 
methods to assess HR V? 
c) Is this reliability satisfactory for HRV to be used as a clinical and 
scientific tool? 
2.4. The intraclass correlation coefficient (ICC). 
The intraclass correlation coefficient (ICC) gives a directionless coefficient (R) 
of the agreement between two or more repeated measures ranging from 0 - 1. 
Published values exist giving outlines concerning what various ICC coefficients 
may represent in terms of a method's reliability (Landis and Koch 1977). 
Authors have applied differing sets of criteria. Some investigators have 
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supported the use of ICC (Lee et al. 1989; Lee 1992) whereas others have 
warned against its use (Bland and Altman 1986; Bland and Altman 1990). Its 
proponents suggest that it is an easily interpreted coefficient, which measures the 
agreement between two or more measures. Others (Bland and Altman 1986; 
Bland and Altman 1990) warn that the measure may be strongly influenced by 
the range of scores on each test. They state that with a heterogeneous population 
with a wide range of baseline scores, the R-value may be artificially inflated as it 
is with a traditional interclass correlation coefficient. Recommendations have 
also been made (Muller and Buttner 1994) as to the specific circumstances in 
which the ICC is or is not appropriate. 
2.5. Studies using the intraclass correlation coefficient. 
Numerous studies have reported very good ICCs for HRV using both ambulatory 
ECGs (Kleiger et al. 1991; Stein et al. 1995; Nolan et al. 1996; Pardo et al. 
1996) and short-term ECG recordings (Piepoli et al. 1996; Pitzalis et al. 1996; 
Marks and Lightfoot 1999). Overall, the results of these studies are positive, 
showing good or excellent levels of reliability. 
2.5.1. Ambulatory ECG recordings. 
A study into the reliability of 24-hour measurement of HRV in normal subjects 
(Kleiger et al. 1991) demonstrated excellent reliability for all time domain 
measures (R = 0.70 - 0.90) and even higher (R = 0.90 - 0.94) for frequency 
domain measures over a period of 3 - 65 days. 
The results from cardiac patients also suggest that HRV is stable over time. One 
study (Pardo et al. 1996) reported ICC values of R > 0.99 for all time and 
frequency domain measures. This value only represented short-term reliability as 
the 24-hour recordings were taken on consecutive days. In an investigation into 
reliability of HRV measures over a two week period, Stein et al. (1995) found 
that in the majority of time domain and all frequency domain indices of HRV, R 
> 0.85 when sampled over 24 hours. Similarly, high ICCs have been shown 
(Nolan et al. 1996) when comparing reliability of a single time domain measure 
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over 2-16 weeks. This occurred in nonnal patients (R = 0.97), those with 
ischaemic heart disease (R = 0.94) and diabetics (R = 0.80 - 0.93). 
2.5.2. Short-term ECG recordings. 
In this review, a short-tenn test is defined as any test that does not use 24-hour 
ambulatory monitoring. These tests can be subdivided into two further 
categories: 
1. Stable, resting protocols, where the subject remains stationary during the 
ECG recording and a resting HR is measured 
2. Test/manoeuvre protocols, where the HR response is monitored as the 
subject moves or perfonns a task during the ECG. 
2.5.2.1. Stable, resting ECG recordings. 
Using healthy, young volunteers Pitzalis et at. (1996) showed a wider range of 
ICC values for the frequency domain measures gained from resting short-tenn 
ECGs (R = 0.29-0.77). These values became more homogenous but were reduced 
overall when controlled respiration was used during the ECG (R = 0.36-0.65). 
The modest size of these coefficients compared with those of some of the studies 
mentioned below may be explained in two ways. Firstly they were calculated 
over three testing periods instead of two as is the case in the majority of studies. 
Secondly, subjects were retested over a wide range of durations from 1-265 
days. This test-retest period is longer than those reported in the majority of 
reliability studies. 
Marks and Lightfoot (1999) used a highly controlled data collection protocol to 
obtain stable, 2.5 and 5-min resting ECGs. They reported very high reliability in 
healthy subjects, demonstrated by very high ICCs. For time domain variables 
these values ranged from R = 0.84 - 0.90 and for frequency domain measures 
these values ranged from R = 0.67 - 0.96. This study again had a very small 
(n=8) sample size. Additionally the subjects were a very homogenous group of 
healthy, female, non-smoking subjects. Although this reduces the external 
validity of the paper by limiting the generalization of the study findings, it does 
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demonstrate that high ICC values may be found even when the population 
distribution is highly homogenous. 
2.S.2.2. Test/manoeuvre ECG recording. 
Toyry et al (1996) produced data incongruent with that from previous studies 
(Pitzalis et al. 1996) by demonstrating very low ICC values for time and 
frequency domain measures of HRV (R = 0.03 - 0.24) in healthy subjects over 
five consecutive days of tests. However, these findings should be treated with 
caution due to very short (1-min) ECG sampling period and the very small 
sample size (n=4). Further discussion of this paper (Toyry et al. 1995) can be 
found in the next section as reliability was also reported using other statistical 
analyses. 
Similar to the findings in healthy subjects, good reliability ofHRV measures was 
also demonstrated in patients with chronic heart failure (Piepoli et al. 1996). 
These researchers found similarly high ICC values (R = 0.74 - 0.84) to those of 
Marks and Lightfoot (1999) and Pitzalis et al. (1996) for frequency domain 
measures obtained from short-term recordings. These findings were obtained not 
only at rest but also during supine exercise at 2SW, SOW and TSW and during 
three sequential, increasing levels of dobutamine infusion, used as two models of 
sympathetic activation 
2.5.3. Summary of reliability assessed by intraclass correlation 
coefficient. 
The majority of HRV repeatability studies report ICC values of R>O. 79 which is 
generally considered as excellent. On the basis of this it can be stated that 
reliability of time domain measures are excellent from both ambulatory and 
short-term ECG recordings. With the exception of the findings of Toyry et al. 
(1996) the reliability of frequency domain measures is also excellent. There 
appears to be only a minor reduction in reliability due to test-retest duration. 
Different disease states known to affect HRV show similar ICes. Additionally, 
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when reviewing the ICCs for each frequency domain measure there is no single 
frequency that repeatedly displays poorer reliability than the others. 
2.6. Reliability of HRV using coefficient of variation (CV), reliability 
coefficient (RC) and limits of agreement (LoG). 
2.6.1. Methods. 
Although the ICC has successfully demonstrated the reliability of repeated 
measures of HRV, a criticism of this method is that it does not give a clinically 
or scientifically meaningful figure by which we can judge reliability. Three 
methods have been used in the study of HRV reliability that give quantitative 
measures of how much variability there is between repeated scores. All three 
methods are based around analysis of the standard deviation (SD) of paired 
differences but express their coefficients differently. The most commonly used 
method is the coefficient of variation or coefficient of variability (CV). This 
expresses the SD of paired differences as a percentage of the population mean. 
The repeatability coefficient (RC) (often reported as the coefficient of 
repeatability) is similar but reports reliability in raw units and as 2 SDs of the 
differences. It further assumes that 95% of the differences observed should fall 
between the boundaries of the coefficient. Lastly, the limits of agreement (LoG) 
(Bland and Altman 1986) are calculated by the same method but is usually 
presented with the mean of differences (to demonstrate any systematic bias) and 
the ±2 SD limits in a graphical form to allow visual inspection of the data. Visual 
inspection allows the reader to see systematic bias and to check the 
homoscedascity of the data. For a full discussion see Bland and Altman (1986). 
These methods each have particular advantages and disadvantages over each 
other. A full account of these arguments is beyond the scope of this paper and the 
reader is directed to two excellent review articles on this subject (Bland and 
Altman 1986; Atkinson and Nevi111998). 
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2.6.2. Ambulatory recordings. 
Brief descriptions of studies investigating the reliability of HRV measures can be 
found in table 2-3. Huikuri et al. (1990) assessed only one time domain measure 
of HRV (SDNN) for each of 22 normal subj ects. They found intrasubj ect CV s to 
range from 1 - 23% from three recordings over seven days. The interindividual 
CV was found to be high (24%). Zeigler et al. (1999) showed CVs for normal 
subjects to range from 4.2 - 14.8% for time domain analysis and 1.8 - 11.8% for 
frequency domain measures. These CV s were found to be much larger in 
diabetic patients, in whom reproducibility of time and frequency domain 
measures varied from 6.4 - 63.9% and 7.5 - 31.0% respectively. This finding is 
perhaps unsurprising for two reasons. First, diabetics typically display lower 
overall levels of HRV and second, these patients may frequently suffer a higher 
number of arrhythmic beats in the presence of diabetic autonomic neuropathy 
(Zeigler et al. 1999). 
Kochiadakis et al. (1997) investigated healthy volunteers along with a group of 
patients with unexplained syncope. The time domain measures showed small 
CVs in normal subjects (1.96 - 4.74%) except for the standard deviation of the 
average NN intervals calculated over 5-min (SDANN) which had a CV of 
36.85%. Values for reliability for the syncopal patients are not provided in an 
appropriate form. They are unfortunately only given as regression coefficients of 
day 1 and day 2 (slope and intercept values). 
Using ambulatory methods in a healthy cohort of 30 children Batten et al. (2000) 
showed a very low CV (0.08 - 0.76%) for time domain measures. Although 
frequency domain measures showed more variation (0.04 - 2.03%), overall their 
reliability was shown to be excellent. 
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Table 2-3 Studies into the reliability of HRV measures using Ambulatory ECG data collection. 
Author and Date. Subjects. Data Collection and HRV Statistical Values Obtained Parameters. Considered a Reliable ~arameters measured. Analrsis Measure br Authors? 
All time domain measures showed Time domain and Two 24-hour ambulatory 
<1%CV. frequency domain 
Batten et al. (2000) Thirty-nine 14 year ECG recordings made. Coefficient of All frequency domain measures> 3 % methods are reliable for 
old children. Time between recordings not Variation. from 24 hour recording and> 4% from both time and frequency gIVen. 
mean of 5-min recording. domain but 24-hour 
recordings more so. 
Geometric measures highly reliable Yes, 24-hour monitoring (CV 1.9 - 2.5%). is reliable. More so in 
Seventeen healthy Two 24-hour Holter Coefficient of Time domain measures for 24-hour healthy subjects then Ziegler et al. 
volunteers and 9 recordings made at a mean Variation. data on healthy subjects ranged from diabetics. (1999) diabetic patients. of 29 weeks apart. CV of 4.2 - 14.8% Time domain Results are more reliable 
measures from 1.8% - 11.9% 
CV for diabetic patients significantly than reflex tests (Zeigler 
greater. Day/night comparisons also 1992). 
given. 
Nineteen patients Yes, in normal subjects a 
with >2 unexplained Two consecutive 24-hour Linear Time domain analysis only. RMMSD high degree of 
Kochiadakis et al. episodes of syncope ambulatory ECGS. A regression and and pNN50 most reliable, CV 2.6% reproducibility shown. 
(1997) in the last 6 months. passive head up tilt test was Coefficient of AND 1.96%. SDANN was worst with Much worse in subjects A control group of used to divide subjects into CV 36.8%. Reproducibility worse in with poor reliability of 
15 healthy subgroups. Variation. syncopal subj ects. HRV measures during 
volunteers. tilt testing. 
25 
Nolan et al. (1996) 
Pitzalis et al. 
(1996) 
Pardo et al. (1996) 
Stein et al. (1995) 
Kautzner et al. 
(1995) 
Twenty three 
normal volunteers, 
67 patients with 
myocardial 
ischaemia, 87 
diabetic patients. 
Twenty young, 
normal volunteers. 
Thirty patients with 
stable coronary 
artery disease. 
Seventeen patients 
with stable chronic 
heart failure. 
Thirty-three 
survivors of 
myocardial 
infarction. 
Two 24-hour ambulatory 
ECGs carried out 2 weeks 
apart. 
Three, 24-hour ambulatory 
ECG recordings made at 
baseline, 25 and 210 days. 
Two consecutive 24-hour 
ambulatory ECG recordings. 
Two 24-hour ambulatory 
ECG recordings carried out 
2 weeks apart. 
A single 48-hour ambulatory 
ECG recording. 
Repeatability 
Coefficient. 
Intraclass 
Correlation 
Coefficient. 
Intraclass 
Correlation 
Coefficient. 
Intraclass 
Correlation 
Coefficient. 
Intraclass 
Correlation 
Coefficient. 
Comparison of 
the absolute 
values of 
relative errors. 
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For pNN50 counts: Normal patients, R 
= 0.97, RC = 0.21 
Myocardial ischemia patients: R = 
0.94, RC = 0.41 (log units) 
Diabetic patients. R = 0.41 - 0.91, RC 
= 0.61 - 0.98 (log units) 
Time domain analysis only: R values 
ranged from 0.57 SDNN - 0.79 
rMSSD. 
Time domain measures ranged from R 
= 0.992 for pNN50 to R = 0.99 for 
SDANN. 
Frequency domain measures were 0.99 
for HF and LF. 
Time domain analysis ranged from 
SDNN, R=0.9l-pNN50 (%) R=O.27. 
Frequency domain analysis results 
were all R>0.86. 
Time domain analysis. Day to day 
errors ranged from 10 - 20% in all 
measures except pNN50 which showed 
error of 45%. 
Yes, good (R >0.8) for 
all groups and small RC 
mean small 
improvements may be of 
biological significance. 
Not stated. 
Yes, the degree of 
reliability is excellent 
over the short time 
period measured. 
Yes, for time domain, 
certain variables are 
reliable. All frequency 
domain variables are. 
Yes, most measures 
were reliable on a day-
to-day basis except 
pNN50. 
Zuanetti et al. 
(1991) 
Kleiger et al. 
(1991) 
Huikuri et al. 
(1990) 
Forty-nine patients 
with frequent 
ventricular 
arrhythmia. 
Fourteen normal 
volunteers. 
Twenty two normal 
volunteers. 
Two 24-hour ambulatory 
ECG recordings carried out a 
median of 192 days apart. 
Two 24-hour ambulatory 
ECG recordings carried 3 -
65 days apart. 
Three 24-hour ambulatory 
ECG recordings on two 
consecutive days and after 1 
week. 
Correlation. 
Coefficient of 
Repeatability 
Intraclass 
Correlation 
Coefficient. 
Standard Error 
Measurement. 
Coefficient of 
Variation 
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pNN50 was only measure used. There 
was a correlation of r = 0.83 between 
recordings. CR in log units was 0.03 
+/- 0.66. 
All standard time domain parameters 
had high correlation coefficients (R = 
0.70 - 0.90). All frequency domain 
parameters showed higher values (R = 
0.90 -0.94) 
Only 24-hour average HRV variability 
measured, CV 6% between days. 
Yes, the 0.03 value 
indicates little bias 
between the two 
readings and the CR 
value shows good 
reproducibility. 
Yes the high R - values 
show excellent 
reproducibility 
regardless of the length 
between test and retest. 
Yes, the mean 24-hour 
heart rate variability was 
reliable within subjects. 
2.6.3. Resting/Stable ECG monitoring. 
Freed et al. (1994) investigated the immediate reliability of frequency domain 
HRV measures in anaesthetised patients undergoing surgery. By comparing 
sequential 10-min periods of ECG data they reported CV s for total spectral 
power (TP), HF and LF of 9, 11 and 15% during a baseline measure before 
surgery. Further CVs of 6,9 and 12% were reported for these variables ten hours 
after surgery. This suggests that frequency domain measures of HRV can be 
reproducible when they are derived from adjacent 10-min sampling periods. The 
clinical usefulness of these data is not great due to the short test-retest period. It 
does, however, serve to demonstrate the possible application of stable, short-term 
HRV measures in the frequency domain during tests such as orthostatic 
manoeuvre or head-up tilt. 
Ponikowski et al. (1996) investigated the optimal length of recording for the 
evaluation of both time and frequency domain HRV measures drawing attention 
to the VLF component and its possible time dependency. Using a group of 
chronic heart failure patients, resting ECGs were recorded over periods of 5, 10, 
20 and 40-min. The reliability of measurements made within the sampling period 
was analysed using both the CV and RC. Bland-Altman plots were also used to 
illustrate the time domain analyses. The results of this study are lengthy and the 
reader is directed to the original paper for a full review (Ponikowski et at. 1996). 
In brief, time domain analyses were found to show poor reliability. Reliability of 
the standard deviation of normal-to-normal intervals) SDNN (reported as SDRR) 
was relatively independent of sampling duration, CVs were 26.2, 30.2 25.3, 
25.4% for 40, 20, 10 and 5-min recordings respectively. Both the percentage of 
sequential normal-to-normal intervals differing by 50% (pNN50%) and the 
logarithmic transformation of this variable showed very poor reliability, with 
CVs ranging from 70.2 - 139% over the same time periods. Frequency domain 
analysis, when expressed in raw units was very poor for all sampling durations. 
Coefficients of variation were very high for all measures; for TP they were 
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Table 2-4 Studies into the reliability ofHRV measures using short-term ECG collection methodology. 
Author and Date. Subjects. Data Collection and HRV Statistical Analysis Values Obtained Parameters. Considered a Reliable 
(!arameters measured. Measure bl: Authors? 
Twenty-one healthy Two 10- min ECG recordings made Only data for LF analysed. No, CV accounted for 14 
(Lord et al. 200 I) volunteers and twenty with subjects laid supine and paced Coefficient of CV was 45% for controls and 15% of the total 
one cardiac transplant breathing made one week apart. Variation CV was 76% for transplant patients population variation in 
patients. each case. 
HF = 23.6 and 40.8 ms2.Hz during paced 
Two 4-hour, Holter ECGs made respiration and supine to seated. (Jauregui-Renaud et al. Twenty healthy during paced breathing, sitting, Repeatability LF/HF ratio 5.1 and 1.63 ms
2
.Hz 
2001) 
volunteers. standing, and cold pressor test Coefficient. during seated to standing and supine Yes for both measures. 
Measures made 2 weeks apart. to seated respectively. 
All values given for pulse interval 
Two 15 min ECG recordings during variability. For spontaneous breathing, 
(Parati et al. 200 I) Eight hypertensive 15 min of supine rest with both Coefficient of VLF LF and HF CVs were 6,5 and Yes for all measures. females. spontaneous and paced taken 1 Variation 12%. For paced breathing CVs were all 
month apart. 6%. 
Time domain analysis: RMSSD, CV Reproducibility 
Four measures taken during 2, 15 RMSSD and CVS all showed CV 21 % - unsatisfactory during cold Fifteen hypertensive 57.9% in controls. Much worse in pressor and orthostatic 
patients with sleep min recording: spontaneous and Coefficient of patients. manoeuvre tests. (Salo et al. 1999) 
apnoea and 9 age- normal breathing, orthostatic Variation Frequency domain measures were In other conditions said to 
matched controls. manoeuvre and cold pressor test. mostly> 30% but more dependent on be acceptable but only Measures taken 44 weeks apart. the conditions, also better in controls <30%. 
than patients. 
Time domain measures between day 
Eight physically active, Two sets of 5 and 2.5-min ECG variation from R=0.67 to 0.9 Yes nearly all correlation (Marks and Lightfoot Intraclass Frequency domain measures between 
1999) college age females, all recordings made with subjects laid Correlation day variation from R=0.67 to 0.96. coefficients classified as 
non-smokers. supine with paced breathing (10-12 Coefficient Different results for 2.5 vs. 5-min 'Good' or 'Almost BPM) made within I week. 
recordings R>0.67 except LF (R = 0.53) perfect' . 
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Figures given are for nonnal breathing. 
Time domain analysis: SDNN=6% 
(Sinnreich et al. 1998) Two recordings of 6-min of supine Seventy healthy RMSSD=8%. 
Kibbutzim rest both with and without controlled Coefficient of Frequency domain analysis. VLF= 9%, 
Yes, said to indicate 
breathing made 6-7 months apart. Variation. LF= 11.5% HF =12% TP= 7%. Similar considerable temporal 
results for controlled breathing. stability. 
Two recordings of30-min rest Limits of 
LF reported only. RC of201 Yes, the short tenn change 
(Cloarec-Blanchard et Fourteen healthy followed by nitroglycerin infusion or 
b.min-I.Hz 1/2 for nitro glycerine infusion in LF and LF/HF ratio 
al.1997) volunteers. 20 second tilt from supine to 60 
Agreement. and 295 b.min-1/Hz 1/2 for head up tilt. during sympathetic 
degrees head up with 10 min ECG Repeatability LF/HF ratio, RC 120 b.min-I.Hz Yo. activation is repeatable in 
made I week apart. Coefficient. Limits were much narrower when healthy adult males. 
expressed in nu. 
Twenty young, nonnal 
Three, 10-min ECG recordings Intraclass 
Time domain analysis: R values ranged 
(Pitzalis et al. 1996) during: rest, controlled breathing and 
from 0.27- 0.56. In frequency domain Reproducibility was 
volunteers. passive 70 degree head up tilt. made Correlation analysis R = 0.29 - 0.77 at baseline, described as either low or 
at baseline, 25 and 2 I 0 days. Coefficient. 0.36 - 0.65 during controlled breathing fair. 
and tilt test. LF/HF was always lowest. 
Time domain analysis. Using VC, 
SDRR values ranged from 25.3 - 30.2% 
PNN50 values CVs were 100%. 
(Ponikowski et al. Sixteen patients with Two 60-min recordings taken from 
Reliability Duration did not affect reproducibility. Both time domain and 
1996) chronic heart failure. which, 5, 10,20, and 40 min samples 
Coefficient. Frequency domain CV values ranged frequency domain 
extracted a mean of 25 days apart. Coefficient of from 45- 111%. 
measures show poor 
Variability. Log transfonned CV values ranged from reproducibility in patients 
8-64.1% with chronic heart failure. 
Square root transfonned VC values 
ranged from 24.1 93.5%. 
Four series of 5-min stages from rest Intraclass SD was the only time domain parameter 
No, this study extends 
(Piepo1i et al. 1996) Ten patients with to 80% HRmax from dobutamine 
Correlation measured, VC 16%. previous findings that 
chronic heart failure infusion and four stages from rest to Coefficient. In the frequency domain LF varied from 
HRV variables obtained 
75 W of cycle ergometry. Coefficient of CV 6.8% - 13.7%. 
from short -tenn static 
Variation. HF varied from CV 14.1 % - 25% sampling periods are 
unreliable. 
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Two incremental tilts from 0-80 Coefficient of Slopes of regression lines for LF% and No, large intersubject and (Bootsma et al. 1996) Nineteen healthy men. degrees with 5-min ECGs taken Variation tilt analysed. CV was 22% for all intrasubject variation in 
every 5 degrees 1-8 months apart. subjects. slope oflines. 
Five tests repeated on five successive Intraclass There was no general trend days; controlled breathing, deep Correlation Time domain analysis. RMMSD CV toward increase or 
(Toyry el al. 1995) Four healthy men. breathing Valasalva manoeuvre, Coefficient and was 18%, R = 0.24 decrease and therefore no baroreflex sensitivity test and Coefficient of The frequency domain parameters CVs learning effect. The day-
orthostatic test. One min of ECG data Variation. were 28 - 52%, R = -0.03 - 0.24. to-day reproducibility was 
analysed poor. 
Pre-operative CVs for frequency domain 
Fifteen patients analysis; TP 9%, HF 11 % and LF 15%. Immediate variability in 
(Freed el al. 1994) undergoing surgery via Two sets of adjacent 10-min Coefficient of Post operative CVs for frequency frequency domain HRV 
either anaesthetic or segments of ECG analysed during Variation. domain analysis: TP 6%, HF 9% and variables is low. 
epidural. pre- and post operative periods. LF 12%. 
Time domain parameters CV and 
Varying data collection times during, RMSSD showed Sdintru values of 1.26 Twenty healthy subjects 1ntrasubj ect and 1.46 at rest. They were reduced to 
(Ziegler el al. 1992) and twenty-one type I lying supine, standing, deep standard deviation 1.18 and 1.27 during deep breathing. Reproducibility of HRV 
diabetics. breathing, and Va1sa1va manoeuvre factor (SDF) Frequency domain parameters ranged parameters not discussed. 
on consecutive days. from 1.5 - 1.71 at rest. Values similar in 
diabetics. 
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45.9-57%, for VLF, 3.6-53.4%, for LF, 79.5-111.7% and for HF, 66.1 - 71.4%. The 
authors applied both square root and log transformation to the data in an attempt to 
reduce these coefficients. The latter was more successful, reducing the CVs for TP 
and VLF to <10% and HF to 19.9 - 22.3%. The CV for LF power remained at an 
unacceptably high level (32 - 64%). Following log transformation, it was clearly 
shown that the reliability of LF is positively related to the duration of the sampling 
period. The authors conclude that the reliability of HRV measures, especially 
pNN50 and LF is very poor in chronic heat1 failure patients. 
Reliability of resting HRV in a large group (n=70) of healthy subjects was also 
investigated by Sinnreich et al. (1998). These investigators reported CVs for 
frequency domain measures from 5-min recordings taken in the field of 6.1 - 12.0% 
and 6.0 -10.7% for free and metronomic breathing respectively. These CVs from 5-
min duration ECG recordings taken six to seven months apart are significantly lower 
than those reported by Ponikowski et al. (1996) for 5, 10, 20 or 40 min recordings 
for frequency domain measures. 
A further study investigated the reliability of the LF component of resting HRV in 
healthy patients cardiac transplant recipients (Lord et at. 2001). These researchers 
found poor agreement between measurements made a week apart. CV s were large 
for normal subjects (45%) and transplant recipients (76%). It was concluded that the 
LF component of HRV was not reproducible, especially in cardiac transplant 
recipients. It should be noted, however, that very little RR interval variability is 
present in the denervated heart of a transplant recipient. Such low values are prone 
to large test retest CVs dur to only very small test-retest differences. 
2.6.4. Test/manoeuvre ECG recording. 
Cloarec-Blanchard et al. (1997) investigated the reliability of change in HRV due to 
sympathetic activation via nitroglycerin infusion and 60° head-up tilt on healthy 
subjects. The researchers used beats.min-1Hz-1I2 to report their frequency domain 
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units as opposed to the recommended msec2 . Using Bland-Altman plots and RC it 
was found that from test 1 to test 2 there was no systematic bias and showed limits 
of agreement of ±201 and 0.039 beats.min-1Hz-1/2 for raw and normalised units 
respectively during nitroglycerin infusion. The limits for 60° head-up tilt were 
slightly larger at ±347 and 0.072 beats.min-1Hz-1/2 for raw and normalised units 
respectively. These limits were deemed to provide sufficient precision for the 
method to be used over the test-retest period (one week). An important point 
addressed was the length of the recording. The shOlt (5 min) recording periods used 
in this study were defended on the grounds of their increased likelihood of being 
stable measurements and in being useful for assessing HRV and changes in HRV 
during a series of short tests. The authors also constructed sample size tables. These 
tables clearly show the use of normalised units to be preferential in terms of 
reducing sample size in a study using such a measure. Further discussion of these 
tables may be found later in this paper when the necessary level of reliability is 
addressed. The use of 5-min recordings is also deemed to be preferable when 
examining the changes in HRV during a given period such as the cold pressor or 
orthostatic tolerance test 
Toyry et al. (1995) used a battery of tests (deep breathing, Valsalva manoeuvre, 
phenylephrine infusion and an orthostatic test) to investigate baroreflex function in 
healthy subjects. From all the tests the mean CV reported for the route means square 
differences of normal to normal intervals (RMSSD) was 18%. For frequency domain 
measures CVs were poor, ranging from 28 - 39%). The results of this study should 
be observed with caution due to the shOlt and varied duration of testing (40 s to 5 
min) and in the very small subjects numbers (n = 4). 
Salo et al. (1999) also compared reliability in healthy subjects and patients with 
hypeltensive sleep apnoea during a battery of tests including, spontaneous breathing, 
deep breathing, Olthostatic manoeuvre and cold pressor test. Reliability of RMSSD 
was measured by CV and found to be relatively poor throughout the conditions in 
both nOlmal subjects (19.0 - 48.0%) and in hypeltensive sleep apnoea patients (30.4 
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-57.9%). In normal subjects, the repeatability of LF varied greatly but was mostly 
very poor with values from 3.0 - 46.6%. For HF similar values (3.0 - 87.5%) were 
found as was true for TP. Reliability of the LF:HF ratio was even worse with almost 
all values greater than 34.0%. Overall, reliability was significantly worse for all 
frequency domain measures in the patients with hypertensive sleep apnoea (3.3 -
197.8%). It was concluded that time domain analysis was more reproducible than 
frequency domain methods (Salo et al. 1999). It was clearly stated that some of the 
very high CV s found were not acceptable but it was also stated that some 
coefficients, namely those <30% were acceptable. The basis of such a cut off point is 
not explained. The consequence of creating such a point will be discussed later when 
the necessary level of reliability is addressed. 
Bootsma et al. (1996) examined the reliability of %LF during repeated head up tilt 
in healthy subjects. They specifically examined the reliability of the slope of the 
regression line between increased tilt and increase in %LF. Using the CV it was 
found that the slopes of these lines varied by 22% between test and retest. 
Only one study has made comparisons between reliability of HRV measures in 
healthy subjects and patients (diabetics) during test manoeuvres (Ziegler et al. 
1992). Using the Standard Deviation Factor (SDF), it was found that diabetic and 
healthy subjects showed similar levels of reliability for the time domain measure of 
RMSSD and the CV or RR intervals (1.2 - 1.3%). Frequency domain variables 
showed poorer reliability in both controls (1.5 - 1.7%) and in diabetics (1.4 - 1.7%). 
This is the only study in the published literature found to use this method of analysis 
and the authors justification, although sound, is beyond the scope of this paper. For 
comparison with other studies the SDF can be expressed as variation in percent by 
the following fOllliula: (SDF-1) * 100 %. It can be seen that the variation shown 
between tests in this study is high for both time (18 - 34%) and frequency (37 -
71 %) domain measures ofHRV. 
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Jauregui-Renaud et al. (2001) used shott-term ECG analysis to study healthy 
subjects undergoing a variety of tests. They reported the reliability coefficient (RC) 
but called it the 95% coefficient of reliability and unusually reported it as a 
percentage where it is normally expressed in raw units. This percentage can be 
considered as approximately twice the CV. In all frequency domain variables 
reported, 95% or more of cases fell within the RC. These limits were however found 
to be rather large. For HF power expressed as normalised units (HFnu) they were 
40.8, 23.6, 28.6 and 37.9% respectively during the following conditions: paced 
breathing, supine to seated, seated to standing and cold pressor test. For the same 
battery of tests the RC values for LF:HF ratio were much smaller at 3.6, 1.6,5.1 and 
2.8% respectively. 
2.7. Discussion of Findings. 
2.7.1. Introduction. 
Prior to any discussion of the findings of the above studies it is necessary to indicate 
the complexity of analysing such a data set. The Task Force of the European Society 
of Cardiology and the North American Society of Pacing and Electrophysiology 
Report (Taskforce 1996) lists 18 possible measures of HRV which can be measured 
using either 24-hour ambulatory or short-term stable conditions. Add to this the 
large number of possible study populations such as healthy individuals, diabetics, 
CHF patients and the number of possible outcomes is large. Vary the duration over 
which reliability is assessed from sequential readings through to a year as is shown 
in the literature reviewed here and the number of possible options runs into the 
hundreds. Within the short-term recordings there are a number of 'tests' which have 
been employed such as cold pressor test, orthostatic maneuvers and the number of 
possible reliability coefficients runs into the thousands. This is of course ignoring 
the different statistical techniques employed to demonstrate reliability. 
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Instead of systematically reviewing the effect of each of these variables while 
attempting to hold the remainder constant, the following discussion will focus on 
trends displayed in the data. This will be done by posing a number of pertinent 
questions and attempting to answer them using evidence from the literature. Results 
from the literature concerning these trends may not always be completely 
homogenous. Where this occurs attempts to explain differences in findings will be 
made. 
2.7.2. AmbulatOlY VS. short-term tests which are more reliable? 
The results of studies using ICC suggest that 24-hour Holter tape monitoring of 
ambulatory ECG data to be a more reproducible method of HRV analysis than short-
term recording of stable ECGs. It should be noted, however, that both methods have 
demonstrated excellent levels of reliability for HRV using the ICC. When other 
statistical methods are employed to assess reliability the results have not always 
been in agreement. Overall there is much more variation in reliability coefficients 
when they are reported using statistical methods other than ICC. In general it can be 
seen that CVs are larger for both time and frequency domain measures when short-
telm ECG data are analysed (Ponikowski et al. 1996; Lord et al. 2001) although 
some values reported still show good reliability (Freed et al. 1994; Sinnreich et al. 
1998). Both ambulatory and resting methods have large reported ranges of reliability 
values. Reliability values for ambulatory recordings have been reported as poor 
(Kochiadakis et al. 1997; Batten et al. 2000) and there is significant overlap between 
the coefficients for ambulatory and resting methods (Huikuri et al. 1990; Ziegler et 
al. 1992). From this evidence it is not possible to state categorically whether one 
method of data collection yields consistently more reliable results compared with the 
other. 
For clinicians and researchers alike it is encouraging that short-term and ambulatory 
tests have been shown to possess similar reliability coefficients. This may increase 
the use of HRV as a regular screening tool for cardiac patients, especially post-MI 
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patients and it may be employed as a fast, non-invasive method to increase the 
accuracy of risk assessment in these populations. Although ambulatory HRV data 
have shown to be independently predictive of cardiac events in a healthy elderly 
cohort (Tsuji et al. 1994; Tsuji et al. 1996), patients with stable, chronic angina (van 
Boven et al. 1998; Weber et al. 1999; Forslund et al. 2002) and in post-MI patients 
(Kleiger et at. 1991; Bigger et al. 1993; Forslund et al. 2002). Such a relationship 
has only recently been demonstrated using short-telm recordings (Sosnowski et al. 
2002). It should be noted that the 5-min recording in this study was actually 
extracted from a 24-hour Holter recording after being identified as the first stable 5-
min period free of ectopic beats. Further studies that have demonstrated short-term 
methods to be reliable (Sinnreich et at. 1998) may allow quantification of the 
predictive power of these easily undertaken methods. 
From a practical stand-point this means that results from the different methods 
cannot yet be used interchangeably. The two methods measure different aspects of 
HR V. Certain measurements in the time domain should not be generated from short 
telm recordings (Taskforce 1996). Certain frequency domain measures cannot be 
calculated accurately from short (5 min) sampling periods. Oscillations in HR in the 
Very Low Frequency band (VLF) have been proposed as a marker of sympathetic 
activity (Saul et al. 1988). Even slower changes in the Ultra Low Frequency band 
(ULF) are also known to exist (Kobayashi and Musha 1982) which as yet required 
clarification as to their physiological significance. According to the 
recommendations of the Taskforce (1996), neither of these measures can be 
calculated accurately from short (5 min) ECG recording periods. 
The two types of data collection methods have different sources of error that 
contribute to their overall reliability. The main source of variation from 24-hour 
recordings is the activity of the subject during monitoring, including physical 
activity, psychological stress and other factors known to affect HR. In short-term 
recordings the subject is also the biggest source of variation. What is of primary 
impOliance is whether the reading is a tlUly stable ECG and changes in data 
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collected are more likely to be from antecedent variables as opposed to changes 
during the test period itself. It is then surprising how broadly similar the various 
measures of reliability are for both of these methods. 
One pattern that emerges is that short-term assessment of HRV, when combined 
with a battery of tests, seems to yield less reproducible results than stable short-term 
tests and ambulatory data. In addition to this, more complex tests seem to yield 
consecutively less reproducible results compared with more simple ones. The 
Taskforce. (1996) recommend 24-hour ambulatory data collection and/or 2-5 min 
stable collection techniques. It may be that HRV measures in the frequency domain 
(which are those which can be accurately assessed in short sampling periods) may 
not be suited to measuring HR response during manoeuvres. More traditional 
responses to these bedside tests such as HR and blood pressure have been shown to 
be more reliable when assessed concurrently with HRV (Toyry et al. 1995). 
2.7.3. Time domain vs. fi'equency domain analysis - which is more reliable? 
Ambulatory studies using the ICC which report values for both time and frequency 
domain measures of HRV are scarce. From those that have been carried out, there is 
no definitive answer to the above question. Frequency domain measures from 24-
hour recordings have been shown to be more reliable than time domain (Kleiger et 
al. 1991) or at least equal to them (Stein et al. 1995; Nolan et al. 1996; Pardo et al. 
1996). Using the CV to measure reliability, Zeigler et al. (1999) showed time and 
frequency domain measures to be equally reliable whereas Batten et ai. (1999) 
demonstrated frequency domain measures to have lower overall reliability than 
frequency domain measures. It should be noted that all CVs in this study were found 
to be excellent and the poorest value still only demonstrated 2% variation. Where 
both time and frequency domain measures have been calculated from short-term 
stable ECG recordings, the results also indicate similar levels of reliability. However 
the level of reliability between studies is not consistent and both excellent (Marks 
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and Lightfoot 1999) and very poor (Pitzalis et al. 1996) levels of reliability have 
been reported. 
What these studies demonstrate is that when ambulatory recordings are used there 
seems to be no difference in the reliability between the time or frequency domain 
analyses of ECG data. Although findings are somewhat inconsistent, overall no large 
discrepancies seem to occur. Knowledge of this fact and the high degree of 
intercorrelation between certain time and frequency domain measures (Bigger et al. 
1992) may be helpful in enabling researchers to choose which variables they 
investigate and report. By reducing the often large number of colinear variables 
reported in investigations into HRV, the statistical analysis and the description of 
findings may be simplified. 
One clear pattern that emerges in the literature is the reduced reliability of studies 
that use manoeuvres or bedside tests. The amount of variation between tests is 
almost uniformly >10% and commonly around 30% (Toyry et al. 1995; Cloarec-
Blanchard et al. 1997; Salo et al. 1999). Although good reliability of certain 
variables has been shown (Jauregui-Renaud et al. 2001) this seems to be the 
exception rather than the rule. 
2.7.4. The effect of disease state of study population on reliability. 
The 1996 Task Force recommended that HRV should only be used in two clinical 
situations: as a predictor of risk after acute MI and as an early warning sign of 
diabetic neuropathy. Despite this, levels of HRV have been assessed in numerous 
populations and coefficients for the reliability of HRV in these populations are 
available. 
Using the ICC, excellent reliability has been shown in healthy patients (Kleiger et al. 
1991) and in cardiac patients (Pardo et at. 1996). Nolan et al. (1996) also found 
similar ICC values for healthy volunteers, ischaemic heat1 disease patients and 
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diabetics. However, Nolan et al. (1996) also used the RC to show reliability. 
Looking at these statistics there is a clear increase in the size of the RC from healthy 
subjects (0.21 log units) to ischaemic heart disease patients (0.41 log units) to 
diabetics (0.61-0.87 log units). It should be noted however that for each group the 
time from test to retest was progressively longer. 
Using a battery of tests, Salo et al. (1996) found greatly decreased reliability in 
patients with hypertensive sleep apnoea compared with healthy controls. Poor 
reliability of HRV was shown by Ponikowski et al. (1996) in chronic heart failure 
patients, whereas Sinnreich et al. (1998) showed very good reliability of short-term 
measures when healthy subjects were studied. Zeigler et al. (1999) found CVs 
approximately three times larger when assessing reliability of HRV in diabetic 
patients in comparison with healthy controls. Lord et al. (2001) showed a very high 
CV for normal subjects (45%), which was significantly increased in heart transplant 
recipients (76%). 
It seems that healthy subjects produce more reliable HRV results compared to a 
number of populations studied. This would seem to suggest that caution is needed 
when a test is used in a population with a specific condition unless the method itself 
had been shown to be reliable in that population. Generalisation from studies which 
have shown a test to be reliable in a normal population may be inappropriate for a 
group in a specific disease state. This is especially true when reliability coefficients 
are being used to calculate sample sizes for investigations. A power calculation 
based on the reliability coefficient gained from a normal healthy population may 
lead to the underestimation of necessary sample size and reduced statistical power in 
the study of an altemative population. 
2.7.5. The effect of time from test to retest on reliability. 
The evidence discussed here suggests reliability is independent of the time from test 
to retest. Although some of the most reliable measurements have been generated 
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from sequential ECG data (Pardo et al. 1996) but when the interval between 
recordings is 24-hours or more, there seems to be little effect of retest duration on 
reliability. Comparison of like with like in telIDS of duration is very difficult. This is 
partially due to the large spread of test-retest durations and the large number of other 
variables. Overall, although some short test-retest periods demonstrate very good 
reliability (Kochiadakis et al. 1997) others do not (Kautzner et al. 1995). Values for 
reliability have also been shown to be very similar from one test to another 
regardless of whether the test was over a long duration (Sinnreich et al. 1998) or 
over two sequential readings (Freed et al. 1994). In one study (Nolan et al. 1996) 
four groups of diabetic patients were retested at varying periods. The RC (log units) 
values showed an effect of time on reliability as the coefficients increase with time 
with values of 0.61 (29 days), 0.68 (63 days) 0.98 (92 days), and 0.87 (115 days). 
These observations indicate that the test-retest duration and reliability relationship is 
not linear. 
2.7.6. Do certain measures demonstrate lower reliability than others? 
In the analysis of time domain measures there are no clear patterns. The variables 
listed in each analysis are numerous and varied. It would seem that due to their 
interdependence on each other, poor reliability on one variable is often accompanied 
by poor reliability on another. Kautner et al. (1995) and Stein et al. (1995) reported 
anomalous values for pNN50 and PNN50% respectively when compared to other 
measures ofHRV. Kautzner et al. (1995) recognised that pNN50 may be an inferior 
measure in the population tested (acute MI survivors). Similarly, the greatly reduced 
ICC value in the study of Stein et al. (1995) was attributed to the low levels of 
pNN50% in the population studied (congestive heart failure patients). These finding 
may be of importance when choosing time domain analyses for such a population. 
The literature is equivocal as to whether one frequency domain measure is more or 
less reliable than its counterparts. Several studies demonstrate LF power to possess 
poorer reliability than other spectral components (Freed et al. 1994; Piepoli et al. 
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1996; Sinnreich et al. 1998) whereas other studies show the least reproducible 
variable is HF power (Marks and Lightfoot 1999; Jauregui-Renaud et al. 2001). 
2.7.7. The appropriate levels of reported accuracy. 
Within the literature the criteria for categorisation of the various statistics used to 
demonstrate reliability of methods are varied. For instance using the ICC, some 
researchers Pitzalis et al. (1996) cite the categories put forward by Landis and Koch 
(1977). Others (Nolan et al. 1996) cite alternative categories (Bartko 1966). When 
the CV has been used, the description of an acceptable amount of error has varied 
from 5% (Lord et al. 2001) based on recommendations found in the Task Force 
Report (1996) to a seemingly arbitrary 30% put forward without justification (Salo 
et al. 1999). Atkinson and Neville (1998) advise caution when such seemingly 
arbitrary analytical goals such as the commonly adopted target for a CV less than 
10% are adopted. 
Instead of applying such rigid assessment criteria, researchers should make 
qualitative decisions as to whether the accuracy of their measurement is suitable for 
the proposed use. To this end the RC and LoG are excellent methods by which to 
assess reliability. The latter displays the upper and lower-most limits of a 
biologically significant change in the variable of interest Cloarec-Blanchard et al. 
(1997) calculated the RC and LoG of LF and LF:HF ratio during head up tilt and 
nitroglycerin infusion. During the more commonly used test of sympathetic 
stimulation of head up tilt they found an RC of 201 beats·min-I/Hz-1I2• Using the 
variances estimated in the study, they calculated the necessary sample size to ensure 
sufficient statistical power in future studies. They did not however base the 
differences expected on any empirical data and instead simply gave a range of 
sample sizes for detecting expected changes from 25 beats.min- I /Hz- 1I2 to 250 
beats' min-11Hz -112. 
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Although this is of some use for future research, the application of such criteria is 
limited by the data from which they are derived. Again, using Cloarec-Blanchard et 
al. (1997) as an example, their findings are limited methodologically to research 
projects concerning changes in the LF and LF:HF components ofHRV during head-
up tilt. The applications of these findings are also limited by the population on which 
the original study was carried out, in this case, healthy adult males. No expected 
values due to tilt are cited by the authors thereby limiting the usefulness of the 
sample size calculations given. Without being over-critical of the work of Cloarec-
Blanchard et al. (1997) it is obvious that if one were to study a group in which the 
usefulness of the head-up tilt technique has been demonstrated such as syncopal 
patients (Fitzpatrick et al. 1991; Rubin et al. 1993), the sample sizes cannot be 
accurately estimated from the tables provided. This is because the necessary sample 
size is derived in part from the effect size (d). When assessing the impact of 
measurement reliability, it is necessary to modulate d to create the Measurement 
Error Correction (Hunter and Schmidt 1990). Where RC is reported, the MEC is 
obtained by: MEC = d.J RC. From the literature there is some, albeit limited, data 
to suggest that reliability of this manoeuvre is slightly worse in syncopal patients 
than healthy controls (Vardas et al. 1994). This would increase the value ofRC and 
eventually decrease the statistical power of any study using the measure. Ironically 
this study (Vardas et at. 1994) is one of those rej ected from the original discussion 
of reliability due to inappropriate statistical analysis. Vardas et al. (1994) used t-tests 
to detelmine reliability, a statistic which cannot be used to compute the MEC. 
2.8. Conclusions and Recommendations. 
From the studies reviewed, it is possible to make several recommendations. All 
studies into the reliability of HRV measures should use appropriate statistical 
analyses. The following should clearly be excluded: the Pearson product moment 
correlation, repeated measures t-tests and repeated measures ANOVA (unless being 
used in conjunction with another method to assess reliability). 
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Appropriate statistics may include the ICC, although caution as to which model is 
employed should be taken. Many of the studies cited in this review give no details of 
how the ICC was calculated or which of the six possible models of ICC were used. 
The coefficient of variation may also be used. This statistic should be accompanied 
by a check for systematic bias and a check for homoscedascity of the data, neither of 
which occur by the calculation of CV. 
The British Standards Institution recommends the use of the RC. This coefficient is 
best used in conjunction with the LoG which can easily be calculated from the RC. 
Again, a check for systematic bias should be carried out. The LoG then checks the 
homoscedascity of the data. 
On the basis of this review the following method for establishing suitable levels of 
reliability has is recommended and has been adopted for current and future research. 
1. The intended reliability of the method should be made a priori on the 
basis of previous research. 
2. This should include an estimate of sample size based on: 
a. Expected effect size based on previous empirical data or pilot data 
b. An estimate of reliability of the measurement either from the 
literature but preferably from empirical investigation. 
3. Using the approach advocated by Hunter (1990) the necessary sample 
size for the desired statistical power should be calculated. 
4. If the sample size is logistically and financially viable, the research 
should go ahead as planned. 
5. If the sample size is too great two approaches are open to the researcher: 
a. a smaller sample is used and the reduced statistical power of the study 
is repo11ed. 
b. the researcher must attempt to improve the reliability of the method. 
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Using the above process (1-4), the investigator can then determine whether the 
degree of reliability displayed by the method is acceptable for their own purposes. 
Furthermore, due to the large variation in previously reported values for reliability 
on HRV measures all investigators should be encouraged to publish their own 
coefficients. 
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CHAPTER 3. AGREEMENT AND RELIABILITY OF THREE DIFFERENT 
METHODS USED TO ASSESS HEART RATE VARIABILITY. 
Abstract. 
Numerous instruments are commercially available to measure heart rate variability 
yet little is known concerning the agreement between such instruments. The 
objective of the present study was to assess agreement between measures of heart 
rate variability in three commercially available instruments. 
Thirty subjects (20 males) median age 27.5 (range 19-59 years) underwent 
simultaneous ECG recordings, under three different resting conditions: supine, 
standing and supine with controlled breathing, using three commercially available 
analysers. Intraclass correlation coefficients showed excellent agreement (lower 
95% C.I, R> 0.75) between all instruments under all conditions. ANOVA revealed 
small but significant (P < 0.05) differences in SDNN in all conditions and RR 
interval length recorded in the standing and controlled breathing conditions. This 
was due to discrepant ECG recording protocols that were unrelated to consistent 
operator timing. 
This study demonstrates that measures of HRV generated by the three instruments 
agree well. Any discrepancies were due to the recording protocols of the systems. 
This may lead to incomparable results between instruments. It is therefore 
recommended that: a) if different instruments are used in the same study or b) multi-
center study designs are planned or c) heart rate variability results are discussed with 
reference to studies using other instruments, levels of agreement need to be reported 
to ensure comparability. 
Different aspects of this chapter, in truncated fonTI, have been published in Clinical Physiology and Functional Imaging and 
Physiological Measurement, see appendix VI. 
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3.1. Introduction 
Experimental and clinical studies have shown heart rate variability (HRV) to be a 
measure of autonomic modulation (Akselrod et al. 1981; Pagani et al. 1988; 
Malliani et al. 1991; Pagani et al. 1997) and particularly cardiac vagal tone 
(Hohnloser et al. 1992; Badra et al. 2001; Goldberger et al. 2001). There is much 
interest in the use of HRV as a non-invasive measure of autonomic control. This is 
partially due to the fact that decreased HRV is an independent indicator of sudden 
cardiac death in patients following acute myocardial infarction (Kleiger et al. 1991) 
and in the general population (Tsuji et ai. 1996). 
There are two distinct methodologies that can be used in the assessment of HRV. 
The majority of studies have used 24-hour, Holter recorded, ambulatory ECG 
collection. From such recordings, time and frequency domain analyses of the whole 
data set are carried out. Such long-term recordings are not always practical or 
feasible and it has been shown that useful, predictive measures can be gained from 
shorter ECG recordings (2 - 15-min) either extracted from the longer, 24-hour 
Holter recordings (Bigger et ai. 1993; Faber et al. 1996) or from analysis of a single 
ECG recorded under stable, usually resting, conditions. 
In 1996 the European and North American Task Force report on measurement of 
HRV (Taskforce 1996) recommended that either method could be used and gave 
specific guidelines for the type of analysis that should be carried out on the data 
gained from shot1 and long-term recordings. The repol1 recommends that frequency 
domain measures may be easier to interpret in terms of physiological regulation than 
time domain measures and that they be carried out in preference to time domain 
analysis in short (2 - 7-min) recording periods. It was also recommended that a 
standard duration of 5-min be used for comparison between studies. 
Data from 24-hour ambulatory recordings have shown attenuated HRV in a variety 
of disease states such as angina (Weber et al. 1999; Forslund et al. 2002) heart 
failure (Saul et al. 1988; Scalvini et al. 1998) diabetes (Ewing et al. 1991), 
56 
following myocardial infarction (Kleiger et al. 1991; Bigger et at. 1993) and in a 
variety of other cardiovascular conditions (Huikuri et al. 1999; Yamada et al. 2000; 
Hayano et al. 2001) . Data from short-telID recordings are more limited and HRV 
has been shown to be attenuated in only a few disease states, such as hypeliension 
(Konrady et al. 2001) and following myocardial infarction (Bigger et al. 1993; Faber 
et al. 1996) 
In epidemiological studies using healthy populations, short-telID recordings have 
been more extensively utilised. In such studies, indices of HRV show variation 
according to age, sex and lifestyle (Byrne et al. 1996; Gregoire et al. 1996; Fukusaki 
et al. 2000; Kuch et al. 2001; Migliaro et al. 2001) in a manner similar to those of 
24-hour ambulatory recordings (Coumel et al. 1994; Reardon and Malik 1996; Stein 
et at. 2000) . 
From the distribution of dates in the literature it is clear that short-term HRV 
measurements are becoming more commonplace. Numerous laboratories are 
utilising new technologies to make large numbers of faster, short-term HRV 
recordings. In order to confirm global findings and ensure comparability between 
laboratories using HRV measurements it is important to quantify the agreement 
between the methods of assessment being used. There are a large number of 
commercially available instruments capable of measuring HRV (Kennedy 1995). 
Systematic bias between instruments used in different studies would make 
comparison of the results of those studies difficult. Systematic bias between 
instrumentation used in a single, multi-centre study, for example, would invalidate 
the findings unless the bias had been reported and corrected either methodologically 
or statistically. In either case, knowledge of the agreement between instruments is of 
great value. Therefore, whenever more than one instrument is used in data collection 
it is recommended that a suitable coefficient to describe agreement be repOlied by 
the researchers. 
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3.1.1. Potential sources of error in HRV analysis. 
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Figure 3-1 The components ofHRV instrumentation (Adapted from Kennedy 1995). 
Kennedy (1995) provides a schematic representation of the instrumentation involved 
in the process ofHRV analysis. Figure 3-1 has been adapted from this and illustrates 
points at which variability in data collection, analysis and reporting may appear. By 
employing such a model and substituting the specifications of more than one set of 
HRV instrumentation it is possible to identify points where variation in 
measurement and analysis may occur. 
Ideally, if one were to monitor and analyse a single ECG trace (or electronic signal) 
using various pieces of HRV instrumentation, each would produce identical results. 
If this is not the case then the cause of the variation should be investigated and 
identified. Once identified it may be possible to eradicate intra-equipment variation. 
One benefit of using a simulated ECG signal or trace with known characteristics is 
that an accurate measure of the internal validity of the equipment can be gained. The 
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known input should produce a known output and any variation from the expected 
output is due to instrumentation. One disadvantage is that the external validity of the 
instrumentation is not tested. Any error from ECG recording, storing or digitisation 
may not be assessed. More importantly the researcher gains knowledge concerning 
the instrument's ability to measure a real subject's HRV. 
A variety of methods have been used to assess agreement or concurrent validity 
between instruments. What follows is a brief review of the available literature 
concerning variation in measurement and analysis of HRV. There is a paucity of 
data related directly to this topic for two reasons: 
a) The volume ofliterature comparing any HRV methods is very limited. 
b) Where this literature exists it mainly concerns analysis of 24-hour 
ambulatory data. 
Whereas many of the issues relating to analysis of 24-hour data are shared with 
those of short-term recordings, others are clearly of less impOliance in short-term 
HRV analysis. To provide a full review, all threats to inter-equipment validity will 
be discussed. Due to the scarcity of pertinent literature, those studies mentioned will 
be described and examined in detail. 
3.1.2. Studies assessing agreement between HRV instrumentation. 
Molgaard (1991) examined the concurrent validity of the Reynolds Pathfinder 2 
system (Reynolds Medical, Hertford, UK) by examining the agreement between 
HRV measures derived from simulated ECG signals on this system and the Oxford 
Medilog 4-24 (Reynolds Medical, Hertford, UK). Very small coefficients of 
variation (CVs) were demonstrated for time domain HRV measures between the two 
systems. Where variation did occur it was said to be due to detection of 'false long 
NN pauses' (normal-to-normal beat intervals) or extended RR intervals. These were 
said to be due to movement of the recording tape. Although this study (Molgaard 
1991) is an example of the assessment of agreement between two commercially 
available methods to measure HRV the methodology elicits little insight into 
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possible sources of variation in short term measurements such as those addressed in 
the present study. 
In a second such study (Jung et ai. 1996) agreement ofHRV measures derived from 
eleven Holter tapes recorded on a single Holter recorder (Tracker, Reynolds 
Medical, Hertford, UK) analysed on four commercially available HRV analysis 
systems: 
a) Del Mar Avionics HRV Analyzer Version 1.01, Irvine, California; 
b) Ela Medical Version V1.27, Montrouge, France; 
c) Marquette Version 5.8, Milwaukee, Wisconsin; 
d) Oxford Instruments HRV Version 7.11, Abingdon, United Kingdom. 
Analysis of differences in mean recordings from the systems by ANOVA showed 
that time domain measures from the various systems were not comparable. Although 
ANOV A does not strictly assess agreement the large differences in means for each 
system suggest the level of agreement would be unacceptable between the systems. 
Post-hoc analyses of the means suggested good agreement between the Oxford 
Instruments HRV Version 7.11 and the Ela Medical Version V1.27 system on 
certain variables but not all. 
It was concluded that Holter tape analysis using different commercially available 
systems is statistically not comparable. One reason put forward for this was 
differences in the removal of ectopic beats although this could not be confirmed due 
to the insufficient provision of visual information by all the systems. There was no 
relationship between HRV variables and the number of beats sampled or number of 
beats removed. 
A critical appraisal of the study by its authors concluded that the use of a tape 
recorded on one system, being analysed by another system led to the poor measures 
of agreement. This was described as an inherent weakness of the study. The authors 
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noted the attractiveness of repeating such a study utilising a methodology involving 
the simultaneous application of four different Holter recorders, each corresponding 
to the HRV systems to be used for subsequent analysis. It was concluded that this 
was not feasible at the time of the study. 
An approximation of the above proposal was undertaken two years later (Simula et 
al. 1998). Simula et al. (1998) made simultaneous, 24-hour ECG recordings using 
analogue (Marquette 8500, Milwaukee, Wisconsin) and digital (Oxford Medilog 
FD-3, Hertford, UK) recorders. The digital signal was analysed using an Excel 
Medilog 2 system. The analogue signal was firstly analysed using the software in the 
Marquette system and again, using the Excel system. The authors stated that HRV 
analysis followed the 'careful' removal of ectopic beats but gave no details of how 
this was undertaken. Two separate comparisons were made in the study. 
a) The comparison of the digitally derived HRV parameters (spectral and 
temporal) with those derived from an analogue signal 
b) The comparison of an analogue ECG signal after processing by a digital 
recorder. 
The former pair of variables was found to show excellent agreement. The latter pair 
showed poor agreement and significant bias. This demonstrated, similarly to Jung et 
al. (1996), the problems associated with analysing analogue ECG recordings using a 
digital analyser. 
What the above studies (Jung et al. 1996; Simula et al. 1998) illustrate is that when 
Holter recorded ECG traces are fed into their original or designated analysis 
software the systems show agreement in terms of the HRV measurements produced. 
There are further possible sources of variation not addressed fully in these studies, 
namely those that do not corne from the analysis system itself. 
One such source of variation is observer annotation of the ECG signal generated 
from the Holter tape. Kroll et al. (1996) investigated the observer reliability 
regarding rhythm annotation in the analysis of ambulatory HRV and the effect of 
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interobserver differences in calculating temporal and spectral measures. Eleven 
ECGs from nine patients with varying amounts of both atrial and ventricular ectopy 
were analysed on the same HRV analysis system (Marquette Laser XP, Milwauke, 
Wisconsin) by two different physicians. The repeatability coefficient (RC) was 
determined as the square root of the sum of the squares of the differences between 
paired values from each trial divided by the sample size. This is equivalent to the 
standard deviation of the paired differences. The coefficient of variability (CV) was 
determined as the standard deviation of the paired differences divided by the mean 
of each set of measurements was also calculated. The low-frequency measures such 
as the standard deviation of the mean for all normal to normal intervals in each 5-
min epoch (SDANN) demonstrated the lowest (0.6%) CVs. Measures of higher 
frequency oscillation, such as the number of intervals differing by more than 50 
milliseconds (PNN50) or the route mean square of the standard deviation of adjacent 
intervals (RMSSD) had CVs more than ten times the variation of the low frequency 
measures (7.7% and 7.5% respectively). 
Due to consistency in the equipment used, the source of variation demonstrated in 
this study (Kroll et al. 1996) was identified as originating from interobserver 
differences in beat annotation. Indeed it was found that the interobserver differences 
in calculated measures of high frequency HRV were correlated with differences in 
annotation of supraventricular ectopy. There was no relationship between 
interobserver annotation and low frequency HRV variables. The latter showed 
excellent reliability in any case. 
There was no interobserver disagreement in the presence or absence of ventricular 
ectopy, and therefore little effect on the calculated high frequency variables. 
Between 50% and 75% of the variation observed in high frequency variables was 
explained by interobserver differences in identification of supraventricular ectopy 
and sinus arrhythmia. 
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The multi-centre study design has frequently been the chosen method for HRV 
studies to obtain large sample sizes and to utilise pre-recorded Holter tape recordings 
for subsequent analysis of HRV. In such a design there are numerous combinations 
of recorders, analysers and investigators which may all contribute to the final 
presentation of HRV data. Therefore, the effect of data analysis in different 
laboratories on HRV measures needs to be quantified. Yi et at. (2000) studied 24-
hour ambulatory recordings from post myocardial infarction (MI) patients using 
either a Reynolds Tracker Recorder (Hertford, UK), (R) or a Marquette 8500 system 
(Milwauke, Wisconsin, USA) (M). The same tapes were then analysed using three 
different analysis systems at three venues by four independent operators. 
At centre one, the M and R were both used. Full visual reviewing of M took place 
but R was used with minimal intervention, beats were rejected by being 63% lower 
or 175% higher than preceding NN intervals. The tapes were also analysed at a 
second centre with a CardioData Mk4 analysis system (Mortara Instruments inc., 
Milwaukee, Wisconsin, USA) which uses template matching for ectopic beat 
removal. In this analysis, operator oveRReading and interpretation were also used. 
The data were finally reanalysed at a third centre, again using the CardioData MK4 
(using same strategy as before) but analysed by an operator with no knowledge of 
previous readings. Only time domain parameters were calculated and all were global 
readings, except the short-term measure ofRMSSD. 
Unlike the findings of Jung et at. (1996) NN interval was found to be highly reliable, 
as were all global readings of HRV. The agreement between systems in the 
assessment of RMSSD was found to be poor. Due to the large percentage of the 
total measurement represented by the limits of agreement it was concluded that, 
particularly in post-MI patients, consistent classification of RMSSD may be difficult 
to achieve in a multi-centre study. 
The intersystem agreement reported in this study (Yi et al. 2000)is actually a 
combination of interobserver error and technical system error. With the exception of 
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RMSSD the cross-instrument analyses were shown to be less problematic than the 
combinations used by Jung et al. (1996). Additionally, the technicians were all 
highly trained in the analysis and editing of Holter tapes, and the errors resulting 
from their analyses were found to be less than those reported previously by Kroll et 
al. (1998). These data seem to suggest that high levels of agreement may be 
achieved in a multi-centre study using different analysis systems when adequate care 
is taken within all aspects of the analysis. 
Data concerning the agreement of HRV parameters assessed during short-term 
recordings of heart rate is limited to a single study (Carrasco et al. 1998). Carrasco 
et al. (1998) assessed agreement between four spectral and four temporal HRV 
parameters obtained from ECG and blood pressure wave analysis in 10 healthy 
subjects under 5 different conditions. 
Blood pressure wave was recorded using a Finapres monitor, which gives numerical 
details of heart rate, systolic and diastolic blood pressure using a 
photoplethymsograph as a servo to a blood pressure cuff. The cuff can then respond 
to maintain a reference value allowing monitoring of the blood pressure. This allows 
the measurement of the arterial pressure wave (APW) which is in tum digitised. This 
digitised signal is then sent to a computer via a communication protocol of the 
manufacturer's design. The ECG signal was obtained through a CM5 lead from a 
78330A ECG monitor which was band-pass filtered (1.0-250 Hz) and damped (-40 
dB/dec). This signal was AID converted and digitised at 500 Hz prior to analysis. 
Both the ECG signal (RR interval data) and the APW signal (PP interval data) were 
filtered and interpolated similarly in accordance with the Task Force 
recommendations (Taskforce 1996) using the R wave fiducial point and consecutive 
maxima of the pressure wave as measures of hemi rate and blood pressure 
respectively. 
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Agreement was assessed by analysis of means, con-elation and limits of agreement. 
Strangely the limits provided were 2.26 SD either side of the mean difference not 
1.96 as recommended (Bland and Altman 1986). Although some of the temporal 
parameters measured displayed good limits of agreement in resting measures, there 
was a systematic underestimation of these HRV variables by the Finapres monitor 
especially during standing and exercise conditions. A similar pattern of results was 
shown in the frequency domain analyses except in the standing condition where the 
PP data significantly overestimated total power (TP), high frequency power (HF) 
and underestimated low frequency power (LF) and the ratio of low to high frequency 
power ratio (LF:HF). From these results it was concluded that the two methods 
were not interchangeable. 
From the available data it therefore, seems viable to hypothesise that when 
simultaneous measures of ECG activity are made on a subject and subsequently 
analysed by their designated HRV analysis system high levels of agreement between 
the methods should be evident. This hypothesis is based mostly on data from 24-
hour Holter tape analyses. Whether this translates to short-term recordings of the 
ECG is unknown. From the data provided by Can-asco et al. (1998) it seems that 
short-term recordings show some inter-equipment agreement under certain 
conditions. Utilising simultaneous ECG recordings as opposed to blood pressure 
wave should serve to enhance agreement between commercially available methods 
to determine HRV. 
3.1.3. Studies assessing reliability of HRV instruments. 
The Task Force report noted that there were limited data on the reliability of HRV 
measures over time. Good reliability of HRV measures is important if changes in 
HRV due to interventions are to be observed. Of equal importance to researchers and 
clinicians is the comparability of different methodologies used to assess HRV in 
different laboratories. 
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Numerous investigations have been canied out to assess the reliability of HRV 
measures using ambulatory, (usually 24-hour) BeG recordings (Huikuri et al. 1990; 
Kleiger et al. 1991; Van Hoogenhuyze et at. 1991; Zuanetti et al. 1991; Durant et al. 
1992; Ziegler et al. 1992; Klingenheben et al. 1993; Kamalesh et al. 1995; Kautzner 
et al. 1995; Stein et at. 1995) Investigations into the reliability of short-term 
measures of HRV are less numerous but have become more commonplace recently. 
These studies can be subdivided into those for which the BeG has been recorded 
under resting or stationary conditions(Freed et al. 1994; Piepoli et al. 1996; 
Ponikowski et al. 1996; Sinnreich et al. 1998) (Marks and Lightfoot 1999; Jauregui-
Renaud et al. 2001; Lord et al. 2001) and those which investigate change in HRV 
measures during some form of test or manoeuvre (Ziegler et at. 1992; Ponikowski et 
al. 1996; Sinnreich et al. 1998; Jauregui-Renaud et al. 2001; Lord et al. 2001) . The 
results of both these groups of investigations vary widely due, in part to the varying 
statistical analyses used and also to the different populations studied. 
The increase in research into short-term HRV analysis in the frequency domain is 
undoubtedly connected with recent advances in data collection and automated 
processing through custom-built software. Time and especially frequency domain 
analysis of short term BeG data has, therefore, become simpler and more accessible. 
This does not, however, ensure results are comparable. In fact, a greater reliance on 
automated data analysis by custom-built software results in more opportunities for 
differential treatment of BeG data. This may in tum, result in greater variation in the 
analysis and results between laboratories. 
The aim of the present investigation was twofold. First, to determine if simultaneous 
BeG measurements analysed by three commercially available HRV instruments 
yielded similar results in terms of the HRV parameters produced. The second aim 
was, to determine whether the results from each instrument were stable over time. 
The first part of this study is, therefore, an assessment of the concurrent validity of 
three instruments. The second part is an assessment of their absolute reliability as 
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defined by Baumgarter (1989). Both of these constructs are of great importance 
when undertaking empirical research. 
3.2. Methods. 
3.2.1. Study population. 
All procedures were approved by the local ethics committee. All volunteers gave full 
written informed consent for their participation in the study. Thirty healthy 
volunteers (20 males) with a median age 27.5 (range 19-59 years) agreed to take part 
in the study. All subjects indicated they were in good health as defined as absence of 
cardiovascular disease and were not on any medication which may have affected 
HRV during the study period. 
3.2.2. Instrumentation and data analysis. 
Heart rate variability was measured simultaneously using three automated pieces of 
equipment: the HVR analysis module within the CardioPerfect ST software using 
the Medical Graphics Card02 CP stress system (Medical Graphics Corporation, St 
Paul, Minnesota USA), a Cardiotens 24-hour ambulatory ECG recorder (Meditech 
Ltd. Budapest, Hungmy) and a TF5 HRV analysis instrument (Advanced Medical 
Diagnostics Ltd., Leeds, UK). Table 3-1 gives the technical specifications of the 
equipment used. 
3.2.3. Study design. 
Subjects attended the laboratory on two occasions a mean of seven (SD ±3) days 
apart. On each occasion subjects undelwent three simultaneous measurements of 
HRV. Subjects were asked to refrain from strenuous exercise and heavy alcohol 
consumption on the day prior to the test and to abstain from caffeine containing 
foods and beverages and tobacco use on the day of the tests. Subjects were 
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instructed to eat a light breakfast at least two hours prior to testing. All testing was 
conducted between 8.00 AM and 1.00 PM. 
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Table 3-1 Technical specifications of the three HRV instruments used. 
Recording Sampling 
Analysis Frequency bands 
RR interval itltering 
Name Measures Given 
Method Rate .and interpolation 
Medgraphics 
Fully variable. 
12-Lead 
Fast Fourier Default values: Total Power. VLF, 
Cardio ECG Automated and 
Transformation or VLF 0.0033-0.04 LF, HF in raw and 
Perfect HRV directly into 1000 Hz manual filtering 
Discrete Fourier LF 0.04-0.IS, HF normalised units. 
Module non-portable available 
Transformation 0.IS-0.40 
(CP) recorder 
HF O.IS - 0.40 All Time-domain 
CardioTens 
SOOHz for 
Ambulatory S-Lead ECG Non-variable. Automated filtering Total Power, LF 
ECG Fast Fourier 
ECG and portable LF 0.04 - O.1S only. and HF. LF:HF 
1000Hz for Transformation 
recorder. recorder. HF O.IS - 0.40 ratio in raw and 
RR intervals 
(CT) normalised units. 
VariaCardio Chest strap Automated and 
SOO Hz for manual filtering Total Power, VLF, TFS HRV with signal Non-variable. 
ECG Fast Fourier available. LF and HF in raw 
analyser. to remote LF 0.04-0.IS 
1000 Hz for Transformation and normalised (TFS) wireless HFO.IS-0.40 
RR interval. units SDNN and 
receiver. 
MSSD. 
For a fitlllist of abbreviations and definitions of terms see Appendix 2. 
69 
On reporting to the laboratory subjects were prepared for the three recordings. This 
included the cleaning and preparation of the skin for the attachment of surface 
electrodes (Medico tes t Ltd, Denmark). Due to the simultaneous recordings, 
placement of electrodes for the 12 lead ECG was slightly modified. Lead V4 was 
placed slightly lateral to the midclavicular line and V5 was placed slightly medial to 
the anterior axillary line. All five-lead ECG electrode placements were standard and 
the TF5 chest strap was correctly placed in accordance with manufacturer's 
instructions. 
Subjects were then asked to lie supine on a bed while the signals from the equipment 
were checked for interference and signal quality. This allowed the subject's HR to 
stabilise. The time taken for this was at least five minutes. 
Each subject then underwent three sequential 5-min ECG recordings under the 
following conditions. 
1 
2 
Lying supine with natural breathing 
Standing with natural breathing 
(supine) 
(standing) 
3 Lying supine with controlled respiration at 12 breaths per min (breathing) 
For conditions 1 and 2 subjects lay or stood in a quiet laboratory and were instructed 
to relax but remain wakeful. For condition 3 subjects were also asked to breath in 
time with a metronome with verbal instructions to breathe in and out in a rhythmic 
manner which elicited a speed of 12 breaths-min- I . Between each condition subjects 
were given at least 3 minutes to adjust to change in posture and to practise the 
controlled breathing exercise. During this time the ECG was monitored, but these 
recordings were not entered into the analysis ofHRV. 
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3.2.4. Heart rate variability analysis 
Both the CP system and the CT automatic protocols were set to sample 300 seconds 
of ECG recording. The automatic protocol in the TFS system sampled either 300 
seconds or 300 beats whichever was the longer. Following recording of the ECG 
data the three systems were set to edit out artefacts using their default automated 
protocols. For both the TFS and the CT system the default criteria for the removal of 
an abnormal beat was an RR interval differing by >200 ms from the previous one. 
For the CP system the default value was a difference of 10% between beats. After 
removal of abnormal beats, both the TFS and CT systems performed their analysis 
on 2S6 NN intervals. The CP system linearly interpolated NN intervals based on 
preceding intervals replacing any abnormal sections of data with interpolated beats. 
The CP system allowed a full beat-by-beat visual inspection of the length of each 
RR interval and of the raw ECG signal. The TFS allowed inspection of the length of 
each RR interval via a graphical representation. These latter features allowed for 
manual removal of abnormal beats but this mode was not used in the present study. 
Instead, for consistency, only automatic filtering was used for all three systems. 
The second part of the data analysis was the transfOlmation of the NN interval data 
into frequency domain data. This was again carried out by the default method. In all 
three systems this was fast Fourier transformation. The frequency domain data was 
then reported in the frequency bandwidths recommended in the Task force report 
(Camm et al. 1996): VLF, (0.0033-0.04 Hz) LF (0.04 - O.lS Hz) and HF (O.lS -
0.40 Hz). These frequencies were again, the default values for each system. Only 
HF, LF in raw and normalised units and LF:HF ratio were used from the frequency 
domain analysis. Measures of TP could not be compared between all three 
instruments as the CT and TFS report TP as LF+HF (0.04-0AHz) whereas TP 
reported by the CP also includes the VLF band (0.0033 - OAHz) Additionally, TP 
was not compared as a measure due to the short (S-min) recording duration. It has 
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previously been stated that the values of TP and VLF may be dubious when obtained 
from such short recordings and should be avoided (Taskforce 1996). 
The Taskforce also recommend that RMSSD and SDNN be the only time domain 
measures taken from stationary, 5-min recordings. On this basis, only these 
measures were extracted from the time domain analysis produced by the three 
instruments. 
3.2.5. Statistical analysis. 
All statistical analysis was carried out using SPSS version 11.0 (SPSS inc. Chicago, 
Illinois, USA). Prior to statistical analysis, the normality of all data was assessed 
using a Kolmogorov-Smimov test. 
To assess agreement between the three instruments the intraclass correlation 
coefficient (ICC) was calculated between the three data sets. A number of possible 
coefficients may be calculated to assess agreement. A mixed model 3.1 ICC is 
recommended for use when more than two trials are being assessed (Hopkins 2000). 
This ICC is unbiased for any sample size. Both the R-value for the ICC and the 
upper and lower 95% confidence intervals (CI) were reported in accordance with 
previous recommendations. A lower 95% C.l. of R = 0.75 was interpreted as 
demonstrating methods to show close enough agreement to be able to replace one 
another (Lee et al. 1989; Lee 1992). Lee et al. (1989, 1992) and others (Bland and 
Altman 1986; Bland and Altman 1990) have recommend the use of a test of mean 
differences in addition to the ICC. A test which generates no probability value is 
recommended, such as a plot of mean values versus test-retest differences. The use 
of more than two data sets necessitated the use of a repeated-measures ANOVA to 
avoid multiple plots. Alpha was not adjusted for multiple comparisons because in 
this case, the experimental hypothesis is that no difference between the means exists. 
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Adjustment of alpha in this scenario would increase the likelihood of making a type 
one enor. 
To assess absolute reliability the coefficient of variation (CV) was calculated. This 
statistic is the standard deviation of the mean squares of pairs of values divided by 
the mean of the population and expressed as a percentage. This allows easy 
interpretation as well as permitting the researcher or clinician to make a value 
judgement about the suitability of the method. The CV can be used in the calculation 
of sample size for future research using numerous formulae. This fact, and the use of 
this statistic in previous studies prompted the choice of CV from the anay of 
reliability statistics available. Additionally, as the CV does not utilise an alpha value 
it is suitable for the multiple comparisons in the present study. 
For global comparison with previous data as recommended by (Atkinson and Nevill 
1998) the ICC 3.1 was also calculated for pairs of repeated measurements to 
estimate reliability from each instrument. This model has been previously 
recommended for reliability analysis (Shrout and Fleiss 1979). 
3.3. Results. 
Data were gathered from 30 volunteers. Data from one participant were not entered 
into the analysis due to the detection of a suspected anhythmia. This participant was 
referred to their general practitioner for further testing according to guidelines set 
out by the local ethics committee. The retest data on a second subject was rejected 
after analysis due to anomalous decrements in all HRV parameters. It was found that 
this subject had consumed a considerable amount of alcohol the previous evening. 
Standing data on one subject were omitted due to the occunence of a cartilage injury 
between test and retest and technical failure lead to the omission of controlled 
breathing data for another subject. 
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3.3.1. Agreement. 
To assess agreement, rm-ANOVA and ICC were performed on the data obtained 
from the first test, 28 complete data sets were entered into the analysis. Tables 3-2 -
3-4 show the mean (±SD) HRV values from simultaneous ECG measurements by 
the three instmments in conditions 1-3, the values of repeated measures ANOV A as 
test of systematic bias and ICCs with 95% C.1. as a measure of agreement. 
All frequency domain parameters showed high levels of agreement as indicated by 
the high values of the ICC. None of these values showed any systematic bias 
between the means for measurements made by each instmment (rm-ANOV A, P > 
0.05). Although excellent agreement between the time domain parameters was 
shown, mean values of time domain parameters were not as homogenous. Repeated 
measures ANOVA demonstrated systematic bias approaching statistical significance 
(P = 0.06) for RMSSD and significant bias (P = 0.05) for SDNN and RR interval 
data between machines. Post-hoc analysis by paired t-test showed that in both cases, 
the overall increase in variance between groups was due to a significant difference 
existing in measurements from the CT instmment. 
In condition 2 (standing), high levels of agreement between instmments were 
demonstrated in the majority of frequency domain measures. One parameter which 
was an exception to this was the LF:HF ratio in which the lower bound of the 95% 
C.1. for the ICC was less than the recommended level of R=0.75 to show excellent 
agreement. In the lying position, rm-ANOV A and post-hoc paired t-tests 
demonstrated the time domain parameter SDNN to again be systematically 
overestimated by the CT instmment. 
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Table 3-2. Mean (±SD) scores and reliability of all instruments in data collection condition l:lying supine with free breathing. 
HRV TF5 CardioTens Cardioperfect ANOVA ICC 95% C.I Measure 
LF (ms2) 918.4 961.7 987.4 P=.36 .97 .94-.99 
±986.5 ±1002.4 ±1213.6 
LF (nu) 45.5 47.2 46.1 P= .60 .95 .91-.98 
±23.8 ±22.0 ±24.5 
HF (ms2) 1194.4 1185.1 1245.8 P=.67 .99 .98-1.0 
±1434.4 ±1323.8 ±1454.6 
HF (nu) 54.5 51.1 52.4 P=.18 .97 .94-.98 
±23.8 ±21.8 ±23.1 
LF:HF 1.6 1.5 1.5 P=.79 .95 .92-.98 
±2.2 ±2.0 ±1.8 
RMSSD (ms) 45.7 45.7 47.9 P=.06 .99 .98-1.0 
±24.9 ±23.6 ±25.3 
SDNN (ms) 53.3 63.2* 54.2 P=.05 .93 .87-.96 
±20.7 ±25.8 ±20.9 
Mean RR 944.0 937.6* 945.7 P=.05 .99 .99-1.0 {ms} ±133.8 ±131.2 ±135.8 
LF - low frequency spectral power, HF - high frequency spectral power, nu - nonnalsied units, LF:HF - the ratio of low to high frequency spectral 
power, RMSSD - route mean square of the standard deviation ofnonnal to nonnal interval differences, SDNN - the standard deviation ofnonnal to 
nonnal intervals, mean RR - mean time (ms) between nonnal r-waves. 
* Indicates result is significantly (P <0.05) different from both other instruments. 
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Table 3-3. Mean (±SD) scores and reliability of all instruments in data collection condition 2:standing with free breathing. 
HRV TF5 CardioTens Cardioperfect ANOVA ICC CI Measure 
LF (ms2) 1396.2 1635.8 1485.4 P=.45 .95 .90-.97 
±1921.8 ±1952.7 ±1663.0 
LF (nu) 67.2 70.5 66.7 P=.35 .92 .85-.96 
±20.1 ±18.8 ±22.8 
HF (ms2) 456.1 513.5 577.3 P=.28 .92 .85-.96 
±502.7 ±551.2 ±627.9 
HF (nu) 32.8 28.7 33.2 P=.23 .91 .86-.93 
±20.1 ±18.2 ±22.8 
LF:HF 3.9 5.3 4.4 P=.38 .79 .60-.90 
±4.1 ±8.2 ±5.9 
RMSSD (ms) 30.5 32.1 33.1 P=.45 .95 .90-.98 
±16.1 ±15.5 ±16.8 
SDNN (ms) 52.9 63.1* 54.8 P=.01 .96 .93-.98 
±21.9 ±23.7 ±21.2 
Mean RR 795.3 795.4 807.4 P=.31 .99 .97-.99 (ms} ±102.7 ±102.9 ±110.2 
LF - low frequency spectral power, HF - high frequency spectral power, nu - normalsied units, LF:HF - the ratio of low to high frequency spectral 
power, RMSSD - route mean square of the standard deviation of normal to normal interval differences, SDNN - the standard deviation of normal to 
normal intervals, mean RR - mean time (ms) between normal r-waves. 
* Indicates result is significantly (P <0.05) different from both other instruments. 
76 
Table 3-4: Mean (±SD) scores and reliability of all instruments in data collection condition 3: lying supine, controlled breathing (12 
breaths.min- I ) 
HRV TF5 CardioTens Cardioperfect ANOVA ICC CI 
Measure 
LF (ms2 ) 966.2 868.8 889.3 P=.69 .98 .97-.99 
±1652.7 ±1151.1 ±1485.8 
LF (nu) 35.5 36.4 39.1 P=.22 .98 .97-.99 
±22.8 ±22.2 ±25.7 
HF (ms2) 1379.6 1505.6 1186.4 P=.08 .91 .83-.96 
±1060.1 ±1293.1 ±955.8 
HF (nu) 64.5 62.0 61.0 P=.28 .93 .87-.96 
±22.8 ±21.8 ±25.7 
LF:HF 1.6 1.5 1.5 P=.27 .88 .76-.94 
±2.9 ±2.3 ±3.2 
RMSSD (ms) 50.0 68.4 51.4 P=.26 .98 .97-.99 
±21.2 ±23.0 ±20.2 
SDNN (ms) 56.0 68.7.0* 55.2 P=.001 .90 .81-.95 
±20.5 ±28.4 ±18.5 
Mean RR 972.7* 970.0* 975.6* P=.001 .99 .99-1.0 (ms) ±140.6 ±134.4 ±143.4 
LF - low frequency spectral power, HF - high frequency spectral power, nu - normalsied units, LF:HF - the ratio oflow to high frequency spectral 
power, RMS SD - route mean square of the standard deviation of normal to normal interval differences, SDNN - the standard deviation of normal to 
normal intervals, mean RR - mean time (ms) between normal r-waves. 
* Indicates result is significantly (P <0.05) different from both other instruments. 
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Figure 3-2: CV (%) for TF5 for all HRV measures in conditions 1-3. 
LF - low frequency spectral power, HF - high frequency spectral power, nu - normalsied units, LF:HF - the ratio oflow to high frequency spectral 
power, RMSSD - route mean square of the standard deviation of normal to normal interval differences, SDNN - the standard deviation of normal to 
normal intervals, mean RR - mean time (ms) between normal r-waves. 
* Indicates result is significantly (P <0.05) different from both other instruments. 
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Figure 3-3 CV (%) for CT for all HRV measures in conditions 1-3. 
LF - low frequency spectral power, HF - high frequency spectral power, nu - normalsied units, LF:HF - the ratio of low to high frequency spectral 
power, RMSSD - route mean square of the standard deviation of normal to normal interval differences, SDNN - the standard deviation of normal to 
normal intervals, mean RR - mean time (ms) between normal r-waves. 
* Indicates result is significantly (P <0.05) different from both other instruments. 
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Figure 3-4. CV (%) for CP for all HRV measures in conditions 1-3. 
LF low frequency spectral power, HF - high frequency spectral power, nu - normalsied units, LF:HF - the ratio of low to high frequency spectral 
power, RMSSD - route mean square of the standard deviation of normal to normal interval differences, SDNN - the standard deviation of normal to 
normal intervals, mean RR - mean time (ms) between normal r-waves. 
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* Indicates result is significantly (P <0.05) different from both other instruments. 
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Figure 3-5. Mean CV s (%) for all measurements for all three instruments in conditions 1 - 3 
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Table 3-5. Intraclass correlations coefficients for reliability of each instrument in each condition. 
Instrument TF5 CT MG 
Condition C1 C2 C3 C1 C2 C3 C1 C2 C3 
LF 
.95 .77 .87 .84 .90 .83 .85 .94 .86 
LF(nu) .51 .65 .16 .52 .82 .70 .80 .50 .52 
HF .79 .87 .65 .92 .92 .82 .71 .79 .47 
HF(nu) .74 .65 .73 .90 .82 .67 .86 .78 .56 
LF:HF .77 .71 .64 .89 .88 .82 .85 .82 .81 
RMSSD .88 .85 .69 .90 .91 .91 .93 .86 .79 
SDNN .57 .85 .83 .87 .67 .72 .77 .72 .76 
Mean RR .93 .89 .84 .99 .87 .86 86 .93 .92 
LF - low frequency spectral power, HF - high frequency spectral power, nu - normalsied units, LF:HF - the ratio oflow to high frequency spectral 
power, RMSSD - route mean square of the standard deviation of normal to normal interval differences, SDNN - the standard deviation of normal to 
normal intervals, mean RR - mean time (ms) between normal r-waves. 
* Indicates result is significantly (P <0.05) different from both other instruments. 
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In condition 3 (breathing) all frequency domain measures again, showed excellent 
levels of agreement. The SDNN measure from the CT was again shown to 
significantly exceed the value of this measure from the other instruments. Also in 
this condition, there was also a small, but statistically significant difference in the 
mean RR interval. Post-hoc analysis showed this interval increased systematically in 
all three instruments by a total of 5.6 ms from the CT (lowest) to the MG (highest). 
3.3.2. Reliability. 
The CV for each parameter measured in each position is displayed by instrument in 
Figures 2-4. From figures 2-4 it can be seen that the CV s for the eight parameters 
measured vary greatly from one another in terms of their reliability both within and 
between conditions 1-3. Within each condition it can generally be seen that CVs for 
time domain variables and frequency domain variables expressed in normalised units 
tend typically to be lower. 
What can also be seen from the figures is that although the general pattern of 
reliability is similar between parameters and positions by instrument there are a 
number of very large CV s generated singularly by the TF5 and CT that differ greatly 
in comparison to parallel measures from the remaining two systems. F or instance 
CV for the LF(nu) in the CT (235%) is much greater than the CV for LF(nu) 
recorded by the TF5 and MG «20%). 
In order to facilitate an overall comparison of the reliability of HRV measurements 
made by the three instruments the mean CV in each position and the overall mean 
CV are shown figure 3-5. From this it can be seen that the MG instrument 
demonstrated the lowest overall CV: the highest CV and therefore least reliable 
instrument was the CT. Between conditions 1-3, CVs obtained in condition 1 (Figure 
3-5) were generally lower for each HRV measure than when subsequently measured 
in conditions 2 and 3. These lower CV s demonstrate greater reliability of the 
measurement of these HRV measures in the supine position. 
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Intraclass correlation coefficients were also calculated for the purpose of comparison 
of the present results with previous data expressed using this statistic. In this case 
the ICC for the repeated measurements made by each instrument under each 
condition were calculated. These data (Table 3-5) show the variable nature of the 
ICC coefficients. The ICC values range from excellent (R = 0.99) to very poor (R = 
0.16). Although a poor R-value in one instrument is often accompanied by others 
from those remaining, this is not a unifOllli scenario. 
3.4. Discussion. 
3.4.1. Agreement. 
The ICCs generated from the parallel acquisition of ECG data recording from the 
study participants clearly show excellent levels of agreement between the TF5, CT 
and CP instruments. In total, 24 ICCs were generated for eight HRV parameters 
measured under three different conditions. In all, twenty-three of these ICCs had 
lower bound 95% C.l. which were greater than R = 0.75. This has previously been 
deemed to represent agreement between methods in the measurement of the same 
quantity. 
Another criterion sometimes used for supporting interchangeability is the similarity 
of the mean measured results obtained by the two methods (Lee et al. 1989). The 
results of the repeated-measures ANOVA and post-hoc paired t-test used to assess 
this highlighted several instances where parameters demonstrated significant 
differences. Specifically, mean NN interval and SDNN showed systematic 
differences between all three instruments during condition three. In condition two 
there were also differences between NN interval means (not significant) and again 
SDNN was found to differ significantly. In this instance, only one instrument (CT) 
was found to deviate from the other two. 
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The results of the ICC tend to suggest that all three instruments were comparable in 
their ability to record, process and interpret ECG data in terms of the variability of 
the NN intervals. The similarity of results suggest that the treatment of the data 
following recording, the removal of abnormal beats and where appropriate the 
interpolation of RR intervals (and creation of NN interval data) does not have a 
significant effect on the outcome of the HRV parameters measured. Additionally, it 
seems that the post-hoc processing of these data and the mathematical 
transformation ofNN interval data into time and frequency domain HRV data is also 
very similar. The majority of data confirm that these three commercially available 
analysers show excellent agreement in the measurement of simultaneous HRV 
readings. 
In terms of interpretation of these results it is difficult to make comparisons with 
previous data due to the lack of similarity between data collection protocols. The 
majority of literature concerning agreement of HRV instrumentation concentrates on 
the use of 24-hour ambulatory ECG recordings made on to Holter tape machines, 
and the subsequent analysis of these recordings via various HRV analysis 
instruments. 
The data from the present study are in agreement with those of Simula et al. (1997). 
The conclusions of this study were that when analysed by the correct corresponding 
system, the 24-hour ECG recordings (analogue and digital) were highly comparable. 
The problems elucidated by Simula et al. (1997) when recordings from one system 
were analysed by another system were not assessed in the present study. 
The current data also agree somewhat with those of Yi et al. (2000) who 
demonstrated high levels of agreement between a number of commercially available 
HRV analysis instruments using a series of pre-recorded Holter tapes. Although the 
agreement was not as good as demonstrated in the present study, the tapes analysed 
by Yi et al. were exposed to an extra process whereby variation prior to analysis 
could have occurred. Although trained technicians were used to annotate the tapes 
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and aid the automated protocols of the instruments in the removal of abnormal RR 
intervals, it was found that up to 75% of the variation between readings could be 
accounted for by interobserver differences. 
These findings are also in agreement with those of a previous study (Kroll et al. 
1996) in which it was demonstrated that a number ofHRV analysis systems showed 
good levels of agreement. Kroll et al. (1996) specifically assessed the effect of 
interobserver differences on agreement between Holter tape analyses. It was 
determined that those time domain measures representative of the high frequency 
oscillations ofRR intervals were particularly prone to disagreement. This was found 
to be due to the removal of differing numbers of shorter RR intervals during marked 
sinus arrhythmia as these cycles are attributed to ventricular ectopic beats by some 
but not all observers. 
Unlike the data in the present study, Jung et al. (1996) demonstrated poor agreement 
between HRV parameters obtained from a single Holter recording. Again, the reason 
put forward for this by the researchers was the inconsistency in the removal of 
ectopic beats and artefacts from the RR interval data. In this case the researchers 
commented that the problem was not in the interobserver differences in beat 
removal. Instead a technical issue was raised. It was claimed that the systems used 
did not allow the necessary visual inspection of the RR interval data prior to 
processing and subsequent HRV analysis. Under such circumstances the user of the 
instrument has to rely solely on the automated software algorithms provided by the 
manufacturers to remove and interpolate RR intervals deemed abnormal. This can 
create variation in the raw ECG signal prior to any subsequent analysis. 
A similar problem was encountered in the present study. Both the TF5 and the CP 
system allow visual inspection of the raw ECG signal. The systems also represent 
each RR interval measured either graphically (TF5) or in numerical form (CP). The 
algorithm for beat removal in the TF5 is fixed, whereas in the CP it is variable. By 
default, both these instruments interpolate and replace abnormal RR intervals. 
86 
Although the CT allows observation of the tachogram for visual inspection, it does 
not facilitate the post-hoc removal of ectopic beats by the researcher. Instead it 
simply reports the total number of beats sampled and the number rejected. 
In order to ensure that each system was assessed as equally as possible it was 
decided that no post-hoc manual removal of beats would be undertaken in the 
present study. Non-parametric analysis (Kruskall-Wallace) demonstrated that a 
small but significantly greater number of beats was removed by the CP (0.89) 
compared to the TFS (O.S) during the S-min of ECG data collection under condition 
3. The CT however was found to have removed a much greater number (7) of beats 
compared with the other two instruments during this time. 
Further analysis of the tachogram revealed that there were in fact significant 
differences in the actual number of RR intervals being sampled by each instrument 
under certain conditions. 
In the condition 3 there were systematic difference in the mean RR interval reported 
by all three instruments. This finding was not wholly unexpected. It was initially 
assumed that the raw RR interval data obtained from the TFS would differ from the 
other two instruments because the collection interval for the TFS is always the 
longer option from 300 s or 300 beats. When the mean RR interval of a subject is 
greater than 1000 ms the TFS will sample more beats than the CT and CP 
instruments. The data collection window of the latter two instruments is set at 300 s. 
An unexpected finding was that all the instruments differed significantly from each 
other in the number of RR intervals sampled. More surprisingly the biggest 
difference was between the CT (414.3) and the other two remaining systems (TFS, 
33S.8; CP, 314,8). Fm1her visual analysis of the tachogram from the CT showed a 
discrepancy between the assumed time window of ECG recording and that which 
actually occurred. 
87 
Schedule is Download Recorder ECG recording ECGtrace Recorded 
created for ECG Schedule runs battery begins at ceases to ECG trace 
recorder using CT to check. One designated time be recorded is then 
software on PC .. Recorder ~ min before ~ as displayed on ~ after 300 -.. uploaded to 
(must start a (1-2 mins) recording recorder. seconds Pefor 
minimum of 3 min starts, clock analysis. 
from present time) appears. 
ECG begins ECG ceases 
recording as to be 
soon as battery recorded 
check is done. when data 
collection is 
stopped by 
Figure 3-6. Supposed (top route) and actual (bottom route) process of data collection by CT 
instrument. 
Operator Operator marks ECG trace 
starts ECG start of ECG ceases to be 
trace data collection recorded 
recording. on TF5. after 300 seconds or 
300 beats. 
Figure 3-7. Actual process of data collection by TFS instrument. 
Operator Operator marks ECG trace 
starts ECG startofECG ceases to be 
trace data collection recorded 
recording. on CPo after 300 seconds. 
Figure 3-8. Actual process of data collection by CP instrument. 
Figures 3-6 - 3-8 show the processes by which the exact timing, for recording of the 
ECG signal is obtained. The CT was used at the marker for the start point of the 
other two ECG recordings as it was subject to a 'countdown' and the other two were 
manual in nature. From the observed discrepancies in the assumed and actual data 
collection protocols it can be seen that the TF5 and CP instruments still recorded the 
same ECG data, except where the TF5 collected data over a longer duration due to 
the mean RR interval exceeding 1000 ms. 
Despite the above discrepancies, the majority of frequency domain parameters 
demonstrated excellent agreement. This it to be expected despite the differences in 
raw RR signal recorded by each instrument. The RR intervals may have been drawn 
from slightly different segments of the same ECG but as they represent sampling 
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from a stable ECG they should demonstrate similar pattems of frequency oscillation. 
The similarity in HRV parameters derived from several short-term segments of a 
single ECG has been shown previously (Ponikowski et al. 1996; Marks and 
Lightfoot 1999). In the present study this demonstrates the stability of the 
tachogram, which is a prerequisite for HRV analysis. Altemately, it helps to 
demonstrate where some of the small variation found between the instrumentation 
may have come from. 
Unacceptable agreement (lower 95% CI, R < 0.75) was demonstrated in only one 
variable (LF:HF ratio) and only in condition 2. To explain this, the nature of the 
variable itself must be examined. The LF:HF ratio is dependent on the raw units 
scores of low frequency (LF) and high frequency (HF) oscillations. Small variations 
in either of these values affect the ratio, which is therefore prone to summative 
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variation from both sources. The fact that the lowest agreement was found in the 
standing position reflects the dynamic variation which occurs in this specific 
variable. It is important to note that the CT instrument deviates significantly from 
the remaining two instruments and differences in sampling epoch as described 
earlier may account for variation in the LF:HF ratio. Specifically the CT was 
found to begin sampling earlier than the other systems. In this condition this 
would mean it sampled ECGs during a period where the tachogram was still 
stabilizing. Visual analysis of the raw tachogram signal confirmed this suspicion. 
Figure 3-9 is derived from the initial model of HRV data collection published by 
Kennedy (1996). It gives a visual representation how the three systems used in 
the present study. The shaded areas represent differences in the HRV data 
collection and interpretation process. The italicised boxes represent data at 
various stages of processing. These demonstrate where the differences m 
processing by the systems are translated into differences in data . 
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This model demonstrates how frequency domain measures remained very similar 
between the instruments despite differences in the raw RR and later NN data 
entering the analysis. 
3.4.2. Reliability. 
Overall CV s for HRV parameters in the present study showed a wide variation, 
ranging from <1 % to >100%. The initial aim of this study was to assess the 
reliability of each data collection instrument. The large range of values obtained 
made this very difficult. Closer observation of figures 3-1 - 3-3 shows that for the 
majority ofHRV measures made, the CVs generated showed similar fluctuations. 
For example, large CVs were recorded by all instruments for LF:HF ratio in the 
standing condition and small CV s were reported for RR interval in the supine 
condition. There are also deviations from this pattern where data from one 
instrument created a large CV which did not agree with the remaining two. An 
example of this is the CV generated by the CT for LFnu in the supine condition. 
These discrepancies can be partially explained again by the differences in actual 
ECG sampling epochs in the CT system. This can also explain a number of the 
large CV s found using this instrument. 
3.4.2.1. Reasons varied CV values. 
To explain variation from test to retest using the other two systems one has to 
look at the similarities between CV s generated by the TF5 and the CP. The fact 
that the size of the CV s tend to follow each other from parameter to parameter 
and from condition to condition suggest that it is not the systems per se which 
are responsible for test-retest differences but biological variation in the subjects. 
In order to assess the CVs generated in the present study comparison with 
previous investigations using similar methodologies is necessary. U sing short 
(la-min) sequential ECG recordings from patients lying supine and anaesthetised 
it would be expected that CV would be low. Freed et at. (1994) demonstrated CV 
from 5-16% and these are indeed lower than the range of CVs from the 
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comparable (supine) condition in the present study (TF5 = 5.5-125%; CP = 8.5-
94.7%). The usefulness of determining the reliability of HRV from sequential 
ECG recordings (Freed et al. 1994) is questionable except in the determination of 
a baseline for test and maneuver HRV analysis. 
3.4.3. Comparisons with previous data. 
Using an identical data collection protocol to the supine condition in the present 
study, CVs from 25-139% for time domain and 45-111% for frequency domain 
measures have previously been reported (Ponikowski et al. 1996). These are, 
overall, slightly higher than those generated by all three systems analysed in the 
present study. The authors suggested that good reliability of HRV measures 
should not be taken for granted in research and suggested that research groups 
should report reliability coefficients as part of justification of sample sizes used. 
Lord et al. (2001) studied the reliability of the LF oscillations in the frequency 
domain to assess this variable's usefulness in intervention studies. The LF 
component was found to show poor reliability in both normal subjects (CV = 
45%) and in heart transplant recipients (CV = 76%). By making repeated 
measures at three specific times, a significant effect due to time of day was 
demonstrated. Time of day and a training effect were presented as underlying 
factors in the high CVs found. The CVs for this particular variable under similar 
data collection conditions in the present study were 170.8% (TF5), 52.5% (CT) 
and 18.3% (CP). These coefficients are widely spread and not comparable to 
those of Lord et al. except that they are (excluding, CP) undesirably high. Lord 
et al. (2001) warned that longitudinal changes in HRV due to intervention should 
be interpreted with caution. Data from the current study support this notion 
although it should be noted that the recommendations of Lord et al. are based on 
the reliability of measures from denervated hearts after transplantation and 
should not, therefore, be generalised. As discussed previously (Ponikowski et al. 
1996) the effect of poor levels of reliability on necessary sample size for 
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interventions studies was also raised by Lord et ai. and the data presented herein 
confinn that this may be problematic. 
The findings of the present study show generally higher CVs than those reported 
in a similar study (Sinnreich et ai. 1998). In this study, CVs from data recorded 
in the supine position ranged from 6% (SDNN) to 12.1 % (HF) and were similar 
during controlled breathing (6.1 %, SDNN - 10.7%, HF). These coefficients are 
lower than those of any instrument in the present study and may be explained by 
certain methodological differences. Sinnereich et al. (1998) used a Marquette 
8500 Holter system to make the ECG recordings, a system previously 
demonstrated to have moderate reliability during 24-hour recordings (Kautzner et 
al. 1995). Processing of the RR intervals included automatic and manual editing 
of the ECG by a skilled operator whereas the present study deliberately relied 
only on automatic processing. 
The spectral decomposition of the NN data by Sinnreich et al. was carried out 
using autoregressive modeling as opposed to fast Fourier transfonnation (FFT) in 
the present study. This method detennines spectral amplitude peaks as well as 
power spectral densities for each data set. This eliminates possible variation from 
peaks crossing boundaries between LF and HF due to variation in breathing 
frequencies. In the present study this phenomenon was noted in a number of 
subjects in the supine position. Sinnereich et ai. employed a familiarisation 
protocol with each subject. This was not true of the present study. Finally, both 
data collection conditions in the study by Sinnereich et ai. involved the subject 
lying supine. It may be that the slightly lower CVs in the controlled breathing 
condition reported by Sinnreich et al. are due to increased subject relaxation 
increased protocol familiarity. This may be particularly true of the controlled 
breathing data collection condition, which always followed the spontaneous 
breathing condition. 
In the present study the lowest overall CVs were found in the first data collection 
condition, supine. Data collected in both the standing and controlled breathing 
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conditions showed poorer overall reliability. In these conditions the subject had a 
shorter familiarisation or adjustment time and in both cases had recently moved 
either from a supine to a standing position or vice versa. 
From the discussion of the data from the present study, especially in light of the 
findings of Sinnreich and coworkers several recommendations can be made 
regarding data collection methodologies in the analysis ofHRY. 
The poorer reliability demonstrated in the standing condition and in the 
controlled breathing may be addressed in two ways: 
1. Unless data are specifically required in the standing position data 
collection should be restricted to one position, lying supine with or 
without controlled breathing. 
2. If a standing measure is deemed necessary a longer adjustment period 
than that in the present study (3-min) between changes in posture should 
be used. 
In the case of all HRV measures a familiarisation period should be employed 
with all study participants, particularly for data collection during controlled 
breathing to which the subjects may not be accustomed. 
Marks et al. (1999) used a highly controlled methodology to assess HRV 
reliability. They calculated HRV data on a 5-min data section taken from a total 
of 20-min of resting ECG. Controlled breathing (12 breaths'min) was used 
throughout the data collection and the small number of subjects used, (n=8) were 
all highly physically active, female, non-smokers. Each subject was checked for 
exposure to cigarette smoke using a carbon monoxide meter. Interestingly, one of 
the reasons cited for performing this study was to assess the practicality of using 
HRV as a regular screening tool in a clinical setting. In such a setting the degree 
of control exerted over the recording protocol in this study would be impractical. 
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3.4.4. Recommendations. 
Overall it is recommended that studies of the reliability of HRV data should be 
specific in their aims. If the reliability coefficient gained is to be used to assess 
the effectiveness of a specific intervention in a controlled scientific investigation 
then the most reliable estimates of HRV possible should be pursued through the 
use of scientific control and rigour. If HRV is to be used as a general screening 
tool on a daily basis in an office or surgery, a pragmatic approach to reliability 
will result in the production of a more practible level. 
As part of a laboratory study subjects should be tested at a similar time of day on 
all visits. They should have fasted overnight and should have had no tobacco or 
caffeine containing substances on the day of the test. Alcohol consumption 
should also be avoided on the day of the test and certainly limited on the night 
prior to testing. There is some evidence that, in female subjects, phase of the 
menstrual cycle should also be accounted for (Yildirir et ai. 2002), but this may 
not be feasible to control for in a clinical setting. All of the above parameters 
should be recorded along with the HRV data as they may help to account for 
anomalous results. 
Ponikowski et ai. (1996) correctly noted that good reliability is essential for 
maximal utility in clinical research. There is an inverse relationship between the 
statistical power of a study and the square of the reliability coefficient for a given 
sample size. Conversely, for a given statistical power, the necessary sample size 
increases in exponentially to the size of the reliability coefficient. 
3.5. Conclusions. 
3.5.1. Agreement. 
Agreement between all three instruments was excellent. Where there were 
significant differences between the measures (RR interval, SDNN) this was due 
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to differences in the raw data sampled. From these findings it can be concluded 
that the instruments studied may be used interchangeably with one another. Each 
of the instruments used in the present study has advantages and disadvantages. 
The highest degree of control over data collection is afforded by the CP system. 
This system allows automatic and manual data editing. It also records and 
displays the full ECG signal to allow full visual inspection. The main problem 
associated with this system is that it is static in nature and only suitable for 
laboratory based investigation. It is also the most expensive of the three 
instruments used. 
The TF5 system also facilitates the visual inspection of the ECG signal. This 
system also allows automatic and manual editing of the data. This system has a 
major advantage of being portable is therefore ideal for use in clinical as well as 
laboratory settings. The TF5 is the middle-priced of the three systems. 
The CT system is also portable. This ambulatory data collection instrument is 
specifically designed for 24-hour data collection protocols. It can be used for 
shorter collection times but because of its intended use it does not store full ECG 
traces, and does not permit manual editing of the data. This instrument IS, 
however, considerably less expensive than the CP and TF5 systems. 
3.5.2. Reliability. 
The large CVs found in the present study and the similarity in patterns between 
HRV measures between conditions, and instruments suggests that biological 
variation was the major source of variation between test and retest. 
From the existing literature and the data from the present study it is suggested 
that the calculation of study-specific reliability coefficients (ICC, LoA, CV) be 
undertaken. This should be done using data collection conditions similar to those 
to be employed in the study. A similar sample to the study population should be 
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used and this should be done for each HRV parameter to be included in the 
study. On the basis of these coefficients, researchers should then calculate 
necessary sample sizes or at least give estimates of statistical power in each 
published study. 
Appendix 3 contains a number of sample size calculations for possible future 
studies using HRV parameters used in accordance with the Taskforce (Camm et 
ai. 1996) recommendations. The HRV parameter values are taken from the 
published literature and the sample sizes have been modified by the CV s 
obtained in the present study (TF5, CT or CP). 
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CHAPTER 4. HEART RATE VARIABILITY AND EXERCISE. 
Abstract. 
The aim of this chapter was to systematically review the literature concerning 
measures of heart rate variability (HRV) and their relation to acute an chronic 
exercise. 
Using cross sectional comparisons, it can be shown that measures of HRV, 
particularly those associated with vagal modulation are commonly found to be 
significantly greater in elite athletes than in sedentary controls. When 
comparisons are made between individuals in groups based on levels of activity 
or fitness who are not elite athletes, this difference is obvious. Longitudinal 
studies, which have used exercise as an intervention to alter HRV show highly 
heterogeneous results. Interpretation of the findings of such studies is made 
difficult by the many methodological disparities. 
When measured during exercise, there is a large and statistically significant drop 
in global measures of HRV. These measures tend to decrease linearly as a 
function of exercise intensity. Numerous studies have shown that measures 
found to adequately describe vagal and sympathetic ANS modulation at rest, 
perform poorly under exercise conditions. This is particularly true at higher 
exercise intensities. 
In conclusion, studies into the longitudinal effects of exercise interventions on 
resting measures of HRV give heterogeneous findings and more research is 
needed in this area to clarify this issue. During exercise, recommended HRV 
measures, commonly used at rest, do not adequately describe the ANS response 
to exercise. Further work to evaluate these measues and possible to investigate 
alternatives is, therefore, required. 
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4.1. Introduction. 
During exercise it is known that heart rate (HR) increases linearly with work rate 
and that the chronotropic response of the heart during exercise is influenced by 
the subject's training state. At rest, it is known that endurance trained 
individuals display a distinct, resting bradycardia compared with untrained 
controls (Ekblom et at. 1973; Lewis et at. 1980) 
The interaction of the sympathetic (SNS) and parasympathetic or vagal (PNS) 
branches of the autonomic nervous system and their control over HR has been of 
interest to researchers for over 100 years. Historically, surgical procedures using 
animal models (Rosenblueth et at. 1934) and pharmacological treatments of both 
animals (Hughson et at. 1977; Ordway et at. 1982) and humans (Sutton et at. 
1967; Lewis et at. 1980; Katona et at. 1982) have been employed to quantify the 
influence of the SNS and PNS on HR at rest and in response to acute and chronic 
exerCIse. 
Surgical and pharmacological procedures are both invasive and expenSIve, 
making a non-invasive method of studying autonomic control desirable. To study 
PNS control over HR, the use of the alterations in RR interval during respiration 
(aI-Ani et at. 1996) was proposed and developed (Katona and Jih 1975; Fouad et 
at. 1984). The alterations in RR interval during respiration were termed the 
'variation in heart period' or 'VHP' (Kenney 1985) and although sharing many 
common features should be thought of as distinct from 'heart rate variability' as 
it will be discussed here. 
Heart rate variability (HRV) is defined as: "The cyclical changes in sinus rate 
over time." (Ori et at. 1992). It is a non-invasive tool which can be used to study 
the autonomic control of HR (Akselrod et at. 1981; Pagani et at. 1986; Malliani 
et ai. 1991; Dreifus 1993; Camm et at. 1996). For a technical review of the use 
of HRV the reader is directed to the report from the Task Force of the European 
Society of Cardiology and the North American Society of Pacing and 
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Electrophysiology (Camm et al. 1996) although several other excellent reviews 
spanning over 30 years of research are available (Luczak and Laurig 1973; 
Sayers 1973; Ori et al. 1992; Stein and Kleiger 1999; Pumprla et al. 2002; 
Routledge et al. 2002) 
The aim of the present review is not to outline the many applications of HRV, 
but to concentrate on its use in providing insight into the acute and chronic 
effects of exercise on autonomic control of the heart. The validity of HRV to 
represent autonomic balance fully has been discussed in detail elsewhere 
(Pomeranz et al. 1985; Pagani et al. 1986; Malliani et al. 1991; Montano et al. 
1994; Camm et al. 1996; Pagani et al. 1997; Warren et al. 1997; Goldberger 
1999; Houle and Billman 1999; Stein and Kleiger 1999) and discussion of this, 
and technical procedures will only be undertaken when pertinent. A full list of 
abbreviations and technical terminology can be found in appendix 1 and where 
technical terms are used for the first time in the text they are defined. 
4.2. Assessment of autonomic function in athletes and controls at rest 
usingHRV. 
Surgical and pharmacological studies of autonomic regulation lead to the 
classical view that the resting bradycardia observed in trained individuals was 
due to increased PNS activity. This view was supported by empirical research in 
humans (Frick et al. 1967; Ekblom et al. 1973; Smith et al. 1989) and in a 
theoretical review (Scheuer and Tipton 1977). Evidence refuting this claim was 
also provided empirically (Sutton et al. 1967; Lewis et al. 1980) and this opinion 
also has an accompanying review (Badeer 1975). Katona et al. (1982) stated that 
several authors (Raab et al. 1960; Frick et al. 1967; Ekblom et al. 1973) may 
have misinterpreted pharmacologically derived data. A paper frequently cited as 
supporting a parasympathetic influence on resting bradycardia is that of Ekblom 
et al. (1973). Closer scrutiny of this paper reveals that although the authors make 
postulations supporting this notion, they are not supported by data. Data gained 
during atropine infusion showed some evidence for increased PNS activity after 
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training in only five out of seven subjects. During exercise no effect was 
evident. Evidence from propanol infusion clearly showed decreased SNS activity 
at rest and during exercise. From the evidence using double blockade the authors 
concluded that decreased PNS drive was responsible for the observed 
bradycardia. The authors do state: 
"The well known decreased HR with increased physical fitness to be due 
to reduced beta-adrenergic receptor activity in combination with 
increased parasympathetic activity." 
They do not however, support this statement with any of their own data. It is 
therefore possible that subsequent authors have misinterpreted this statement as 
empirical support for a parasympathetic origin of bradycardia due to training. 
A number of alternative explanations for the commonly observed bradycardia in 
athletes exist. These include alterations in the mechanical strain put on the 
pacemaker cells by cardiac hypertrophy (Lewis et al. 1980) metabolic alterations 
in the pacemaker cells and neurotransmitter sensitivity (Ekblom et al. 1973; 
Katona et al. 1982). It has also been suggested that genetic factors may be 
important (Smith et al. 1989). 
It is clear from the data presented that the study of autonomic control of HR by 
surgical and pharmacological methods has failed to identify a single cause of 
bradycardia. What follows is a review of how non-invasive measures of VHP 
and HRV have made additions to knowledge concerning resting bradycardia in 
relation to chronic exercise levels. 
Kenney (1985) demonstrated a significant correlation (r = 0.92, P < 0.001) 
between V02 11lax and VHP in 21 healthy subjects. By dividing subjects into high, 
moderate, and low fitness groups based on V02 11lax, significant differences 
between amplitudes of sinus arrhythmia were demonstrated. It was concluded 
that age related decrease in sinus arrhythmia may be due to concomitant 
decreases in activity and not due to ageing per se as previously claimed 
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(Hrushesky et at. 1984). This finding was later supported by longitudinal data 
from the same laboratory (Schraufek et at. 1990). 
Maciel et at. (1985) compared respiratory sinus arrhythmia (RSA) between 
athletes and sedentary controls. To test the theory further that training-induced 
increases in PNS activity were responsible for resting bradycardia in athletes, 
pharmacological parasympathetic blockade was achieved via atropine infusion. 
No significant difference was found in RSA amplitude between groups. No 
comparison of ~HR due to atropine infusion between groups was made. In 
athletes, RSA amplitude was found to correlate negatively (r = -0.69) with 
V02 max' The statistical nonsignificance of this relationship was probably due to 
the small (n=7) sample size. The authors concluded that their data indicated no 
increase in resting activity of the PNS due to exercise. These findings should be 
treated with caution due to the small sample sizes. 
Reiling and Seals (1988) found significantly longer RR intervals but similar 
levels of RSA in athletes and controls as measured by maximum to minimum RR 
interval differences. Standard deviation of the RR intervals (SDRR), which is a 
time domain measure of global HRV was also similar (72 ± 15 vs. 70 ± 9 ms) in 
the two groups. The results may be due to RSA possessing insufficient sensitivity 
to detect differences in such groups. Certainly, SDRR gives only a global 
indication of HRV and does not differentiate between PNS and SNS influence of 
HR. A more detailed analysis of autonomic function may have revealed 
differences between groups. 
In contrast to these findings, Dixon et at. (1992) compared highly trained runners 
(>50 miles per week) with sedentary controls using autoregressive power spectral 
analysis of short-term resting ECG trace. It was found that the athletes had 
significantly greater high frequency spectral power (HF), reduced low frequency 
spectral power (LF) and a lower LF:HF ratio compared with controls while lying 
supine. HF, LF and LF:HR were used as markers of PNS activity, SNS activity 
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and autonomic balance respectively. It was concluded that the greater HF 
component in athletes gave evidence of enhanced vagal tone and that training 
modifies HR control in part, through neurocardiac mechanisms. 
Gallagher et al. (1992) found that LF, HF and LF:HF derived from 
autoregressive spectral analysis revealed significant differences in level and 
balance of autonomic control between groups. A significantly elevated RSA in 
trained vs. untrained individuals was also found, demonstrating a shift towards 
what was termed a 'parasympathetic cardioprotective balance'. These findings 
are at odds with the HR data reported, which show the trained group to have a 
higher resting HR (71 bpm) compared with the two remaining groups (69 and 54 
bpm). The authors erroneously stated that this demonstrated resting bradycardia 
in their subjects. 
The studies reported so far have all used short-term data collection methods. 
Data on HRV can also be obtained by ECG monitoring over 24-hours. Goldsmith 
et al. (1992) utilised 24-hour monitoring to study autonomic activity in 
endurance-trained men and sedentary controls. They found that the pronounced 
bradycardia shown in trained individuals was accompanied by greater SDNN, 
total spectral power (TP)*, LF and HF. Additionally, HF made up a larger 
percentage of TP in trained (3%) vs. untrained (1.3%) subjects. This was 
interpreted as demonstrating predominating vagal activity. The increased LF was 
interpreted similarly, although the reason given for this interpretation was 
somewhat circular. The authors seem to develop their hypotheses on their own 
findings stating that if LF power was sympathetic in nature then it would be 
higher in untrained subjects. As LF was found to be lower in trained subjects 
they concluded it to be vagal in nature. 
There is considerable debate over the origin of LF fluctuations in RR interval. 
Some authors (Pomeranz et al. 1985; Rimoldi et al. 1990; Malliani et at. 1991; 
Kamath and Fallen 1993; Montano et at. 1994) support the view that it is purely 
a measure of SNS activity whereas others (Akselrod et al. 1981; Appel et al. 
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1989; Stein and Kleiger 1999) believe it to be influenced by both branches of the 
ANS. Carnm et al. (1996) have also reinterpreted evidence from authors of the 
former viewpoint (Pomeranz et al. 1985; Malliani et al. 1991) which are reported 
as supporting a combined PNS and SNS contribution to LF. 
Janssen et al. (1993) compared selected spectral and time series measures of 
HRV in highly trained cyclists and sedentary controls. Fast Fourier 
transformation (FFT)* was used to determine LF and HF spectral power; LF was 
also calculated in normalised units (nu) * . In the supine position the cyclists 
showed significantly longer RR intervals, a reduced LF (nu) and greater 
pNN50% than controls. No differences were found between coefficient of 
variation (CV)* or standard deviation SD* of the RR interval data. Both groups 
showed significant alterations in all measures (except CV) during a transfer from 
the supine to the standing position. The magnitude of this change was greater for 
RR interval, LF (nu) and pNN50% in athletes. The supine data were interpreted 
to indicating an increased level of PNS (or decreased level of SNS) activity in 
athletes. The differences in response to standing were said to be indicative of 
better quality autonomic control in the athletes. 
The authors state that LF and HF were calculated; this is necessary to calculate 
LF(nu) used here as recommended (Malliani et al. 1991) as a measure of purely 
sympathetic activity. Interestingly, HF, which is commonly used as an indicator 
of PNS activity, was not reported in raw or normalised units. Instead, the time 
domain measure of pNN50% was reported. This makes an unusual mixture of 
time and frequency domain measures. Although pNN50% is thought to give 
some inference of PNS activity it is currently recommended that when using 
short duration recordings, frequency domain measures should be used in favour 
of time domain alternatives (Carnm et al. 1996). The authors give no justification 
for this choice of measures. 
Puig et al. (1993) reported significantly greater variability in all time domain 
measures when comparing athletes with controls when measured in the supine 
position (15 min duration). Using FFT they also reported increased TP, LF and 
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HF spectral components (raw units) in athletes. Unlike Janssen et al. (1993) LF 
(nu) was found to be similar in athletes (20.4) and controls (20.7). It was 
concluded that these results demonstrated an increase in parasympathetic activity 
without reduction in sympathetic tone. 
In paradox to the above findings, DeMeersman (1993) analysed the RSA 
amplitude of active individuals and matched controls (n = 146) divided into six 
age categories from 15-75 years. In both groups RSA declined with age but that 
in each age category active subjects displayed significantly greater amplitude of 
RSA. It was concluded that exercise plays an important role in augmenting and 
maintaining HRV. In agreement with these findings, Sacknoff et at. (1994) 
demonstrated increases in the time domain measures of SDRR and pNN50 in 
athletes compared with control subjects. This is in contrast with frequency 
domain analysis of the same data which paradoxically showed attenuated levels 
of TP, LF and HF in the athletes compared with controls. The authors noted that 
the correlations typically observed between time and frequency domain measures 
(See. Appendix 1) were not present in athletes. It seems more likely that what 
was interpreted as low levels of HRV in athletes may be an artefact of the 
extremely large values for TP, LF and HF reported for the control groups. 
Unfortunately, no physical description of either group is given (e.g. bodyweight, 
activity level, 1702 max), as this may have helped to explain the spectral values 
obtained from the 15-min ECGs analysed which are up to ten times larger than 
normal values available in the literature (Camm et al. 1996). 
Comparing physically active postmenopausal women with sedentary aged 
matched controls it was found that all time and frequency domain measures (with 
the exception of LF:HF ratio) of HRV were augmented in active women (Davy 
et ai. 1996). Augmented parasympathetic activity and reduced sympathetic 
outflow were evident in the trained group. Spontaneous cardiac baroreflex 
sensitivity (SBRS) was found to account for the majority of the variability in HF 
power. 
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Macor et ai. (1996) found no statistically significant differences in spectral 
components (raw units) between highly trained cyclist and controls. Analysis of 
HF (nu) revealed a significantly greater contribution to autonomic balance by the 
PNS in cyclists compared with controls. The authors concluded that competitive 
cycling caused an increase in vagal traffic to the SA node. Returning to the raw 
units for spectral powers reported, large differences were clearly evident in LF 
(Controls: 381, range 15-9809 ms2 vs. cyclists: 933, range 116-7525 ms2) and HF 
(Controls: 730, range 10-8318 ms2 vs. cyclists: 890, range 87-3981 ms2). The 
lack of statistical significance in these measures may be an artefact of the 
analysis used. Although the researchers do not state which measures of central 
tendency are reported. These appear to be given as mean values. Assuming this, 
the data display a strong positive skew and wide, heterogeneous dispersions of 
LF and HF .. 
Skewed distributions are commonly reported in the literature (Bigger et ai. 1993; 
Bigger et ai. 1995). This, and heterogeneous variances may preclude the use of 
parametric statistical analysis. The analysis of the data by Macor et ai. (1996) 
using (parametric) independent t-tests may therefore, be inappropriate. 
A similar problem is evident in a further study (Lazoglu et ai. 1996), this time 
comparing cyclists, weight lifters and sedentary controls. No statistically 
significant differences were found in either time or frequency domain HRV 
measures derived from 24-hour Holter monitoring. There are three 
methodological problems with this study. Firstly, the cyclists are defined by 
V02 max (> 55 mI' kg'min- l ), the weight lifters by duration of activity (> 5 h'week), 
the sedentary group are not defined. Secondly, ANOV A was used to identify 
differences between these groups despite the large intergroup differences in SDs 
reported. This heterogeneity of variances violates one of the assumptions 
underlying the use of ANOV A, greatly reducing the differential power of the 
statistic. Thirdly, the cyclists did not display the significant bradycardia that 
would be expected based on previous data when compared with either weight 
lifters or controls. This may indicate a degree of similarity in the three groups. 
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Although not reported, it was likely to be based on previous evidence that the 
distributions of spectral measures from 24-hour recordings were skewed, but no 
statistical assessment ofthe distributions was given in the methods section. These 
studies (Lazoglu et al. 1996; Macor et at. 1996) demonstrate the importance of 
correct data treatment and analysis when utilising such a sensitive measure as 
HRV. In light of such shortcomings inferences made on the basis of these 
studies should, at best, be cautious. 
A further method by which the RR time series may be transformed into the 
frequency domain is coarse graining spectral analysis (CGSA) (Yamamoto and 
Hughson 1991). This method disregards all non-harmonic or fractal power in the 
frequency spectrum and analyses only the harmonic components. It provides 
different measures to those derived from methods of general spectral analysis 
(GSA). A full list and definition of these measures can be found in appendix II. 
Gregoire et al. (1996) used this method to identify differences in total power 
(TP), the parasympathetic nerveous system indicator (PNS) and the sympathetic 
nerveous system indicator (SNS) between four groups of trained and untrained 
individuals defined by age and sex. TP was almost three times greater in trained, 
mature females compared with untrained, mature controls. This difference was 
accompanied by a significantly (greater than four fold) reduction in SNS 
indicator value. Although these findings are similar to those reported previously 
(Mac or et al. 1996) they are at odds with the majority of studies inasmuch as no 
differences between either TP, SNS indicator of SNS indicator were found 
between trained and untrained groups of: young males, mature males or young 
females. The lack of any statistically significant differences in the young group 
may be due in part to the relative fitness of the untrained group as indicated by 
their 1702 peak. Recently the sensitivity of spectral measures derived from CGSA 
has also been questioned (Myslivecek et al. 2002). 
A second study using 24-hour Holter monitoring (Jensen-Urstad et al. 1997) 
compared highly trained runners with sedentary controls. It was found that 
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runners demonstrated greatly increased time and frequency domain measures of 
HRV over the whole period. When the period was divided into night and day 
periods, these differences persisted for all measures in the night period. This 
pattern was continued into the day period for all measures except HF which, 
although it was almost doubled in the runners, failed to reach statistical 
significance. The lack of significance may in part, be due to the small, unequal 
sample sizes in the groups (runners n=16, controls n=13). Using a similar 
methodology, Bonaduce et at. (1998) compared 15 male cyclists with age-
matched controls. Although this cross-sectional comparison was made when the 
cyclists were in what was described as a 'detrained state' (1 month without 
vigorous training) they still displayed significantly greater values for all time and 
frequency domain measures of HRV than controls. Following logarithmic 
transformation of the data, all frequency domain measures were significantly 
increased in the cyclists. The magnitude of the difference in HF was actually less 
than that reported previously (Jensen-Urstad et al. 1997), illustrating the 
importance of statistical treatment of HRV data which commonly displays 
skewed distributions. 
Analysis ofHF (nu) and LF (nu) derived from autoregressive spectral analysis of 
10-min sitting ECGs revealed a parasympathetic predominance in athletes 
compared with controls as indicated by increased HF (nu) (Shin et al. 1997). LF 
(nu) was also decreased in athletes compared with controls but this difference 
was not statistically significant (P =0.07). The authors did not supply data for LF 
and HF raw units or TP therefore inference regarding magnitude of HRV in 
athletes and controls is not possible. 
In three groups of age-matched subjects categorised as poor, average and good 
V02 lIlax Tulppo et at. (1998) found no significant difference in parasympathetic 
activity measured by the two dimensional vector analysis of Poincare plots* or 
HF CCV%*. Similarly, Melanson (2000) studied differences in HRV in three 
groups of subjects determined by their levels of self-reported physical activity. 
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Significant differences were found in the group reporting the lowest level of 
physical activity. This group had significantly lower HRV than the moderate and 
high exercise level groups for all time and (log transformed) frequency domain 
measures. The lack of a dose-response relationship was attributed partially to the 
fact that HF in particular may have been depressed in the high activity level 
group by previous exercise. The inability of HRV parameters to predict RR 
interval duration when regression analysis was applied to the data was 
interpreted as demonstrating a lack of relationship between parasympathetic 
activity and RR interval. 
Migliaro et at. (2002) observed no statistically significant differences in HRV 
parameters between active and sedentary young adults. It should be noted that 
the exercise group appear to be only recreational athletes although no 
physiological data for either group was presented. It is therefore difficult to 
compare the findings of this study with the remainder of the literature, which 
typically reports the effect of training in athletes or groups clearly defined by 
physiological characteristics such as V 02 max. 
In summary, the majority of studies show significantly greater PNS activity in 
trained vs. untrained individuals (Kenney 1985; Dixon et at. 1992; Gallagher et 
at. 1992; Goldsmith et at. 1992; De Meersman 1993; Janssen et at. 1993; Puig et 
at. 1993; Sacknoff et at. 1994; Macor et at. 1996; Davy et at. 1997; Jensen-
Urstad et at. 1997; Shin et at. 1997; Melanson 2000). Although some studies 
report no significant differences in markers of PNS activity (Maciel et at. 1985; 
Reiling and Seals 1988; Tulppo et at. 1998; Migliaro et at. 2001), this can often 
be attributed to methodological and statistical shortcomings of the studies. 
Where high-level athletes who undertake high volumes of intense training are 
compared with controls, differences in autonomic function are evident. Where 
comparisons between 'active' and 'inactive' individuals are made differences are 
less obvious, even when the groups are clearly defined by an accepted 
physiological marker such as V02 max. 
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Caution must be employed when making inferences from cross-sectional studies 
as confounding variables such as self-selection, and genetic influence cannot be 
controlled for. Although patterns in the data may emerge, it is impossible to 
infer causality from such a study design. For this reason a number of longitudinal 
studies have been carried out to assess pre and post-training alterations in ANS 
activity in a variety of populations. 
4.3. Longitudinal data concerning the effects of exercise on HRV. 
Elements of data from a number of studies cited in the following section have 
already been presented in section one as some studies have utilised combined, 
cross-sectional and longitudinal designs. 
Where RSA magnitude has been used to indicate vagal tone, the findings of 
longitudinal investigations into the effects of training are equivocal. Two studies 
have revealed no statistically significant change in previously sedentary adults 
(Maciel et al. 1985; Seals and Chase 1989) although in the latter study an 
increased SDRR in 8 of 11 subjects (P < 0.001) was observed. RSA was found 
to increase post-training in a small (n = 9) group of track athletes (De Meersman 
1992) although the 8-week training programme they undertook involved a large 
volume (61 km·week) of high intensity (75 - 95% V02 max) daily training. Again 
using high intensity (85% V02 max) exercise, AI-Ani et al. (1996) found 
significant increases in RSA magnitude after only 6-weeks of aerobic training 
(25 min·day). Such increases in RSA amplitude may be evidence of a dose 
response to training intensity. 
The use of spectral analysis to monitor longitudinal changes has also provided 
equivocal results. Many studies show no significant alterations in HRV measures 
despite an increase in V 02 max, often accompanied by decreased HR (Boutcher 
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and Stein 1995; Davy et al. 1997; Bonaduce et al. 1998; Loimaala et al. 2000; 
Myslivecek et al. 2002; Perini et al. 2002). 
4.3.1. Studies showing no significant effect a/training on HRV. 
Boutcher et al. (1995) showed no change in LF or HF in sedentary middle-aged 
men who exercised at 60% V 02 max three times a week for 8 weeks. Exercising at 
70% V02 max resulted in no statistically significant increases in time or frequency 
domain measures of HRV in postmenopausal women (Davy et al. 1997). 
Increases in all time and frequency domain HRV measures were evident but none 
of these reached statistical significance. This again, may be due to violation of 
the assumptions underlying the statistical test used. From the results given, the 
standard deviations (of particularly the frequency domain measures) post-training 
are, on average, double their pre-training levels. This heterogeneity of variances, 
wide dispersion of scores, and the small sample size (n = 8) of this study afford it 
little statistical power. These factors may have increased the likelihood of a type 
two error being made. 
Following five months of intense training Bonaduce et al. (1998) found no 
changes in HRV measures despite increases in V02 max, and heart geometry. 
Using 24-hour Holter monitoring, Loimaala et al. (2000) found significant 
increases in V 02 lIlax and reduced HR in previously sedentary adults following five 
months of running at either 55 or 75% VOl max' These changes were however, not 
accompanied by any alterations in spectral HRV measures. Perini et al. (2000) 
also found no significant differences in HR or HRV measures at rest after eight 
weeks of progressive exercise training in elderly males and females despite 
significant (18%) increases in VOl max' Based on previous findings (Goldsmith et 
al. 1992; Furlan et al. 1993; Bonaduce et al. 1998) Leicht et al. (2003) recruited 
a calculated sample of (n = 12) young and (n = 12) mature previously sedentary 
volunteers and trained them for 16 weeks. There were however, no differences 
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mid or post-training in either group in any of the spectral measures of HRV 
reported. 
4.3.2. Studies showing a significant effect of training on HRV 
In contrast to the above findings a number of studies have reported significant 
alterations in autonomic balance measured by spectral analysis following 
exercise interventions (aI-Ani et al. 1996; Hedelin et ai. 2000; Melanson and 
Freedson 2001; Portier et ai. 2001). 
In addition to RSA amplitude analysis, AI-Ani et al. (1996) also employed 
spectral analysis and found highly significant increases in both LF and HF. The 
authors reported more than a doubling of HF (2051 ± 541 vs. 5131 ± 905 ms2) 
and an almost three-fold increase in LF (912 ± 147 vs. 2464 ± 621 ms2) resulting 
in an effect size far in excess of any other reported in the literature. Perhaps 
more remarkable is that in two subjects, there were even greater changes in HF 
power but in the opposite direction (8281 ± 706 vs. 2602 ± 813 ms2). The values 
reported in this study are well in excess of those reported (Camm et ai. 1996) for 
the normal population (LF = 1170 ± 416 and HF = 975 ± 203 ms2). Reliability 
coefficients are not reported and no control group was used in the study. The 
results of this study should therefore be interpreted with caution. 
Schuit et al. (1999) exercised previously sedentary, older subjects with 3 x 45-
min supervised training sessions at 60-80% 1702 max for six months. Subjects in 
the experimental group showed a small increase in 24-Hour measures of: SDNN, 
LF and VLF (log units) while the control group (no exercise) showed small 
decreases in all HRV variables (P >0.05). Changes in SDNN and HF were found 
to be strongly correlated with changes in average RR interval length. Changes, 
especially in daytime HRV remained statistically significant when this was 
controlled for. The changes in the control group were attributed to reduced 
physical activity due to normal seasonal variation (winter). It is of interest to note 
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that neither pNN50 or HF, which are typically used as markers of PNS activity, 
increased in this study. 
Conversely, Hedelin et at. (2001) found a decrease in LF, when measured in the 
standing position following, seven months of aerobic training. This decrease was 
not associated with increased V02 l1lax in the mixed group of athletes studied. The 
effect of training does not seem to be homogenous as both increase and decreases 
in V 02 lIlax and HRV measures were reported. Portier et at. (2001) found 
decreased LF in standing and supine postures in athletes during an intensive 
training period when compared with a period of relative rest. When expressed in 
normalised units LF and HF were decreased and increased respectively during 
the intensive training period. This significant decrease in the LF:HF ratio when 
measured supine or standing was interpreted as showing a shift towards 
parasympathetic dominance 
Following 12 weeks of intense aerobic training (70-80% V 02 lIlax) Melanson et at. 
(2001) found significant increases in RMSSD, pNN50 and HF power (log units) 
in previously sedentary, adult males when compared with pre-training values and 
controls. In contrast to other studies the decrease in resting HR observed was not 
statistically significant. In light of this finding and the lack of a statistically 
significant relationship between training-induced bradycardia and HF power 
Melanson et at. (2001) concluded that spectral measures of HRV were not good 
indicators of PNS activity. 
Using CGSA, (Myslivecek et at. 2002) it was found that 12 weeks of walking 
training reduced SNS indicator values in pre- and post-menopausal females. 
This was only true when measured in the free-standing position and no 
differences were found in SNS indicator, PNS indicator or TP when subjects 
were assessed in either the sitting or left lateral decubitus position. 
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Iwasaki et at. (2003) employed a very large training stimulus in a previously 
sedentary mixed group of subjects over 12 months. Spectral measures showed 
significant improvement in LF power at 3, 6, 9 and 12 months compared with 
baseline. HF almost doubled from 763 ± 233 to 1318 ± 246 at three months but 
this difference failed to reach statistical significance probably due to the small (n 
= 11) sample size. Utilising CGSA, (Carter et al. 2003) positive, overall group 
changes in TP, fractal power,* HF, PNS and SNS indicators were found 
following 12 weeks ofperiodised training. When subjects were divided into four 
groups by sex and age (n = 6 per group) young females showed increased TP, 
fractal power, HF and PNS indicator values. Older females showed increases in 
SDNN, HF, and TP. It should be noted that these results represent a seven 
significant findings from a total of 32 comparisons made without the use of a 
correction factor for alpha. 
4.3.3. Summary. 
The data are clearly equivocal and seems to be dependent on the measures used. 
Poor application of statistical analyses and low statistical power may in part, be 
responsible for some of the nonsignificant results published. This is especially 
true when raw units are reported. These are commonly skewed, and have wide 
dispersion, the former prohibits the use of parametric statistics, the latter reduces 
statistical power. When normalised units or raw units are suitably transformed 
training is commonly found to produce significant alterations in spectral power. 
4.4. Heart rate variability during exercise. 
The 'research relationship' between exercise and HRV is both complex and 
circular in nature. HRV has been used as a non-invasive measure of autonomic 
balance during exercise. Conversely, as the vagal withdrawal and sympathetic 
activation which accompany rhythmic exercise are well documented (Astrand et 
al. 1987) exercise has been used as a tool with which to gain insight into the 
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origins of HRV. This is particularly true of the rhythmic HR oscillations the LF 
and HF bands. 
This circular relationship makes the discussion of HRV during exerCIse a 
complex topic. In addition to this, a number of exercise protocols have been 
used. Rhythmic exercise has been studied using either a single intensity of 
steady state exercise (Arai et al. 1989; Dixon et al. 1992; Kamath and Fallen 
1993; Myslivecek et al. 2002), a number of steady state intensities, (Perini et al. 
1990; Breuer et al. 1993; Gregoire et al. 1996; Macor et al. 1996; Piepoli et al. 
1996; Tulppo et al. 1996; Perini et al. 2000; Perini et al. 2002), incremental 
stages, (Yamamoto et al. 1992; Casadei et al. 1995), ramping (Yamamoto and 
Hughson 1991; Nakamura et al. 1993; Tulppo et al. 1998) and even simulated 
altitude (Yamamoto et al. 1996). Static, isometric exercise has also been used 
(Taylor et al. 1995; Raymond et al. 1997; Iellamo et al. 1999). 
Research in this area can be divided into two distinct methodologies, studies that 
have used general spectral analysis (GSA) and those which have used coarse 
grained spectral analysis (CGSA). The former uses either FFT or autoregressive 
modelling to decompose the power spectrum from the original time series. 
Although these methods can create the same measures, values may differ (Fagard 
2001). CGSA can produce measures, which provide similar insights into 
autonomic function to those gained from GSA. Although some of these 
measures are analogous to those extracted by GSA, values are not always 
comparable. The findings of studies using CGSA are therefore discussed 
separately. 
4.4.1. The HRV response to exercise - results from studies using general 
spectral analysis. 
Despite the disparity in methodologies used there are several patterns that 
emerge from studying HRV during exercise. Firstly, when expressed in either the 
frequency domain (as TP) or in the time domain (as SDNN), HRV is greatly 
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reduced during exercise (Arai et at. 1989; Furlan et al. 1990; Perini et al. 1990; 
Dixon et at. 1992; Breuer et al. 1993; Casadei et al. 1995; Macor et at. 1996; 
Perini et al. 2000). Where incremental exercise has been used, it is clear that the 
decrease in HRV occurs as a function of exercise intensity (Perini et at. 1990; 
Breuer et al. 1993; Casadei et at. 1995; Tulppo et at. 1996; Tulppo et ai. 1998) 
and that the decrease in variability may quickly reach the limit of resolution of 
some analysis systems (Rimoldi et al. 1990; Pagani et at. 1995). 
Methodologically this means time and frequency domain measures of HRV can 
be difficult to interpret, especially at higher exercise intensities. 
The acquisition ofTP from short-term HRV measures gives little insight into the 
autonomic function of the heart at rest or during exercise and measures should be 
interpreted with caution (Camm et al. 1996). Of more interest are the changes 
seen in the LF and HF power spectra. It would be expected that HF would 
decrease during exercise as a function of intensity and that LF would increase 
due to the proposed association of these measures with PNS and SNS activity 
respectively (Pagani et al. 1986). This is however, not the case. 
4.4.1.1. Spectral measures of HRV during exercise. 
When expressed in raw unit (msec2) both LF and HF decrease exponentially as a 
function of exercise intensity (Arai et al. 1989; Perini et at. 1990; Rimoldi et at. 
1992; Casadei et al. 1995; Tulppo et al. 1996; Tulppo et al. 1998; Perini et al. 
2000; Perini et al. 2002). Little therefore, can be gained from the study of these 
frequency components when expressed this way. In order to gain insight into the 
changes in autonomic control associated with exercise, researchers have used one 
or more of the following: 
o normalised units, 
o the expression of LF and HF as percentages, 
o the LF:HF ratio. 
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4.4.1.2. Changes in LF% and HF% during exercise. 
As most exercise is undertaken in the upright position, exercise HRV measures 
should only be compared with resting measures made in the standing position to 
control for the orthostatic stress induced by assuming this posture (Pagani et at. 
1986; Bernardi et at. 1996). 
During a single bout of steady state (50% V02 max) exercise it was found that 
LF% was greater when compared with measurements made when the subject laid 
supine, but unchanged when compared with standing values (Dixon et at. 1992; 
Kamath and Fallen 1993). HF% was also unchanged compared with standing 
values. 
Using multiple, relative exercise intensities, LF% and HF% were found to be 
similar to standing values at 50 W but then to fall rapidly at 100 Wand 150 W 
(Perini et ai. 1990). Similarly LF% has been shown to increase slightly whereas 
there is a slight decrease in HF% at 110 W. These values then rapidly decrease in 
an almost inverse linear pattern with exercise intensity up to 221 W (Casadei et 
at. 1995). In healthy, older subjects a similar decline in LF% has been 
demonstrated (Perini et at. 2000), but this was found to be accompanied by an 
almost linear reduction in HF% power over exercise intensities equal to 5 - 25 
I k -1 ·-1 m. g .mm. 
Macor et at. (1995) studied subjects while resting and cycling in the supine 
position at 20, 40 and 60% of V02 max .. In contrast to previous findings it was 
found that LF% increased between rest and low intensity exercise, it then 
decreased but remained elevated compared with resting values. In common with 
previous findings HF% was found to be drastically reduced (25 times) at 20% 
V 02 max and by over a 100 times at 60% V 02 max. 
Using LF% and HF% to study autonomic balance during exercise, there is some 
evidence to suggest a slight augmentation of LF%, accompanied by a reduction 
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in HF% at lower intensities. As exercise intensity increases, both these values 
drop dramatically, indicating a greater proportion of the total spectral power to 
be in the VLF waveband (Perini et al. 1990; Casadei et al. 1995). A reduction in 
HF% would be expected, as HF is predominantly, vagally mediated. Such 
findings also support the partial parasympathetic mediation of LF. This explains 
in part, the observed decrease in both these measures with increased exercise 
intensities. Such findings do not, however, support the sympathetic evolution of 
LF. In fact, a complete removal of LF from the power spectrum at higher 
exercise intensities has been reported (Perini et al. 2000). 
4.4.1.3. LFnu, HFnu and LF:HF ratio during exercise. 
To exclude the influence of the VLF waveband on the study of autonomic 
balance during exercise several authors have presented LF and HF in normalised 
units and by using the LF:HF ratio. As the balance between LF (nu) and HF (nu) 
is quantitatively identical to the LF:HF ratio, for simplicity only the latter will be 
discussed here. 
The use of the LF:HF ratio as a measure of sympathovagal balance is supported 
by evidence from orthostatic stress tests and pharmacological manipulation 
(Pagani et al. 1986; Furlan 1987; Montano et al. 1994; Pagani et al. 1997; van de 
Borne et al. 1997). The use of active standing, passive tilting and 
pharmacological sympathetic stimulation are known to increased the LF:HF 
ratio. This has led to the use of the LF:HF ratio as a marker of sympathetic 
activation. If this were the case, during exercise, one would expect the LF:HF 
ratio to increase as a function of exercise intensity. 
During a single steady-state bout of exercise LF:HF was found to be unchanged 
compared with standing values (Kamath et al. 1991). During incremental 
exercise a number of authors have found the LF:HF ratio to be increased at lower 
intensities and to then decline with increasing exercise intensity (Arai et al. 1989; 
Rimoldi et al. 1992; Breuer et al. 1993; Casadei et al. 1995; Tulppo et al. 1996). 
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This pattern of change is not however, universally reported. During incremental 
exercise Perini et al. (1990) found LF:HF ratio decreased steadily up to 50% 
VOl max.. It then increased, although not significantly at 70% VOl max .. Findings 
from the same laboratory using older subjects (Perini et al. 2000) showed LF:HF 
ratio to remain unchanged during low intensity exercise before decreasing at 
higher intensities. The authors cited a largely decreased activity in the LF power 
spectrum to be the reason for this. 
To examine further the relationship between LF:HF ratio, exercise and 
sympathetic activation Breuer et al. (1994) assessed spectral measures of HRV, 
plasma catecholamines and lactate levels simultaneously. Subjects undertook two 
separate exercise protocols, differences in the above measures were assessed 
when subjects went from rest (sitting on a cycle ergometer) to pedalling at a rate 
which elicited a HR of either 100 or 150 BPM. In absolute units, LF and HF 
decreased dramatically at both intensities when compared with resting values. 
The LF:HF ratio at 100 BPM was found to increase from 2.0 at rest to 3.3. At 
150 BPM blood lactate and catecholamine levels were all significantly increased 
from rest. However, in agreement with previous studies, the LF:HF ratio was 
significantly reduced. In addition to exercise, Breuer et al. (1994) also used 
sequential infusion of atropine and catecholamines to simulate the vagal 
withdrawal and sympathetic stimulation that is known to accompany exercise. 
Increased HR via atropine infusion was associated with a significant decrease in 
power in both the LF and HF bands. During the subsequent infusion of 
catecholamines, HR increased significantly and all HRV disappeared completely. 
These findings lend support to the notion that vagal activity modulates both LF 
and HF power. They do no however support the use of LF or therefore LF:HF 
ratio as markers of sympathetic activation. The pharmacological findings and 
lack of association between catecholamine levels and LF, or LF:HF ratio during 
exercise question the usefulness of HRV under such condtions. The authors 
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concluded that the use of HRV may not be justified during exercise above the 
anaerobic threshold, especially as a tool to assess PNS and SNS activity. This 
viewpoint is supported by findings from an alternative method of spectral 
analysis (Yamamoto and Hughson 1991; Yamamoto et al. 1992) which will be 
discussed in the next section. 
4.4.1.4. The role of methodological heterogeneity in the disparity of 
results. 
Prior to discussion of HRV analysis via CGSA it is useful to quantify the role of 
methodological variation to the heterogeneity of results from empirical 
investigations during exercise. Casadei et al. (1994) assessed HRV during 
incremental exercise using GSA and reported their findings in three ways used in 
previous investigations. 
When reported in raw units the expected decrease in TP, was evident. LF 
increased non-significantly from rest to 110 W but then decreased until it 
disappeared totally at 221 W. HF was dramatically reduced at 110 Wand then 
remained unchanged until the end of exercise. Using normalised units it was 
found that LF (nu) initially increased (110 W) but then fell linearly until it had 
disappeared at 221 W. Conversely, HF (nu) initially decreased but then increased 
with exercise intensity until it accounted for 80.4% of spectral power at 221 W. 
When expressed as a percentage of total RR variance (including the VLF 
component) it was found that LF% initially increased but then disappeared and 
HF% remained unchanged throughout the protocol. VLF% remained unchanged 
from rest to 147W (accounting for less than 30% of TP) but then increased 
dramatically until it accounted for more than 65% ofTP. 
The authors stated that the use of LF and HF in raw units and in normalised units 
during exercise may be misleading. The former is modulated very strongly by the 
reduction in total spectral power which accompanies the reduced RR interval 
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associated with exercise. The increase in HF (nu) was attributed to non-neural 
factors such as stretch and atrial node activity. 
It was concluded that spectral analysis of RR interval variability is unable to 
provide adequate assessment of PNS or SNS activity. The decrease in power in 
the LF and HF bands has been interpreted as a withdrawal of vagal activity. This, 
therefore, gives no additional information to that which could be gained from 
analysis of a more simple measure such as SDNN. The authors also claimed that 
the use of normalised units may be misleading due to the alternative genesis of 
HF oscillations during higher intensity exercise. Likewise, it was concluded that 
RR interval oscillations in the LF band cannot reflect sympathetic activation as 
they disappear at higher workloads where adrenergic activity is known to be 
increased. 
4.4.1.5. Reasons for the unexpected behaviour of spectral measures during 
exercIse. 
The decrease in LF:HF observed at higher exercise intensities is largely due to 
increased HF%. There is evidence that the origin of some HF oscillations during 
exercise may be non-neural in nature (Bernardi et ai. 1990). During incremental 
exercise, sedentary subjects displayed the expected pattern of changes in LFnu 
(initial increase followed by a decrease as exercise intensity was augmented) and 
HFnu (initial reduction followed by increase). A similar but more pronounced 
effect was found in highly trained cyclists. However, in cardiac transplant 
recipients no evidence of an LF peak was found at rest or during exercise. A 
small amount of power was detected in the HF frequency at rest (1.17 ms2) 
which increased significantly with exercise a 25 W (7.16 ms2). Although this 
value decreased at 50 W (3.44 ms2) it was still significantly raised compared with 
resting values. 
Casadei et ai. (1996) attempted to quantify the non-neural contribution to RSA in 
an attempt to explain the preservation of HF during exercise by measured HRV 
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at rest and during exercise in subjects with or without ganglionic blockade (OB). 
At rest, OB abolished the RR interval fluctuation in the LF band. HF was greatly 
reduced but was still present and showed a high coherence with the breathing 
signal and the RR interval. During steady state exercise (25% V02 11lax) mean RR 
interval and RR variance were greatly reduced. This moderate level of exercise 
was accompanied by an increased LF:HF ratio common with increased 
sympathetic activation and vagal withdrawal. During exercise GB abolished LF 
and decreased the absolute power of HF but failed to cause a significant change 
in RSA at rest. It was calculated that at rest, non-neural mechanisms are difficult 
to identify but during exercise the proportion of HF power due to non-neural 
mechanisms was increased by 32% (range 17-75 %). 
It was concluded that RR interval oscillations in the LF band are entirely neurally 
mediated but that non-neural mechanisms contribute to the RSA in young 
healthy subjects. Although the contribution of non-neural factors at rest is 
negligible, during moderate intensity exercise may account for up to one third of 
RSA amplitude. 
Further evidence from the existence of non-neural oscillations comes from power 
in the HF band in patients with fixed atrial pacing (Lombardi et at. 1995). The 
possible origins of these non-neural sources of HF oscillation include mechanical 
stretching of the SA node (Bolter 1994). It is known that changes in intramural 
pressure similar to breathing can cause cyclic acetlycholine release, although 
evidence of persistent HF oscillation under muscarinic blockade suggests a more 
direct effect such as increased spontaneous depolarisation due to increased CI-
conductance (Kohl et al. 1994). 
Regardless of the origins of these oscillations, their presence in terms of the use 
of HRV during exercise, means that despite the greatly reduced RR variance 
during exercise, a degree of HF variability will be preserved. This non-neural 
power input to the HF band will serve to grossly overestimate the level of cardiac 
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vagal activity. This will be especially true when HF%, HFnu or LF:HF ratio are 
reported. These findings explain the perhaps unexpected behaviour (increase) of 
LF:HF ratio at higher exercise intensities. It may therefore be concluded that 
although LF:HF ratio may serve as a reliable estimate of cardiac sympathovagal 
balance at rest, it may severely overestimate cardiac vagal tone during exercise 
and any pathological condition where RR variance is known to be reduced 
(Casadei et at. 1996). 
4.4.1.6. The use of alternative exercise protocols to investigate the 
behaviour of spectral measures during exercise. 
All the data on which the above conclusions are made are all based on upright 
exercise. Using recumbent cycling, Macor et at. (1995) demonstrated changes in 
HRV coherent with the notion that LF and HF represent sympathetic and 
parasympathetic activity respectively. To elucidate further the effects of 
increased thoracic blood volume and altered orthostatic load, Perini et al (1998) 
observed the effect of water immersion on HRV responses at rest and during 
exercise. Resting and incremental exercise HRV measures were made with 
subjects either in air or immersed in water (head out). At rest it was found that: 
HF, LF and VLF demonstrated a three-fold increase when expressed in raw units. 
Power in the HF band expressed as HF(nu) and HF% was increased whereas 
LF(nu) LF% and VLF% remained unchanged .. 
During exercise, alterations in HRV measures were similar to those shown 
previously (Casadei et ai. 1994). LF% increased initially and was then reduced 
and a converse effect of exercise on HF% was observed and VLF% increased 
with exercise intensity. These changes were independent of whether the exercise 
took place in air or water. 
The increase in HF during resting immersion was attributed to a greater 
respiratory effort being responsible for an enhanced vagal tone. This claim is 
based on evidence that the vagal nerves are involved with transmission of 
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fluctuations in the entire frequency bandwidth (Pomeranz et al. 1985; Saul et al. 
1990). 
4.4.1.7. Alternative data treatment. 
Alternative data manipulation techniques have also been suggested in an attempt 
to rectify the unexpected behaviours of standard HRV measures and ratios 
(Warren et al. 1997). By using GSA during several intensities of steady state 
exercise these authors were able to assess the behaviour of HF/TP and LF/TP. 
These were derived from a number of different HF and LF bands as measures of 
parasympathetic and sympathetic activity respectively. LF, HF and LF:HF from 
traditional frequency bands were also assessed. Warren et al. (1997) also 
attempted to validate new and existing indices using muscarinic, p-receptor and 
combined blockade at rest and during exercise. They found that HF (0.1-1.0 Hz) 
provided a reliable index of vagal activity during exercise. Its behaviour 
corroborated HR response and was supported by pharmacological data. An 
equivocal index of sympathetic activity was provided by LF/TP (0.004-
0.110.004-1.0 Hz). If corroborated by further findings these results could be of 
great importance in providing information regarding autonomic fluctuations 
during exercise. 
4.4.1.8. Summary of findings using GSA during exercise. 
In conclusion, several authors (Perini et al. 1990; Casadei et al. 1995; Casadei et 
al. 1996; Perini et al. 2000; Perini et al. 2002) agree that HRV is a useful 
measure for assessing the resting autonomic balance but that its use during 
exercise is limited. It is clear that the correct treatment and representation of data 
is crucial as certain representations of findings may be misleading. It seems that 
insight into autonomic control during exercise from traditional GSA measures of 
HRV may be limited to lighter exercise intensities. Few studies have attempted 
to validate findings with autonomic blockade. Where this has been done during 
exercise (Warren et al. 1997) proposed new data treatment techniques show 
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promise in the ability of HRV to provide information regarding exercise 
autonomic function. Conversely to this, exercise itself has provided researchers 
with insight into the origins, and therefore uses, of HRV measures derived from 
this method. 
4.4.2. Heart rate variability response to exercise: findings from studies 
using coarse graining spectral analysis. 
In light of such equivocal findings, research concerning HRV during exercise has 
been carried out using further alternative treatments of the RR interval data. One 
such method is CGSA. This method has been used to examine both the linear and 
non-linear (fractal or chaotic) features of RR interval data. Although a full 
review of fractal dynamics is beyond the scope of this chapter, where necessary, 
basic explanations of the mathematical methods used will be given. For a full 
review the reader is directed to the excellent technical reviews which already 
exist in this area (Hagerman et al. 1996) 
4.4.3. HRV during exercise: Studies using CGSA. 
In a series of papers Yamamoto et al. (1991, 1991b, 1992) and Nakamura et al. 
(1992) first introduced the concept of CGSA, then used the method to examine 
the activity of the PNS and SNS during exercise. CGSA provides improved 
resolution of short-term HRV spectra by removing the fractal component* 
known to exist in HR data (Saul et al. 1988), from the harmonic components*. 
This separation facilitates enhanced analysis of the latter. The fractal component 
is a series of oscillations occurring at differing frequencies. Under GSA these 
oscillations constitute the VLF component of HRV. Fourier analysis of RR 
interval data has shown the existence of fractal 'noise' at frequencies from 
0.00003-0.01Hz (10 hours - 10 seconds) and it is believed that this noise may 
affect assessment ofsympathovagal balance (Yamamoto and Hughson 1991). 
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Due to the removal of parts of the spectrum the high and low frequency bands 
calculated by CGSA are not quantitatively similar to the LF and HF derived from 
GSA. The use of this terminology would therefore be incorrect. Using CGSA the 
low and high frequency bands are commonly reported as Low and High 
respectively, although this is not universal. The LF:HF ratio from GSA is 
therefore replaced in CGSA by the Low:High ratio. Originally High was 
referred to as the PNS indicator. Both Low and Low/High were referred to as the 
SNS indicator (Yamamoto and Hughson 1991; Yamamoto et al. 1991). 
Confusingly, some authors have calculated the additional ratio of High/Total 
Power and also called this the PNS indicator (Gregoire et al. 1996; Amara and 
Wolfe 1998; Myslivecek et al. 2002). 
4.4.3.1. Harmonic oscillations during exercise measured by CGSA. 
In their introductory paper to CGSA (Yamamoto and Hughson 1991) gave an 
illustration of the effects of ramped (15 W'min-1) exercise on Low and High 
spectral peaks. It was found that both Low and High spectral peaks declined as 
exercise intensity increased. Both spectral peaks were eliminated by the time 
'moderate' exercise intensity was reached. From this it would seem that CGSA 
would be oflittle or no use in the study of exercise HRV. 
The same authors (Yamamoto et al. 1991b) performed GSA and CGSA on RR 
data from six, 14 min, steady-state exercise stages and found the PNS indicator 
declined steadily from rest to 60% of ventilatory threshold (T vent) and that the 
SNS indicator increased only above the Tvent . The authors stated that this gave an 
indication of the expected autonomic response to exercise. The authors seem to 
largely ignore two facts concerning these data. Firstly, these data contradict their 
own previous findings (Yamamoto and Hughson 1991). Secondly, and perhaps 
more importantly, the data from GSA differ greatly from those published 
previously (Arai et al. 1989). The authors also fail to mention the great 
similarities in patterns of data using GSA or CGSA. In terms of the Low:High 
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ratio the large increase (1.77 - 6.19) cited as a major finding using CGSA is 
mirrored by a change of similar magnitude shown by GSA (4.0 - 13.5 
approximately). This latter finding failed to reach statistical significance, 
probably due to the large interindividual differences in changes in Low/High 
from 100 - 110% T vent. The LF:HF ratio data computed from GSA in this study 
show changes that are diametrically opposed to those reported in studies carried 
out before (Arai et al. 1989; Perini et al. 1990) and after (Breuer et al. 1993; 
Casadei et al. 1995; Tulppo et al. 1996) in which the LF:HF ratio was calculated 
using the same analyses. On this basis the author's claims that CGSA may be a 
more sensitive tool for use during exercise may be based on spurious data and 
therefore, seriously flawed. 
These authors further investigated the response of GGSA derived HRV, at Tvent 
(Yamamoto et al. 1992) this time using a ramping protocol (2 W·min). Again a 
steady decrease in PNS indicator up to T vent was accompanied by an increase in 
SNS indicator above T vent. Although the authors reported these findings as 
evidence of a large increase in SNS activity at T vent these results should also be 
treated with caution for a number of methodological reasons. 
Yamamoto et al. (1992) make no mention of the large reduction in SNS indictor, 
clearly evident in their results, which occurred at the final work rate, 40 Wabove 
T vent. Additionally, values for the PNS indicator can be seen to increase from 30 
W to 40 W above T vent. Methodologically, none of the results were acquired 
from steady state exercise. The ramping protocol used creates only 'quasi-steady 
state' conditions. The authors attempted to control for this by removing linear 
trends in the data. The authors gave no data concerning the success of this 
delineation and it is clear from the results, that many of the responses at lower 
intensities and at T vent were non-linear in nature. The authors note the use of 
such a protocol is unlikely to demonstrate T vent and the normal respiratory 
indicators of this phenomenon indeed show no evidence of the normal changes 
associated with it. Warren et al. (1997) make the point that certain RR interval 
treatments give results that may be coincidental with established theories of 
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autonomic response. Although they do not make direct reference to CGSA, their 
further observation that exercise HRV has not been validated by autonomic 
blockade or microneurographic studies during exercise is indeed true with 
regards to CGSA. Data regarding validation of the harmonic components at rest 
using pharmacological blockade (Tulppo et al. 2001) and from tilt, in patients 
with autonomic failure (Blaber et al. 1996) provide equivocal results. Lack of 
agreement between CGSA derived measures of central sympathetic outflow and 
direct microneurographic estimates has also been shown (Notarius et al. 1999). 
Using CGSA during exercise Nakamura et ai. (1993) reproduced previously 
obtained results (Yamamoto et al. 1992) using an identical protocol. Nakamura 
et ai. (1993) concentrated their investigation further into changes in the fractal 
component of HRV. This had, until now, been largely ignored. The fractal 
component was assessed by plotting the log frequency vs. log power with fJ 
estimated as the slope of the linear regression of this plot. This plot is 
representative of the complexity of a time series with values 1 < fJ < 3 indicating 
a fractal nature. The more complex the time series the higher the value of fJ (1-3). 
Mathematically, fJ is representative of the number of independent oscillators 
responsible for the generation of any given time series (Yamamoto et al. 1992). 
Physiologically, it is claimed that fJ is representative of the number of inputs 
which affect the cardiovascular control centres and therefore, control HR 
(Goldberger 1990). 
Nakamura et al. (1993) found that fJ approximated 3 during mild exercise and 
decreased linearly during moderate to high exercise intensities. This occurred 
sumultaneously with the decrease in PNS and increase in SNS indicators 
observed at high intensity exercise, and fJ was reduced to <2 indicating a single 
dominant controller to be impinging on HR. As this intensity of exercise 
coincided with a marked lactacidaemia the authors hypothesised that the arterial 
chemoreceptor afferent may be that input. 
Further investigation into the fractal nature of the VLF component of RR interval 
data (Hagerman et al. 1996) confirmed the chaotic nature of the RR interval 
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oscillations in the VLF band by calculating the Lyuapunov exponent*. The 
values obtained were in agreement with previous work (Nakamura et al. 1993). 
Using the 11/ slope* it was found that the complexity of the fractal component 
was reduced but not removed with increasing exercise intensity. 
Further examination of the non-harmonic component in relation to other stimuli 
such as beta-adrenergic blockade (Yamamoto and Hughson 1994; Yamamoto et 
al. 1995; Tulppo et al. 2001; Perkiomaki et al. 2002) sinus arrhythmia 
(Yamamoto et al. 1995) simulated altitude (Yamamoto et al. 1996) has 
continued. However, discussion of these findings is beyond the scope of this 
paper. 
Discussion of the use of the harmonic SNS and PNS indicators derived from 
CGSA is, however, pertinent. Using the method of Yamamoto et al. (1991), 
changes in the PNS and SNS indicators similar to those previously reported have 
been observed during absolute exercise intensities of 50 Wand 100 W (Gregoire 
et al. 1996) and at a single relative exercise intensity of 40% HRmax (Myslivecek 
et al. 2002). The responses noted were found to differ little in groups defined by 
age, gender and habitual physical activity levels (Myslivecek et al. 2002). 
4.4.3.2. Summary of findings from CGSA. 
To conclude, it seems that CGSA may be a more useful tool with which to 
observe the changes in autonomic function that accompany exercise. In contrast 
to the findings derived from GSA, it is commonly found that the expected 
decrease in PNS indicator during low intensity exercise is followed by an 
increase in the SNS indicator at higher intensities. This pattern, followed by an 
abrupt increase in the SNS indicator at or around the T vent is analogous to the 
known sympathetic response observed during incremental exercise using 
invasive methods (Wallin et al. 1992; Kingwell et al. 1994). However, the 
harmonic components derived from this method during exercise have not yet 
been fully validated. Until there is concurrent microneurographic or 
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pharmacologic data regarding PNS and SNS indicators, responses to exercise 
results from CGSA exercise studies should be treated with caution. 
In addition to the information produced by the PNS and SNS indicators, the 
ability of CGSA to separate the harmonic and fractal components of the heart 
signal provides further insight into the nature of autonomic control of HR. The 
fractal component increases as a percentage of the total spectral power with 
increasing exercise intensity but the component's chaotic nature at rest is 
simplified, approaching unity during high intensity exercise. The parallels 
between this harmonising effect and the changes in this component at time of 
death warrant further investigation. 
4.5. Cross-sectional and longitudinal studies examining differences in the 
HRV response to exercise. 
Few studies have attempted to compare the HRV response to exercise between 
groups of subject This is in part, due to the unresolved methodological issues 
which accompany the use of HRV (particularly from GSA) during exercise. In 
the existing data, findings are equivocal. 
Using autoregressive spectral analysis during upright exercise (50% max 
workload) Dixon et al. (1992) found no difference in autonomic balance during 
exercise between athletes and controls despite significant differences at rest. 
Similar findings were produced during recumbent cycling (Macor et at. 1996) at 
20,40 and 50% V02 11lax .. 
Using incremental, upright cycling Tulppo et al. (1998) found that HF power 
during exercise from 50 - 100 W was significantly higher in an 'average' 
(V02peak 51 ± 4 ml'kg-I'min-I) compared with a 'poor' fitness group (V02 peak 34 ± 
3 ml·kg-I·min- l ). This difference was not evident at rest and disappeared at higher 
exercise intensities. Longitudinally, Perini et al. (2002) found no differences in 
LF(nu) or HF(nu) response to exercise after an 8 wk aerobic training programme. 
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Using CGSA, Gregoire et at. (1996) found that young, trained subjects showed 
greater preservation of TP when cycling at 100 W compared with untrained 
controls. This increase was also accompanied by a greater SDRR. There were no 
differences in the SNS or PNS indicators in young subjects either at rest or 
during exercise. The same method was used to monitor longitudinal changes due 
to endurance training (Myslivecek et at. 2002). During exercise (40% HRmax) it 
was found that PNS and SNS indicators were significantly increased and 
decreased respectively in the exercise group post-training compared with 
baseline values and changes in controls. 
Cross-sectional findings from GSA are clearly equivocal although there may be 
some evidence of preserved parasympathetic tone during low to moderate 
intensity exercise. Perini et at. (2001) failed to show any longitudinal alteration 
in HR V measures during exercise due to training. It should be noted that no 
statistically significant differences in resting HRV measures were detected in this 
study either. 
4.5.1. The usefitlness of HRV measures during exercise. 
It seems clear that if GSA is to be used to investigate differences in autonomic 
control during exercise that it may only serve to provide researchers with 
additional, useful information at lower exercise intensities. 
Where CGSA has been used, clearer distinctions between trained and untrained 
groups and pre- and post-training conditions have been demonstrated. This 
method is not without its limitations. Gregoire et at. (1996) were unable to 
process data from higher exercise intensities due to low signal:noise ratios and 
loss of spectral power. Additionally it has been noted (Amara and Wolfe 1998; 
Myslivecek et al. 2002) that the PNS indicator shows large intra- and intersubject 
variation. This measure is highly sensitive to small fluctuation in HF spectral 
power. During exercise, where TP is greatly reduced this may be problematic 
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when making intra- and intergroup comparisons. This phenomenon was 
illustrated in the findings of Myslivecek et ai. (2002). Where pre- and post-
training comparisons were made in a heterogeneous group (pre- and post-
menopausal females) no significant differences were found. This was attributed 
to the wide spread of scores for the PNS indicator. 
In section 3.3.1 the findings of Leicht et al. (2003) were discussed. Analysis of 
RR interval by GSA failed to show any differences in HRV measures post-
training at rest. During walking exercise, (2 km per hour) LF and TP were found 
to be significantly raised when compared with pre-training values in mature 
sUbjects. There was also improved preservation of TP at a work rate 
corresponding to 50% HRmax. 
4.6. Summary 
Resting HRV analysis via simple RSA amplitude, time series and the more 
complex spectral measures is capable of detecting differences in indicators of 
autonomic balance between athletes and controls. When 'trained' and 'untrained' 
individuals are compared the data are equivocal. This is possibly due to unclear 
definitions of these terms and group allocation criteria. 
Longitudinal studies are also equivocal in their findings. This may be due in part 
to research design, such as insufficient training stimulus. The heterogeneity of 
findings from similar study designs suggests a simpler methodological or 
statistical issue may be responsible 
Both study designs show clear examples of a fundamental problem in the use of 
HRV, namely the large interindividual differences which exist in the measures. 
The large spreads of scores commonly reported create overlap between group 
dispersions. This in tum, makes the detection of significant differences between 
group means difficult. Methodologically, it seems that researchers are more 
likely to detect differences in raw units when data undergo suitable 
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transformation. This process can normalise the frequently skewed distributions 
and allow the application of parametric statistical analyses. In terms of spectral 
measures, the use of normalised units or the analogous measure %TP both serve 
to enhance the statistical power associated with given sample sizes. It seems 
that HRV measures may give clear indications of both cross-sectional and 
longitudinal differences in autonomic function if the data are treated and 
analysed carefully. 
During exercise the large reductions in spectral power observed are a 
fundamental problem. Although the use of normalised units and the LF:HF ratio 
to eliminate this difficulty has been employed, traditional measures from GSA do 
not reflect the known patterns of PNS withdrawal and SNS activation with 
increasing exercise intensity although alternative methods are available. 
There are also several methodological problems associated with the assumptions 
underlying the use of FFT on RR interval data, namely recording duration and 
tachogram stationarity. In spite of this, there is evidence to suggest that GSA 
may be able to provide information regarding autonomic control during low-to-
moderate exercise intensity. This information may add to that gained from 
resting HRV measures. Clarification of the behaviour of the HF and LF 
components during incremental exercise is also needed. 
With the use of the GGSA method, a clear illustration of PNS withdrawal and 
SNS activation during exercise can be shown. In addition, more information 
regarding the nature of HR control may be gleaned from analysis of the fractal or 
non-harmonic component of the RR interval data. This area warrants further 
investigation and its application to the study of group differences in trained vs. 
untrained and longitudinal changes in autonomic control due to exercise is 
therefore recommended. Of further interest would be the comparison of GSA and 
CGSA measures derived from the same RR interval data. In the literature this is 
limited to a single study. In this study, the changes in LF and HF differ from all 
previous and subsequent studies. 
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From the limited data where CGSA has been utilised to study group differences 
and changes, the problem of sensitivity has been raised. This problem may 
necessitate the use of more homogenous groups or larger sample sizes from those 
of previous studies in order to show clear differences in autonomic function 
using CGSA. 
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CHAPTER 5. DIFFERNCES IN RESTING MEASURES OF HEART 
RATE VARIABILITY IN FIT AND UNFIT SUBJECTS AS DEFINED BY 
V02 PEAK. 
Abstract. 
Numerous studies have attempted to show differences in HRV measures between 
athletes and control subjects, between active and inactive individuals, and 
between subjects categorised as fit or unfit with mixed results. The aim of this 
chapter was to identify whether significant differences in resting HRV measures 
existed between subjects classed as fit or unfit using the objective measurement 
of V02 peak. 
Resting, five minute HRV measurements were made in 29 volunteers (20 males, 
median age 39, range 19 - 63 years and nine females, median age 35, range 19-
56 years). These subjects then completed an incremental treadmill test to 
V02 peak. Subjects were divided into the fitness categories of high fitness (HI) and 
low fitness (LO). Standard time and frequency domain HRV measures were then 
compared between groups. 
Where necessary, data were transformed to allow application of parametric 
analyses. No significant differences were found in any HRV measures between 
groups using parametric analyses. The same comparison was made using 
analysis of covariance where appropriate and also with non-parametric 
equivalents. Still, no significant differences were found. 
In conclusion, it appears that differences in HRV measures between fit and unfit 
subjects are not statistically significant and that differences in statistical analyses 
between studies are not the cause of the heterogeneity of results reported in the 
literature. 
151 
5.1. Introduction 
Several studies have compared measures of heart rate variability (HRV) between 
subject groups based on fitness levels. Results have been heterogeneous ill 
nature, reporting both differences and similarities between such groups. 
The methodologies used to allocate subjects to groups and the classifications of 
these groups are different between studies. When athletes and sedentary controls 
are compared studies have frequently shown statistically significant differences 
in time and frequency domain measures ofHRV (Katona et at. 1982; Reiling and 
Seals 1988; Dixon et at. 1992; Janssen et at. 1993; Puig et at. 1993; Sacknoff et 
at. 1994; Jensen-Urstad et at. 1997). 
This grouping of subjects according to such criteria gives results representative 
of only a small minority of the population. Elite athletes such as those often used 
are exceptional often in number of ways. Differences between athletes and 
sedentary controls are often due to training volumes, types and intensities beyond 
the reach or capability of the general pUblic. 
More generalisable comparisons are that of recreational athletes and controls, 
active and inactive subjects or the division of a population according to a 
lifestyle or physiological measures. Studies have compared populations based on 
self-reported physical activity (Melanson 2000), maximum workload (Migliaro 
et at. 2001) and V02 max (Shin et at. 1997). Evidence of statistically significant 
differences in HRV measures between these groups has been equivocal. Some 
studies show large differences while other data fail to reach statistical 
significance. In certain cases, either no differences are evident at all or the effect 
is in the opposite direction to that which would be expected. 
There may be a number of reasons for the disparity in findings. Long and short-
term HRV measurement techniques have both been used. Where short-term 
measures have been used, sampling durations have varied. The HRV measures 
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reported have varied between studies. Some studies have focused on HRV 
measures representative of mainly parasympathetic modultion. This is often in 
an attempt to provide evidence of increased parasympathetic modulation to 
explain the resting bradycardia observed in physically active subjects (Janssen et 
al. 1993; Jensen-Urstad et al. 1997). On occasion, this has been done at the 
expense of reporting other HRV measures which may offer additional insight 
into autonomic differences between groups (Janssen et al. 1993). 
Statistical treatment of HRV data has also differed between studies. Due to it's 
dynamic nature, HRV data often display a wide kurtosis. Frequency domain data 
commonly have skewed distributions (Goldsmith et al. 1992; Bigger et al. 1993). 
Many studies give no information concerning normality of HRV data. In some 
cases where measures of central tendency and distribution are given, it is clear 
that inappropriate statistical analyses have been carried out. 
The purposes of the present study were threefold. Firstly, to compare all 
recommended, short-term HRV measures from two groups of subjects allocated 
on the basis of V02peak derived from maximal exercise testing. Secondly, to use a 
variety of statistical methods representative of the current literature to assess the 
role these may play in the heterogeneity of published results. This included 
identifying and controlling for any confounding variables which may affect the 
statistical analysis of differences in HRV. Thirdly, to make recommendations on 
the representation of differences in HRV measures between groups and give 
estimates of necessary sample sizes to provide adequate statistical power in 
further studies. 
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5.2. Methods. 
5.2.1. Subjects. 
Twenty nine university staff and students (20 males median age 39 range 19 - 63) 
and nine females median age 35 (range 19 - 56) were included in the study. All 
subjects were healthy, defined as being free from illness at the time of testing. 
None were known to be taking any medication or have any cardiovascular 
problems that may have influenced the tests carried out. All subjects volunteered 
to participate in the study. Written, informed consent was given separately for 
each part of the study: resting HRV measures, exercise testing and blood lactate 
testing. Subjects were, therefore, able to participate in the study without 
consenting to blood sampling if they so chose. Complete blood lactate analysis 
was only completed on 20 subjects. One subject was excluded from the HRV 
analysis due to technical failure. Full HRV data during exercise was not 
collected on a large proportion of the subjects due to low signal:noise ratio. This 
limitation is further discussed later in the text. 
5.2.2. Equipment. 
5.2.2.1. Heart rate variability measurement. 
HRV measures were made simultaneously using two instruments 
simultaneously; at rest and during exercise. Instrument one was a CardioPerfect 
ST 2001 HRV module (Cardio Control, Delft, The Netherlands). The system 
used a standard 12 lead ECG with a sampling frequency of 1000Hz. The 
sampling time for each HRV analysis was set at 5-min in agreement with current 
guidelines (Camm et at. 1996). The signal was digitised directly and the full 
ECG trace was shown in real time on a computer screen, this signal was 
simultaneously stored on the hard drive of a PC (Dell Computers, Texas, USA.) 
for post hoc analysis. Each sampling period was stored as a single patient ECG 
record. To analyse the variability in RR interval data an automated protocol 
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within the HRV module software was used. The automated filtering system is 
adjustable, and a standardised configuration was used which treated the data as 
described below. 
Editing of the raw RR interval data was carried out using an automatic-threshold-
detection algorithm. The software rejected RR intervals which differed by more 
than 20% from the previous interval. This interval was then interpolated with an 
interval generated on the preceding interval data. The remaining analysis was 
based on the corrected data file of 'normal' RR intervals. The RR data were then 
passed through a Hanning type window to remove baseline trends. The RR 
interval time series was decomposed to the frequency domain via fast Fourier 
analysis. The resulting power spectrum was divided into the following spectral 
bands HF (0.15-0.40 Hz) LF (0.04-0.15 Hz) and VLF (0.0033-0.04Hz). In 
addition to this time domain analysis was also carried out to give the following 
values RMSSD, SDNN and RR interval. 
The second HRV analysis instrument was a VariaCardio (TF5) HRV analysis 
system (Advanced Medical Diagnostics Group Ltd. Leeds, UK). This system 
used a purpose built chest-strap with two electrodes, placed either side of the 
subject's heart. The chest strap sampled at rate of 500 Hz. This signal was then 
sent to a receiver and digitised. The ECG trace and a graphical representation of 
RR interval were displayed in real time on the screen of a designated portable 
computer (IBM Systems USA). The sampling period for each measurement was 
set at 300 seconds or 300 beats which ever was longer. The instantaneous HR 
was derived from the identification of QRS complexes which was sampled at a 
higher rate of 1000 Hz. The RR interval and full ECG data were both stored on 
the hard disk of the designated portable computer prior for post hoc analysis. 
Stored RR interval data were then edited automatically by the software. The 
manufacturers do not give details of the algorithm used to edit the data. To 
ensure effective editing all data were manually edited by a single researcher. 
This was done by visually analysing the raw ECG trace and the graphical 
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representation of the RR interval data given. The researcher rejected intervals 
which appeared to represent potential artefacts, interference or noise. This 
filtered data set was then stored on the hard disk of the PC as a separate data file 
labelled filtered data. All further analysis was carried out on this filtered data set. 
The RR interval time series were decomposed to the frequency domain via fast 
Fourier analysis. The reSUlting power spectrum was divided into the following 
spectral bands HF (0.15-0.40 Hz) LF (0.04-0.15 Hz). Time domain analysis was 
also carried out to give the following values mean squared standard deviation 
(MSSD), SDNN and NN interval. The MSSD was then transformed to the 
RMSSD manually. 
The reasons for the simultaneous use of two HRV systems were twofold. Firstly 
the dual analysis protocol was used to maximise the possibility of capturing the 
maximal amount of data. This is because it is known, especially during exercise 
that changes in the signal-to-noise ratio may prohibit the spectral analysis of RR 
interval data (Gregoire et ai. 1996). Secondly, although HRV analysis is now 
commonplace during exercise there are no data pertaining to the agreement 
between different analysis systems under such conditions. 
5.2.2.2. Respiratory measurements. 
The volume of expired air (V E) and gas exchange measurements were made 
breath-by-breath, using a Medical Graphics Cardi02 online breath-by-breath 
analysis system (Medical Graphics Corporation, st. Paul Minnesota, USA). 
Automated software from the same company (Breeze Suite) created a full set of 
nine-panel-plots (Wasserman et ai. 1999) by which aerobic threshold could be 
detected. Blood lactate analysis was carried out using a YSI 1500 Sport lactate 
analyser (Analytical Technologies, Hanford House, UK). 
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5.2.3. Protocol 
5.2.3.1. Assessment of V02 ~ and CPO~ 
Subjects visited the laboratory on a total of three occasions to undertake different 
parts of the testing protocol. During visit one Vo 2 peak and CPOpeak were 
determined for each subject. Each subject completed a incremental exercise test 
(Bruce) on a motor-driven treadmill (Cardio Control, Delft, The Netherlands) to 
volitional exhaustion. This allowed an estimate of V02peak which was chosen in 
preference to true VOl max. V02peak has been found to be simple to measure, 
enduring standard of aerobic fitness (Mancini et al. 2000). It is less physically 
stressful than VOl max for the subject and is therefore useful when using 
volunteers from clinical populations and the general population. Many subjects 
within these categories frequently have difficulty attaining true VOl max as defined 
by current guidelines (ACSM 2000). During the test VE and 02 and CO2 
exchange were monitored continuously. 
After at least 40-min rest the subjects performed a constant maximal workload 
exercise test on the treadmill. In this instance the researcher manually controlled 
the speed and gradient of the treadmill to elicit a VOl close to (within 10%) the 
value achieved during the Bruce test. Cardiac output (CO) was then assessed 
using the CO2 rebreathing technique (Defares 1960). Cardiac power output 
(CPO) was subsequently calculated using CO and blood pressure measured by a 
hand-held anearoid sphygmomanometer. 
Two non-invasive methods are available to assess cardiac output the equilibrium 
method (Collier 1955) and the exponential method (Defares 1960). The 
exponential method was chosen as subjects experience significantly fewer 
adverse side effects compared with the equilibrium measure (Vanhees et al. 
2000). There are data to support both the validity (Marks et al. 1985; Kuji et al. 
1991) and reliability (Marks et al. 1985) of this method. Briefly, during the 
constant maximal workload test the subject's air supply was changed from room 
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air to breathing from a bag containing 5% C02 and 14% O2 for 10-20 s. The 
subject then rebreathed from this bag until a plateau in the increase in CO2 
concentration was observed. The increase in CO2 and plotting of the CO2 
concentration during the manoeuvre was carried out by an automated protocol 
within the BreezeSuite software. 
5.2.4. Calculations. 
Cardiac power output was derived from the following equation: 
CPO = CO x MAP x K Equation 5-1 
Where MAP is mean arterial pressure, CO is cardiac output as derived from the 
indirect Pick principle via the rebreathing manoeuvre and K is the conversion 
factor (2.22 x 10-3). 
It was therefore first necessary to calculate mean arterial pressure by 
MAP = (SBP +2DBP)/3 Equation 5-2. 
The estimation of cardiac output in this manner is based on the indirect Pick 
principle. The rebreathing manoeuvre gives an estimation of the mixed venous 
PC02. The arterial CO2 is estimated from the end tidal partial pressure of CO2. 
These two values are converted to concentrations automatically by dissociation 
tables within the MedGraphics software. These values are then substituted into 
the indirect Pick equation to give a measure of CO. Equation 5-1 is then used to 
produce CPO and heart rate obtained from successive RR intervals via the 12-
lead ECG can also be used to calculate stroke volume. 
5.2.5. Heart rate variability measurement. 
During the second visit, each subject's resting HRV was analysed. In accordance 
with current guidelines for the capture of RR interval data for HRV analysis 
subjects attended the laboratory having refrained from eating or smoking for 2 
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hours. Subjects were also asked to refrain from alcohol or caffeine containing 
beverages and exercise on the day of the test, and exercise and heavy alcohol 
consumption on the evening prior to the test. Where subjects had failed to meet 
the requirements of the protocol an assessment was made on the potential impact 
of their behaviour on HRV measures and where necessary the test was 
rescheduled. 
Disposable electrodes (Blue Sensor Medicotest, Olstykke, Denmark) were placed 
in the standard configuration for 12-lead ECG and the TF5 chest strap was 
placed laterally across the subject's heart in accordance with manufacturer's 
instructions. Subjects were then asked to lie on a bed in a quiet laboratory (18-22 
°C). Subjects were asked to relax and the researchers monitored their HR 
visually until it became stable. Two simultaneous 5-min ECG recordings were 
then made. Two researchers were required to synchronously start both pieces of 
equipment. Although some auditory clues may have been available, the subject 
was purposely not informed of the start of the recording period. At the end of 
the first recording the subject was asked to stand with feet shoulder width apart 
with hands placed on the back of a tall stool. Subjects were asked not to 
'shuffle' or transfer their weight laterally during the data collection period. A 
second 5-min ECG recording was made when the subjects HR was deemed to be 
stable following the change in position. 
5.2.6. Measurement of HRV, blood lactate and CPO during incremental 
exercise. 
At the third visit to the laboratory, consenting subjects were first required to give 
a resting blood lactate sample. An arterialised capillary finger prick sample was 
taken from the index finger of the left hand and the whole blood was then 
transferred via micropipette to the YSI 1500 Sport Lactate analyser. All data 
were recorded from the analyser immediately and stored electronically for later 
analysis. 
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Subjects were then required to complete three stages of incremental exercise (25, 
50 and 75% V02peak). During this test ECG was continually monitored and 
breath-by-breath analysis of expired air was carried out using the techniques 
already described. The intensity of this exercise was determined from the VOl at 
each level. When the level of predetermined VOl was reached, a further 5-min 
ECG sample was taken. During this period, a blood pressure measurement was 
taken. At the end of 5-min a blood lactate measurement was made using the 
procedure described previously. At the end of each stage the subjects performed 
the rebreathing manoeuvre described earlier but with the addition of being 
instructed to breathe in time with a metronome eliciting a breathing rate of 0.15 
Hz. This was done in accordance with the manufacturer's instruction to ensure 
the adequate rebreathing of the reference gas mixture from the bag. 
5.2.7. Data analysis. 
Data from the resting and supine condition were divided into two groups; high 
fitness (HI) and low fitness (LO) determined by V02peak values obtained during 
maximal exercise testing. Chi squared analysis was used to determine whether 
gender had a significant association with group allocation. 
5.2.7.1. Normality of distribution and homogeneity of variances. 
Normality of distribution for each HRV measure was assessed for the whole 
group using a Shapiro-Wilk's statistic. Additionally homogeneity of variances 
between the LO and HI groups was assessed simultaneously with a spread vs. 
level Levene's Test. This was undertaken for raw data and where necessary 
repeated with a power estimation of transformation by natural logarithms (In). 
This procedure produced a plot of the natural logs of the interquartile ranges 
against the natural logs of the medians for all cells. It additionally produced an 
estimate of the power transformation for achieving equal variances in the cells. 
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This spread-versus-Ievel plot determines the power for a transformation to 
stabilise variances across groups. 
5.2.7.2. Statistical tests of difference. 
Where appropriate, age, height, weight and body mass index were then analysed 
by independent {-test (either raw or log transformed units) to ascertain whether 
significant differences were evident between the HI and LO groups. 
Where significant differences were found the variable was correlated with all 
measures of HRV to identify the magnitude and similarity of the relationship 
with any HRV measures. This was done to estimate the influence of this variable 
on the HRV measure and to estimate the suitability of the variable as a covariate 
in further analysis. Where no relationships between subject descriptor variables 
and measures of HRV were found, independent {-tests were used to examine 
differences between the two groups. Where a suitable covariate was identified 
analysis of covariance (ANCOVA) was used to control for the effect of this 
variable. 
5.3. Results. 
The subject characteristics for the LO and HI groups are given in table 5-1. Chi2 
analysis revealed no significant association between gender and group allocation. 
Heterogeneity of variances meant V02peak required natural logarithmic 
transformation prior to the application of parametric statistical analysis. 
Following transformation the mean Vo 2 peak in the HI group was significantly 
greater than the LO group. With the exception of age (P = 0.06), other subject 
characteristics did not differ between groups. 
All HRV variables were first assessed using independent {-tests (Table 5-2). Age 
was identified as a possible confounding variable and correlated with all HRV 
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measures to estimate the strength of its relationship with each. In the LO group, 
age was found to correlate significantly with HF, HFnu, LFnu and RMSSD. In 
the HI group, similar relationships with age were only found between HF and 
RMSSD. Age was therefore entered as a covariate into the analysis of these two 
variables only. 
Table 5-1. Descriptive characteristics of subjects divided by fitness level. 
LO HI Independent t-test 
V02peak (log units) 3.2 3.8 (= 7.90, 
± 1.4 ± 1.2 P = 0.001 
Age (years) 42.1 32.1 (= 1.96, 
± 14.5 ± 12.3 p= 0.06 
Height (cm) 173.5 178.0 (= 1.38, 
±8.4 ± 8.0 P = 0.18 
Weight (kg) 78.7 77.6 (= 0.25, 
± 11.0 ± 12.8 p= 0.80 
8MI 26.0 24.4 (= 1.50, 
± 3.0 ± 2.6 p= 0.15 
Values are (mean ± SD) for subject variables. All values are raw units (unless otherwise stated) 
and independent {-test values are based on the assumption of homogenous variances. 
Table 5-2. Parametric analysis of heart rate variability between high and low fitness level 
subjects. 
HRV measure LO HI Independent t- Analysis of 
test covariance 
(controlling for 
age) 
TP (ms2) 3079.0 2568.3 (= 0.55, 
± 2707.4 ± 1869.2 P = 0.57 
LF(ln) 2.9 2.9 (= 0.07, 
± 0.5 ± 0.5 p= 0.95 
HF(ln) 2.7 2.8 (= 0.83, F= 2.1, 
±0.7 ± 0.5 P = 0.45 P=0.16 
LF (nu) 57.9 53.2 (= 0.62, 
±17.3 ±21.4 P = 0.54 
HF (nu) 42.1 45.7 (= 0.49, 
±17.2 ±20.2 P = 0.62 
LF:HF ratio 1.77 1.9 (=0.19, 
± 1.89 ± 1.9 P= 0.84 
SDNN (ms) 60.4 56.5 (= 0.50, 
± 22.3 ± 18.1 P= 0.62 
RMSSD (In) 3.7 3.8 (= 0.46, F= 0.79, 
±0.7 ± 0.5 p= 0.65 P = 0.38 
RR interval 961.0 982.6 (= 0.45, 
(ms} ±138.8 ± 107.9 P = 0.65 
Values are (mean ± SD) for subject variables. All values are raw units (unless otherwise stated) 
and independent (-test values are based on the assumption of homogenous variances. Analysis of 
covariance was used when a suitable covariate was identified and all assumptions were met. 
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From Table 5-2 it can be seen that independent t-tests showed no significant 
differences between the two groups. When age was used as a covariate in the 
analysis of HF and RMSSD the P-value moved closer to, but did not obtain 
statistical significance at the P < 0.05 level. 
The final analysis of differences (Table 5-3) was carried out usmg non-
parametric analysis (Mann-Whitney U-test) when data were close to or non-
normally distributed or where heterogeneity of variances was shown between 
groups. This analysis also showed no significant differences between the values 
of HRV measures for the two groups. 
Table 5-3. Non-parametric analysis of selected HRV measures. 
HRV Measure Reason for LO HI Mann-
non- Whitney u-
parametric test. 
anal~sis. 
TP (ms) Close to non- 3079.0 2568.3 Z = -0.17, 
normal ± 2707.4 ± 1869.2 P = 0.86 
distribution 
LF (ms) Non-normal 1343.5 2048.5 Z = -0.70, 
distribution ± 1914.9 ± 2054.9 p= 0.94 
HF (ms) Non-normal 411.3 485.4 Z = -0.84, 
distribution ±410.3 ± 614.6 P = 0.38 
RMSSD (ms) Heterogeneous 48.8 48.5 Z = -0.34, 
variances ± 31.5 ±21.0 P= 0.73 
Non-parametric analysis of selected HRV measures. Where non-normalcy of distribution is the 
reason for this analysis measures of central tendency are median ± interquartile range, all other 
values given are mean ±SD. 
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5.4. Discussion. 
The aims of the present study were to examine differences in HRV measures 
between two groups of healthy subjects allocated on the basis of fitness and to 
examine the role of statistical analysis in explaining the heterogeneous nature of 
existing data from similar study designs. 
By dividing the subject group according to V02peak attained on a maximal 
treadmill test, it was possible to compare subjects with high and low levels of 
fitness. The VOl of the HI group was significantly greater than that of the low 
(29.1 ± 3.6 vs. 43.9 ± 3.2 ml·kg·-1min-', P = 0.001). The magnitude of this 
difference is smaller than that reported in previous studies (Gallagher et al. 1992; 
Goldsmith et al. 1992; Davy et al. 1996). This is probably due to the sampling 
method used in the present study. Whereas previously subjects have been 
recruited purposely to enter either a fit or unfit group, here subjects were 
recruited as an opportunity sample and allocated to groups based on V02peak from 
maximal treadmill test performance. The HI subject group were also 
significantly younger than the LO group (P = 0.001) but they did not differ 
significantly on any other physical characteristic. 
Analysis of HRV measures between the LO and HI groups found no significant 
differences. The results suggest that, in a normal healthy population, there are no 
significant differences in HRV measures between fit and unfit subjects. 
Resting bradycardia has been observed in active, or fit subjects. In an attempt to 
explain the underlying causes of this bradycardia, differences in HRV markers of 
vagal tone have been measured in fit and unfit groups. Where cross-sectional 
comparisons of HRV measures have been made between athletes and sedentary 
controls, data suggest significant differences between groups on all HRV 
measures when 24-hour monitoring is used (Goldsmith et al. 1992; Jensen-
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Urstad et al. 1997). Although not in unanimous agreement, short-term EeG 
measurements have produced some similar results. 
Puig et al. (1993) found significantly greater values for time domain measures in 
a group of mixed (aerobically and anerobically trained) athletes when compared 
to controls. Dixon et al. (1992) and Sacknoff et al. (1994) found increased vagal 
tone (HF) and reduced mixed vagal/sympathetic tone (LF) in endurance-trained 
athletes when compared to controls. Jannssen et al. (1993) found similar results 
using pNN50% as a marker of vagal tone and Shin et al. (1997) found no 
difference in LF but a significantly increased values for HF. This was taken as 
evidence for an increased vagal tone in athletes. 
A number of studies show mixed results concerning HRV markers of vagal and 
sympathetic tone in athletes and controls. Aubert et al. (2001) found greater time 
domain measures ofHRV in aerobically trained athletes than controls. Although 
they also found greater overall spectral power in this group, this was due to 
increased power in the LF band. Such findings demonstrate that differences 
between athletes and controls are not as homogenous as would perhaps be 
inferred if increased vagal tone is responsible for the bradycardia observed in 
athletes. Macor et al. (1996) found a greater percentage of HF power (HF%) in 
cyclists compared to controls but this was mainly due to greater LF power in the 
control group, as HF in raw units was similar between groups. Similarly, Shin et 
al. (1997) found a difference in HFnu but failed to provide raw units making 
confirmation of the reason for this difference difficult. 
Results from short-term analysis therefore provide less than unanimous support 
for the notion that training induced bradycardia is due to increased vagal tone. 
More importantly they do not fully support the notion that chronic exercise 
training increases vagally-mediated measures ofHRV. 
When comparisons between controls and recreational athletes or fit and unfit 
subjects are made, the results remain equivocal. Some studies have shown very 
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large differences between active and sedentary subjects. Davy et al. (1997) found 
significantly higher TP, LF, HF and SDNN in active postmenopausal women 
compared to controls. The active groups were selected on the basis of habitual 
physical activity but the difference in fitness levels was very large. The fit group 
had almost double the VOlmax of the unfit group (50.3 ± 2.5 vs. 26.7 ± 0.8 ml'kg-
I·min-I). In the present study, the raw V02 values were less distinct between 
groups to those above (44.1 ± 2.3 vs. 26.4 ± 3.3 ml'kg-I'min-I) which may go 
some way to explain why in the present study, as in the majority of other studies 
using this type of group allocation, reported results are negative. 
In agreement with data from the present study, Gallagher et al. (1992) found no 
difference in LF:HF ratio between fit and unfit groups based on VOl max test 
scores. This was despite a difference between the groups of more than 40 ml'kg-
I·min-I. Melanson (2000) allocated men to low, medium and high activity 
groups based habitual activity questionnaire results. He found no statistically 
significant differences between any of the groups although in the high activity 
group TP and HF were marginally higher than the low group (P = 0.07, P = 0.06 
respectively). Migliaro et al. (2001) classified subjects as being either active or 
sedentary and verified groups allocation based on performance on an exercise 
stress test. Again, no significant differences in time or frequency domain 
measures were found. 
The findings of the present study concur with previous data (Gallagher et al. 
1992; Melanson 2000; Migliaro et al. 2001). There were no significant 
differences in either time or frequency domain variables between the groups 
despite a difference in VOlmax of 14.8 ml·kg-I·min-I. The above studies used a 
variety of group allocation criteria and varied methods by which to analyse group 
differences. For instance, Gallagher et al. provide no statistic to describe the 
spread of their data. However, other measures they report such as RSA show 
heterogeneous variances it is therefore likely that the data used in the ANOV A 
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performed on their data may have violated the assumptions underlying the use of 
this test. 
5.4.1. Impact of statistical methods. 
Melanson (2000) used natural logarithms to allow the application of parametric 
analysis to his data, whereas Migliario et al. (2001) used a less powerful, non-
parametric test to analyse their data. To assess the impact of these differences in 
data treatment data in the present study were carefully checked to ensure the 
assumptions underlying the statistical test used were not violated. Where 
appropriate, transformations were made data were again checked to ensure the 
success of this action. Additionally, non-parametric analyses were also used for 
comparability with previous data. 
Following the application of all the above data treatments, still, no significant 
differences were found between the groups in the present study. This leads to the 
conclusion that differences in HRV measures are not significant between fit and 
unfit individuals. 
The literature concerning HRV in the general population is in agreement that 
ageing is associated with reduced HRV (Coumel et al. 1994; Reardon and Malik 
1996; Stein et al. 1997; Barnett et al. 1999; Kuo et al. 1999; Kuch et al. 2001; 
Parati et al. 2001). There is also evidence that it may be ageing per se and not 
associated reductions in physical activity which is responsible of this decline 
(Fukusaki et al. 2000). Although previous studies have used matched age 
groups, in the present study this was not done. Where age was found to be related 
to HRV measures it was added as covariate to control for its effects. This 
analysis led to the same conclusions being drawn as no differences were evident. 
5.4.2. Application offindings. 
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The findings of the present study may, at first, seem to add little to the already 
existing knowledge base provided by previous data. However, studying two 
groups of healthy subjects divided in this manner provides insight into 
ambivalent findings from previous cross-sectional and longitudinal studies. 
It seems that the differences in data treatment and statistical analysis are not the 
reasons for the equivocal nature in the existing literature. The reason for the 
differences in findings seems more likely to be due to the subject group studied. 
The majority of studies where large differences in HRV measures have been 
shown involve groups which differ greatly from each other in terms of fitness 
(Gallagher et at. 1992; Goldsmith et at. 1992). However, where the values of, 
for example, 1702 max are less disparate between groups (Macor et at. 1996) no 
significant differences in HRV are reported. 
Although the study of cross-sectional differences between disparate groups has 
several methodological advantages the applicability of findings to 'real world' 
situations is limited. Changes in 1702 max due to training interventions are 
genuinely modest compared to cross sectional differences observed between 
groups. Where longitudinal changes in HRV have been studied, increases in 
1702 max due to training have varied, as have reported changes in HRV measures. 
Davy and Seals (1997) found no increase in 1702 max or HRV measures following 
training in older women. Increases in 1702 max of 4.3 ml·kg-1·min-1 (Boutcher and 
Stein 1995) 1.3 ml'kg-1'min-1 (Uusitalo et at. 2002) 1 and 4 ml'kg-1'min-1 
(Loimaala et at. 2000) were all found to occur independently of significant 
changes in HRV. Similarly, two groups of older women who demonstrated 
training induced changes in 1702 max of 3.4 min and 4.7 ml'kg-1'min-1 showed no 
significant alteration in HRV (Perini et at. 2002). 
aI-Ani et at. (1996) reported changes in certain HRV measures following a mean 
change in 1702 max of 6.0 ml·kg-1·min-1. Changes in HRV measures have also been 
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observed accompanying very large (16.5%) changes (Melanson and Freedson 
2001) and very small (0.3%) changes (Portier et al. 2001) in V02max. 
In common with the cross-sectional data, a number of the above studies have 
certain shortcomings in data treatment and analysis. Although the findings of the 
present study may suggest this may not be the reason for any lack of statistically 
significant differences being detected the importance of correct data treatment 
should still be stressed. 
A reason for the equivocal nature of longitudinal findings may be due to the 
nature of measurement. HRV is a dynamic measurement and therefore subject to 
variation over short and long time periods. Numerous studies have reported poor 
reliability coefficients for HRV measurements, particularly short-term measures. 
This lack of reliability coupled with the high intersubject variation displayed by 
mean HRV measures reduces overall effect size (d) of any intervention. The 
simplest way to counteract this is to increase sample size, yet the majority of the 
existing studies have relatively small sample populations. If small sample sizes 
are used some remark as to the power of the study should be made. This may aid 
the reader in assessing the meaningfulness of the data reported. 
None of the studies cited here give any evidence of power calculations in their 
methodologies including the present work. In this incidence it was because the 
data collected here were done so in an attempt to elucidate reasons for previous 
equivocal findings. Interestingly the power calculations made for the present 
study based on the work of Shin et al. (1996) for LFnu and HFnu yielded 
necessary sample sizes of n = 22 and n = 6 respectively. As an example of the 
variability in HRV measurements obtained in studies retrospective analysis 
revealed the power of the present study for HF was only j3 = 0.1. This illustrates 
that although power calculations should be carried they are not guaranteed to 
counteract methodological shortcomings. 
Studies in this area, including the present one are, however, not without credit. 
From the current body of literature, meta-analysis be able to answer more fully, a 
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number of the research questions posed. This is again, not without problem. The 
existing data is disparate in nature concerning population age, sex and fitness 
levels. Cross-sectional data are based on comparisons of many different groups 
using numerous criteria. Longitudinal data contain many different exercise 
interventions in terms of type, duration, frequency and intensity. 
To answer questions concerning the role of the autonomic nervous system in 
resting bradycardia or whether exercise interventions can alter HRV measures, 
some type of meta-regression may also be useful. This will then not only 
ascertain answers to the questions themselves but may also guide further 
empirical research and treatment as to the necessary nature of any intervention 
aimed at, for example increasing certain HRV measures through exercise. 
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CHAPTER6. PATTERNS IN TIME AND FREQUENCY DOMAIN 
MEASURES OF HEART RATE VARIABILITY IN RESPONSE TO 
EXERCISE: THE EFFECTS OF BASELINE HRV CHARACTERISTICS 
IN RESPONSE TO EXERCISE. 
Abstract. 
The primary aim of the present study was to observe changes in time and 
frequency domain measures of HRV derived from short-term recordings during 
three steady state exercise conditions. This was to verify the patterns of changes 
observed in previous studies using similar methodologies. A second aim of this 
study was to assess the effects of resting HRV characteristics on the response to 
exerCIse. 
Twenty nine university staff and students (20 males, median age 39 range 19 -
63) and nine females median age 35 (range 19 - 56) were included in the study. 
Each subject underwent incremental treadmill testing to V02 peak. On a separate 
occasion, subjects then underwent sequential, 5-min HRV recordings during 
supine rest, standing exercise at 25%, 50% and 75% V02 peak. Effects of change 
in position and exercise were assessed using repeated measures ANOV A with 
post hoc repeated measures t-tests. 
All time domain and absolute frequency domain HRV measures decreased 
significantly form supine to standing and through the three exercise intensities 
(P<O.OOl). Normalised spectral power changed significantly between the 
conditions (P<0.05) but did not behave in a uniform manner. When subjects were 
divided according to levels of sympathovagal balance at rest (using the low to 
high frequency power ratio LF:HF) there were significant interactions between 
groups (P<0.005) 
Results of this study agree with previous published data suggesting that 
recommended resting measures of HRV cannot suitable describe the changes in 
autonomic balance which occur during exercise, particularly at higher intensities. 
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Between-subject differences in sympathovagal balance may go some way to 
explaining the heterogeneity of findings in previously published studies. 
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6.1. Introduction. 
One of the most profound effects of rhythmic exercise on the body is the increase 
in heart rate (HR). This increase is known to be a combination of at least three 
different mechanisms: the Frank-Starling law of the heart, humoral factors and 
the autonomic nervous system (ANS). 
The behaviour of the autonomic nervous system has been well documented 
through the use of invasive measures of the sympathetic and parasympathetic 
branches of the ANS. This has led to the accepted theory that initial exercise 
induced tachycardia occurs due to parasympathetic withdrawal but that continued 
increases in HR at higher exercise intensities are brought about via sympathetic 
activation (Robinson et al. 1966; Maciel et al. 1986). 
Since the observation of the rhythmic oscillations in RR interval was proposed as 
a possible non-invasive measure to assess the functioning of the short-term 
cardiovascular control systems (Akselrod et al. 1981) heart rate variability 
(HRV) has been frequently used as a marker of autonomic modulation of HR. 
Although most commonly used during resting conditions, short-term measures of 
HRV have been used to assess autonomic response to a number of stimuli 
including both physical and mental stressors (Pagani et al. 1995). 
There are well-documented associations between HRV and autonomic function 
at rest. The study of HRV during exercise has yielded results inconsistent with 
accepted theory (Casadei et al. 1995) and concurrent, invasive markers of 
autonomic activity (Wallin et al. 1992; Breuer et al. 1993; Kingwell et al. 1994). 
One consistent finding during exercise is a reduction in the overall variability in 
HR (Levy et al. 1998). This leads to reduced spectral power in all frequency 
bands (Perini et al. 1990; Perini et al. 2000; Perini et al. 2002). Findings 
concerning the remaining measures derived from RR interval variation are 
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inconsistent. This may in part be in part due to the varied methodologies 
reported in the literature. 
Such variations include: 
o The type of exercise undertaken 
o The intensity of exercise 
o The use of relative or absolute exercise intensities 
o The use of single steady state, incremental or ramped exercise protocols 
o The age, gender and physiological characteristics of the study population 
o The length of the RR interval recording 
o The mathematical methods used to transform RR intervals into the 
frequency domain 
The aim of the present study was firstly, to observe changes in time and 
frequency domain measures of HRV derived from short-term recordings during 
three steady state exercise conditions. This was done to verify the patterns of 
changes observed in previous studies using similar methodologies. A second aim 
of this study was to assess the effects of resting HRV characteristics on the 
response to exercise. 
6.2. Methods. 
6.2.1. Subjects 
Twenty nine university staff and students (20 males median age 39 range 19 - 63) 
and nine females median age 35 (range 19 - 56) were included in the study. All 
subjects were healthy, defined as being free from illness at the time of testing. 
None were known to be taking any medication or have any cardiovascular 
problems that may have influenced the tests carried out. All subjects volunteered 
to participate in the study. Written, informed consent was given separately for 
each part of the study: resting HRV measures, exercise testing and blood lactate 
testing. Subjects were, therefore, able to participate in the study without 
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consenting to blood sampling if they so chose. Complete blood lactate analysis 
was only completed on 20 subjects. One subject was excluded from the HRV 
analysis due to technical failure. Full HR V data during exercise was not 
collected on a large proportion of the subjects. This will be discussed fitrther in 
the results and limitations sections. 
6.2.2. Equipment. 
6.2.2.1. Heart rate variability measurement. 
HRV measures were made simultaneously using two instruments simultaneously; 
at rest and during exercise. Instrument one was a CardioPerfect ST 2001 HRV 
module (Cardia Control, Delft, The Netherlands). The system used a standard 
12-1ead ECG with a sampling frequency of 1000Hz. The sampling time for each 
HRVanalysis was set at 5-min in agreement with current guidelines (Camm et 
al. 1996). The signal was digitised directly and the fit/I ECG trace was shown in 
real time on a computer screen, this signal was simultaneously stored on the 
hard drive of a PC (Dell Computers, Texas, USA.) for post hoc analysis. Each 
sampling period was stored as a single patient ECG record. To analyse the 
variability in RR intenJal data an automated protocol within the HRV module 
software was used. The automated filtering system is adjustable, and a 
standardised configuration was used which treated the data as described below. 
Editing of the raw RR intenJal data was carried out using an automatic-
threshold-detection algorithm. The software rejected RR intenJals which differed 
by more than 20% from the previous in tenJa I. This interval was then 
interpolated with an intenJal generated on the preceding intenJal data. The 
remaining analysis was based on the corrected data file of 'normal' RR 
intervals. The RR data were then passed through a Hanning type window to 
remove baseline trends. The RR interval time series was decomposed to the 
ji'equency domain via fast Fourier analysis. The resulting power spectrum was 
divided into the following spectral bands HF (0.15-0.40 Hz) LF (0.04-0.15 Hz) 
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and VLF (0.0033-0.04 Hz). In addition to this time domain analysis was also 
carried out to give the following values RMSSD, SDNN and RR interval. 
The second HRV analysis instrument was a VariaCardio (TF5) HRV analysis 
system (Advanced Medical Diagnostics Group Ltd. Leeds, UK). This system used 
a purpose built chest-strap with two electrodes, placed either side of the 
subject's heart. The chest strap sampled at rate of 500 Hz. This signal was then 
sent to a receiver and digitised. The ECG trace and a graphical representation 
of RR interval were displayed in real time on the screen of a designated portable 
computer (IBM Systems USA). The sampling period for each measurement was 
set at 300 seconds or 300 beats which ever was longer. The instantaneous HR 
was derived from the identification of QRS complexes which was sampled at a 
higher rate of 1 000 Hz. The RR inten1al and full ECG data were both stored on 
the hard disk of the designated portable computer prior for post hoc analysis. 
Stored RR inten1al data were then edited automatically by the software. The 
manufacturers do not give details of the algorithm used to edit the data. To 
ensure effective editing all data were manually edited by a single researcher. 
This was done by visually analysing the raw ECG trace and the graphical 
representation of the RR inten1al data given. The researcher rejected inten1als 
which appeared to represent potential artefacts, interference or noise. This 
filtered data set was then stored on the hard disk of the PC as a separate data 
file labelled filtered data. All fitrther analysis was carried out on this filtered 
data set. The RR inten1al time series were decomposed to the frequency domain 
via fast Fourier analysis. The resulting power spectrum was divided into the 
following spectral bands HF (0.15-0.40 Hz) LF (0.04-0.15 Hz). Time domain 
analysis was also carried out to give the following values mean squared standard 
deviation (MSSD), SDNN and NN interval. The MSSD was then transformed to 
the RMSSD manually. 
The reasons for the simultaneous use of two HRV systems were twofold. Firstly 
the dual analysis protocol was used to maximise the possibility of capturing the 
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maximal amount of data. This is because it is known, especially during exercise 
that changes in the signal-to-noise ratio may prohibit the spectral analysis of RR 
interval data (Gregoire et al. 1996). Secondly, although HRV analysis is now 
commonplace during exercise there are no data pertaining to the agreement 
between different analysis systems under such conditions. 
6.2.2.2. Respiratory measurements. 
The volume of expired air (VE) and gas exchange measurements were made 
breath-by-breath, using a Medical Graphics Cardi02 online breath-by-breath 
analysis system (Medical Graphics Corporation, St. Paul Minnesota, USA). 
Automated software from the same company (Breeze Suite) created a fitll set of 
nine-panel-plots (Wasserman et al. 1999) by which aerobic threshold could be 
detected. Blood lactate analysis was carried out using a YSI 1500 Sport lactate 
analyser (Analytical Technologies, Hanford House, UK). 
6.2.3. Protocol 
6.2.3.1. The Assessment V02peak and CPO~ 
Subjects visited the laboratory on a total of three occasions to undertake 
different parts of the testing protocol. During visit one V02peak and CPOpeak were 
determined for each subject. Each subject completed a incremental exercise test 
(Bruce) on a motor-driven treadmill (Cardio Control, Delft, The Netherlands) to 
volitional exhaustion. This allowed an estimate of V02peak which was chosen in 
preference to true V02 max. Vo 2 peak has been found to be simple to measure, 
enduring standard of aerobic fitness (Mancini et al. 2000). It is less physically 
stressfitl than V02 max for the subject and is therefore usefitl when using 
volunteers from clinical populations and the general population. Many subjects 
within these categories ji-equently have difficulty attaining true V02 max as defined 
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by current guidelines (ACSM 2000). During the test VE and 02 and CO2 
exchange were monitored continuously. 
After at least 40 min rest the subjects performed a constant maximal workload 
exercise test on the treadmill. In this instance the researcher manually controlled 
the speed and gradient of the treadmill to elicit a VOl close to (within 10%) the 
value achieved during the Bruce test. Cardiac output (CO) was then assessed 
using the C02 rebreathing technique (Defares 1960). Cardiac power output 
(CPO) was subsequently calculated using CO and blood pressure measured by a 
hand-held anearoid sphygmomanometer). 
Two non-invasive methods are available to assess cardiac output the equilibrium 
method (Collier 1955) and the exponential method (Defares 1960). The 
exponential method was chosen as subjects experience significantly fewer 
adverse side effects compared with the equilibrium measure (Vanhees et al. 
2000). There are data to support both the validity (Marks et al. 1985; Kuji et al. 
1991) and reliability (Marks et al. 1985) of this method. Briefly, during the 
constant maximal workload test the subject's air supply was changed from room 
air to breathing from a bag containing 5% C02 and 14% O2 for 10-20 s. The 
subject then rebreathed from this bag until a plateau in the increase in CO2 
concentration was observed. The increase in CO2 and plotting of the CO2 
concentration during the manoeuvre was carried out by an automated protocol 
within the BreezeSuite software. 
6.2.3.2. Calculations. 
Cardiac power output was derived from the following equation: 
CPO = CO x MAP xK Equation 6-1. 
Where MAP is mean arterial pressure, CO is cardiac output as derived from the 
indirect Fick principle via the rebreathing manoeuvre and K is the conversion 
factor (2.22 X 10-3). 
It was therefore first necessary to calculate mean arterial pressure by 
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MAP = (SBP +2DBP)/3 Equation 6-2. 
The estimation of cardiac output in this manner is based on the indirect Fick 
principle. The rebreathing manoeuvre gives an estimation of the mixed venous 
PC02. The arterial CO2 is estimated from the end tidal partial pressure of CO2. 
These two values are converted to concentrations automatically by dissociation 
tables within the MedGraphics softvvare. These values are then substituted into 
the indirect Fick equation to give a measure of co. Equation 6-1 is then used to 
produce CPO and heart rate obtained from successive RR intervals via the 12-
lead ECG can also be used to calculate stroke volume. 
6.2.3.3. Heart rate variability measurement. 
During the second visit, each subject's resting HRV was analysed. In 
accordance with current guidelines for the capture of RR interval data for HRV 
analysis subjects attended the laboratory having refrained from eating or 
smoking for 2 hours. Subjects were also asked to refrain from alcohol or caffeine 
containing beverages and exercise on the day of the test, and exercise and heavy 
alcohol consumption on the evening prior to the test. Where subjects had failed 
to meet the requirements of the protocol an assessment was made on the 
potential impact of their behaviour on HRV measures and where necessary the 
test was rescheduled. 
Disposable electrodes (Blue Sensor Medicotest, Olstykke, Denmark) were placed 
in the standard configuration for 12-lead ECG and the TF5 chest strap was 
placed laterally across the subject's heart in accordance with manufacturer's 
instructions. Subjects were then asked to lie on a bed in a quiet laboratory (J 8-
22 QC). Subjects were asked to relax and the researchers monitored their HR 
visually until it became stable. Two simultaneous 5-min ECG recordings were 
then made. Two researchers were required to synchronously start both pieces of 
equipment. Although some auditory clues may have been available, the subject 
was purposely not informed of the start of the recording period. At the end of 
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the first recording the subject was asked to stand with feet shoulder width apart 
with hands placed on the back of a tall stool. Subjects were asked not to 'sh4fle' 
or transfer their weight laterally during the data collection period. A second 5-
min ECG recording was made when the subjects HR was deemed to be stable 
following the change in position. 
6.2.4. Measurement of HRV, blood lactate and CPO during incremental 
exercise. 
At the third visit to the laboratory, consenting subjects were first required to give 
a resting blood lactate sample. An arterialised capillary finger prick sample was 
taken from the index finger of the left hand and the whole blood was then 
transferred via micropipette to the YSI 1500 Sport Lactate analyser. All data 
were recorded from the analyser immediately and stored electronically for later 
analysis. 
Subjects were then required to complete three stages of incremental exercise (25, 
50 and 75% V02peak). During this test ECG was continually monitored and 
breath-by-breath analysis of expired air was carried out using the techniques 
already described. The intensity of this exercise was determined fi'om the V02 at 
each level. When the level of predetermined V02 was reached, a filrther 5-min 
ECG sample was taken. During this period, a blood pressure measurement was 
taken. At the end of 5-min a blood lactate measurement was made using the 
procedure described previously. At the end of each stage the subjects performed 
the rebreathing manoeuvre described earlier but with the addition of being 
instructed to breathe in time with a metronome eliciting a breathing rate of 0.15 
Hz. This was done in accordance with the mamifacturer's instruction to ensure 
the adequate rebreathing of the reference gas mixture from the bag. 
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6.2.5. Data analysis. 
6.2.5.1. Data treatment and statistical analyses. 
From the CardioPerfect system the following measurements were used: low 
frequency spectral power in raw (LF) and normalised units (LFnu), high 
frequency power in raw (HF) and normalised units (HFnu), the ratio of LF:HF, 
the root mean square of successive normal-to-normal intervals (RMSSD), the 
standard deviation of all normal-to-normal intervals (SDNN) and the mean RR 
interval (RR). 
All data were tested for normality of distribution using a Shapiro-Wilk's test. 
Where distributions were found to be skewed logarithmic transformation (In) was 
used to allow the use of parametric statistical analysis. Descriptive statistics 
were displayed as mean ± SD unless otherwise stated and as raw or normalised 
units unless log transformation has been carried out (In). 
6.2.5.2. Heart rate variability during exercise. 
To observe differences in these measurements over time, repeated-measures 
analysis of variance (rm-ANOV A) was applied. Data were first checked for the 
assumption of sphericity using Mauchly's test. Where the data displayed 
sphericity, significance at the given degrees of freedom for that comparison was 
accepted. Where the data were found to violate this assumption the given value 
of epsilion was used to adjusted (reduce) the degrees of freedom (and hence the 
value of P for any given value of F). As the assumption of sphericity is 
commonly violated in biological data, where no reasonable adjustment of df 
could be made the multivariate test value was taken. The calculation of this value 
does not require the assumption of sphericity. Where a significant main effect 
was found post-hoc analyses were carried using a repeated measures t-test out to 
identify points at which significant changes occurred without adjustment of 
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alpha. This was done despite the use of multiple comparisons being made to 
ensure findings were comparable to those of previous studies. 
6.2.5.3. The effect of baseline characteristics on heart rate variability 
during exercise. 
To study the effects of baseline characteristics on HRV responses to exercise the 
subject group was split into two groups. Those who showed vagal predominance 
(LF:HF> 1 ) (VA) and those with sympathetic predominance (LF:HF<l) (SY) at 
baseline (supine). To assess the effect of gender on group allocation I analysis 
was used. To assess any interaction between condition and group a two-way 
mixed analysis of variance was used (mixed-ANOV A). Post hoc analysis 
between conditions was carried out using repeated measures t-test between 
groups. Independent t-tests were used for between group-comparisons where 
appropriate. 
Although graphical representations of all data are provided, rm-ANOV A did not 
include data from the supine condition due to the large increase in between-
condition variance this created. Therefore, all analyses were carried out on four 
conditions: standing 25%, 50% and 75% V02 peak. 
In all cases, a value of P :s 0.05 was taken as showing a significant difference. 
All analyses were carried out using SPSS version 11.0. SPSS Inc. (Chicago IL. 
USA). 
185 
6.3. Results. 
6.3.1. The effects of exercise on heart rate variability. 
The physiological characteristics of the subjects are given in table 6-1. The 
patterns of the RR interval (Figure 6-1) demonstrate a significant (F = 3.6, P < 
0.0005) overall effect of exercise condition on RR interval. It should be noted 
that not all data are present in the 75% V02 peak condition. This was due to low 
signal:noise ratio at this exercise intensity, which prevented the accurate 
detection of RR intervals. 
Table 6-1. Descriptive statistics for all subjects (mean ± SD) 
Age (years)* 
Height (em) 
Mass (kg) 
BMI 
VOZ peak (In) 
Males 
36 (22 - 55) 
176.2 ± 8.5 
80.1 ± 11.0 
25.4 ± 3.6 
3.2 ± 1.2 
*Median and range reported. 
6.3.1.1. Time domain data. 
Females 
40 (22 - 55) 
165.4 ±7.0 
66.4 ± 8.1 
25.9 ± 2.6 
2.8 ± 1.1 
Figure 6-2 shows the responses to exercise of the two time domain HRV 
measures used. There were significant effects for condition in both RMSSD (F 
= 3.6, P < 0.05) and SDNN (F= 10.1, P < 0.0005). Post hoc analyses revealed 
no change in RMSSD from standing to 25% or from 50 to 75%. Values for 
SDNN decreased significantly between all conditions except between 50 and 
75%. Again, it should be noted that the data at 75% Voz peak are representative of 
only n = 19 cases. 
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Figure 6-2. RMSSD from supine rest to 75% V02 peak in all subjects. 
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Figure 6-3. SDNN from supine rest to 75% VOl peak in all subjects. 
6.3.1.2. Frequency domain data. 
Due to the skewed nature of the data, logarithmic transformations of the 
frequency domain data were carried out prior to statistical analysis. Figure 6-4 
shows LF and HF in raw units (ms2) in all conditions. There was a significant (F 
= 61.1, P < 0.0005) and HF (F = 25.2, P < 0.0005) from standing to 50% 
VOl peak. 
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Figure 6-4. High and low frequency power (raw units) from supine rest to 75% V02 peak in 
all subjects. 
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Figure 6-5. High and low frequency power (normalised units) from supine rest to 
75% V02 peak in all subjects. 
Power in both frequency bands was decreased as a function of exercise intensity 
(Figure 6-4). This was more pronounced in LF than HF. Post hoc analysis 
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(repeated measures t-test) showed LF decreased significantly (P < 0.05) between 
each condition except from 50-75% V02 peak. Power in the HF band remained 
unchanged from standing to 25% then only decreased significantly from 25 -
50% V02 peak. 
When expressed in normalised units (Figure 6-5) rm-ANOVA showed no main 
effect of intensity (F = 1.9, P > 0.05). Post hoc analysis (repeated measures t-
test) showed LF only decreased significantly from 50 to 75% V02 peak (t = 5.4, P 
< 0.0001). There was also no significant overall effect of condition on HFnu (F 
= 1.3, P > 0.05). Post hoc analysis revealed HFnu remained unchanged from 
standing to 25% but increased significantly from 25 to 50% (t = 5.4, P = 0.0001) 
and from 50 to 75% (t = 2.1, P < 0.05). 
6.3.2. The effect of subject baseline characteristics of heart rate 
variability response to exercise. 
The data were split into groups dependent on sympathovagal balance at rest. 
Fourteen (3 females) subjects were placed in the VA group, the remainder made 
up the SY group (2 females). Analysis by X2 confirmed no effect of gender on 
group allocation. 
6.3.2.1. Time domain measures. 
During supine rest independent t-tests revealed no statistically significant 
differences between SY and VA groups in any time domain measures (P> 0.05). 
Analysis of RR interval data by mixed-ANOV A (Figure 6-6) revealed a 
significant main effect of condition (F = 9.4, P < 0.0005) but no significant 
interaction between the two groups (F = 2.5, P > 0.05). There was no main 
effect of condition on RMSSD (F = 1.9, P > 0.05) (Figure 6-7). Figure 6-8 
shows the SDNN values for the SY and VA groups. There was a main effect of 
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condition (F = 9.4, P < 0.005) for SDNN but the group interaction observed 
failed to reach statistical significance (F = 2.5, P > 0.05). 
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Figure 6-6. NN interval from supine rest to 75% VOl peak in subjects classified as vagally 
(VA) or sympathetically (SY) dominant at rest. 
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Figure 6-7. RMSSD from supine rest to 75% VOl peak in subjects classified as vagally (V A) 
or sympathetically (SY) dominant at rest. 
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Figure 6-8. SDNN from supine rest to 75% V02 peak in subjects classified as vagally (VA) or 
sympathetically (SY) dominant at rest. 
4 
3.5 I"·:·d ~:I 
3 
2.5 
~ 
c 
" 2 g 
I 1.5 
1L 
J: 
0.5 
0 
-0.5 
Supine Standing 25% 50% 75% 
Figure 6-9. HF power from supine rest to 75% V02 peak in subjects classified as vagally 
(VA) or sympathetically (SY) dominant at rest. 
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Figure 6-10. LF power from supine rest to 75% V02 peak in subjects classified as vagally 
(VA) or sympathetically (SY) dominant at rest. 
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Figure 6-11. HFnu from supine rest to 75% V02 peak in subjects classified as vag ally (VA) 
or sympathetically (SY) dominant. 
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6.3.2.2. Frequency domain measures. 
Power in the HF band (log units) during supine rest was significantly higher (t = 
2.8, P < 0.05) in the VA group (Figure 6-9). During standing and exercise, rm-
ANOVA showed a significant main effect of condition (F = 13.6, P < 0.005) and 
a significant interaction between groups (F = 6.4, P < 0.005). Independent t-tests 
showed HF in the VA group slightly was higher when standing (P > 0.05) and 
significantly higher (t = 3.8, P < 0.05) at 25% V02 peak. It remained elevated at 
50% although not significantly. This trend continued in the 75% V02 peak 
condition where the difference remained, statistically significant (P < 0.05) 
Analysis of LF power (log units) in the supine condition by independent t-test, 
revealed no difference between groups (t = 0.76, P> 0.05). Analysis of LF by 
rm-ANOV A (Figure 6-10) revealed a significant main effect of condition (F = 
46.0, P < 0.05) but no significant interaction between groups (F = 0.86, P > 
0.05). Post hoc analysis revealed no significant differences between groups in 
any condition. 
There was a significant main effect for HFnu and LFnu (F = 16.6, P < 0.05) but 
no interaction between groups (F = 0.25, P> 0.05). Post hoc analysis showed no 
differences between groups in any condition (Figures 6-11 and 6-12). 
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Figure 6-12 LFnu from supine rest to 75% V02 peak in subjects classified as vagally (VA) or 
sympathetically (SY) dominant. 
6.4. Discussion. 
6.4.1. Heart rate variability during exercise. 
Studies concerning the effects of exercise on HRV measurements have used a 
variety of methodologies. Some have used only a single exercise intensity 
(Rimoldi et al. 1990; Kamath et al. 1991). Where multiple intensities have been 
used, HRV measurements have been made using a variety of exercise protocols 
including the following: 
1. Ramping protocols with continuous ECG recording (Tulppo et al. 1996; 
Tulppo et al. 1998). 
2. Three minute incremental stages using relative workloads with a 256 beat 
ECG recording period (Arai et al. 1989). 
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3. Five minute incremental stages using relative workloads with a 256-point 
beat ECG recording period. (Perini et al. 1990; Perini et al. 2000; Perini 
et al. 2002) 
4. Discontinuous stages at workloads which elicit a given heart rate using a 
256 s ECG recording period (Breuer et al. 1993). 
5. Five minute stages at absolute workloads with a 256 beat ECG recording 
made in the last 2-3 min (Casadei et al. 1995). 
Few studies give information concerning the stability of the tachograms analysed 
and it seems that none of the above studies have recorded steady state ECGs for a 
full 5-min at relative workloads. Therefore, although the present study is 
comparable to several previous studies (Arai et al. 1989; Perini et al. 1990; 
Casadei et al. 1995; Perini et al. 2000; Perini et al. 2002) it remains 
methodologically unique. 
The main findings of the present study were threefold. Firstly, compared to 
resting values there was a decrease in the variation of RR interval. This lead to a 
reduction in spectral power of the time series recorded over five minutes of 
steady state exercise. Secondly, at rest, HFnu and LFnu are commonly 
considered markers of vagal and mixed vagal/sympathetic activity respectively. 
During exercise, neither measure behaved as would be expected if this were still 
true. Thirdly, when subjects were divided by vagal or sympathetic predominance 
at rest significant differences in the changes in LF and HF were found during 
exercise. These findings will be discussed separately in detail in the following 
sections. 
6.4.1.1. Time domain measures of HRV during exercise. 
An almost linear reduction in total HRV as measured by SDNN was evident with 
increasing exercise intensity. It is known that SDNN correlates with 
pharmacologically derived indices of vagal activity (Uusitalo et al. 1996). These 
findings therefore fit with the accepted theory regarding vagal withdrawal during 
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exercise. Similarly, RMSSD also correlates with vagal activity. No reduction 
was found between standing to 25% V02 peak. However, RMSSD decreased 
between 25 and 50% V02peak. Although some reduction was evident neither 
RMSSD nor SDNN declined significantly from 50 - 75% V02 peak. This may 
indicate that complete vagal withdrawal had occurred by 50% V02 peak. These 
findings concur with those previous studies which have demonstrated reduced 
values for time domain measures with increased exercise intensity (Perini et al. 
1990; Tulppo et al. 1996; Levy et al. 1998; Tulppo et al. 1998; Perini et al. 2000; 
Perini et al. 2002). 
6.4.1.2. Frequency domain measures. 
When the time series of RR intervals is transformed into the frequency domain 
there was reduced spectral power in the LF and HF bands. This finding is also in 
agreement with previous general spectral analysis (GSA) studies which have 
used fast Fourier transformation (FFT) (Breuer et al. 1993; Gregoire et al. 1996; 
Myslivecek et al. 2002) and those which have used autoregressive modelling 
(Arai et al. 1989; Bernardi et al. 1990; Perini et al. 1990; Kamath et al. 1991; 
Casadei et al. 1995; Tulppo et al. 1996; Tulppo et al. 1998; Perini et al. 2000; 
Perini et al. 2002). 
From supine to standing there was a significant (P < 0.05) increase in LFnu 
confirming this measure's known association with sympathetic activation 
brought on by orthostatic stress. This finding agrees with others that have either 
compared supine and standing values (Pagani et al. 1986; Byrne et al. 1996) and 
recorded HRV during passive tilt (Furlan 1987; Furlan et al. 2000) or active 
standing (Jauregui-Renaud et al. 2001). Standing was associated with reduced 
HFnu. This also agrees with previous data and has been interpreted as being 
representative of vagal withdrawal. Given the increase in LFnu between supine 
and standing conditions, it would be expected that LFnu and HFnu would 
continue to increase and decrease respectively during exercise. This seems 
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logical as exercise is a condition known to augment sympathetic outflow. This 
was not found to be the case. At 25% VOl peak HFnu was found to increase and a 
reciprocal decrease in LFnu was observed. Although unexpected, similar 
findings have been reported previously in young (Warren et at. 1997) and elderly 
(Perini et al. 2002) subjects. More commonly however, at lower exercise 
intensities LFnu and HFnu have been found to increase and decrease respectively 
(Bernardi et al. 1990; Rimo1di et al. 1992; Casadei et al. 1995). This is 
commonly interpreted as demonstrating parasympathetic withdrawal and/or 
sympathetic activation in line with current theory regarding the origins of 
exercise tachycardia. In the study of Perini et at. (2002) the changes in LFnu 
and HFnu were interpreted as reduced sympathetic activation in their elderly 
subjects, Warren et al. (1997) cite methodological reasons for their findings. 
However, in the healthy, non-elderly population studied here, it would be 
expected that LFnu would increase. 
One explanation for the conflicting results between this study and previous data 
may be due to methodological differences. In the present study LFnu in the 
standing condition may have been elevated for two reasons. For most subjects, 
HRV was measured in the supine and standing conditions on separate occasion to 
exercise measures. The resting measures were made on the first occasion which 
subjects had undergone HRV recording. In a small cohort it was necessary to 
record HRV prior to the onset of the exercise test. Both these conditions (an 
unfamiliar protocol and an impending exercise test) may have elevated 
psychological stress levels in subjects. This has previously been show to elevate 
LFnu (Pagani et al. 1995). It is possible that as the subject commenced exercise 
they may have relaxed as their attention was drawn toward the task. A second 
explanation for the fall in LFnu may lies with the workloads used. Studies which 
have shown raised LFnu at the onse of exercise have typically used absolute 
workloads. In the present study, a relative workload of 25% VOl peak was used as 
the initial stage. For all subjects this was very light exercise. In some cases such 
a low oxygen consumption was difficult to maintain during treadmill exercise. 
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The mean value for oxygen consumption all subjects throughout the first stage of 
exercise was actually 13% higher than the target value corresponding to of 25% 
of predetermined V02 peak. 
At 50 and 75% V02 peak LFnu was significantly reduced. This produced 
conversely, a significant rise in HFnu. These, and similar findings from previous 
studies (Casadei et at. 1995; Bernardi et at. 1996) would lead to the somewhat 
unlikely conclusion that sympathetic activity is decreased at higher intensity 
exercise. Even more unlikely, the rise in HFnu suggests increased vagal activity. 
One reason for such findings may lie within the origins of the LF and HF 
fluctuations themselves. Although HF has known to be of vagal origin, the belief 
that LF represents mainly sympathetic outflow (Pagani et at. 1986; Malliani et at. 
1991) has been challenged on numerous occasions (Eckberg 1997; Goldberger 
1999). Pharmacological data suggest fluctuations in the LF band to be at least 
partially vagally mediated (Akselrod et at. 1981; Pomeranz et at. 1985). This 
may go some way to explaining the reduction in spectral power in both 
frequencies observed during exercise. This does not, however, explain the 
increase in the relative shift of power into the HF spectral band during exercise. 
Pharmacological data have been shown to be able to eradicate the LF spectral 
peak under dual blockade (Pagani et at. 1986). Data from the denervated hearts 
of transplant patients (Bernardi et at. 1990) support the view that LF is purely 
autonomic in origin. Fluctuations in the HF band may still be observed under 
complete pharmacological blockade and in the denervated heart (Bernardi et at. 
1990). Oscillations in the HF band may therefore be non-neural in nature. 
Animal data suggest alterations in intramural pressure (Blinks 1965) and 
myocardial stretch (Kohl et at. 1994) may both be able to causes synchronous 
depolarisation of cells near the SA node resulting in oscillation in nodal firing at 
frequencies within the HF band. In an attempt to quantify the input of these 
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mechanisms (Casadei et al. 1996) it was estimated that more than 40% of HF 
power may be of non-neural origin during moderate exercise. 
During exercise there two factors are which may increase HFnu. Firstly, overall 
spectral power is reduced. This occurs in both spectral bands and is mainly due 
to changes in nervous activity. Secondly, as respiratory depth and frequency 
increases during exercise the non-neural power input to the spectrum, which 
contributes exclusively to the HF band, increases. The combination of reduced 
spectral power from neural input, combined with preserved HF power from non-
neural origins artificially inflates HFnu and reciprocally decreases LFnu. 
Therefore, at higher exercise intensities the use of HFnu and LFnu and the 
LF:HF ratio may be misleading. Further to this, there are practical issues 
concerning data collection at high (75% V02 peak) exercise intensities. In the 
present study only 14 full data sets could be recorded. In other recoreds, a low 
signal:noise ratio meant in some cases more than 50% of the RR intervals 
analysed were interpolated. 
6.4.2. Differences in heart rate variability response to exercise in 
relation to subject baseline characteristics. 
Despite problems with the use of GSA during exercise, a number of studies have 
been carried out, successfully examining the role of ANS control during low 
intensity exercise. The remainder of this discussion will relate only to data 
collected in the supine, standing and 25% V02 peak exercise condition. 
As mentioned previously, in transition from rest (standing due to orthostatic 
stress) to exercise the data is somewhat equivocal regarding LFnu and HFnu. 
This may in part be due to subject characteristics. 
Arai et al. (1989) found that when subjects exercised at an intensity which 
produced a HR of 120-140 BPM an increase in LF:HF ratio was evident. 
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Likewise, Bernardi et al. (1990) exercised subjects at 120 Wand found an 
increase in LFnu. Kamath et al. (1991) found a small increase in LFnu when 
subjects cycled at 50% of maximal predicted power as did Breuer et al. (1995) 
when subjects cycled at a workload eliciting a HR of 100 BPM. Casadei et al. 
(1994) also found increased LFnu at the absolute workload of 110W. 
Perini et al. (1990) used 21 % V02 max as their lowest exercise intensity and found 
a decrease in LF:HF. Similarly, Warren et al. (1997) found a decrease in LF:HF 
when subjects cycled at 0 W. Using elderly subjects, Perini et al. (2000) found 
reduced LF at an exercise intensity which produced a VOl of 10 ml·kg'min- l . In 
a further study (Perini et al. 2002) this direction of change was reversed 
following an aerobic training programme, when subjects exercised at an intensity 
eliciting a VOl of 0.3 L"min. 
In the present study both LF and HF were reduced as a function of exercise 
intensity when the entire study population was analysed. When subjects were 
divided into SY and VA groups the reductions in the latter were much less 
pronounced from supine to standing and 25% VOl peak. This indicates a 
preservation of HF power during orthostatic stress and exercise in this group. It 
has previously been suggested that such a preservation of HF power may be 
cardioprotective in nature (Davy et al. 1996) as it may reduce the likelihood of 
arrhythmia. Animal data support this suggestion (Hull et al. 1994). Data from 
the present study are illustrative of the influence baseline HF and LF may have 
on changes in these measures during exercise. These data may also be helpful in 
explaining the diversity of findings related to changes in LF and HF during 
exercise. 
The large decreases in spectral power observed in the LF and HF bands during 
exercise create difficulties in making inferences from exercise HRV data. 
Numerous researchers have reported findings in normalised units in an attempt to 
overcome this problem. 
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Findings from GSA concerning the behaviour of LFnu and HFnu during exercise 
have been disparate in nature. Given the respective vagal and sympathetic 
modulation of HFnu and LFnu assigned by some authors (Pagani et al. 1986; 
Malliani et al. 1991) a decrease in the former and increase in the latter would be 
expected during exercise. Such patterns of change have been shown previously 
(Yamamoto and Hughson 1991; Perini et al. 2000). However, the data are not 
homogenous, and decreases in LFnu (and an accompanying increase in HFnu) 
during the onset of exercise have also been reported (Kamath et al. 1991 ; 
Rimoldi et al. 1992). In older men and women, Perini et al. (2002) found an 
immediate decrease in LFnu (increased HFnu) at the onset oflight exercise when 
measurements were made prior to exercise training. Following an effective 
(increased V02 max) training period this pattern was reversed; subjects showed 
increased LFnu and increased HFnu. These changes were not accompanied by 
any changes in LFnu or HFnu at rest. In the present study there was interaction 
between SY and VA groups during exercise. These data support the findings of 
Perini et al. (2002) and suggest factors other than subject baseline characteristics 
may be responsible for the disparate nature of data from pervious studies using 
these measures. 
The findings of Perini et al. (2002) suggest changes in subject fitness level may 
be associated with alterations in the responses of LFnu and HFnu during 
exercise. Further investigation of the relationship between subject fitness or 
exercise performance and HRV exercise response may therefore be warranted. 
6.5. Conclusions. 
Findings from HRV studies during exercise are disparate in nature. This study 
demonstrates that the heterogeneous nature of findings may be in part, a result of 
differing subject baseline HRV characteristics. If GSA is to be used as a tool to 
investigate autonomic control during exercise, there are several methodological 
issues that need to be resolved particularly concerning measures taken from ECG 
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recordings at higher exercise intensities (>50% V02 mw..). Due to reduced spectral 
power at higher intensities it seems that GSA, in its present form, is most useful 
only during light exercise. The opposing behaviour of LFnu and HFnu to that 
which would be expected as respective sympathetic and vagal markers is 
problematic. Further work is required to elucidate causes for the differing 
behaviour of these measures reported during exercise. 
6.6. References. 
ACSM (2000). ACSM's Guidlines for Exercise Testing and Prescription. 
Philadelphia, Lippincott Williams and Wilkins. 
Akselrod, S., D. Gordon, F. AUbel, D. C. Shannon, A C. Berger and R. J. 
Cohen (1981). "Power spectrum analysis of heart rate fluctuation: a quantitative 
probe of beat-to-beat cardiovascular contro1." Science 213(4504): 220-222. 
Arai, Y., J. P. Saul, P. Albrecht, L. H. Hartley, L. S. Lilly, R. J. Cohen and W. S. 
Colucci (1989). "Modulation of cardiac autonomic activity during and 
immediately after exercise." American Journal of Physiology 256(1 Pt 2): H132-
141. 
Bernardi, L., F. Salvucci, R. Suardi, P. L. Solda, A. Calciati, S. Perlini, C. 
Falcone and L. Ricciardi (1990). "Evidence for an intrinsic mechanism 
regulating heart rate variability in the transplanted and the intact heart during 
submaximal dynamic exercise?" Cardiovascular Research 24(12): 969-981. 
Bernardi, L., F. Valle, M. Coco, A. Calciati and P. Sleight (1996). "Physical 
activity influences heart rate variability and very-low-frequency components in 
Holter electrocardiograms." Cardiovascular Research 32(2): 234-237. 
Blinks, J. R. (1965). "Convenient apparatus for recording contractions of isolated 
heart muscle." Journal of Applied Physiology 20(4): 755-757. 
Breuer, H. W., A Skyschally, R. Schulz, C. Martin, M. Wehr and G. Heusch 
(1993). "Heart rate variability and circulating catecholamine concentrations 
during steady state exercise in healthy volunteers." British Heart Journal 70(2): 
144-149. 
Byrne, E. A, J. L. Fleg, P. V. Vaitkevicius, J. Wright and S. W. Porges (1996). 
"Role of aerobic capacity and body mass index in the age-associated decline in 
heart rate variability." Journal of Applied Physiology 81(2): 743-750. 
203 
Camm, A. J., M. Malik, J. T. Bigger, B. G., S. Cerutti, R. J. Cohen, P. Coumel, 
E. Fallen, L. Hamilton, H. L. Kennedy, R. E. Kleiger, F. Lombardi, A. Malliani, 
A. J. Moss, J. Rottman, G. Schmidt, P. J. Schwartz and D. H. Singer (1996). 
"Heart rate variability: standards of measurement, physiological interpretation 
and clinical use. Task Force of the European Society of Cardiology and the North 
American Society of Pacing and Electrophysiology." Circulation 93(5): 1 043-
1065. 
Casadei, B., S. Cochrane, J. Johnston, J. Conway and P. Sleight (1995). "Pitfalls 
in the interpretation of spectral analysis of the heart rate variability during 
exercise in humans." Acta Physiologica Scandinavia 153(2): 125-131. 
Casadei, B., J. Moon, J. Johnston, A. Caiazza and P. Sleight (1996). "Is 
respiratory sinus arrhythmia a good index of cardiac vagal tone in exercise?" 
Journal of Applied Physiology 81(2): 556-564. 
Collier, C. R. (1955). "Determination of mixed venous C02 tensions by 
rebreathing." Journal of Applied Physiology 9: 25-29. 
Davy, K. P., N. L. Miniclier, J. A. Taylor, E. T. Stevenson and D. R. Seals 
(1996). "Elevated heart rate variability in physically active postmenopausal 
women: a cardioprotective effect?" American Journal of Physiology 271(2 Pt 2): 
H455-460. 
Defares, J. G. (1960). "Determination PvC02 from the exponentiao Co2 rise 
during rebreathing." Journal of Applied Physiology 13: 159-164. 
Eckberg, D. L. (1997). "Sympathovagal balance: a critical appraisal." Circulation 
96(9): 3224-3232. 
Furlan, R. (1987). "Effects of tilt and treadmill exercise on short-term variability 
in systolic arterial pressure in hypertensive men." Journal of Hypertension 
5((suppl 5)): S234-S425. 
Furlan, R., A. Porta, F. Costa, J. Tank, L. Baker, R. Schiavi, D. Robertson, A. 
Malliani and R. Mosqueda-Garcia (2000). "Oscillatory patterns in sympathetic 
neural discharge and cardiovascular variables during orthostatic stimulus." 
Circulation 101(8): 886-892. 
Goldberger, J. J. (1999). "Sympathovagal balance: how should we measure it?" 
American Journal of Physiology 276(4 Pt 2): H1273-1280. 
Gregoire, J., S. Tuck, Y. Yamamoto and R. L. Hughson (1996). "Heart rate 
variability at rest and exercise: influence of age, gender, and physical training." 
Canadian Journal of Applied Physiology 21(6): 455-470. 
204 
Hull, S. S., Jr., E. Vanoli, P. B. Adamson, R. L. Verrier, R. D. Foreman and P. J. 
Schwartz (1994). "Exercise training confers anticipatory protection from sudden 
death during acute myocardial ischemia." Circulation 89(2): 548-552. 
Jauregui-Renaud, K, A. G. Hermosillo, M. F. Marquez, F. Ramos-Aguilar, M. 
Hernandez-Goribar and M. Cardenas (2001). "Repeatability of heart rate 
variability during simple cardiovascular reflex tests on healthy subjects." 
Archives of medical research 32(1): 21-26. 
Kamath, M. V., E. L. Fallen and R. McKelvie (1991). "Effects of steady state 
exercise on the power spectrum of heart rate variability." Medicine and Science 
in Sports and Exercise 23(4): 428-434. 
Kingwell, B. A., J. M. Thompson, D. M. Kaye, G. A. McPherson, G. L. Jennings 
and M. D. Esler (1994). "Heart rate spectral analysis, cardiac norepinephrine 
spillover, and muscle sympathetic nerve activity during human sympathetic 
nervous activation and failure." Circulation 90(1): 234-240. 
Kohl, P., A. G. Kamkin, 1. S. Kiseleva and D. Noble (1994). "Mechanosensitive 
fibroblasts in the sino-atrial node region of rat heart: interaction with 
cardiomyocytes and possible role." Experimental Physiology 79(6): 943-956. 
Kuji, N., O. Tochikubo, M. Shimizu, K Minamizawa, K Kimura, T. Nihei and 
M. Ishii (1991). "[Non-invasive measurement of cardiac output by the C02 
rebreathing method and its reliability in clinical practice]." Kokyu To Junkan 
39(6): 579-585. 
Levy, W. C., M. D. Cerqueira, G. D. Harp, K A. Johannessen, 1. B. Abrass, R. S. 
Schwartz and J. R. Stratton (1998). "Effect of endurance exercise training on 
heart rate variability at rest in healthy young and older men." American Journal 
of Cardiology 82(10): 1236-1241. 
Maciel, B. C., L. Gallo, Jr., J. A. Marin Neto, E. C. Lima Filho and L. E. Martins 
(1986). "Autonomic nervous control of the heart rate during dynamic exercise in 
normal man." Clinical Science (London) 71(4): 457-460. 
Malliani, A., M. Pagani, F. Lombardi and S. Cerutti (1991). "Cardiovascular 
neural regulation explored in the frequency domain." Circulation 84(2): 482-492. 
Mancini, D., T. LeJemtel and K. Aaronson (2000). "Peak VO(2): a simple yet 
enduring standard." Circulation 101(10): 1080-1082. 
Marks, C., V. Katch, A. Rocchini, R. Beekman and A. Rosenthal (1985). 
"Validity and reliability of cardiac output by C02 rebreathing." Sports Medicine 
2(6): 432-446. 
205 
Myslivecek, P. R., C. A. Brown and L. A. Wolfe (2002). "Effects of physical 
conditioning on cardiac autonomic function in healthy middle-aged women." 
Canadian Journal of Applied Physiology 27(1): 1-18. 
Pagani, M., F. Lombardi, S. Guzzetti, O. Rimoldi, R. Furlan, P. Pizzinelli, G. 
Sandrone, G. Malfatto, S. Dell'Orto, E. Piccaluga and et al. (1986). "Power 
spectral analysis of heart rate and arterial pressure variabilities as a marker of 
sympatho-vagal interaction in man and conscious dog." Circulatory Research 
59(2): 178-193. 
Pagani, M., D. Lucini, O. Rimoldi, R. Furlan, S. Piazza and L. Biancardi (1995). 
Effects of Physical and Mental Stress on Heart Rate Variability. Heart Rate 
Variability. M. Malik and A. J. Camm. New York, Futura Publishing. 
Perini, R., N. Fisher, A. Veicsteinas and D. R. Pendergast (2002). "Aerobic 
training and cardiovascular responses at rest and during exercise in older men 
and women." Medicine and Science in Sports and Exercise 34(4): 700-708. 
Perini, R., S. Milesi, N. M. Fisher, D. R. Pendergast and A. Veicsteinas (2000). 
"Heart rate variability during dynamic exercise in elderly males and females." 
European Journal of Applied Physiology and Occupational Physiology 82(1-2): 
8-15. 
Perini, R., C. Orizio, G. Baselli, S. Cerutti and A. Veicsteinas (1990). "The 
influence of exercise intensity on the power spectrum of heart rate variability." 
European Journal of Applied Physiology and Occupational Physiology 61(1-2): 
143-148. 
Pomeranz, B., R. J. Macaulay, M. A. Caudill, 1. Kutz, D. Adam, D. Gordon, K. 
M. Kilborn, A. C. Barger, D. C. Shannon, R. J. Cohen and et al. (1985). 
"Assessment of autonomic function in humans by heart rate spectral analysis." 
American Journal of Physiology 248(1 Pt 2): H151-153. 
Rimoldi, 0., R. Furlan, M. R. Pagani, S. Piazza, M. Guazzi, M. Pagani and A. 
Malliani (1992). "Analysis of neural mechanisms accompanying different 
intensities of dynamic exercise." Chest 101(5 Suppl): 226S-230S. 
Rimoldi, 0., M. Pagani, M. R. Pagani, G. Baselli and A. Malliani (1990). 
"Sympathetic activation during treadmill exercise in the conscious dog: 
assessment with spectral analysis of heart period and systolic pressure 
variabilities." Journal ofthe Autonomic Nervous System 30 Suppl: S129-132. 
Robinson, B. F., S. E. Epstein, G. D. Beiser and E. Braunwald (1966). "Control 
of heart rate by the autonomic nervous system. Studies in man on the 
interrelation between baroreceptor mechanisms and exercise." Circulatory 
Research 19(2): 400-411. 
206 
Tulppo, M. P., T. H. Makikallio, T. Seppanen, R. T. Laukkanen and H. V. 
Huikuri (1998). "Vagal modulation of heart rate during exercise: effects of age 
and physical fitness." American Journal of Physiology 274(2 Pt 2): H424-429. 
Tulppo, M. P., T. H. Makikallio, T. E. Takala, T. Seppanen and H. V. Huikuri 
(1996). "Quantitative beat-to-beat analysis of heart rate dynamics during 
exercise." American Journal of Physiology 271(1 Pt 2): H244-252. 
Uusitalo, A. L., K. U. Tahvanainen, A. J. Uusitalo and H. K. Rusko (1996). 
"Non-invasive evaluation of sympathovagal balance in athletes by time and 
frequency domain analyses of heart rate and blood pressure variability." Clinical 
Physiology 16(6): 575-588. 
Vanhees, L., J. Defoor, D. Schepers, S. Brusselle, T. Reybrouck and R. Fagard 
(2000). "Comparison of cardiac output measured by two automated methods of 
C02 rebreathing." Medicine and Science in Sports and Exercise 32(5): 1028-
1034. 
Wallin, B. G., M. Esler, P. Dorward, G. Eisenhofer, C. Ferrier, R. Westerman 
and G. Jennings (1992). "Simultaneous measurements of cardiac noradrenaline 
spillover and sympathetic outflow to skeletal muscle in humans." Journal of 
Physiology 453: 45-58. 
Warren, 1. H., R. S. Jaffe, C. E. Wraa and C. L. Stebbins (1997). "Effect of 
autonomic blockade on power spectrum of heart rate variability during exercise." 
American Journal of Physiology 273(2 Pt 2): R495-502. 
Wasserman, K., 1. E. Hansen, D. Y. Sue, R. Casaburi and B. 1. Whipp (1999). 
Principles of Exercise Testing and Interpretation. Baltimore, Maryland, USA., 
Lippincott Williams and Wilkins. 
Yamamoto, Y. and R. L. Hughson (1991). "Coarse-graining spectral analysis: 
new method for studying heart rate variability." Journal of Applied Physiology 
71(3): 1143-1150. 
207 
CHAPTER 7. THE DEVELOPMENT OF A MODIFIED, GENERAL 
SPECTRAL ANALYSIS HEART RATE VARIABILITY FRAMEWORK 
FOR USE DURING EXERCISE. 
Abstract. 
The aim of the present investigation was to assess whether valid indices of vagal 
and sympathetic activity could be generated through the manipulation of spectral 
HRV measures within the limits imposed by commercially available analysers. 
Twenty nine university staff and students (20 males median age 39 range 19 - 63) 
and nine females median age 35 (range 19 - 56) were included in the study. Each 
subject underwent incremental treadmill testing to V02 peak. On a separate 
occasion, subjects then underwent sequential, 5-min HRV recordings during 
supine rest, standing exercise at 25%,50% and 75% V02 peak. Vagal modulation 
was measured using HF power measured from 0.1- 0.5 Hz and sympathetic 
modulation was measured using the ratio ofLF (0.01 - O.1Hz)ITP (0.01-0.5 Hz). 
Effects of exercise on these measures were assessed using repeated measures 
ANOV A with post hoc repeated measures t-tests. 
Results showed a significant decrease in HF from rest through all exercise 
intensities (P<O.OOOl). Post hoc analyses showed that the largest changes in HF 
were between 25 and 50% V02 peak. LF/TP was altered significantly across all 
conditions (P<O.OOl). LF/TP was unchanged from rest to 25% V02 peak but 
increased from 25% V02 peak to 50 % V02 peak. At 75% V02 peak there was a 
small decrease in LF ITP. 
The results of the study demonstrate that HF power measured from 0.1- 0.5 Hz 
provides a good index of vagal activity during exercise. The ratio of LF (0.01 -
O.1Hz)/TP (0.01-0.5 Hz) was put forward as an index of sympathetic activity. 
Although some of the behaviour of this measure during exercise suggest it may 
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be of some use as a marker of sympathetic activity the majority of the results 
suggest that this is at best, an equivocal marker. Additionally its use may be 
limited to lower «75% VOl max) exercise intensities. Low signal:noise ratio 
made recording and analysis of the EeG data at high (75% VOl peak) exercise 
intensities difficult. 
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7.1. Introduction. 
In a previous chapter the effects of exercise ion HRV measures obtained by 
general spectral analysis (GSA) were examined. The findings were found to be in 
agreement with previous data. They showed an overall decrease in global 
measures ofHRV in the time and frequency domains. 
The behaviour of time domain measures (RMSSD, SDNN) from short-term HRV 
measurement fits reasonably well with classical theory regarding autonomic 
changes during exercise (Robinson et at. 1966; Frick et at. 1967; Sutton et at. 
1967; Ekblom et at. 1973; Nyberg 1981). The behaviour of frequency domain 
measures during exercise, does not fit well with their assigned roles as makers of 
vagal (HF, HFnu), or sympathetic (LF, LFnu) tone, or of sympathovagal balance 
(LF:HF ratio). Although there are much data to offer support for frequency 
domain measures as non-invasive markers of autonomic control at rest, the 
behaviour of these variables during exercise is commonly found to be 
paradoxical to their behaviour at rest. 
What follows is a brief discussion of each frequency domain variable 
recommended for use from short-term analysis by the Task Force of the 
European Society of Cardiology and the North American Society of Pacing and 
Electrophysiology (Camm et at. 1996). Each variable will be discussed in terms 
of: 
o Its role as an autonomic marker at rest. 
o Physiological and pharmacological data to support or refute this role. 
o Its behaviour during exercise and the congruency between this and resting 
data. 
7.1.1. High frequency power (HF). 
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This distinct peak in the frequency spectrum represents respiration-mediated 
regulation of HRY. It is reduced under conditions of orthostatic stress such as 
standing (Janssen et at. 1993) and tilt (Pagani et ai. 1986; Montano et ai. 1994; 
Vardas et ai. 1994; Bootsma et ai. 1996) compared to when it is measured in the 
supine position. It is totally abolished by atropine (Pomeranz et al. 1985; 
Rimoldi et al. 1990; Uusitalo et al. 1996) and glycopyrrolate (Warren et ai. 
1997) suggesting purely vagal modulation. However, direct, microneurographic 
evidence is more equivocal. Whereas a direct relationship between HFnu and 
vagal activity has been demonstrated (Pagani et at. 1997), more recently HF has 
been found to demonstrate no relationship with microneurographically measured 
vagal activity (Notarius et al. 1999). 
Despite this, the majority of evidence suggests HF to be a good marker of vagal 
activity. Therefore, during exercise it would be expected that HF in raw units 
(ms2) and in normalised units (HFnu) would decrease at lower exercise 
intensities indicating vagal withdrawal. At higher exercise intensities there 
should be no distinct HF peak. 
The behaviour of HF follows such a pattern. The spectral power in the HF band 
(0.15 - 0.4 Hz) is dramatically reduced with increasing exercise intensity (Arai et 
al. 1989; Rimoldi et al. 1990; Tulppo et al. 1998), as is power in the entire, 
measured, spectral range (commonly 0.04 - 0.4 Hz). When HF is expressed in 
normalised units (HFnu), dramatic reductions in TP often mean HF represents a 
greater proportion of TP, therefore increasing the normalised value. This, 
paradoxically, may be interpreted as an increase in vagal activity during intense 
exercise (Casadei et al. 1995). At very high exercise intensities HF power may 
actually increase. There is evidence that the source of this increase may be non-
neural (Casadei et al. 1995) and linked to mechanical stimuli due to increased 
breathing effort (Bernardi et ai. 1990). 
In summary, it seems that the behaviour of HF and HFnu at lower exercise 
intensities is congruent with its assigned role as a vagal marker at rest. However, 
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at moderate and high intensities it seems that paradoxical rises in this vagal 
marker may invalidate its use. 
7.1.2. Low frequency power (LF). 
The role of the LF peak in the power spectrum (0.04 -0.15 Hz) is much less 
clearly defined than that of HF. There is evidence to suggest LF is linked to 
baroreceptor mechanisms (Kamath and Fallen 1993) and Meyer waves (Furlan 
1987). Contradictory evidence for a central origin of LF also exists (Cooley et 
ai. 1998). Studies using orthostatic stress tests show shifts toward LF 
predominance due to tilt (Pagani et ai. 1986; Malliani et ai. 1991; Montano et ai. 
1994), although data are somewhat equivocal (Saul et ai. 1990). Evidence of 
attenuated increases in LF power in response to tilt under J3-adrenergic blockade 
suggest a sympathetic origin (Rimoldi et ai. 1990), although the findings of 
published studies do not always concurr (Hopf et ai. 1995; Introna et ai. 1995). 
Data from cholinergic blockade also suggest a strong vagal influence on LF 
(Akselrod et ai. 1981) particularly in the supine position (Pomeranz et ai. 1985). 
Paradoxically, LF power under vagal blockade may be reduced (Vybiral et ai. 
1990) despite reported increases in RR interval (Raczkowska et ai. 1983). This, 
and findings of increased LF under ,B-adrendergic blockade (Cacioppo et ai. 
1994; Jokkel et ai. 1995) have lead to the opinion that LF may be a poor maker 
of sympathetic activity (Appel et ai. 1989; Houle and Billman 1999). 
Microneurographic evidence, paradoxically suggests both a link (Pagani et al. 
1997) and direct dissociation (N otarius et ai. 1999) between LF and direct 
measures of sympathetic activity. Simultaneous assessment of LF activity has 
also been found to be discordant with the gold standard of cardiac sympathetic 
activity; direct measurement of noradrenaline spillover (Kingwell et al. 1994). 
It is clear from the contradictory nature of the evidence that to consider LF (or 
LFnu) as a purely sympathetic index would be both simplistic, an incorrect. A 
consensus viewpoint (Stein and Kleiger 1999) has been put forward that LF is at 
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best a complex and mixed (vagal and sympathetic) component of HRV. 
Additionally, LF may be a marker of sympathetic activity under certain 
conditions such as tilt. 
Due to the equivocal nature of the data, it is difficult to predict how LF should 
act during exercise. Those proponents of LF and especially LFnu as markers of 
sympathetic predominance would expect an increase in both measures with 
increasing exercise intensities. If LF and LFnu are interpreted as mixed vagal-
sympathetic markers, a decrease in LF but an increase in LFnu would be 
expected. Neither ofthese scenarios is consistently supported by empirical data. 
When expressed in raw units, LF uniformly shows a decrease during exercise 
when compared to resting conditions (Arai et al. 1989; Rimoldi et al. 1990; 
Breuer et al. 1993). When normalised for the overall reduction in TP, LFnu has 
been reported to increase from rest to very light exercise (Perini et al. 1990; 
Casadei et al. 1995; Perini et al. 2000; Perini et al. 2002). However, during 
incremental exercise the proportion of TP represented by LF (LFnu) is most 
commonly observed to decrease as a function of exercise intensity (Perini et al. 
1990; Kamath and Fallen 1993; Casadei et al. 1995; Perini et al. 2000; Perini et 
al. 2002). Maximal exercise is usually accompanied by a large decrease in LFnu 
as HF oscillations make up a much greater proportion ofTP. 
From the above evidence it can be stated that LF is at best an equivocal marker 
of sympathetic activation at rest. During exercise, the decreases in LF and LFnu 
observed directly contradict the known sympathetic activation that occurs at 
higher intensities. On this basis, LF and LFnu are not useful indices of cardiac 
sympathetic activation during exercise. 
7.1.3. Low frequency to highfrequency ratio (LF:HF ratio). 
Proponents of the LF:HF ratio (Pagani et al. 1986) recommend its use as an 
index of sympathovagal balance. Forgoing the previous discussion of the origins 
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and nature of LF, LF:HF seems an intuitively inviting concept by which the 
balance between sympathetic and vagal actions on the SA node may be 
measured. Taking into account the shortcomings of both the numerator and 
denominator in this equation it is obvious that the LF:HF ratio has numerous 
problems associated with its use as a measure of sympathovagal balance. 
Using upright tilt, it has been shown that LF:HF increases with the angle of tilt 
(Iwase et at. 1987; Montano et al. 1994; Mukai and Hayano 1995). However, 
both Montano et at. (1994) and Muakai et al. (1995) report the change in LF:HF 
to be due to decreased HF (indicating vagal withdrawal) as opposed to increases 
in LF (to indicate sympathetic activation). This illustrates and inherent weakness 
in the use of a ratio to describe sympathovagal balance. The use of a ratio means 
that mathematically, one component must always change in light of the activity 
of the other. Physiologically there is no evidence for any such behaviour of the 
vagal and sympathetic inputs to the SA node. The mathematical, linguistic and 
philosophical nature of LF:HF have been challenged (Eckberg 1997; Goldberger 
1999). A full discussion of these points is beyond the scope of the present text, 
but empirical data suggesting further weaknesses of this ratio. Using direct 
measurement, some subjects have been found to decrease their sympathetic nerve 
traffic when in the upright position (Burke et al. 1977). Wallin et al. (1992) 
found tilt to be effective in increasing noradrenaline spillover from the 
myocardium, but found this increase was not accompanied by increased power in 
the LF band. 
The majority of data from passive tilt do seem to support the use of LF:HF as a 
sympathovagal marker (Furlan 1987). However, under exercise conditions, the 
behaviour of the ratio does not conform to that which would be expected if it is 
indeed, representative of the balance between vagal and sympathetic influence on 
the SA node. Based on pharmacological data (Nyberg 1981) one would expect a 
consistently increasing LF:HF ratio with increasing exercise intensities. During 
light exercise (HR < 100 BPM) this would be due to vagal withdrawal and at 
higher intensities (HR > 1 00 BPM) due to sympathetic activation (Robinson et al. 
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1966; Nyberg 1981). Due to the mathematical nature of the LF:HF ratio, the 
causes of any change would of course, not be obvious. 
From the discussion ofHF, HFnu, LF and LFnu the commonly observed pattern 
of change in LF:HF should be obvious. In certain cases LF:HF does increase at 
the onset of (light) exercise (Bernardi et al. 1990; Perini et al. 1990; Rimoldi et 
at. 1992; Breuer et al. 1993). Most commonly it then decreases as the exercise 
becomes more intense; it often shows a significant, sharp increase at very high or 
maximal exercise intensities. In some cases LF:HF drops at the onset of exercise 
(Arai et al. 1989). Only one study has found LF:HF to increase at high exercise 
intensities (Yamamoto et al. 1991). 
With the exception of the work of Yamamoto et at. (1991) who gIVe no 
explanation for their disparate findings, it is clear that LF:HF is a poor marker of 
sympathovagal balance during exercise. Most importantly it behaves in an 
almost reverse manner to that expected. The ratio also displays great variation 
between studies and within subjects in a single study. It is therefore an 
unsuitable maker of sympathovagal balance (Goldberger 1999). 
7.1.4. Alternative methodologies. 
Due to the above problems associated with GSA of RR interval data a number of 
alternative data treatments have been used in attempts to gain insight into the 
autonomic control of HR during exercise. A common approach is to use coarse 
graining spectral analysis (CGSA) instead of GSA. Proponents of this method 
(Yamamoto and Hughson 1991; Yamamoto et al. 1991; Yamamoto et al. 1992) 
have successfully shown patterns of behaviour in the high (parasympathetic 
indicator) and low (sympathetic indicator) frequency spectral bands which 
concur with current theory of sympathovagal interaction during exercise. 
In addition to observing the harmonic (low and high) components of HRV, 
CGSA by the nature of its mathematics separates the non-harmonic component 
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of the RR interval data and allows analysis of this component. It has been shown 
that the high complexity of this chaotic or fractal component observed at rest, 
decreases during exercise as the RR intervals become more uniform. This has 
been used as a marker of sympathetic predominance (Yamamoto and Hughson 
1994) and validated using data from autonomic blockade (Yamamoto et al. 1995; 
Hagerman et al. 1996). 
This method is however, not without its problems. Gregoire et al. (1996) found 
that CGSA was unable to identify expected differences in autonomic control 
between trained and untrained individuals. This was in spite of clear differences 
in RR interval length at absolute exercise workloads. Based on this work 
Gregoire et al. (1996) and Myslivecek et al. (2001) have stated the subtraction of 
the non-harmonic component from the total power spectra increases the 
sensitivity of the PNS indicator (High/TP) to very small changes in HF. 
Gregoire et al. (1996) concluded that in their study, it was this large variability 
which made intergroup comparisons difficult. 
Another alternative method to GSA includes the use of Poincare plot analysis. 
By plotting each interbeat period as a function of the previous one a two-
dimemsional vector analysis can be carried out (Brennan et al. 2001; Brennan et 
al. 2002). This method gives estimates of both instantaneous and long-term RR 
interval variability (Kamen and Tonkin 1995). Additionally, qualitative analysis 
of Poincare plots has led to the identification of several distinct patterns, known 
to be representative of certain conditions and pathologies (Bergfeldt and Haga 
2003). This geometric method has the advantage of being largely independent of 
spectral power, and has been used successfully during exercise (Tulppo et al. 
1996; Tulppo et al. 1998). It has, however, been stated that Poincare analysis 
may offer little more information than simple time domain measures of HRV 
(Carrasco et al. 2001). 
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7.1.5. Availability of different heart rate variability analyses. 
Numerous methods to analyse RR interval data are available and the availability 
of commercial systems to carry out this analysis is also increasing. The analysis 
available within each system will in some way, determine how the RR interval 
data are treated by the researcher. For example, most commercially available 
analysers which designed for short-term ECG recording and analysis are capable 
of GSA via either autoregressive modelling or fast Fourier transformation. 
Frequency domain analysis is usually accompanied by standard time domain 
measures suitable to extract from short-term recordings. Few analysers are 
capable of CGSA, in fact one manufacturer (Advanced Medical Diagnostics 
Group Ltd. Leeds, UK) recently removed this function from its commercial 
software (VariaCardio, TF5) during updating. 
To use GSA during exercise, modifications to the existing recommendations 
(Camm et al. 1996) for resting HRV measurement need to be made. Warren et 
al. (1997) attempted to validate several, modified versions of GSA as markers of 
sympathetic and parasympathetic activity during exercise using autonomic 
blockade. They noted that several previously reported techniques had yielded 
results that 'coincide nicely' with the established theories regarding autonomic 
response to exercise. However, none of these techniques had been 
microneurgraphially or pharmacologically validated. 
Warren et al. (1997) used a modified version of HF (0.1 - 1.0 Hz) which 
encompassed all breathing frequencies observed during exercise. This was found 
to be a valid measure of vagal activity during exercise and muscarinic blockade 
(glycopyrrolate). They found a modified version of LF (0.004-0.1 Hz) divided 
by TP (0.004 - 1.0 Hz) to be an equivocal index of sympathetic activity based on 
exercise and fJ I-adrenergic blockade (esmolol) data. 
The primary aim of the present study was to attempt to recreate these data using 
frequency bandwidths permissible by commercially available analysers. This is 
217 
because software in such analysers is commonly set to conform to current 
recommendations or is only variable within a specific range. Two commercially 
available analysers with adjustable frequency bandwidths were explored. From 
this, the bandwidths for use in the present study were determined. 
The secondary aim of the study was to elucidate whether the new GSA 
framework could provide insight into the differential responses to exercise of fit 
and unfit subject groups determined by their V02 max. This way the logical 
validity (Baumgarter 1989) of the new measures could be assessed. A number of 
differences between fit and unfit subjects would be expected. 
Breifly, at rest it would be expected that fit subjects would display greater vagal 
activity compared to less fit counterparts. It is known that transfer to the upright 
position is commonly accompanied by vagal withdrawal and sympathetic 
activation (Jasson et al. 1997; Furlan et al. 2000). There is some evidence to 
suggest that adjustment to orthostatic stress (standing) and increased HR during 
low intensity exercise is the result of greater vagal withdrawal and reduced 
sympathetic activation in fit subjects (Winder et al. 1978; Portier et al. 2001; 
Myslivecek et al. 2002). At higher exercise intensities fitter subjects display a 
lower level of sympathetic activation compared to less fit subjects (Hughson et 
al. 1977; Kingwell et al. 1994). 
On this basis it was hypothesised that the more fit subjects would have a higher 
vagal indicator value at rest and that expected decreases in this value during 
standing and exercise would be larger. It was hypothesised that increases in the 
sympathetic indicator during exercise would be greater in the unfit group. It was 
also hypothesised that these may occur at lower exercise intensities in the less fit 
subjects compared to the fit group. 
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7.2. Methods. 
7.2.1. Subjects. 
Twenty nine university staff and students (20 males median age 39 range 19 - 63) 
and nine females median age 35 (range 19 - 56) were included in the study. All 
subjects were healthy, defined as being free from illness at the time of testing. 
None were known to be taking any medication or have any cardiovascular 
problems that may have influenced the tests carried out. All subjects volunteered 
to participate in the study. Written, informed consent was given separately for 
each part of the study: resting HRV measures, exercise testing and blood lactate 
testing. Subjects were, therefore, able to participate in the study without 
consenting to blood sampling if they so chose. Complete blood lactate analysis 
was only completed on 20 subjects. One subject was excluded from the HRV 
analysis due to technical failure. Full HRV data during exercise was not 
collected on a large proportion of the subjects. This will be discussed filrther in 
the results and limitations sections. 
7.2.2. Equipment. 
7.2.2.1. Heart rate variability measurement. 
HRV measures were made simultaneously using two instruments simultaneously; 
at rest and during exercise. Instrument one was a CardioPerfect ST 2001 HRV 
module (Cardio Control, Delft, The Netherlands). The system used a standard 
12 lead ECG with a sampling frequency of 1000Hz. The sampling time for each 
HRVanalysis was set at 5-min in agreement with current guidelines (Camm et 
al. 1996). The signal was digitised directly and the full ECG trace was shown in 
real time on a computer screen, this signal was simultaneously stored on the 
hard drive of a PC (Dell Computers, Texas, USA.) for post hoc analysis. Each 
sampling period was stored as a single patient ECG record. To analyse the 
variability in RR interval data an automated protocol within the HR V module 
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software was used. The automated filtering system is adjustable, and a 
standardised configuration was used which treated the data as described below. 
Editing of the raw RR interval data was carried out using an automatic-
threshold-detection algorithm. The software rejected RR intenJals which differed 
by more than 20% from the previous interval. This intenJal was then 
interpolated with an interval generated on the preceding intenJal data. The 
remaining analysis was based on the corrected data file of 'normal' RR 
intenJals. The RR data were then passed through a Hanning type window to 
remove baseline trends. The RR interval time series was decomposed to the 
frequency domain via fast Fourier analysis. The resulting power spectrum was 
divided into the following spectral bands HF (0.15-0.40 Hz) LF (0.04-0.15 Hz) 
and VLF (0.0033-0. 04Hz). In addition to this time domain analysis was also 
carried out to give the following values RMSSD, SDNN and RR in tenJa I. 
The second HRV analysis instrument was a VariaCardio (TF5) HRV analysis 
system (Advanced Medical Diagnostics Group Ltd. Leeds, UK). This system used 
a purpose built chest-strap with two electrodes, placed either side of the 
subject's heart. The chest strap sampled at rate of 500 Hz. This signal was then 
sent to a receiver and digitised. The ECG trace and a graphical representation 
of RR intenJal were displayed in real time on the screen of a designated portable 
computer (IBM Systems USA). The sampling period for each measurement was 
set at 300 seconds or 300 beats which ever was longer. The instantaneous HR 
was derived from the identification of QRS complexes which was sampled at a 
higher rate of 1 000 Hz. The RR interval and fit/I ECG data were both stored on 
the hard disk of the designated portable computer prior for post hoc analysis. 
Stored RR intenJal data were then edited automatically by the software. The 
mamifacturers do not give details of the algorithm used to edit the data. To 
ensure effective editing all data were manually edited by a single researcher. 
This was done by visually analysing the raw ECG trace and the graphical 
representation of the RR intenJal data given. The researcher rejected intervals 
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which appeared to represent potential artefacts, interference or noise. This 
jiltered data set was then stored on the hard disk of the PC as a separate data 
jile labelled jiltered data. All fitrther analysis was carried out on this jiltered 
data set. The RR inten1al time series were decomposed to the frequency domain 
via fast Fourier analysis. The resulting power spectrum was divided into the 
following spectral bands HF (0.15-0.40Hz) LF (0. 04-0. 15Hz). Time domain 
analysis was also carried out to give the following values mean squared standard 
deviation (MSSD), SDNN and NN inten1al. The MSSD was then transformed to 
the RMSSD manually. 
The reasons for the simultaneous use of two HRV systems were twofold. Firstly 
the dual analysis protocol was used to maximise the possibility of capturing the 
maximal amount of data. This is because it is known, especially during exercise 
that changes in the signal-to-noise ratio may prohibit the spectral analysis of RR 
inten1al data (Gregoire et al. 1996). Secondly, although HRV analysis is now 
commonplace during exercise there are no data pertaining to the agreement 
between different analysis systems under such conditions. 
7.2.2.2. Respiratory measurements. 
The volume of expired air (Ve) and gas exchange measurements were made 
breath-by-breath, using a Medical Graphics Cardi02 online breath-by-breath 
analysis system (Medical Graphics Corporation, St. Paul Minnesota, USA). 
Automated software from the same company (Breeze Suite) created a fidl set of 
nine-panel-plots (Wasserman et al. 1999) by which aerobic threshold could be 
detected. Blood lactate analysis was carried out using a YSI 1500 Sport lactate 
analyser (Analytical Technologies, Hanford House, UK). 
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7.2.3. Protocol. 
7.2.3.1. The Assessment O%2p.ak and CPO~ 
Subjects visited the laboratory on a total of three occasions to undertake 
different parts of the testing protocol. During visit one V02peak and CPOpeak were 
determined for each subject. Each subject completed a incremental exercise test 
(Bruce) on a motor-driven treadmill (Cardio Control, Delft, The Netherlands) to 
volitional exhaustion. This allowed an estimate of V02peak which was chosen in 
preference to true V02 max. Vo 2 peak has been found to be simple to measure, 
enduring standard of aerobic fitness (Mancini et al. 2000). It is less physically 
stressful than V02 max for the subject and is therefore usefitl when using 
volunteers from clinical populations and the general population. Many subjects 
within these categories frequently have difficulty attaining true V02 max as defined 
by current guidelines (ACSM 2000). During the test VE and O2 and CO2 
exchange were monitored continuously. 
After at least 40 min rest the subjects performed a constant maximal workload 
exercise test on the treadmill. In this instance the researcher manually controlled 
the speed and gradient of the treadmill to elicit a V02 close to (within 10%) the 
value achieved during the Bruce test. Cardiac output (CO) was then assessed 
using the CO2 rebreathing technique (Defares 1960). Cardiac power output 
(CPO) was subsequently calculated using CO and blood pressure measured by a 
hand-held anearoid sphygmomanometer). 
Two non-invasive methods are available to assess cardiac output the equilibrium 
method (Collier 1955) and the exponential method (Defares 1960). The 
exponential method was chosen as subjects experience significantly fewer 
adverse side effects compared with the equilibrium measure (Vanhees et al. 
2000). There are data to support both the validity (Marks et at. 1985,' Kuji et al. 
1991) and reliability (Marks et al. 1985) of this method. Briefly, during the 
constant maximal workload test the subject's air supply was changed from room 
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air to breathing Fom a bag containing 5% C02 and 14% 02 for 10-20 s. The 
subject then rebreathed from this bag until a plateau in the increase in CO2 
concentration was obsenJed. The increase in CO2 and plotting of the CO2 
concentration during the manoeuvre was carried out by an automated protocol 
within the BreezeSuite software. 
7.2.4. Heart rate variability measurement. 
During the second visit, each subject's resting HRV was analysed. In 
accordance with current guidelines for the capture of RR intenJal data for HRV 
analysis subjects attended the laboratory having refrained from eating or 
smoking for 2 hours. Subjects were also asked to refrain from alcohol or caffeine 
containing beverages and exercise on the day of the test, and exercise and heavy 
alcohol consumption on the evening prior to the test. Where subjects had failed 
to meet the requirements of the protocol an assessment was made on the 
potential impact of their behaviour on HRV measures and where necessary the 
test was rescheduled. 
Disposable electrodes (Blue Sensor Medicotest, Olstykke, Denmark) were placed 
in the standard configuration for 12-lead ECG and the TF5 chest strap was 
placed laterally across the subject's heart in accordance with mamifacturer's 
instructions. Subjects were then asked to lie on a bed in a quiet laboratory (J 8-
22°C). Subjects were asked to relax and the researchers monitored their HR 
visually until it became stable. Two simultaneous 5-min ECG recordings were 
then made. Two researchers were required to synchronously start both pieces of 
equipment. Although some auditory clues may have been available, the subject 
was purposely not informed of the start of the recording period. At the end of 
the first recording the subject was asked to stand with feet shoulder width apart 
with hands placed on the back of a tall stool. Subjects were asked not to 'shlifJle' 
or transfer their weight laterally during the data collection period. A second 5-
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min ECG recording was made when the subjects HR was deemed to be stable 
following the change in position. 
7.2.5. Measurement of HRV, blood lactate and CPO during incremental 
exercise. 
At the third visit to the laboratory, consenting subjects were first required to give 
a resting blood lactate sample. An arterialised capillary finger prick sample was 
taken from the index finger of the left hand and the whole blood was then 
transferred via micropipette to the YSI 1500 Sport Lactate analyser. All data 
were recorded from the analyser immediately and stored electronically for later 
analysis. 
Subjects were then required to complete three stages of incremental exercise (25, 
50 and 75% V02peak). During this test ECG was continually monitored and 
breath-by-breath analysis of expired air was carried out using the techniques 
already described. The intensity of this exercise was determined from the VOl at 
each level. When the level of predetermined VOl was reached, a further 5-min 
ECG sample was taken. During this period, a blood pressure measurement was 
taken. At the end of 5-min a blood lactate measurement was made using the 
procedure described previously. At the end of each stage the subjects performed 
the rebreathing manoeuvre described earlier but with the addition of being 
instructed to breathe in time with a metronome eliciting a breathing rate of 0.15 
Hz. This was done in accordance with the manufacturer's instruction to ensure 
the adequate rebreathing of the reference gas mixture from the bag. 
7.2.6. Data treatment. 
Data were selected from n = 29 cases and placed into two groups according to 
the following criteria. Subject groups were designed to be of roughly equal size 
with an equal mean age although subjects were not age matched. Subjects were 
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then allocated to either a high fitness (HI) or low fitness (LO) group based on 
their relative V02peak from the incremental treadmill test protocol described 
previously. 
Each subject was required to have a full data set up to 50% V02peak. It was also 
required that resting HRV data had been collected on the same day as exercise 
data. Data from some subjects were then rejected on the basis of unsuitability 
(usually non-stationarity) of recorded tachograms. Those with an excessive 
number of interpolated beats (>20%) at exercise levels up to 50% V02peak were 
also rejected from the analysis. 
7.2.7. Post-hoc heart rate variability analysis. 
The ECG data were stored on the hard disk of a computer (Dell Microsystems, 
Texas, USA) and HRV analysis was carried out as described previously except 
for the following data treatments. 
The LF band was altered from the default and recommended (Camm et al. 1996) 
bandwidth of 0.04-0.15 Hz to 0.004-0.1 Hz. The HF bandwidth was altered from 
0.15-0.40 Hz to 0.1 - 0.5 Hz. This was as close to the bandwidths used by 
Warren et al. (1997) for exercise HRV analysis as all software would allow. 
Power in the modified HF band (ms2) was then used as a marker of vagal 
activity. The marker of sympathetic activity used was the modified LF band 
(ms2) divided by the total spectral power (0.004 - 0.50 Hz) or LF/TP. 
7.2.8. Statistical analysis. 
All values for RR interval, HF and LF were checked for nonnality of distribution 
using a Shapiro-Wilk' s test. Where skewed distributions were found and data 
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were suitable, natural logarithms were taken and the data again checked form 
normality. 
7.2.8.1. Analysis of complete data set. 
Changes in HF and LF/TP were analysed from rest to 50% V02peak by repeated 
measures analysis of variance (rm-ANOV A). Data were checked for 
homogeneity of variances (Levene's test) and sphericity (Mauchly's test). Where 
either of these assumptions were not met, an appropriately adjusted alpha value 
was assumed. Differences between LF and HF from 50 - 75% V02peak were 
analysed by repeated measures t-test (rm t-test) due to missing cases in the latter 
condition. Further, post hoc analysis was also carried out using rm t-test. 
7.2.8.2. Analysis of HI and LO fitness groups. 
Differences in the behaviour of HF and LF/TP during exercise between the HI 
and LO groups were analysed by two-way mixed ANOV A with repeated 
measures (mixed ANOVA) from rest to 50% V02peak. Differences between 50 
and 75% V02peak were analysed using rm t-test. This was due, again, to the 
reduced number of cases with complete data sets at the latter intensity. Post hoc 
analysis was carried out by comparing values for HF and LF/TP in each 
condition with baseline values. At each intensity, HF and LF/TP were also 
compared with values from the preceding condition. This was done using either 
rm t-test or a Wilcoxon matched pairs U-test. A value of P ::; 0.05 was accepted 
as statistically significant. 
7.3. Results. 
From the 29 original subject cases, six were rejected because resting data were 
recorded on a separate occasion to exercise data. Data from four subjects were 
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found to be incomplete on all necessary measures up to 50% V02peak . The 
tachograms of two subjects were rejected due to significant non-stationarity. 
Complete data were analysed on n = 17 subjects (n = 8 in the LO group, n = 9 in 
the HI group). There were two females in each group. Results of power analysis 
on the basis of the work of Warren et ai. (1997) suggested this sample size would 
produce statistical power in excess of fJ = 0.8 at P = 0.05). However it should be 
noted that the sample size estimation carried out was at best crude, due to 
differences in study population and methodologies. 
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Figure 7-1 Changes (mean ± SD) in RR interval during incremental exercise. 
* Significantly different from baseline. t Significantly different from preceding value. 
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Figure 7-2 Changes (mean ± SD) in HF power (O.1-0.SHz) during incremental exercise. 
*Significantly different from baseline. t Significantly different from preceding value. 
7.3.1. Whole group data. 
Independent t-tests showed the groups to be similar in terms of height, weight 
and BMI. Non-parametric analysis (Mann-Whitney V-test) showed the groups 
did not differ significantly in age (Table 7-1). The only significant difference 
between the two groups was in V02peak. This was shown to be greater in the HI 
group when expressed in absolute terms and also through non-parametric 
analysis when expressed in relative terms. 
Of the 17 subjects entered into the final analysis data were not available at 
75% V02peak in n = 5. Four of these subjects were in the HI fitness groups and 
only one in the low fitness group. 
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Table 7-1. Population characteristics of the LO and HI fitness groups. 
LO HI Significant (P S O.O5} 
Age 45.0 30.9 No* 
± 14.9 ± 11.7 
Height (em) 174.4 179.1 No 
± 6.1 ± 8.2 
Weight (kg) 79.1 79.6 No 
± 14.9 ± 10.9 
BMI 25.9 24.7 No 
± 3.5 ± 2.2 
V02peak (l'min-1) 2.3 3.6 Yes ± 0.6 ± 5.3 
V02peak (ml'kg-1 'min-1) 28.5 45.4 Yes* ± 3.8 ± 6.7 
All values are means ± SD. *Non-parametric analysis used. 
Figure 7-1 shows the RR interval data for all subjects and separately in the HI 
and LO groups. Mixed ANOV A with repeated measures carried out on the 
natural logarithms this data revealed a significant main effect of exercise 
intensity (F = 115.1, P = 0.0001). 
There was a clear effect of exercise intensity on HF (Figure 7-2) which was 
reduced with increasing exercise intensities (F = 38.1, P = 0.001). HF decreased 
between each exercise intensity, post hoc analysis revealed the reduction in HF 
from rest to 25% V02peak was not statistically significant. Values of HF at 50 
and75% V02peak were significantly lower than those at preceding intensities and 
from baseline values. 
The effect of exercise intensity of LF/TP was less pronounced (Figure 7-3). No 
values differed significantly from baseline. There was no change in LF/TP from 
rest to 25% V02peak (t = 0.8, P = 0.44). There was a clear increase in 
LF/TPfrom 25% to 50% V02peak which was close to statistical significance (t = 
1.7, P = 0.09). The only statistically significant difference was a decrease from 
50 -75% V02peak (t = 2.4, P = 0.04). 
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Figure 7-3 Changes (mean ± SD) in LF/TP during incremental exercise. 
* Significantly different from baseline. t Significantly different from preceding value. 
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Figure 7-4 Changes (mean ± SD) in HF during incremental exercise in HI and LO fitness 
groups. 
* Significantly different from baseline. t Significantly different from preceding value. 
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Figure 7-5 Changes (mean ± SD) in LF/TP during incremental exercise in HI and LO 
fitness groups. 
*Significantly different from baseline. t Significantly different from preceding value. 
7.3.2. LO and Hljitness groups. 
When the subjects were divided into LO and HI fitness groups based on V02peak 
there was a group x intensity interaction for HF (Figure 7-4) which was close to 
statistical significance (F = 3.0, P = 0.07). Post hoc analysis of both groups 
showed significant reductions in HF from 25-50% and from 50-75% V02peak. 
The 50 and 75% V02peak values for HF were also significantly reduced from 
baseline values in both groups. Independent t-test showed that HF was not 
significantly different between groups in any of the exercise conditions. 
There was no group x intensity interaction for LF/TP (Figure 7-5). The LO 
group showed a trend toward increased values over all exercise intensities. There 
was a significant (Z = 2.1, P < 0.05) increase from 25-50% in the LO group 
which did not exist in HI. No values for LF/TP were found to differ significantly 
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from baseline. Independent t-tests showed no differences in LF/TP between 
groups at rest or during exercise. 
7.4. Discussion. 
The aim of the present investigation was to assess whether valid indexes of vagal 
and sympathetic activity could be generated through the manipulation of spectral 
HRV measures within the limits imposed by commercially available analysers. 
The results of the study demonstrate that HF power measured from 0.1- 0.5 Hz 
provides a good index of vagal activity during exercise. The ratio of LF (0.01 -
0.10Hz)/TP (0.01-0.5 Hz) was put forward as an index of sympathetic activity. 
Although some of the behaviour of this measure during exercise suggest it may 
be of some use as a maker of sympathetic activity the majority of the results 
suggest that this is at best, an equivocal marker. Additionally its use may be 
limited to lower «75% V02 max) exercise intensities. 
7.4.1. HF as a vagal index. 
Warren et al. (1997) suggested the use of HF from 0.1-1.0 Hz as a measure of 
vagal activity during exercise. In the present study this was modified to allow 
data collection using commercially available analysers. These are limited in the 
spectral range over which RR intervals are analysed. The justification for 
altering the HF band for use in exercise study is that the centre of the HF peak is 
closely linked to respiratory frequency (Hayano et al. 1991; Ori et al. 1992; 
Brown et al. 1993; Casadei et al. 1996; Uusitalo et al. 1996; Malpas 2002). The 
recommended (Camm et al. 1996) frequency range for HF (0.15-0.40 Hz) may 
exclude some of the very low respiratory rates shown at rest by fit subjects and 
the high rates associated with (intense) exercise. By expanding the HF band, all 
respiratory-mediated vagal activity is included for analysis. 
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Warren et al. (1997) found their version of HF declined throughout incremental 
exercise intensities of 0, 50, 100 and 150 W demonstrating vagal withdrawal. 
This pattern of HF reduction corroborated the observed HR response. The 
validity of HF as vagal maker was further supported by pharmacological data. It 
was found that changes in HF were attenuated by both muscarinic and combined 
autonomic blockade. Changes in HR at low exercise intensities were not altered 
by ji-adrenergic blockade (esmolol). HF was slightly lowered by esmolol but 
this was atributed to a small amount of, baroreflex-mediated vagal withdrawal 
that did not cause a significant tachycardia. 
7.4.1.1. HF during exercise - replication of previous data. 
In the present study autonomic blockade was not used. However, it was found 
that the small increase in HR from rest to 25% V02peak was accompanied by the 
smallest reduction in HF. The larger increase from 25-50% V02peak was mirrored 
by a large, statistically significant reduction in HF power. This would be 
expected as vagal withdrawal has been found to be the major cause of exercise 
induced tachycardia up to this intensity. From 50-75% V02peak HR continued to 
increase linearly but the reduction in HF was less pronounced, indicating that the 
majority of vagal withdrawal had already occurred. 
When using HF (0.15 - 0.40 Hz) as makers of vagal tone during exercise a 
paradoxical increase in this measure is often found at higher exercise intensities 
(Tulppo et al. 1996; Tulppo et al. 1998) (Casadei et al. 1995). This has been 
attributed to increased respiratory rate and depth enhancing respiratory sinus 
arrhythmia. Bernardi et at. (1990) provided evidence for this and the 
contribution of this non-neural input was later quantified as approximately 60% 
during intense exercise (Casadei et al. 1995). Warren et at. (1997) found this to 
be the case in four of their ten subjects. In the present study, all subjects 
demonstrated a reduction in HF from 50 - 75% V02peak. The mean group 
reduction was 1.6 log units from 3.8 to 2.2 (t = 5.1, P < 0.001). 
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7.4.1.2. Logical validity of HF as a vagal index. 
Warren et at. (1997) verified the validity of their measure of HF using //-
adrenergic, muscarinic and combined autonomic blockade. In the present study 
the logical validity of HF was determined by splitting the subjects into two 
groups of high fitness (HI) and low fitness (LO). The differences in HR response 
to exercise and the relationships between HR and HF in the two groups were then 
compared. The HI fitness group demonstrated a longer RR interval at rest 
compared to the LO group (Figure 7-1). The longer RR interval in HI was 
maintained from rest to 25% V02peak. HF was elevated at rest in HI compare to 
LO and remained so at 25% V02peak. The changes in HF were very similar 
between these two conditions in both groups. From 25-50% V02peak the decrease 
in RR interval was much more marked in HI. Similarly, the reduction in HF, 
although significant in both groups was much greater in HI. This fits with 
current theory by suggesting a greater proportion of the exercise-induced 
tachycardia observed was due to vagal withdrawal in the fitter subjects. From 
50-75% the decreases in RR interval in LO and HI were very similar. The 
decrease in HF in the LO group was statistically significant (t = 2.54, P = 0.04), 
however the decrease in the HI group was of a much greater magnitude (t = 
13.7, P < 0.001) and showed less within-subject variation. This may indicate 
that at this higher exercise intensity vagal withdrawal may still be occurring, and, 
to a greater degree, in the fit subjects. This reaction is much less evident in the 
LO group. 
Although it is evident from Figure 7-3 that HF at 50 and 75% V02peak is actually 
higher in LO it should be noted that HI were working at higher absolute 
workloads. This difference is therefore expected. Finally the large standard 
deviations evident in the LO group at the 75% level indicate a varied response to 
changes in exercise intensity, whereas the very smaller spread of scores in the HI 
group suggest a more uniform reaction. The meaningfulness of this result is as 
yet unclear. 
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7.4.2. LFITP as a sympathetic index. 
Warren et al. (1997) found LF (0.004-0.1 Hz) I TP (0.004-1.0) to be an equivocal 
marker of sympathetic activity. The ratio was only found to increase 
significantly from baseline at exercise intensities of 150 and 200 W. This finding 
fits well with data concerning sympathetic activation and its role in exercise HR. 
Current theory suggests that increased sympathetic activity only plays a major 
role during exercise eliciting a HR greater than 100 BPM. 
7.4.2.1. LF/TP During exercise - replication of previous data. 
In the present study LF/TP remained unchanged from rest to 25% V02peak and 
then increased (P = 0.063) from 25-50% V02peak. This again fits with theory 
regarding sympathetic activation. From rest to 25% Vo 2 peak RR interval 
decreased from 800 to 680 ms (80 - 90 BPM). From 25% - 50% V02peak the 
decrease was 680 - 550 ms (90 - 120 BPM). It is therefore, between 25 and 
50% V02peak that an initial increase in sympathetic activity would be expected. 
The present data support this notion. From 50-75% V02peak Warren et al. (1997) 
showed a less marked increase in LF/TP than the previous increment. In the 
present study LF/TP actually showed a significant decrease from 50-75% V02peak • 
This would seem to invalidate it as a measure of sympathetic activity. However, 
several methodological issues must be addressed before LF/TP is dissmissed. 
Firstly, data were only present on 70% of subjects at this level. Of this fraction, 
88% of the LO group had data present. In the HI group this value was only 44%. 
This lack of data was due mainly to low signal:noise ratios present at 75% 
V02peak. In many of the data sets which were present, a large proportion of the 
RR intervals were interpolated. It may therefore be wise to treat data obtained 
for LF/TP (and HF) at 75% V02peakwith some caution. Lastly, the behavior of 
LF/TP was not uniform between subjects. Whereas most subjects showed a 
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decrease in LF/TP from 50-75% V02peak, one subject showed a very marked 
increase and two others showed smaller increases. 
7.4.2.2. Logical validity ofLF/TP as a sympathetic index. 
When the data were split by subject fitness level (LO and HI) there was no 
interaction between groups across the exercise conditions. A clear trend of 
elevated LF/TP in LO was, however, evident. Values for LF/TP were higher at 
rest and remained elevated throughout all exercise intensities. From 25-50% 
V02peak there was a significant increase in LF/TP from baseline values in the LO 
group only. This change was coincidental with the point at which the HI group 
demonstrated a greater reduction in HF. This reduction was also accompanied 
by a more marked decrease in RR interval in HI compared to LO. This can be 
interpreted as inferring that from 25-50% V02peak subjects in the HI group 
increased their HR by vagal withdrawal whereas the less fit (LO) subjects were 
more reliant on sympathetic activation to increase HR. As mentioned previously, 
relative workloads were assigned to each group based on previous maximal 
V02peak values. Because of this fact, the absolute workload and size of the work 
increment in the HI group was much greater. 
It seems LF/TP may be useful maker of sympathetic activity within the range of 
resolution of the recording system or at lower exercise intensities. Until the 
former is clearly defined it remains to be determined as to which of these two 
possibilities is the limiting factor in the use of this measure. 
7.4.2.3. Problems with LF/TP. 
Warren et at. (1997) concluded that LF/TP was at best an 'equivocal' maker of 
sympathetic activation based on its behavior during exercise. Closer 
examination of their results reveals that from 0 - 150 W LF/TP increased 
constantly, the lack of statistically significant differences found are probably due 
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to the small (n = 10) sample size. The second reason for rejection of LF/TP 
comes from the data achieved under pharmacologial blockade and is more 
convincing. Under j3-adrenergic blockade LF/TP showed quantitatively similar 
increases as in the placebo condition. LF/TP also increased at 50 W, a workload 
at which j3-adrenergic blockade failed to attenuate HR response. Both these 
scenarios show a clear uncoupling of the activity of LF/TP and sympathetic 
nervous outflow. 
In the present study it seems that LF/TP may be a similarly equivocal maker to 
the ratio described by Warren et al. (1997). Prior to any further investigation, 
caution must be used in assuming LF/TP is a marker of sympathetic activation 
due merely to the fact that its behavior is coincidental with current physiological 
theory. The fact that LF/TP here and previously described (Warren et al. 1997) 
bears some relationship to the expected pattern of behavior during exercise 
warrants further investigation. It is an obvious improvement on LF (0.04-0.15 
Hz) which has been used previously in raw and normalised units to indicate 
sympathetic activity during. When LF power (ms2) is measured during exercise 
a large decrease in spectral power is commonly observed at the onset of exercise 
(Furlan 1987; Rimoldi et al. 1990; Rimoldi et al. 1992). LF then continues to 
decrease with greater exercise intensities (Arai et al. 1989; Bernardi et al. 1990; 
Breuer et al. 1993). To control for the overall reduction in spectral power 
observed investigators have used LFnu or LF:HF to represent sympathetic 
activity during exercise. The use of these ratio has lead to similarly paradoxical 
results with large decreases in LFnu and LF:HF reported during exercise, 
especially at higher exercise intensities (Perini et al. 1990; Breuer et al. 1993; 
Perini et al. 1993; Casadei et al. 1995; Perini et al. 2000; Perini et al. 2002). 
There is evidence to suggest that LF is at least, in part mediated by vagal activity 
(Akselrod et al. 1981; Vybiral et al. 1990; Cacioppo et al. 1994; Jokkel et al. 
1995) the overall decline in HF and TP must be controlled for and a ratio is the 
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only option to do this it may simply be a question of which ratio is used and 
within which frequency bands the numerator(s) and denominator(s) lie. 
7.5. Conclusions and limitations. 
Data from the present study support the use ofHF (0.1-1.0 Hz) as an index of 
vagal activity during exercise. They also partially support the use of LF/TP as a 
sympathetic index. Trends toward differences between fit and unfit subjects in 
these indices demonstrate their logical validity and further support their use. The 
lack of many statistically significant differences between groups was probably 
due to the small sample size employed. Although sample size calculations were 
made, they were based on findings using different vagal and sympathetic makers. 
This highlights a real problem when undertaking novel research of this type. The 
fact that calculations were attempted at all is an advance on much of the previous 
data in this field. Furthermore, the present data may now be used to provide 
sample size estimates for further investigation. Investigating the logical validity 
of these methods using absolute workloads would facilitate comparison of 
findings made using these ratios with those published previously (Warren et al. 
1997). This may elucidate more clearly, differences in vagal and sympathetic 
activity between fit and unfit subjects during exercise. It is of note that non-
invasive makers of sympathetic activation are available. Both baroreflex function 
testing and other applications of beat-to-beat blood pressure monitoring are well 
established as makers of sympathetic activation (Uusitaalo et al. 1996) and 
further work may be directed at improving the understanding and application of 
these methods and quantifying the relationships between them and potential 
markers of sympathetic activity from HRV. 
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CHAPTER 8. HEART RA TE VARIABILITY AND TRAINING 
INDUCED-BRADYCARDIA: INFERENCE FROM MET A-ANALYSIS. 
Abstract 
Chronic exercise training produces a resting bradycardia which is thought to be 
due, in part to increased vagal modulation. The aim of the present study was to 
determine the cross-sectional and longitudinal effects of exercise training on 
heart rate and measures of heart rate variability associated with vagal cardiac 
modulation and to quantify the relationship between changes in these measures. 
Random effects models of effect size (d) for change in high frequency (HF) 
power, standard deviation of normal to normal intervals (SDNN) and RR interval 
were calculated. Within-group herterogeneity was assessed using the Q statistic. 
Where heterogeneous effects were found subgroup analyses were performed 
using the between-group Q statistic. 
Cross-sectionl differences between sedentary and active subjects were significant 
for all measures (P < 0.0001) and heterogeneous. Subgroup analysis revealed the 
level of athletic training (recreational vs. elite athletes) significantly impacted on 
effect size magnitude. Longitudinal analysis showed significant effects of 
exercise training on HF (d = 0.48, C.l. 0.26 - 0.70, P = 0.00003), SDNN d = 
0.827 (C.l. 0.36 - 1.30, P = 0.001) and RR interval (d = 0.75, C.l. 0.51 - 0.96, P 
< 0.00001). Effect sizes for SDNN and RR interval data were significantly 
heterogeneous and subgroup analysis revealed significantly smaller responses of 
SDNN and RR interval to training in older subjects (P < 0.1). Factors such as 
subject sex and length of training intervention also modulated effect size. Effect 
sizes for change in HF were homogenous, although there was a trend towards an 
attenuated response to training in older subjects (P > 0.1). Serial curve 
estimation (linear, quadratic, cubic) revealed strong associations between HRV 
measures and change in RR interval in cross sectional differences, but only weak 
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(P> 0.05) relationships between effect sizes for change in HF, SDNN and RR 
interval. 
Exercise training results in a significant increase in RR interval duration, SDNN 
and HF power. These changes are influenced by the age of the study population. 
The smaller effect size for HF and the weak relationship between these measures 
suggest factors additional to increased vagal modulation are responsible for 
training bradycardia. 
This chapter, in ltul1cated form has been published in Medicine and Science in Sports and Exercise, see appendix IV. 
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8.1. Introduction. 
The aim of the present study was to assess the chronic effects of exercise training 
on resting heart rate (HR) and overall variability in HR standard deviation of 
normal-to-normal intervals (SDNN) and high frequency spectral power (HF). 
Although a slower resting HR is an accepted phenomenon in athletes (Raab et al. 
1960; Frick et al. 1967; Ekblom et al. 1973; Scheuer and Tipton 1977) the exact 
cause is unclear. Data from selective and dual pharmacological blockade have 
claimed to support the notion that resting bradycardia in athletes is the result of a 
relative increase in vagal tone (Raab et al. 1960; Frick et al. 1967; Ekblom et al. 
1973; Scheuer and Tipton 1977; Williams 1985; Smith et al. 1989). In a number 
of cases, data from such studies (Raab et al. 1960; Ekblom et al. 1973) are open 
to alternative interpretation (Katona and Jih 1975) or have methodological 
shortcomings (Frick et al. 1967). Incongruent results also exist (Maciel et al. 
1985). Additionally, the dual blockade method has produced evidence to suggest 
that decreased intrinsic firing rate of the SA node may be responsible for the 
bradycardia observed following physical training in humans (Sutton et al. 1967; 
Lewis et al. 1980) and animals (Hughson et al. 1977). 
Despite wide acceptance of increased vagal tone as the cause of bradycardia, 
there are little experimental data to support this view (Frick et al. 1967; Katona 
and Jih 1975). Quantification of the role of intrinsic and vagal influences on 
bradycardia is, therefore, difficult (Maciel et al. 1985). 
Non-invasive methodologies based on beat-to-beat variation in HR have been 
used to estimate the vagal contribution to bradycardia (Katona and Jih 1975) and 
have produced results supporting increased vagal tone (Kenney 1985). Early 
studies used simple, time domain analysis by measuring the amplitude of change 
in RR interval during respiration (Respiratory Sinus Arrythimia, RSA). The 
modulation of rhythmic oscillations in RR interval during the respiratory cycle is 
known to be vagally mediated (Pomeranz et al. 1985; Hayano et al. 1991; 
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Malliani et al. 1991; Hedman et al. 1992; Badra et al. 2001). Therefore, greater 
RSA amplitude has been used to indicate an increased vagal tone (Melanson 
2000). These studies have shown training-induced bradycardia to commonly be 
accompanied by greater RSA. On this basis, bradycardia is assumed to be 
vagally mediated. 
The measurement of rhythmic oscillations in RR interval has been developed 
further to provide a large number of measures in both the time and frequency 
domains. The analysis of heart rate variability (HRV) is now, recognised as a 
non-invasive measure by which resting autonomic (particularly vagal) nervous 
activity can be assessed (Pagani et al. 1986). 
At rest, it is assumed that the majority of short-term oscillations in HRV are 
predominantly under vagal mediation. On this basis, simple time domain 
measures of overall RR interval variability have been proposed as useful vagal 
makers. One commonly used 'global' HRV measure is the standard deviation of 
normal-to-normal intervals (SDNN). This is sometimes reported as SDRR (the 
standard deviation of RR intervals). The use of SDNN is more correct as raw 
ECG signals (containing RR intervals) are often contaminated with ectopic beats 
and recording artefacts. These can influence HRV measures significantly and are 
commonly removed by combinations of automated beat-rejection algorithms and 
manual data editing. The resulting time series is commonly referred to as 
normal-to-normal (NN) interval data. Therefore, in the remainder of this chapter 
SDNN will be used regardless of the nomenclature employed by cited authors. 
Spectral analysis of HRV provides information concerning rhythmic oscillations 
in RR interval at a number of frequencies. The most clearly defined of these are 
the high frequency (HF) oscillations between 0.15 - 0.40 Hz that commonly 
display a peak in spectral power concurrent with the centre of the respiratory 
frequency. There are many data to suggest that these HF oscillations are almost 
entirely vagally mediated (Akselrod et al. 1981; Pagani et al. 1986; Camm et al. 
1996). 
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To elucidate whether exercise training is associated with significant resting 
bradycardia a meta-analysis of cross-sectional studies comparing athletes and 
active subjects with controls was carried out. In an attempt to infer causality 
from such findings, a further analysis of exercise intervention studies was also 
completed. In order to determine the degree to which any observed bradycardia 
was vagally mediated meta-analyses of SDNN and HF were carried out. To 
quantify the strength of any relationship between changes in RR interval, SDNN 
and HF correlational analysis was undertaken. To explain any heterogeneity, 
subgroup analyses were also completed. 
8.2. Methods. 
8.2.1. Search strategy. 
The Pubmed and Ovid databases were searched using the MeSH terms 'heart rate 
variability' and: 'exercise' 'activity' 'athlete(s)'. A second search using the 
terms: 'bradycardia' and 'autonomic control' in conjunction with both previous 
search terms was also performed. Full text articles were then obtained and the 
bibliographies were searched manually to obtain further studies not identified 
electronically. 
8.2.2. Criteria. 
Only studies published in the English language and conducted in healthy persons 
of at least 18 years old were included. For longitudinal comparisons, an aerobic 
exercise intervention of at least four weeks duration was required. The use of a 
control group was originally an inclusion criterion but was later revoked. 
However, where a control group was present, the use of randomised group 
allocation remained a criterion. All studies were required to have measured 
either HF or SDNN. 
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Where a trial meeting the above criteria had assessed HRV across an exercise 
intervention, the data were further investigated to see if changes in RR interval 
had also been assessed. Failure to report change in RR interval was did not mean 
the study was excluded from the HRV meta-analysis. However, only studies 
reporting HR V measures and RR interval data concurrently were entered into the 
meta-analysis of changes in RR interval. 
8.2.3. Review process. 
The searches lead to the identification of 67 potential studies for inclusion in 
both analyses. The MeSH terms used provided many irrelevant studies due to 
the commonality of the terms used and their combinations. Studies were 
assessed in terms of the inclusion criteria by a single author. After application of 
the inclusion criteria only 47 of the studies identified were investigated further. 
From herein, the inclusion criteria for each type of comparison and HRV 
measurement analysed were different and are therefore addressed separately 
below. 
8.2.4. Analysis of data from cross-sectional study design. 
8.2.4.1. High frequency power. 
The measure of HRV used was required to be high frequency spectral power 
(HF). It was deemed necessary that this had been derived from either 
autoregressive, Fourier type transformation or reported as the harmonic 
component from coarse graining spectral analysis. These data were required to be 
presented in raw units (msec2) or transformed units. Normalised units ratios and 
percentages of total power were not used in the analysis. 
From the 67 potential studies gained from the search criteria, 27 studies were 
identified as being useful, cross-sectional comparisons of HRV between groups. 
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On further investigation of these studies, four were rejected as neither HF nor 
SDNN were used as measures of HRV (Katona and Jih 1975; Kenney 1985; 
Reiling and Seals 1988; Melanson 2000). Where HF was reported, the results of 
two studies were rejected as only normalised units were given (Shin et al. 1995; 
Shin et al. 1997). In another, the HF (msec2) was given in a format from which it 
was not possible to calculate effect size (Macar et al. 1996). Following 
preliminary analysis of the data one further study was rejected due to the 
inclusion of an unsuitable control group (Sacknoff et al. 1994). Seventeen 
studies with a total of 20 trials were entered into the final analysis. 
8.2.4.2. SDNN 
Two studies from which the reported HF data were used in the above analysis 
failed to report SDNN. No additional studies were added to those included in the 
above section for HF. In all, 12 studies with a total of 15 trials were entered into 
the final analysis. 
8.2.4.3. RR interval. 
Raw RR interval data and differences between groups were available in all 
studies and all trials included in the analysis of both HF and SDNN. Therefore, 
17 studies with a total of 20 trials were included in this analysis 
8.2.5. Analysis of data from longitudinal study design. 
8.2.5.1. High frequency power. 
Inclusion criteria for HF power were identical to those described in previously. 
Twenty potential studies into longitudinal changes in HRV were identified from 
the search criteria described previously. Of these, HF was not assessed in four 
studies (Reiling and Seals 1988; Seals and Chase 1989; De Meersman 1992; 
Levy et al. 1998). Additionally, HF data were recorded but not presented in one 
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study (Hautala et al. 2003). In a further study HF data were presented, but not in 
the required units (Portier et al. 2001). Finally, data were presented in a form 
that did not allow calculation of Cohen's d in two further studies. (Hedelin et al. 
2000; Melanson and Freedson 2001). 
Twelve studies including a total of 17 trials were entered into the analysis. Of 
these trials, two from one study (aI-Ani et al. 1996) were rejected due, to very 
small (n=2) sample size and results deemed to be spurious. Briefly, an effect size 
four times the mean magnitude of all other results was reported. The direction of 
this effect was also in the unexpected direction one study group. The remaining 
subjects (n = 7) showed large changes in the expected direction despite exposure 
to the same training stimulus. This would seem to infer a methodological 
shortcoming in the data. 
8.2.5.2. SDNN 
Some studies included in the analysis of HF did not include measures of SDNN 
(Boutcher and Stein 1995; Perini et al. 2002; Uusitalo et al. 2002). Two studies 
were excluded from the analysis as SDNN was reported in a format that did not 
allow calculation of Cohen's d (Seals and Chase 1989; Melanson and Freedson 
2001). Eleven trials were finally entered into the analysis for longitudinal 
changes in SDNN. 
8.2.5.3. RR interval 
Of the twelve studies entered into the previous analyses, RR data were not 
presented in one study (Hedelin et al. 2000). In two studies, RR interval data 
were not supplied in a way which facilitated the calculation of effect size 
(Melanson and Freedson 2001; Hautala et al. 2003). One study, identified as 
providing information on RR interval data over the course of an exercise 
intervention (Portier et al. 2001) was subsequently omitted from the analysis. 
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This was because neither HF nor SDNN were supplied in required units or in a 
suitable format for meta-analysis. 
8.3. Statistical Methods. 
To compare cross-sectional differences in HRV measures the effect size was 
calculated using Cohen's d statistic. Where possible this was done using means 
and standard deviations of the groups using the following formulae: 
d = M 1 - M 2 / (J pooled Equation 8-1. 
where 
2 2 
(Ypoolea OJ + (Y2 /2 
The same calculations were made when longitudinal designs were analysed. The 
pooled standard deviation was calculated from the pre- and post-test standard 
deviations of the experimental group. Previous studies (Davy et al. 1996; 
Hedelin et al. 2000) have suggested that HRV data does not demonstrate 
regression toward the mean following exercise intervention therefore allowing 
this choice of standard deviations to be used. This method of calculating (J may 
overestimate d slightly as it does not take into account the correlation between 
the two sets of scores (Dunlop et al. 1996). It was chosen because HRV is a 
dynamic measure which commonly shows variation from test-retest and large 
within group variation. These factors serve to reduce estimates of effect size. 
The use of this liberal method of effect size estimation was deemed to be 
advantageous as it allowed inclusion of studies where no control group was used. 
8.3.1. Tests/or Heterogeneity. 
Heterogeneity between study results creates problems in meta-analysis (Higgins 
et al. 2002) and a number of sources are available providing guidance for dealing 
with this issue (Cook et al. 1995; Deeks et al. 1996; Clarke and Oxman 2000; 
NHMRC 2000). Recently, Higgins et al. (2002) reviewed these sources, 
synthesised their recommendations and created guidelines on how heterogeneity 
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may be best assessed and dealt with in meta-analysis. What follows is a brief 
summary of their findings and recommendations. All sources of guidance 
recommended the use of a statistical test for heterogeneity based either on the 
summary statistic (Q) of each study or the Q/(k-l) statistic where Q is the i 
value in a test for heterogeneity and k is the number of studies in the meta-
analysis. This statistic has the particular feature by which a value greater than 
one may be used to provoke further investigation even if the Q statistic itself is 
non-significant. Such a facility is helpful, as it means the statistic is independent 
of sample size. 
Higgins et al. (2002) found that the various sources provided consistent advice 
about what to do is if heterogeneity was detected. All sources advocated that a 
random effects model be used either alongside or instead of a fixed effects model 
to account for unexplained heterogeneity. The Cochrane group provided 
specific guidelines for meta-analyses based on P-vales of heterogeneity statistics. 
They stated that: if P > 0.10 a fixed effects model should be used, if P = 0.05-
0.10 a random effects model should be employed and that if P < 0.05, no meta-
analysis be performed. 
Higgins et al. (2002) also advocated that a cautious examination of potential 
sources of heterogeneity be used. They found that all reviewed sources 
highlighted the possibility of spurious findings arising from subgroup analyses. 
The authors adopted previous recommendations (Oxman and Guyatt 1992) 
which state that a small number of analyses be undertaken on subgroups which 
have been determined a priori. Additionally, the selection of subgroups should 
be based on the following: 
1. causal mechanisms 
11. magnitude of effects 
111. statistical significance. 
Higgins et al. (2002) made the additional recommendation that all subgroup 
analyses be physiologically justified. All the sources reviewed advocated 
caution in interpretation of subgroup analysis results. The decision tree below 
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(Figure 8-1) was used in the present study to check for heterogeneity and identify 
its causes. 
The within-group heterogeneity was assessed by calculation of the Q statistic for 
all data in the analysis using the following formula. 
Q = L w i (8 i -8)2 Equation 8-2. 
The squared distance of each study from the combined effect is calculated. Each 
value is weighted using the formula below, with a greater weight given to more 
precise studies. The 'se' is based on the inverse variance method and all 
calculations are based on log values (Borenstein and Rothstein 1999). 
Wi = 1/[se(0JJ Equation 8-3 
257 
P>O.1 Subgroup analysis 
Findings homogenous. 
~ 
carried out only for 
Results are confidently comparison with 
accepted. other variables. 
Whole Calculation of Q: Between-group Q 
group data f---+ if P - 0.1 calculation value calculated to 
e.g. of(Qlk-I). determine if 
SDNN. subgroups differ 
significantly. 
l 
Subgroup ~ P < 0.1, findings are Subgroup analysis t Within-group Q heterogeneous, carried out to 4 calculated for each accepted only with .. determine sources of Subgroup ~ subgroup to determine caution. heterogeneity t whether heterogeneity persists. Subgroup 
Figure 8-1 Process for the determination of effect size heterogeneity by subgroup analysis. 
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It should be noted that the level of significance employed when using the Q 
statistic is P < 0.10. This is due to the inherent weakness of the statistic in its 
ability to identify heterogeneity both within and between groups. Values which 
approached significance at P = 0.10 and those between P = 0.10 and 0.05 were 
investigated further using the Q/(k-l) statistic. 
8.3.2. Subgroup comparisons. 
In keeping with current recommendations, a priori decisions regarding all 
subgroup analyses were made. In the cross-sectional meta-analyses only two 
subgroups were investigated. In the longitudinal analysis five subgroups were 
identified and investigated. The reasons for this larger number were because 
greater inference can be drawn from this type of analysis and because more 
possible moderator variables were evident in the literature. 
8.3.2.1. Analysis of moderator variables in cross-sectional data. 
From reviewing the data it was obvious that studies could be logically subdivided 
into two groups: 
1. Those that contrasted athletes (such as national standard runners or cross-
country skiers) with sedentary controls. 
11. Those that contrasted moderately 'trained' individuals (usually 
recreational athletes differentiated by higher V02 max or maximal work 
output) with sedentary controls. 
Physiological justification for this subgroup allocation lies in the much greater 
differences in training (volume, intensity and duration) between groups in the 
'athletes vs. controls' comparison and the 'trained vs. controls' comparisons. 
The preceding nomenclature will be used in the remainder of this chapter to 
identify these subgroups. 
The second subgroup analysis was based on the two broad methodological 
categories ofHRV data collection. These are either: 
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1. Twenty four-hour, ambulatory monitoring of the ECG. 
11. Resting, stable ECG recording made over short periods of time 
(commonly 2 - 20 min). 
Although no direct physiological justification of these subgroups or prediction of 
effect direction can be given, the vast difference between these methodologies is 
clear and their analysis can be logically justified. In addition to this there is 
debate over the relative merits of each method and complex issues surrounding 
their application to HRV analysis (Camm et al. 1996) that are beyond the scope 
of this chapter. 
8.3.2.2. Analysis of moderator variables in longitudinal data. 
The potential moderator variables identified in this analysis were classified as 
either: subject characteristics, training intervention characteristics or HRV 
methodolo gical characteristics. 
The first classification of subgroup was subject characteristics. The first 
subgroup analysis in this group was based on subject sex. Trials including 
males, females and mixed groups are all present in the literature. Physiological 
justification for this subgrouping lies in the known differences in HRV measures 
between the sexes (Gregoire et al. 1996; Kuo et al. 1999) and the between-sex 
differences in HRV response to training which exist in the literature (Myslivecek 
et al. 2002). 
The second subgroup analysis concerned subject age. Subjects were divided into 
three groups defined as young (mean age < 30 years) middle aged (mean age 30 -
60 years) or old (mean age > 60 years). This analysis was justified 
physiologically as differences in HRV are evident between age groups (Byrne et 
al. 1996; Kuo et al. 1999). It is also known that responses of other physiological 
measures to training are affected by age. The final subject characteristic use to 
define subgroups was previous training status. It is common for subjects with a 
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relatively high value for a given physiological characteristic to show less 
adaptation than those with lower initial values and vice versa. This phenomenon 
is known as law of initial values and statistically, it commonly translates into 
regression toward the mean. There is some evidence to suggest an opposite 
direction of effect for certain characteristics of HRV (Hautala et al. 2003). There 
are also data to suggest that high levels of HRV may prevent further increases in 
very fit subjects due to physiological factors such as acetylcholine saturation of 
the SA node (Goldberger et al. 1994; Eckberg 1997; Goldberger et al. 2001). 
The second subgroup classification was differences of training intervention. 
However, the only analysis it was possible to carry out was based on intervention 
duration. The two subgroups analysed were comprised of studies :::;12 weeks 
duration and those > 12 weeks. This point of division was derived from the 
literature as 12 weeks seemed to be an upper limit to the shorter interventions 
used. Above this point studies varied from 14 weeks to 2 years in duration. This 
was justified by the occurrence of such a wide range of intervention durations in 
the literature. Many physiological variables show differences in magnitude of 
adaptation dependent on duration of stimulus. It was felt, logically, that studies 
of 8-week duration could not be compared fairly with those of 1 year. 
The last subgroup classification was HRV methodology and contained subgroup 
analysis between short-term and 24-hour EeG recordings as defined in section 
8.3.2.1. 
8.4. Results. 
8.4.1. Heterogeneity of cross-sectional comparisons. 
There was significant heterogeneity of results for differences in RR interval (Q = 
42.51, P < 0.0001). The resulting value for Q/(k-1) was 3.35. Similarly, there 
was significant heterogeneity of results for differences in RR interval (Q = 
37.40, P = 0.0001) and the resulting value for Q/(k-1) was 3.35. The results of 
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trials reporting differences in HF were also heterogeneous (Q = 40.24, P = 
0.0001) with a resulting value for Q/(k-l) of 3.40. 
8.4.2. Differences in RR-interval. 
Seventeen trials were drawn from the 14 studies that met the inclusion criteria 
(Figure 8-2). In total, 476 cases were included in this first part of the meta-
analysis. The overall effect size was d = 1.30 (C.l. 0.61 - 1.99, P = 0.0002). 
When subgroup analysis between comparisons of athletes vs. controls or trained 
individuals vs. controls was carried out, the effect sizes were d = 1.46 (C.l. 0.44 
- 1.60, P = 0.0009) and d = 0.78 (C.I. 0.32 - 1.24, P = 0.001) respectively. The 
trials comparing groups of athletes and controls included some mixed and 
anaerobically trained subject groups in addition to those who were solely 
aerobically trained. When such groups were removed, the overall effect size was 
increased to d = 1.84 c.l. (0.80 - 2.8, P = 0.0002). 
Subgroup analysis revealed the mean effect size for athletes vs. controls to be 
significantly greater than that of trained individuals vs. controls when mixed and 
anaerobically trained groups were excluded (Q = 4.31, P = 0.038). This was not 
the case when 'mixed training' groups were included in the analysis (Q = 1.73, P 
= 0.19). Due to the observed effect of including such trials on overall effect size, 
these group comparisons were not entered into the remaining analysis for RR 
interval or any other HRV variables. Within-group heterogeneity was still 
evident in the athletes vs. controls group (Q = 34.82, P = 0.0003). The results of 
the trained individuals vs. controls group were found to be relatively 
homogenous (Q = 3.4, P = 0.34) although Q/(k-l) = 1.7. 
When studies were compared by HRV measurement method there was a 
significant between groups effect (Q = 6.94, P = 0.008). Those studies using 24-
hour measures showed a greater effect size (d = 0.84, P = 0.004) than those 
using short-term measures (d = 0.26, P = 0.02). When trials were divided in 
this way, results from those using short-term recordings remained heterogeneous 
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(Q = 32.01, P = 0.0009) whereas results from 24-hour monitoring were 
homogenous (Q = 1.28, P = 0.73). 
8.4.2.1. Differences in SDNN. 
Twelve studies were entered into the meta-analysis with a total of 356 cases 
(Figure 8-3). The overall effect size for differences in SDNN was d = 0.79 (C.l. 
0.40 - 1.18, P = 0.0001). When data were grouped by comparison, the effect 
size for athletes vs. controls (n = 322 cases) was d = 0.81, (C.l. 0.35 - 1.27, P = 
0.0006). When trained subjects were compared with controls (n = 43 cases) the 
mean effect size was d = 0.66 (C.l. 0.04 - 1.27, P = 0.0384). The difference 
between these effect sizes was not significant (Q = 0.002, P = 0.96). Further 
calculations of within group Q-values revealed the athletes vs. controls group to 
still have heterogeneous effect sizes (Q = 36.95, P = 0.00003) whereas 
comparisons between trained individuals and controls were homogenous (Q = 
0.48, P = 0.48). 
When between-group differences based on data recording type were calculated 
the effect size gained from 24-hour recordings (d = 1.00 C.I 0.58 - 1.46) was 
significantly greater (Q =3.86, P = 0.049) than that for short-term measures (d = 
0.54 C.l. 0.33 - 0.80). Assessment of within group heterogeneity following this 
subgroup analysis showed results from short-term recordings remained 
heterogeneous (Q = 33.32, P = 0.0002). Conversely, long term recordings 
showed homogenous results (Q = 0.25, P = 0.96). 
8.4.2.2. Differences in HF 
Thirteen studies with a total of n = 422 cases were entered into the final analysis 
for HF (Figure 8-4). Nine of these compared athletes and controls (n = 327 
cases) the remainder compared trained individuals with controls (n 95). 
Analysis of the HF data as a whole indicated a significant overall effect size of d 
= 0.52 (CI 0.14 - 0.88, P = 0.006). 
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EffectName Citation Year NTotal PValue -8.00 -4.00 0.00 4.00 8.00 
RR Athletes Aubert et al. 2001 20 .106 
RR Athletes Aubert et al. (anearobic) 2001 17 .811 
RR Athletes Aubert et al. (mixed) 2001 17 .858 
RR Athletes Bonaduce et al. 1998 30 .000 ....... 
RR Athletes Davy et al. 1996 22 .000 
-
RR Athletes Dixon et al. 1992 24 .000 
---
RR Athletes Furlan et al. 1993 50 .000 .... 
RR Athletes Janssen et al. 1993 29 .001 ....... 
RR Athletes Jensen-Urstad et al. 1997 32 .005 
---
RRAthletes Lazoglu et al. 1996 22 .044 
RRAthletes Lazoglu et al. (anaerobic) 1996 20 .511 
RR Athletes Puig et al. 1993 66 .003 ... 
RR Athletes Sacknoff et al. 1994 30 .000 
-
Random RR Athletes (13) 379 .001 ....... 
RR Trained Bowman etal. 1997 34 .033 
RR Trained Goldsmith et al. 1992 16 .035 
RR Trained Melanson 2000 27 .020 ....... 
RR Trained Migliaro et al. 2001 18 .933 
Random RR Trained (4) 95 .001 ... 
Random Combined (17) 474 .000 
--
Figure 8-2 Cross-sectional comparison of RR interval between trained subjects/athletes and inactive controls. 
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EffectName Citation Year NTotal PValue -8.00 -4.00 0.00 4.00 8.00 
SDNN Athletes Aubert et al. 2001 20 .243 
SDNN Athletes Aubert et al. (anearobic) 2001 17 .750 
SDNN Athletes Aubert et al. (mixed) 2001 17 .633 
SDNN Athletes Bonaduce et al. 1998 30 .004 
SDNN Athletes Davy et al. 1996 22 .001 
SDNN Athletes Dixon et al. 1992 24 .038 
SDNN Athletes Furlan et al. 1993 50 .035 
SDNN Athletes Janssen et al. 1993 29 .001 
SDNN Athletes Jensen-Urstad et al. 1997 29 .024 
SDNN Athletes Lazoglu et al. 1996 22 .022 
SDNN Athletes Lazoglu et al. (anaerobic) 1996 20 .539 
SDNN Athletes Puig et al. 1993 66 .243 
SDNN Athletes Sacknoff et al. 1994 30 .006 
Random SDNN Athletes (13) 376 .002 
SDNN Trained Goldsmith et al. 1992 16 .084 
SDNN Trained Melanson 2000 27 .217 
Random SDNN Trained (2) 43 .038 
Random Combined (15) 419 .000 .. 
Figure 8-3 Cross-sectional comparison of SDNN between trained subjects/athletes and inactive controls. 
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EffectName Citation Year NTotal PValue -8.00 -4.00 0.00 4.00 8.00 
HF Athletes Aubert et al. 2001 20 .251 
HF Athletes Aubert et al. (anearobic) 2001 17 .905 
HF Athletes Aubert et al. (mixed) 2001 17 .552 
HF Athletes Bonaduce et al. 1998 30 .005 
HF Athletes Davy et al. 1996 20 .000 
HF Athletes Dixon et al. 1992 24 .206 
HF Athletes Furlan et al. 1993 50 .007 
HF Athletes Janssen et al. 1993 66 .260 
HF Athletes Jensen-Urstad et al. 1997 29 .139 
HF Athletes Lazoglu et al. 1996 22 .080 
HF Athletes Lazoglu et al. (anaerobic) 1996 20 .048 
HF Athletes Puig et al. 1993 66 .260 
Random HF Athletes (12) 381 .022 
HF Trained Bowman et al. 1997 34 .844 
HF Trained Goldsmith et al. 1992 16 .045 
HF Trained Melanson 2000 27 .289 
HF Trained Migliaro et al. 2001 18 .589 
Random HF Trained (4) 95 .058 
Random Combined (16) 476 .005 • 
-_ .. _ .... 
Figure 8-4. Cross-sectional comparison ofHF power between trained subjects/athletes and inactive controls. 
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Subgroup analysis revealed the mean effect size for athletes vs. controls (d = 
0.55, C.1. 0.07 - 1.04, P = 0.03) was greater than that for trained individuals vs. 
controls (d = 0.42 C.1. = -0.01 - 0.87, P = 0.058) although this difference was 
not statistically significant (Q = 0.02, P = 0.94). Following this subgroup 
analysis, results from comparisons of athletes vs. controls remained significantly 
heterogeneous (Q = 40.24, P = 0.0003) whereas the results from trained 
individuals vs. controls were homogenous (Q = 2.67, P = 0.45). 
When trials were grouped by data recording type the mean effect size for short-
term recordings (d = 0.42, C.1. 0.36-0.48) was significantly (Q = 6.95, P = 
0.008) smaller than that found using 24-hour recordings (d = 0.87 C.1. 0.47 -
1.28). Results of trials using short-term recordings remained heterogeneous (Q = 
32.01 P = 0.00009) whereas results from long-term recordings were homogenous 
(Q = 1.29, P = 0.73) 
8.4.3. Longitudinal comparisons. 
8.4.3.1. Longitudinal changes in RR interval. 
Figure 8-5 shows the results of the meta-analysis for changes in RR interval due 
to exercise training. Sixteen groups were drawn from 11 studies giving a total of 
263 cases. The overall effect size was d = 0.72 (C.1. 0.24 - 1.19, P = 0.003). 
However, the effect sizes for differences in RR interval were found to be highly 
heterogeneous (Q = 50.42, P = 0.00001, Q/(k-l) = 3.45). 
8.4.3.2. Effect of moderator variables on changes in RR. 
The moderator variable subgroup analysis (Table 8-1) revealed significant 
between-group heterogeneity for study subgroups based on subject age. Subject 
sex, length of exercise intervention and HRV data collection technique also 
showed between-group heterogeneity (Q/(k-l) > 1) and although values for Q 
were small they were statistically significant (P = 0.09 - 0.10). Subject activity 
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level prior to exercise intervention was also found to influence change in RR 
interval (Table 8-1) although no significant heterogeneity of effect sizes was 
found. The largest effect size in this analysis was for the previously sedentary 
SUbjects. This effect size remained highly heterogeneous after the data were 
subdivided into the two subgroups (Q = 46.80, P = 0.0001). This was also the 
case for intervention duration and HRV data collection subgroup analyses. 
Table 8-1 The effect of moderator variables on effects sizes for changes in RR interval. 
Effect Effect size N P- Between- Within Categories (mean and total value group Q- P-value group Q- P-value name 95%CI) value value 
Sex Female 0.747 43 0.278 2.1 P=0.71 0.03 - 1.45 
Male 0.799 166 0.001 4.6 P=0.70 0.44-1.15 
Mixed 0.39 54 0.173 38.5 P<0.0001 0.15 - 0.93 
Combined 0.715 263 0.003 Q=4.50 P=0.10 
± 0.240 
Age Young 1.292 51 0.144 Q=36.8 P<0.0001 
± 0.870 
Middle aged 0.692 151 <0.001 Q=2.8 P=0.83 
± 0.163 
Old 0.193 61 0.453 0=1.3 P=0.70 
± 0.256 
Combined 0.715 263 0.003 0=8.81 P=0.01 
± 0.240 
Activity Active 0.436 152 0.123 0=1.8 P<0.88 level ±0.278 
Sedentary 0.849 111 0.011 0=46.8 P<0.0001 
± 0.331 
Combined 0.715 263 0.003 0=1.10 P=0.29 
± 0.240 
Intervention Long duration 1.06 181 0.185 0=42.0 P<0.0001 duration ± 0.413 
Short 0.396 82 0.001 0=4.23 P=0.83 duration ± 0.221 
Combined 0.715 263 0.001 0=2.72 P=0.09 
± 0.240 
HRV 24-hour 0.349 71 0.146 0=2.01 P=0.57 
recording ambulatory ± 0.238 
Short-term 0.829 192 0.010 0=45.6 P<0.0001 
recording ± 0.320 
0.703 263 0.004 0=2.82 P=0.09 
± 0.241 
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8.4.3.3. Changes in SDNN. 
Figure 8-6 shows the results of the meta-analysis for changes in SDNN interval 
due to exercise training. Seventeen trials were drawn from 12 studies giving a 
total of 230 cases. The overall effect size was d = 0.827 (C.l. 0.36 - 1.30, P = 
0.001). The effect sizes for differences in SDNN were found to be highly 
heterogeneous (Q = 37.72, P = 0.0006, Q/(k-l) = 2.35). 
Table 8-2 The effect of moderator variables on effects sizes for changes in SDNN 
Effect Effect size N P- Between Subgroup Categories group 0 P-value P-value 
name (mean ±SEM) total value 
value o value 
Sex Female 0.573 43 0.190 0=4.90 P=0.18 
± 0.428 
Male 1.035 128 0.013 0=0.70 P=0.71 
± 0.410 
Mixed 0.393 55 0.152 0=30.4 P=0.00008 
± 0.270 
Overall 0.781 226 0.002 0=1.66 P = 0.44 
± 0.243 
Age Young 0.833 93 0.023 0=4.1 P=0.19 
± 0.358 
Middle aged 0.422 61 0.045 0=20.51 P=0.00004 
± 0.207 
Old 0.231 63 0.372 0=9.67 P=0.08 
± 0.256 
Overall 0.497 217 0.001 0=2.36 P = 0.31 
± 0.153 
Activity Active 0.721 64 0.011 0=7.04 P=0.31 level ±0.274 
Sedentary 0.253 142 0.134 0=1.03 P=0.95 
± 0.168 
Combined 0.388 206 0.006 0=2.1 P = 0.15 
± 0.139 
Intervention Long 0.478 71 0.204 0=29.83 P<0.00001 duration duration ± 0.230 
Short 0.523 146 0.004 0=7.8 P=0.25 duration ± 0.257 
Combined 0.489 217 0.001 0=0.08 P =0.89 
± 0.165 
HRV 24-hour 0.305 71 0.204 0=1.05 P=0.79 
recording ambulatory ± 0.204 
Short-term 0.621 146 0.004 0=13.6 P=0.13 
recording ± 0.211 
0.497 217 0.001 0=0.71 P = 0.40 
± 0.153 
269 
8.4.3.4. The effect of moderator variables on longitudinal changes 1ll 
SDNN. 
The effect of previously selected moderator variables for values of d, 
representing changes in SDNN are shown in table 8-2. None of the moderator 
variables showed statistically significant differences between groups. The largest 
between-group variation was found for activity level. Although not statistically 
significant (Q = 2.1, P = 0.15) the effect sizes for active individuals were more 
than twice that of sedentary counterparts indicating this result to be somewhat 
heterogeneous (QI(k-l) = 1.05). 
Similarly, other moderator variables clearly influenced effect size. Visual 
analysis oftable 8-2 shows sex (females) age (young) and HRV recording (short-
term) all to have effect sizes approximately double that of other subgroups. None 
of these overall effects were statistically significant and large within-group 
heterogeneity still existed in certain subgroups following these analyses. 
270 
EffectName Citation Year NTotal PValue -8.00 -4.00 0.00 4.00 8.00 
RR Bonaduce et al. 1998 15 .133 
RR Boutcher et al. 1995 19 .089 
RR Carter et al. (a) 2003 6 .749 
RR Carter et al. (b) 2003 6 .388 
RR Carter et al. (c) 2003 6 .581 
RR Carter et al. (d) 2003 6 .666 
RR Davy et al. 1997 8 .188 
RR Iwasaki et al. 2003 11 .000 • 
RR Loimaala et al. (a) 2000 26 .053 
RR Loimaala et al. (b) 2000 28 .601 
RR Perini et al. (a) 2002 8 .620 
RR Perini et al. (b) 2002 10 .878 
RR Pigozzi et al. 2001 13 .847 
RR Schuit et al. 1999 27 .681 
RR Stein et al. 1999 16 .258 
RR Uusitalo et al. 2002 58 .002 ..... 
Random Combined (16) 263 . 003 
-
Effect size (d) for change in RR interval. 
Figure 8-5. Longitudinal analysis of change in RR interval due to exercise training. 
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EffectName Citation 
SDNN Bonaduce et al. 
SDNN Boutcher et al. 
SDNN Carter et al. (a) 
SDNN Carter et al. (b) 
SDNN Carter et al. (c) 
SDNN Carter et al. (d) 
SDNN Davy et al. 
SDNN Hedelin et al. 
SDNN Levy et al. (a) 
SDNN Levy et al. (b) 
SDNN Loimaala et al. (a) 
SDNN Loimaala et al. (b) 
SDNN Pigozzi et al. 
SDNN Schuit et al. 
SDNN Stein et al. 
Random Combined (15) 
Year NTotal PValue -8.00 -4.00 0.00 4.00 8.00 
1998 
1995 
2003 
2003 
2003 
2003 
1997 
2000 
1998 
1998 
2000 
2000 
2001 
1999 
1999 
15 
19 
6 
6 
6 
6 
8 
12 
11 
13 
26 
28 
13 
27 
16 
212 
.487 
.732 
.216 
.062 
.106 
.573 
.429 
.444 
.009 
.000 
.482 
.531 
1.000 
.644 
.183 
.001 ... 
Effect size (d) for change in SDNN 
Figure 8-6. Longitudinal analysis of change in SDNN due to exercise training. 
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EffectName Citation Year NTotal PValue -8.00 -4.00 0.00 4.00 8.00 
HF Bonaduce et al 1998 1998 15 .651 
HF Boutcher et al 1995 1995 19 .732 
HF Carter et al (a) 2003 2003 6 .216 
HF Carter et al (b) 2003 2003 6 .062 
HF Carter et al (c) 2003 2003 6 .106 
HF Carter et al (d) 2003 2003 6 .573 
HF Davy et al 1997 1997 8 .324 
HF Iwasaki et al 2003 2003 11 .079 
HF Leicht et al (a) 2003 2003 12 .435 
HF Leicht et al (b) 2003 2003 12 .247 
HF Loimaala et al (a) 2000 2000 26 .342 
HF Loimaala et al (b) 2000 2000 28 .481 
HF Perini et al (a) 2002 2002 8 .686 
HF Perini et al (b) 2002 2002 10 .506 
HF Pigozzi et al (2001) 2001 13 .996 
HF Schuit et al 1999 1999 27 .346 
HF Stein et al 1999 1999 16 .710 
HF Uusitalo et al 2002 2002 58 .002 
--
Random Combined (18) 287 .001 • 
Effect size (d) for change in HF. 
Figure 8-7. Longitudinal analysis of change in HF power due to exercise training. 
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8.4.3.5. Longitudinal changes in HF. 
A total of 18 group comparisons from 12 studies were entered into the final 
analysis. A total of 287 cases were analysed and the overall effect size was d = 
0.45 (el 0.20 - 0.71, P = 0.001). The effect sizes for differences in HF were 
found to show statistical homogeneity (Q = 19.16, P = 0.32) although limited 
evidence of heterogeneity was evident (QI(k-l) = 1.12). 
Table 8-3. The effect of moderator variables on effects sizes for changes in HF power. 
Moderator Subgroup Effect size N P- Between P-value Subgroup 
variable (mean ± 95% el) total value group Q Q 
Sex Female 0.605 43 0.168 0=6.57 (0.1 - 0.9) 
Male 0.536 166 0.001 0=4.86 
±0.410 
Mixed 0.155 78 0.273 0=5.36 
± 0.297 
Combined 0.454 287 0.001 0=0.76 P =0.68 
± 0.129 
Age Young 0.457 63 0.223 0=10.9 
± 0.372 
Middle 0.618 151 0.001 0=5.29 
aged ± 0.163 
Old 0.228 73 0.333 0=1.44 
± 0.234 
Combined 0.497 287 0.001 0=2.02 P=0.36 
± 0.153 
Activity Active 0.413 52 0.025 0=7.26 level ±0.131 
Sedentary 0.454 235 0.002 0=11.0 
± 0.129 
Combined 0.388 287 0.001 0=0.91 P =0.34 
± 0.139 
Intervention Long 0.454 189 0.185 0=7.95 duration duration ± 0.163 
Short 0.541 82 0.001 0=9.59 duration ± 0.259 
Combined 0.469 271 0.001 0=0.04 P = 0.97 
±0.137 
HRV 24-hour 0.305 71 0.204 0=0.31 
recording ambulatory ± 0.204 
Short-term 0.621 146 0.004 0=17.6 
recording ± 0.211 
0.497 217 0.001 0=1.27 P=0.26 
± 0.153 
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P-value 
P=0.09 
P=0.56 
P=0.06 
P=0.50 
P=0.83 
P=0.86 
P=0.20 
P=0.44 
P=0.16 
P=0.21 
P=0.96 
P=0.17 
8.4.3.6. Effects of moderator variables on longitudinal changes in HF. 
Subgroup analysis revealed no statistically significant between-group 
heterogeneity. However, between age subgroups, group containing older 
subjects clearly showed smaller overall effect sizes then either young or middle-
aged groups. Additionally, there was a clear trend toward larger (double) effect 
sizes in trials which used short-term compared with long-term HRV data 
recordings (Table 8-3). 
8.4.4. Relationships between effect sizes for HRV variables. 
Table 8-4 shows the Pearson product moment correlation coefficients between 
each pair of variables from cross-sectional and longitudinal meta-analyses. 
Table 8-4. Relationships between variables for all analyses. 
Measures Correlation P-value Correlation P- value 
coefficient (2-tailed) coefficient (2-tailed) 
Cross-sectional com pari sons Longitudinal comparisons 
SDNN vs. RR R = 0.727 P = 0.003 r = 0.346 P = 0.226 
HF vs. RR R = 0.660 P = 0.005 r = 0.345 P = 0.191 
SDNN vs. HF R = 0.816 P = 0.0001 r = 0.971 P = 0.0001 
For cross-sectional comparisons, changes in RR interval were significantly and 
positively correlated with changes in SDNN and HF. The relationship between 
effect sizes for SDNN and HF was also a very strong positive correlation. When 
effect sizes for longitudinal change in these three measures were correlated, 
effect sizes for change in HF and SDNN only correlated weakly with RR interval 
(P > 0.05), however, the linear relationship between SDNN and HF remained 
very strong (P < 0.0001) 
275 
Table 8-5. Effects of different fits on percentage variance explained between measures. 
Relationship Regression. Ff P - values 
RR VS. SDNN Linear 0.119 0.226 
RR VS. SDNN Quadratic 0.143 0.427 
RR VS. SDNN Cubic 0.262 0.365 
RR VS. HF Linear 0.119 0.191 
RR VS. HF Quadratic 0.174 0.289 
RR VS. HF Cubic 0.177 0.489 
SDNN VS. HF Linear 0.943 0.0001 
SDNN VS. HF Quadratic 0.945 0.0001 
SDNN VS. HF Cubic 0.946 0.0001 
In addition to assessing linear relationships between RR interval change effect 
sizes and HRV effect sizes, a variety of fits were applied to the data to assess this 
relationship more fully. By a serial fitting process of curve estimation it was 
found that a linear relationship was not the best method by which to describe the 
relationship between RR interval and either SDNN or HF effect sizes (Table 8-
5). The weak linear relationship between effect size for change in RR interval 
and SDNN was improved by fitting a cubic regression line to the data. 
Compared to a simple linear fit, the cubic regression could account for more than 
twice the variance between these variables. A slight improvement in the amount 
of shared variance accounted for between RR and HF was also achieved using a 
cubic fit. Neither of these fits achieved statistical significance. The variance 
accounted for between SDNN and HF was practically unchanged by the fitting of 
either a quadratic or cubic regression to the data. 
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8.5. Discussion. 
Bradycardia is a commonly observed, chronic physiological response following 
exercise training (Raab et al. 1960; Frick et al. 1967; Ekblom et al. 1973; 
Scheuer and Tipton 1977). It is commonly believed that exercise-induced 
bradycardia is at least partially mediated by increased vagal tone at rest. There 
are much data to suggest that heart rate variability measures can be used as 
indices of vagal tone at rest in humans. The aims of this meta-analysis were 
therefore: 
1. To identify whether a resting bradycardia was accompanied by increased 
global and vagally mediated measures of HRV in cross-sectional 
comparisons. 
ii. To assess the effects of exercise interventions on resting bradycardia and 
HRV measures. 
iii. To assess homogeneity of results and where possible, identify moderator 
variables which accounted for any heterogeneity in the above analyses. 
IV. To describe and quantify any relationships between differences and 
changes in the variables analysed. 
8.5.1. Cross sectional analyses. 
The cross-sectional data included in the present meta-analysis clearly show 
resting bradycardia is accompanied by increased vagal tone as measured by 
global (SDNN) and vagal (HF) markers of HRV. All three measures 
demonstrated statistically significant heterogeneity of effect sizes (P < 0.0001). 
Therefore, although the overall effect sizes for differences in all these variables 
are large and significant (d> 0.6, P < 0.001) these results must be treated with 
caution. Despite the use of a random effects model, generalisation of the 
findings of the current analysis must be carried out with caution. 
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8.5.1.1. Effects of moderator variables on cross-sectional data. 
In an attempt to explain the heterogeneity of effect sizes a small number of 
moderator variables were investigated using subgroup analysis. Decisions on the 
subgroup analyses were made a priori and only a small number of potential 
moderator variables were investigated in line with current recommendations 
(Jennings et al. 2002). 
As would be expected, when aerobically trained athletes were compared with 
controls, the magnitude of difference in RR interval length was greater than 
when trained individuals (commonly recreational athletes) were compared to 
similar controls. Both athletes vs. controls and trained individual vs. controls 
subgroups showed statistically significant differences, demonstrating that 
bradycardia is also evident in recreational athletes. The mean effect size for this 
comparison was d = 0.78. However, the confidence intervals associated with 
this value (0.32 - 1.24) illustrate the heterogeneous nature of the data. This 
heterogeneity was further confounded by the small number of studies which were 
entered into the analysis (n = 4) which yielded a small overall number of cases (n 
= 95). 
The subgroup analysis of effect sizes based on the HRV recording method 
demonstrated that a significant amount of the heterogeneity observed in RR 
interval differences could be accounted for by this moderator variable. Studies 
using 24-hour recordings had a significantly greater mean effect size than the 
smaller number of studies using short-term stationary measures. It is known that 
resting bradycardia is most evident during sleep. Athletes have been reported to 
have RR intervals >2 sec during night hours (Goldsmith 1992). Although only 
complete 24-hour recordings were entered into the analysis, this greater effect 
size may be due to the inclusion of nocturnal RR interval data. On this basis it 
may be argued that if researchers want to quantify the full extent of vagal 
modulation on RR interval then 24-hour recordings may be a preferred method. 
Alternately, there are several methodological and practical issues associated with 
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the use of such measures that make short-term measurements of stationary ECG 
signals more appealing. These are discussed in more detail in section 5.5.1.3 
Both HRV measures demonstrated a similar pattern of effect sizes. The global 
HRV measure, SDNN (which does not strictly differentiate between vagal and 
sympathetic sources of variation in heart period) was significantly greater in 
athletes and trained groups than controls. In keeping with the pattern of effect 
sizes for RR interval, the differences were greater in the athletes vs. controls 
comparison, indicating that longer RR intervals in athletes were accompanied by 
greater HRV. 
High frequency spectral power (HF) is known to be a specific vagal indicator 
(Akselrod et al. 1981; Pagani et al. 1986; Tulppo et al. 1996; Nakata et al. 1998; 
Uusitalo et al. 2002). Overall, cross-sectional studies showed HF to be 
significantly elevated (P = 0.006) in active people and athletes compared to 
controls. Interestingly the subgroup analysis effect sizes were similar in 
magnitude to those observed for RR interval. High frequency power was found 
to be elevated in athletes compared to controls and less so when trained 
individuals were compared to inactive controls. This latter comparison failed to 
reach statistical significance. This was due in part, to the smaller sample size (n 
= 95). However, a reduced effect size, (d = 0.55 vs. 0.42) was also evident. 
As with the RR interval data, effect sizes for SDNN and HF were greater when 
extracted from 24-hour ECG recordings than when short-term recordings were 
used. This may be due, again, to the greatest expression of increased vagal tone 
commonly observed during sleep. This would seem to suggest that ambulatory 
measures are favourable to short-term ECGs to evaluate HRV. It should be made 
clear however, that none of the studies included in this analysis give details of 
the activity levels of subjects during Holter recording. This is one factor which 
has previously been reported to influence SDNN significantly (Bernardi 1996). 
Additionally, one assumption underlying the computation of HF spectral power 
is stationarity of the time series from which it is calculated. By the very nature 
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of the recording method, this assumption is commonly not met when ambulatory 
ECG recordings are used. 
8.5.1.2. Correlations between effect sizes. 
To quantify the influence of increased vagal modulation on RR interval, the 
common variance between the HRV measures and RR interval was calculated. 
Simple linear regression showed that SDNN and RR interval shared the most 
common variance (53%) and HF shared slightly less (43.5%). This is surprising 
as HF is regarded as a specific, vagal marker of ANS function. However, it 
should be noted that not all studies that included HF also reported SDNN and 
Vice versa. Due to the relatively small number of studies included in the 
analysis, a single study such as Sacknoff et ai. (1991), which demonstrated a 
very large effect size for RR interval and SDNN, can affect the strength of this 
relationship considerably. Interestingly, the highest shared variance in this 
portion of the analysis was between HF and SDNN in which 66.7% of variance 
was common to both measures. The relationship between effect sizes for HF and 
SDNN is similar to published values for individual subject scores of these 
variables (Bigger et ai. 1992). 
The data from analysis of cross-sectional studies clearly shows a distinct 
bradycardia in physically trained individuals, and that a dose-response may be 
evident. Differences in RR interval and HRV markers show similar patterns 
overall, and within subgroups, suggesting that increase in vagal modulation may 
responsible for at least some (around 50%) of the resting bradycardia observed. 
These data also suggest that the use of 24-hour ambulatory ECG recordings may 
be favourable if differences in RR intervals and HRV measures are to be found. 
Causal inferences cannot be made from cross-sectional data due to the unknown 
status of the subjects prior to training. Biological influences such as heredity and 
methodological influences such as self-selection mean that differences cannot be 
attributed solely to differences in physical activity levels. For this reason meta-
analysis of longitudinal data concerning changes in RR interval and HRV 
measures were also carried out. 
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8.5.2. Longitudinal analysis. 
Meta-analysis showed a significant effect of exercise training on resting RR 
interval. Although the large effect size was accompanied by relatively small 
confidence intervals (Table 8-1) the effect sizes of the studies included in the 
analysis were found to be significantly heterogeneous. Therefore, as with the 
findings of the cross-sectional analysis, these data must be interpreted and 
generalised with caution, despite the use of a random effects model. 
Resting bradycardia is well documented in the literature (Raab et al. 1960; Frick 
et al. 1967; Ekblom et al. 1973; Scheuer and Tipton 1977) and the overall effect 
of exercise on RR interval strongly support the effect of exercise in promoting 
bradycardia ( d = 0.72, C.I. 0.24 - 1.19, P = 0.003). However, the cause is a 
matter of some discussion (Katona and Jih 1975; Maciel et al. 1985). To 
elucidate the influence of increased vagal modulation on RR interval due to 
training, the HRV measures ofSDNN and HF were again analysed. 
The measure SDNN provides only a global index ofHRV. This measure does not 
distinguish between vagally and sympathetically mediated variations in HF. 
However, at rest it is assumed that the vagal branch of the ANS is the dominant 
effector, and therefore, that SDNN is predominantly mediated by vagal 
modulation. Meta-analysis of SDNN showed a large, positive overall effect of 
exercise training on HRV. Effect size and confidence intervals were similar in 
magnitude to that reported for RR interval, providing some support for a 
relationship between changes in SDNN and RR interval. Similarly to RR 
interval, the effect sizes for trials assessing SDNN were highly heterogeneous. 
Again, generalisation and interpretation of these data should be employed only 
with caution. 
Meta-analysis of trials reporting HF showed a moderate, positive effect size (d = 
0.45) indicating an increase in vagally mediated rhythmic oscillations from 0.15-
0.40 Hz. These data strongly support the notion that increased RR interval 
length is mediated by increased vagal modulation (Frick et at. 1967; Ekblom et 
al. 1973; Smith et al. 1989). Additionally, the effect sizes of trials reporting 
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changes in HF due to training were homogenous. On this basis, the evidence 
provided by the random effects model used with these data may interpreted with 
confidence in showing that HF is increased by exercise training in a variety of 
subject populations. 
8.5.2.1. Effects of moderator variables on longitudinal data. 
Prior to discussion of the effects of moderator variables on changes in HR and 
HRV, it is first necessary to explain why a full meta-regression was not carried 
out on these data. The process of meta-regression facilitates the identification of 
variables which predict the outcome (in this case effect size) variable of a meta-
analysis. Commonly these include variables concerning the study population 
such as subject age and sex, and variables concerning any intervention such as 
duration. By regressing continuous data for such variables against the outcome 
variables the relationships between dependent and independent variables can be 
assessed. However, in order to do this a degree of heterogeneity between the 
studies entered into the analysis is necessary. Furthermore, the majority of 
studies included must provide the necessary data to carry out the analysis. 
In the present analysis, the studies included varied greatly in subject group, 
nature of the intervention used and the HRV data collection used. Additionally, 
numerous studies omitted several important covariates that would have created 
gaps in the analysis. This would have weakened the analysis further making any 
powerful regression statistic impossible due to the relatively small total number 
of studies originally included. 
In order to gain insight into the effects of moderator variables a series of 
subgroup analyses were carried out to determine differences between effect sizes 
grouped by logical, predefined variables. These were classified as concerning 
either: subjects, intervention or methodology. 
8.5.2.2. The effect of moderator variables on RR interval change. 
Subject age had a significant effect on change in RR interval due to training. 
Middle-aged subjects showed the greatest increase in RR interval compared to 
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young and old subjects. Middle-aged subjects also made up the greatest 
proportion of the subjects studied. This may be because younger subjects 
typically demonstrate longer RR intervals than older counterparts and therefore 
little improvement is likely to be seen in these individuals. If this were the case 
however, one would expect older subjects to demonstrate the greatest increase. 
A possible reason why this was not evident may be that exercise intensity in 
studies using older subjects is commonly of a lower absolute, and often relative 
exercise intensity. Alternatively, it may be that older subjects (who typically 
show low levels of activity) may have a compromised ability to adapt to a given 
exercise training stimulus when compared with younger conterparts. However, 
evidence from individual trials in which older and younger subgroups have been 
exposed to similar exercise stimuli (Leicht et al. 3003; Carter et al. 2003) do not 
support this notion. 
Exercise intervention duration showed an unexpected effect that was close to 
statistical significance. It was found that greater changes in RR interval were 
found in short (12 weeks or less) interventions compared to those of longer 
duration. Commonly within the literature, shorter interventions use higher 
exercise intensities, although no statistical test of this trend was performed. 
Additionally, it may be that adaptations in the ANS, which cause the observed 
bradycardia, are effective by 12 weeks. This would mean the expression of such 
an effect would be evident at this time point. Empirical data from longitudinal 
analysis of RR interval during training support this (Melanson and Freedson 
2001; Iwasaki et al. 2003). 
Of methodological interest is the moderator variable HRV recording. This has 
been discussed briefly in relation to cross sectional data but warrants further 
discussion here. It is recommended that two broad categories of HRV 
measurements be made: ambulatory 24-hour recordings and resting measures of 
2 - 7 min (Camm et al. 1996). Little data are available on which of these types of 
measurement are more sensitive. However, in the present study the effect size for 
change in RR interval was greater when derived from short-tenn recordings than 
from 24-hour data. This is in direct conflict with the data from cross-sectional 
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comparisons. These conflicting findings cannot be explained at this time. What 
is of note is the highly significant within group heterogeneity (Q = 45.6, P < 
0.00001) that is evident in the short-term recording subgroup, which warrants 
further investigation. 
Due to the strong influence of this methodological factor on effect size, it would 
have been preferable to conduct a further subgroup analysis for all variables 
recorded by each method separately. However, this was deemed to be inpractible 
due to small group numbers within the subgroups, especially the 24-hour group 
(n = 4 studies, n = 71 cases). 
8.5.2.3. Effects of moderator variables on SDNN. 
The largest between-groups effect on SDNN was due to age. Effect sizes for 
young subjects were on average twice that of middle aged and four times that of 
old subjects. These finding agree with data from an individual study in which 
age group comparisons were made (Carter et at. 2003). These researchers found 
significant increases for SDNN in young males but not in their older 
counterparts. In females no significant findings were evident but the effect size 
was larger in younger subjects. The non-significance of these findings are due in 
part to the small sample size used. The congruence of findings from the present 
analysis and those of Carter et at. (2003) demonstrate the usefulness of the meta-
analysis procedure. 
A non-significant, difference in mean effect size was evident between groups 
based on subject sex. Females demonstrated an effect size twice that of males. 
Similar to the findings for younger subjects in the age subgroup analysis, values 
for SDNN are known to be higher in females when compared to males at all ages 
(Kuo et at. 1999). The pattern of change denoted here by the effect sizes within 
subgroups is similar to one previously noted for HF power (Hautala et at. 2003). 
This pattern was, however, not evident within the HF data in the present study as 
these data yielded homogenous results. However, as the majority of data that 
made up the analysis were from resting (supine) stationary tachograms, it can be 
argued that HF and SDNN should both be measuring predominantly vagal 
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modulation of HR. On this basis SDNN may be seen as analogous to HF and 
therefore, to respond in a similar manner. Hautala et al. (2003) have shown that 
subjects with higher initial values of HRV (HF) also show greater increases in 
these measures compared to subjects with lower initial values in response to 
training. An association between HF and other adaptations to training has also 
been demonstrated (Hautala et al. 2003) and vagally mediated HRV has therefore 
been proposed as a possible marker of systemic and local plasticity or 
trainability. Again, this phenomenon warrants further investigation. 
8.5.2.4. Effect of moderator variables on HF. 
As the whole group meta-analysis was homogenous for HF effect sizes, a 
subgroup analysis was not necessary. It was, however, still carried out in order 
to gain insight into possible reasons for heterogeneity in the other measures 
analysed in the review. As would be expected, no significant effects of moderator 
variables were found in the analysis of HF. Similarly to the patterns shown for 
RR interval and SDNN there was a trend towards larger effect sizes for changes 
in HF in younger and middle aged subjects when compared with older 
counterparts. The reduced HF adaptation to a given training stimuli in older 
subjects may be of importance if increasing HF (vagal modulation) is to be put 
forward as a potential beneficial outcome of physical training or rehabilitation 
A further evident pattern was that of larger effect sizes reported for short-
duration measurements compared with 24-hour data. This difference was, again, 
similar in magnitude to those reported for RR interval and SDNN. It may be 
taken as evidence to suggest that when observing intrasubject changes in HR and 
HRV, that short-term measurement of a resting ECG is a method which 
possesses superior sensitivity to 24-hour ambulatory measures. Regardless of 
whether this is true, it can certainly be argued that, particularly for spectral 
analysis, this method is superior in terms of the underlying assumptions behind 
the analysis being met. Additionally, the ease by which such a measure may now 
be made and analysed makes it far superior in terms of accessibility and 
economy when compared with ambulatory ECG measurement. 
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8.5.2.5. Problems with subgroups analysis. 
Despite large differences in mean effect sizes for subgroup analyses of all three 
measures there were few statistically significant findings. One reason for this 
was the large within group heterogeneity of effect sizes that remained in almost 
all subgroups. The reasons for such heterogeneity may be fourfold. Firstly, the 
relatively small number of trails and cases in the overall analysis naturally 
translate into small numbers in certain subgroups. This, in tum, means that small 
disparities in direction and magnitude of effects give rise to large confidence 
intervals for a given overall effect size and therefore create significant 
heterogeneity. 
Secondly, it may be that the varied empirical methods employed in studies are 
responsible. In compiling this analysis a large number of studies were reviewed 
and rejected. Yet, a number of studies are included in this analysis that perhaps 
would not be entered if it were possible to gain sufficient case numbers using 
more strict criteria. For example many studies do not include a control group. 
This is a commonly used criteria for inclusion in meta-analyses in other areas, 
but in the present situation the number of cases included would be too small to 
facilitate any analysis. 
A third reason may be that the moderator variables responsible for the 
differences in effect sizes between groups were not identified. Evidence for this 
lies within the large with-group heterogeneity that was commonly preserved 
following subgroup analysis. However, in any meta-analysis a balance between 
the number of subgroup analyses made and finding the reasons for spreads of 
values must be met. The subgroups analysed in the present study were numerous 
in comparison with other analyses. They were however, made a priori on the 
basis of physiological justification in line with current recommendations 
(Jennings et al. 2002). 
The final reason for the heterogeneity of results is that this may be a feature of 
HRV measurement. Studies measuring changes in HRV commonly show very 
disparate effect sizes. For instance the data of aI-Ani et at. (1992) met the 
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criteria for inclusion in this analysis but after initial entry were removed due to 
their disparate nature. In this study, all subjects were exposed to a similar 
training stimulus. Despite this changes in HRV were found to differ both in 
magnitude and direction between subjects. In addition to this it is commonly 
found that baseline values for HRV measurements also show very large between-
group variation. It is therefore unsurprising that large differences in effect sizes 
for change in such variables are commonplace. 
8.5.3. Correlations between effect sizes. 
Although RR interval was positively related to SDNN and HF change, this 
association was only weak, explaining less than 12% of the variance between 
measures (Table 8-4). Effect sizes for SDNN and HF were very highly 
correlated and it therefore seems suitable to suggest that these two variables are 
measuring similar aspects of HRV. Further to this, the notion that at rest, 
variation in HR is predominantly under vagal control is also supported. 
Visual analysis of these data suggested a simple linear relationship was not the 
best method to describe the relationship between effect sizes for HRV measures 
and RR interval. By fitting serial plots to these data it was possible to explain a 
greater proportion of the shared variance between SDNN and RR. Using a cubic 
model significantly improved the description of this relationship, accounting for 
26% of the common variance (Table 8-5). The effects of different fits on the 
relationship between HF and RR were broadly similar in direction but of slightly 
lesser magnitudes. Again a cubic model gave a better description of this 
relationship but only managed to explain a small additional amount (from 11.9 -
17.7%) of common variance. 
It seems, therefore, that although changes in SDNN and HF mirror changes in 
RR interval in terms of mean effect size, mechanisms other than increased vagal 
modulation may be responsible for the resting bradycardia observed following a 
period of physical training. One such change may be reduced sympathetic 
activity, which is not strongly represented by either of the HRV measures 
analysed here. Other non-neural mechanisms which may influence resting HR 
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include alterations in the mechanical strain put on the pacemaker cells due to 
cardiac hypertrophy (Lewis et al. 1980) and metabolic alterations in pacemaker 
cells and neurotransmitter sensitivity (Ekblom et al. 1973; Katona and Jih 1975). 
It is thought that such adaptations are the result of prolonged exercise training 
and would be typically brought about by the relatively short exercise 
interventions used in the studies included here. 
8.5.4. Study limitations. 
The large degree of heterogeneity of the majority of measures analysed in the 
present study is a major limitation. Effect sizes for RR interval, SDNN and HF 
from cross-sectional studies, as well as RR interval and SDNN from longitudinal 
studies were all highly heterogeneous. These findings should, therefore, be 
interpreted with caution. 
In both the cross-sectional and longitudinal analyses a relatively small number of 
studies were entered into the analysis providing small overall numbers of cases. 
This is due mainly to the small number of published studies in this area but also 
due to the frequent use of small sample sizes in this literature. The inability to 
perform a full meta-regression on the data weakens the conclusions which can be 
made concerning the factors responsible for the range of effect sizes shown in the 
literature. This is not so much shortcoming of the present study but of the 
literature cited which commonly fails to give the necessary information to 
facilitate such an analysis. 
8.6. Conclusions. 
The present data show clearly that resting bradycardia is evident from cross-
sectional comparisons between individuals of differing physical activity levels. 
This difference is accompanied by increased vagal tone as indicated by HRV. 
This increased vagal modulation accounts for approximately half the variance in 
RR interval differences. A dose-response is evident, in as much as when athletes 
are compared to controls, the effect size is greater than when 'active' individuals 
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and controls are compared. In these comparisons, studies using 24-hour 
ambulatory HRV measurements showed a much greater overall effect size 
compared with those using short-term data collection. It should be noted, 
however, that only a small number of studies utilised the latter method. 
In longitudinal analyses of change in RR interval, training induces a resting 
bradycardia, although the overall effect is less pronounced than in cross-sectional 
comparisons. This bradycardia is accompanied by increased global and vagally 
mediated measures ofHRV. The latter, HF power, shows a homogenous positive 
response to training. Subgroup analysis of RR and SDNN reveal subject age 
and gender and previous level of physical activity can all influence the response 
to exercise. Additionally, it seems that in studies where short-term measures of 
HRV have been used, the effect size recorded is more than twice that of studies 
using 24-hour ambulatory HRV measures. However, the small number of studies 
using the latter methodology means caution should be employed prior to any 
generalisations being made regarding the superiority of one technique over the 
other. 
8.6.1. Recommendations. 
Increased availability of technology means that HRV studies are commonplace, 
however more randomised controlled studies would allow for a better quality of 
meta-analysis to be performed. The measurement of a 5-min EeG trace can be 
made very simply and analysed by commercially available instruments to give 
HRV measures. If this was done as an adjunct to the many hundreds of physical 
training studies carried out each year it would very simply and cheaply increase 
the available literature concerning HRV response to exercise. This would, in 
tum, help to clarify the role of the ANS in exercise-induced, resting bradycardia 
further. 
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Authors should report non-significant findings and report all HRV measures even 
if they are not tested statistically. Editors of journals should be encouraged to 
accept such findings for publication. Where HRV data are published this should 
be done in a manner which facilitates their inclusion in meta-analytical studies. 
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CHAPTER 9. HEART RATE VARIABILITY IN PERIPHERAL ARTERY 
DISEASE. 
Abstract. 
The aim of this study was to detennine whether HRV measured at rest and 
during exercise could be altered by an exercise training programme designed to 
increase walking perfonnance in patients with peripheral artery disease. 
Fifty-two volunteers were randomised into 12 weeks of either: supervised 
walking training (SU), home-based walking training (HB) or no exercise (CT). 
Recommended HRV measures were calculated from a 5-min resting ECG 
followed by maximal, graded exercise treadmill testing. All measures were 
repeated after 6 and 12 weeks. In the SU group, HRV measures were also 
recorded during 5-min of steady state exercise (75% baseline 1702 peak) at weeks 
1, 6 and 12. The SU group showed significantly (P < 0.001) increased maximal 
walking time (MWT) but resting HR V measures remained unchanged in all 
groups. HRV measures repeated at equal absolute exercise intensities showed 
increases in RR interval, total and high frequency spectral power and the low-to-
total spectral power ratio across the 12 weeks. 
The lack of change in resting HRV was possibly due to either the low intensity or 
discontinuous nature of exercise undertaken. Alterations in exercise HRV 
suggest augmented cardioneuroregulatory response to exercise after training. 
Such measurements may illustrate training-induced changes in autonomic 
modulation when none are evident at rest. 
This chapter, in tlUncated fonn has been published in The Joumal of Exercise Science and Fitness and an abstract 
published in the Journal of Physiology, see appendix IV. 
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9.1. Introduction. 
Peripheral arterial disease (PAD) is characterised by decreased peripheral blood 
flow and a low resting ankle-to-brachial blood pressure ratio or ankle-brachial 
index (ABI). The most common symptom reported by PAD patients is exercise-
induced, ischaemic leg pain or intermittent claudication (IC) (Zatina et at. 1986). 
Symptomatic patients commonly demonstrate levels of peak exercise 
performance approximately half that of age-matched controls (Eldridge and 
Hossack 1987). This decreased capacity is associated with low levels of physical 
activity and low functional capacity (Hiatt et al. 1994). 
The age-adjusted prevalence of PAD is approximately 12% (Criqui 2001). Only 
a quarter of patients diagnosed with PAD are symptomatic (Stewart et al. 2002). 
However, treatment remains of great importance, as patients have an increased 
risk of coronary and cerebrovascular event similar to that observed in patients 
with coronary artery disease (Dormandy et al. 1999). 
Walking exercise results in large increases in claudication-free exercise time and 
maximal walking distance in PAD patients (Gardner and Poehlman 1995). 
However, a recent review (Stewart et at. 2002) suggested that the exact 
mechanisms by which this increase is facilitated remain unclear. There is 
evidence to suggest that increased efficiency, improved pain tolerance, improved 
gait, and increased limb blood flow may all contribute to increased exercise 
capacity. When compared with healthy controls, there is evidence of altered 
muscle camitine metabolism during graded exercise (Hiatt et at. 1987; Hiatt et 
al. 1992). Altered ventilatory responses and slowed V02 kinetics are also 
evident during steady state exercise in PAD patients, (Haouzi et al. 1997; 
Womack et al. 1997). There is some evidence of cardiopulmonary improvement 
due to exercise training (Hiatt et al. 1994) but such systemic adaptations are 
small when compared with changes in exercise capabilities (Hiatt et al. 1994; 
Regensteiner and Hiatt 1995; Falcone et al. 2003). 
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Information regarding systemic adaptation of the autonomic nervous system is 
less well documented (Hiatt et al. 1994). Evidence exists for skeletal muscle 
denervation in the affected limb of PAD patients (England et al. 1992). This has 
been linked to an attenuated temporal ventilatory response to exercise (Haouzi et 
al. 1997). However, at present, no empirical data are available concerning 
chronic, exercise-induced changes in autonomic function either at rest or during 
exercise. 
9.1.1. 
9.l.1.l. 
Can exercise training affect resting and exercise measures of 
HRV? 
The effects of exercise on HRV in healthy and clinical 
populations. 
Chapter four provided a review of exercise and heart rate variability and chapter 
five provided a meta-analysis of these data. The conclusions drawn from these 
chapters were that exercise training in healthy populations increases global heart 
rate variability (HRV) , vagal measures of HRV such as high frequency power 
(HF) and creates shifts in autonomic balance toward increased vagal modulation. 
Similar effects have been shown in a variety of clinical populations including 
post-myocardial infarction patients (chapter ten) and heart failure patients 
(chapter 11). 
Data from longitudinal studies of autonomic nervous system (ANS) adaptation in 
healthy subjects are somewhat equivocal and several methodological issues are 
apparent (Aubert et al. 2003). Within such studies the lower threshold for 
exercise duration used is 30 minutes, the lower limit for exercise intensity is 60% 
of either V02 max or HR max. Considering this, two confounding factors may act 
to reduce or even negate the effects that aerobic exercise training may have on 
the ANS of PAD patients. Firstly, maximal absolute exercise intensities (W or 
METs) achieved by PAD patients are commonly reported to be approximately 
half that of healthy age-matched counterparts (Eldridge and Hossack 1987). This 
means that training intensities based on maximal achievable work rates will also 
be approximately half that of other subjects. Additionally, exercise duration is 
298 
commonly reduced due to IC in the periphery. This means PAD patients can 
often only exercise for short durations when compared with healthy subjects. 
Claudication-limited absolute exercise intensities and durations may, therefore, 
limit the overall systemic stress placed upon central systems of PAD patients 
during training. If such thresholds exist, below which central adaptations do not 
occur, then changes in ANS function due to exercise analogous to those observed 
in healthy individuals may not be realised in PAD patients. 
In post-myocardial infarction patients, there is evidence that relatively low 
intensity exercise (~50% V02 max or HR max) may provide sufficient stimuli to 
promote cardiopulmonary adaptation. A recent meta-analysis suggested that 
present data provide no evidence of a lower exercise intensity threshold for 
increased exercise capacity and V02 peak (Swain and Franklin 2002). There are, 
however, data to suggest a threshold effect of exercise training on alteration in 
autonomic function measured by HRV (Pardo et at. 2000). By dividing subjects 
into groups based on improvements in exercise capacity « 1.5 METs vs. > 1.5 
METs) Pardo et at. (2000) found significant improvements in HRV measures in 
the latter group only. Two points of criticism regarding this study should 
however be made. Firstly, the group analysis based on improvement in training 
was not one of the original aims of the study presented a priori and group 
allocation was carried out pas hoc. Secondly, there are data to suggest that 
improvement in exercise performance may be related to both initial levels and 
changes in certain HRV measures (Boutcher and Stein 1995; Hautala et al. 
2003). As the authors did not control for initial levels of HRV between groups, 
generalisations based on these findings should be made with caution. 
On the basis of existing data regarding the adaptation of HRV measures to 
exercise training, the first two aims of this chapter were to ascertain the 
following: 
1. Whether resting measures of short-term HRV were attenuated in PAD 
patients as they are in other ischaemic disease states. 
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11. Whether HRV could be improved in PAD patients receiving 12 weeks of 
supervised or home based exercise training compared to a control group 
receiving no treatment. 
9.1.1.2. Chronic changes in HRV during exercise. 
There are some cross-sectional data in healthy populations to suggest that HRV 
measurements made during exercise are affected by levels of habitual physical 
activity (Gregoire et at. 1996; Levy et at. 1998; Myslivecek et at. 2002). There 
are limited longitudinal data supporting the notion of a role for exercise training 
in modifying HRV measures made during exercise (Myslivecek et at. 2002). 
The findings of such studies are, however, heterogeneous (Perini et at. 2002). 
The validity of the research cited above may have been negatively affected by 
the use of HRV measurements not previously validated for use during exercise. 
The third aim of this chapter was, therefore: 
111. To determine whether steady-state exercise HRV measurements could be 
altered following a supervised treadmill walking programme in PAD 
patients. 
9.1.2. Changes in exercise performance in PAD patients. 
Exercise training studies in PAD patients unanimously report increased walking 
performance variables. The findings of these studies have been reviewed 
(Regensteiner and Hiatt 1995; Hiatt 2001; Stewart et at. 2002; Kugler and 
Rudofsky 2003; Nehler et at. 2003) and meta-analysed (Gardner and Poehlman 
1995) previously. Increases in time for pain-free walking range from 44% -
300%. And values for maximal walking distance range from 25% - 442% 
(Nehler et at. 2003). A systematic review of these studies is beyond the scope of 
this chapter, but two hospital-based, supervised, randomised controlled trials are 
of particular merit. In one study (Hiatt et at. 1990) patients were randomly 
assigned to walking exercise or non-exercise control. After three months of 
progressive treadmill walking (one hour, three times a week) maximal walk time 
increased 123% and pain-free walk time increased 165% in the exercise group. 
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Controls showed only a 20% increase in walk time over the same period. The 
same research group (Hiatt et al. 1994) later demonstrated similar improvements 
(128% increase in maximal walk time) in exercise capacity and demonstrated a 
greater efficacy of treadmill walking vs. strength training for increasing walking 
performance. Improved functional capacity and increased levels of habitual 
physical activity were also recorded in the patients receiving the treadmill 
walking exercise protocol. 
9.1.3. Central vs. peripheral changes: which are responsible for 
increased walking performance? 
The magnitude of increases in walking performance with exercise training, are 
commonly in excess of those for changes in central factors such as V02 peak. For 
example, Hiatt et ai. (1990) found that the respective increases of 123% and 
165% for pain free and maximal walk time were associated with only small 
(30%) increases in V02 peak. Changes in V02 peak are unanimously reported as 
being much smaller in magnitude than changes in walking performance (Hiatt et 
ai. 1990; Hiatt et ai. 1994) suggesting other factors must responsible in part for 
the large increase commonly observed. In an attempt to identify these factors, 
changes in a number of measures over the course of exercise training protocols 
have been studied. Improved walking economy, efficiency and altered gait have 
all been reported (Womack et ai. 1997). Such adaptations facilitate 
improvements in walking performance independent of changes in V02 peak (Hiatt 
et ai. 1990; Hiatt et ai. 1994). 
Studies concerning change in peripheral arterial blood flow during exercise and 
more commonly, resting measures of ABI, have provided mixed results 
concerning the role of leg blood flow in improved walking performance. Despite 
Ie being due to anaerobisis in the peripheral musculature, the majority of A TP 
resynthesis during exercise in claudicants remains aerobic (Green and Mehlsen 
1999). On this basis, leg blood flow should be a determinant of walking 
performance. Furthelmore it would be expected that changes in walking 
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performance would be related to changes in leg blood flow. This, however 
appears not to be the case. 
Using resting ABI as an indicator of potential muscle blood flow, there is a large 
body of evidence to suggest that muscle blood flow is not related to onset of 
claudication or maximal walking performance (Gardner et al. 1992; Hiatt et at. 
1992; Brass and Hiatt 2000). Additionally, improvements in ABI due to bypass 
surgery and/or exercise do not to correlate with increases in walking performance 
(Regensteiner et al. 1993). In healthy individuals ABI values at rest are> 1. A 
value of < 0.94 indicates reduced blood flow to the lower limb at rest and is used 
as a diagnostic marker of PAD. Percutaneous angioplasty has been shown to 
increase resting ABI (from 0.6 to 0.9) in the absence of any improvement in 
walking performance (Perkins et al. 1996). Further evidence for the dissociation 
of limb blood flow and walking performance comes from studies showing large 
improvements in walking performance with no concomitant changes in ABI 
(Hiatt et al. 1990; Hiatt et al. 1994). 
It seems therefore, that change in resting ABI is an unlikely candidate to explain 
improved walking performance. The majority of studies show little-or-no 
change in ABI following exercise (Green 2002) and where significant changes in 
ABI are reported, they do not correlate with changes in walking performance 
(Womack et al. 1997). Data derived via the superior technique of measuring 
dynamic leg blood flow during exercise are very limited (Green 2002) and 
provide results which are at best, equivocal. 
9.1.4. Other possible mechanisms for improved walking performance. 
There is little evidence of impaired oxygen extraction across the affected limb in 
P AD patients. However, alterations in muscle metabolism have been 
demonstrated (Hiatt et al. 1987; Hiatt et at. 1992; Okita et at. 1998). In common 
with ABI measurements and VOz peak data, these measures correlate only weakly 
with walking performance. No longitudinal data are available to detennine 
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whether changes in muscle metabolism correlate with changes in maximal 
walking distance. 
Little attention has been paid to the possible contribution of impaired cardiac 
function to reduced exercise capacity. The absence of angina and 
electrocardiographic abnormalities during exercise has been interpreted as 
evidence that they are not limiting factors in exercise performance. However, the 
screening, and consequent exclusion from studies of patients displaying these 
characteristics means data will undoubtedly be biased toward such an 
interpretation. The existing data suggest cardiac function does not limit exercise 
performance. Peak heart rates are commonly only 100 - 125 BPM (Hiatt et al. 
1990; Gardner et al. 1992; Hiatt et al. 1994). Although these may increase 
following training they remain severely attenuated when compared to healthy 
age-matched controls (Martin et al. 1990). Such submaximal values suggest that 
peripheral rather than central factors are responsible for reduced exercise 
performance in PAD patients. Further evidence to support this argument is 
provided by the failure of PAD patients to attain a plateau in oxygen 
consumption during incremental exercise testing (Eldridge and Hossack 1987). 
Some patients can, however, attain a plateau and have previously been found to 
attain higher heart rates (and %HRmax) than those who fail to demonstrate such a 
pattern (Eldridge and Hossack 1987). These authors concluded that a lack of 
sympathetic drive to the heart may be responsible for the non-attainment of a 
classical plateau in oxygen consumption. No measure of sympathetic nervous 
activity was made in this study. 
Evidence for denervation of the ischaemic limb in PAD patients also exists 
(England et al. 1992). It may be that reduced feedback from peripheral 
chemoreceptors and mechanorecptors is responsible for the low reactance of the 
cardiovascular system to exercise (low maximal HR). It is unlikely that this 
central factor is the primary determinant of exercise performance in PAD 
patients but its contribution has not yet been quantified. Additionally, in the 
absence of one single factor being identified as being responsible for reduced 
walking performance, quantification of the contribution from as many central 
and peripheral factors as possible is warranted. Similarly, quantification of the 
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adaptation of any determinants to exercise training may help to elucidate the 
factors which limit exercise performance in PAD patients. The final aim of this 
chapter was, therefore: 
IV. To identify possible predictive measures of improved walking 
performance from resting and exercise baseline measurement. 
9.2. Methods. 
9.2.1. Study population. 
Subjects were 52 consecutive patients (38 males, mean age 64 ± 9) years from 
the vascular outpatient clinic who gave written, informed consent. The study 
was approved by the Hillingdon Hospital local research ethics committee. 
Peripheral artery disease was confirmed in all subjects by an ankle-to-brachial 
index < 0.94 at rest using a Doppler system (Mini Dopplex, Model 2000, 
Huntleigh Diagnostics, Cardiff, UK). The presence of symptomatic IC was 
evaluated using the leg pain score (ACSM 2000). 
9.2.2. Protocol. 
9.2.2.1. Resting heart rate variability analysis. 
All subjects underwent a five minute resting ECG recording using a standard 12-
lead ECG (CardioPerfect ST 2001, Cardio Control, Delft, The Netherlands). 
Heart rate variability was calculated according to recommended standards (Task 
Force 1996) using the method described previously (Chapters: 2 and 3) except 
that heart rate was recorded with subjects in the semi-recumbent position in a 
comfortable chair as opposed to in the supine position. 
9.2.2.2. Exercise heart rate variability measurements. 
In subjects allocated to the supervised exercise condition heart rate variability 
was measured during exercise using both recommended measures (Task Force 
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1996) and those developed specifically for use during exercise (Warren et al. 
1997). Five minute ECG recordings were made during steady state exercise at a 
workload equivalent to 75% of each subject's maximum. Initial measurements 
were only undertaken when it was deemed possible for a subject to attain and 
maintain steady state conditions for this duration of exercise. Exercise HRV 
measures were repeated at the same absolute exercise intensity after 6 and 12 
weeks of exercise training. If subject exercise capacity had improved sufficiently 
at these time points, exercise HRV was also recorded at the new relative exercise 
intensity. 
9.2.2.3. Treadmill testing protocol. 
Subjects were first given a treadmill familiarisation session on the day of testing 
followed by seated rest. After 1702 and heart rate returned to baseline values, 
subjects completed a graded treadmill protocol recommended for use in PAD 
patients (Gardner et al. 1991). Subjects walked on a treadmill (Marquette 2000, 
Marquette Electronics, Milwaukee, WI) at an initial workload of 2 mph for 2 
minutes. Consequent stages of the test increased 2% in grade every 2 minutes. 
The reliability of treadmill test scores, clinical measurements during and after 
this test have been demonstrated previously (Gardner et ai. 1991; Labs et ai. 
1999). During exercise, heart rate was measured and recorded via 12-lead ECG, 
(CardioPerfect ST 2001, Cardio Control, Delft, The Netherlands) 1702 and 
17C02 measurements were made breath-by-breath, using a Medical Graphics 
Cardi02 analysis system (Medical Graphics Corporation, st. Paul, Minnesota) 
and blood pressure was measured by manual sphygmomanometry. Onset, 
change and severity of IC were assessed in the final minute of each stage using 
the leg pain scale (ACSM 2000). This scale rates claudication pain from 1 (mild 
discomfort) to 4 (excruciating and unbearable pain). It is recognised that pain 
stimuli may modulate selected HRV measures in (Lind et al. 1999). On this 
basis, IC may be viewed as a potential confounding variable. However, the 
magnitude of effect exercise exerts on HRV is much greater than that reported 
for pain. Also, as pain cannot be avoided in this population, it was adjudged that 
best practice was to monitor pain so that it may be controlled for, if necessary in 
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later analyses. Additionally, ratings of perceived exertion were measured in the 
last minute of each stage. Treadmill testing and all associated resting and 
exercise measurements were repeated in all groups after six and twelve weeks. 
9.2.2.4. Test termination criteria. 
The following exercise test termination criteria were employed. Volitional 
exhaustion, sustained ST segment depression> 2 mm, acute chest pain, acute leg 
pain other than that of ischaemic origin or achievement of 1702 max. Maximal 
oxygen consumption was defined in two ways. In the first condition, three 
criteria were employed based on those described by the ACSM (2001). These 
were: 
1. a plateau in 1702 (increase of < 2 ml • kg-I • min-I) with an increase in 
workload, 
Ii. a respiratory exchange ratio> 1.15, 
iii. an RPE > 17. 
Second, 1702 max was characterised by a plateau in oxygen consumption only as 
described in this population previously (Eldridge and Hossack 1987). Post hoc 
analysis of respiratory data was also carried out using automated software 
(Breeze Suite. Medical Graphics Corporation, st. Paul Minnesota). Standard 
nine-panel-plots were created by which achievement of anaerobic threshold 
(AnT) and 1702 max could be determined. 
9.2.2.5. Randomisation and group exercise protocols. 
The remaining subjects were randomly allocated to one of three conditions: 
Supervised exercise training (SU), home based exercise training (HB) or non 
exercising controls (CT.) The supervised group attended the hospital twice a 
week. During each session they were required to complete a total of 30 min 
treadmill walking at 75% of maximum walking capacity. They were also 
instructed to undertake one additional weekly unsupervised walking session of 
30 min duration at an intensity eliciting and RPE of 11-13 at home between 
visits. The intensity of exercise was titrated by the researchers to account for 
improvements in exercise tolerance and performance during the trial using the 
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ratings of perceived exertion (RPE) scale (Noble et al. 1983) and measurements 
taken during retesting. The home-based exercise group were asked to complete 
an exercise diary and instructed to walk for total of30 min three times a week for 
the duration ofthe study. They were given a copy of the RPE scale and instructed 
to titrate their exercise intensity to a level equivalent to between levels 11 and 13. 
Weekly follow-up telephone calls were made by the researchers to discuss the 
protocol with subjects, answer any questions they might have and to give 
encouragement in trying to maintain the protocol. The control group were asked 
to maintain their current level of physical activity throughout the 12 weeks of the 
study. 
9.2.3. Statistical analysis. 
All measures were checked for normality of distribution and all underlying 
assumptions for each statistical test were assessed thoroughly before test 
application. Where data transformations or non-parametric equivalent tests were 
used these are outlined in individual results sections. 
9.2.3.1. Changes in resting measures of heart rate variability. 
Changes in heart rate variability measures between groups over the 12 weeks 
were analysed using a mixed (3 X 3) analysis of variance with repeated measures 
(mixedANOVA). Post hoc analysis between groups was carried out using the 
test for least significant differences (LSD). Post hoc analysis within groups was 
carried out using repeated measures t-test with a Bonferroni correction factor for 
multiple comparisons. Due to the large number of potential comparisons, only 
selected variables were analysed statistically. First mean RR interval was 
compared to determine whether evidence of exercise training-induced resting 
bradycardia was present. Global HRV was assessed in the time domain using the 
standard deviation of normal to normal intervals (SDNN). High frequency 
spectral power (HF) was used as a marker of vagal modulation. Sympathetic 
modulation was measured using low frequency power expressed in normalised 
units (LFnu) and LF: HF ratio was used as a marker of sympathovagal balance. 
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9.2.3.2. Changes in measures of heart rate variability made during 
exerCIse. 
Only data from the SU group were entered into this analysis. Heart rate 
variability measures validated for use during exercise (Warren et at. 1997) were 
calculated. Each selected variable was then analysed using repeated-measures 
analysis of variance (rmANOVA) with post hoc analysis (rm t-test). 
9.2.3.3. Baseline measures as predictors of maximal walking distance 
at baseline and change in maximal walking distance at 12 weeks. 
To identify those factors which best predicted maximal walk time (MWT) and 
change in maximal walking time (~MWT), multiple stepwise regression analysis 
was used. Inclusion criteria for predictor variables were a significant (P < 0.05) 
effect on F in analysis of variance, removal occurred at (P> 0.10). 
9.3. Results. 
Forty-nine patients were deemed suitable for enrolment into the study. One 
patient was excluded due to unstable angina symptoms. Two were rejected due to 
symptoms associated with critical ischaemia during treadmill familiarisation. 
After preliminary exercise testing a further two patients were excluded due to 
being unable to walk at 2 mph on level ground and one for displaying consistent 
ST elevation. 
One subject was admitted for elective peripheral bypass surgery after 6 weeks of 
exercise and a further patient suffered an acute ischaemic cerebral event at week 
11. Full data sets at baseline and six weeks were therefore, available in 40 
subjects. Complete study data were available on 39 subjects. 
9.3.1. Baseline data. 
Baseline subject characteristics are given in table 9-1, baseline exercise test data 
and changes in test data at weeks six and twelve are shown in table 9-2. 
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Table 9-1. Descriptive characteristics by group. 
Group Age (yrs) Height (cm) Mass (kg) BMI (kglm2) ABI 
SU 66 ± 8 1.70 ± 0.12 76.9 ± 18.3 26.3 ± 4.5 0.59 ± 0.01 
HB 62± 14 1.69 ± 0.11 79.3 ± 13.0 27.1 ± 4.2 0.57 ± 0.01 
CT 67 ± 6 1.71 ± 0.08 81.3 ± 22.5 27.7 ± 6.7 0.57 ± 0.12 
SU - Supervised exercise, HB - Home based, CT- Control, BMI - Body mass index, ABI - Ankle-
to-brachial index. 
Baseline exercise test data (table 9-2) showed low values for maximal walking 
times and levels of V02 peak. At baseline, all exercise test data were similar 
between groups. No significant changes in physiological measures or pain 
ratings occurred in any group. There was, however a significant (P < 0.0001) 
improvement in MWT in the SU group from baseline to week six. This value 
continued to increase (p = ns) from week six to week twelve. 
Baseline HRV data in table 9-3 show severely attenuated levels of global HRV 
characteristics (TP and SDNN) as well as low values for HF. High mean values 
for LF:TP and LFnu were also evident. One-sided t-tests showed that SDNN, TP 
and HF were all significantly lower than those reported for healthy subjects and 
similar to those reported previously for post-MI patients. 
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Table 9-2 Exercise test data at baseline, six and twelve weeks. 
Group MWT (min) V02 peak RER RPE Pain rating 
(mi. kg·1 • min-1) 
SU 1 6.50 ± 4.0 14.2 ± 3.8 0.96 ± 0.10 16.0 ± 2.0 3.0 ± 0.5 
SU 6 12.0 ± 5.6* 14.3 ± 3.7 1.00±0.10 15.0 ± 2.5 3.0 ± 1.0 
SU 12 12.1 ± 6.3* 13.7 ± 4.2 0.99 ± 0.12 15.1 ± 2.4 2.8 ± 0.9 
HB 1 6.1 ± 3.3 14.3±4.1 1.03 ± 0.08 16.0 ± 2.0 3.0 ± 1.0 
HB6 7.1 ± 4.7 14.0 ± 4.4 1.01 ±0.10 16.0 ± 2.5 3.0 ± 1.0 
HB12 7.2 ± 5.2 13.7±4.1 1.03 ± 0.99 16.1 ± 2.5 2.77 ± 0.9 
CT1 6.4 ± 4.4 14.8 ± 4.7 1.00±0.13 15.0 ± 2.0 3.0 ± 0.5 
CT6 6.3 ± 5.2 14.5±3.9 0.99 ± 0.07 14.7 ± 2.5 3.0 ± 1.0 
CT12 7.1 ±7.1 14.3±5.1 0.99 ± 0.09 14.3 ± 5.1 2.6 ± 0.7 
1 - week one, baseline, 6 - week six, 12 - week twelve, SU - Supervised exercise, HB - Home based, CT- Control, MWT - Maximal, walking time, RPE - Rating of 
perceived exertion, RER - Respiratory exchange ratio 
* Significantly different from baseline. (P<O.OOI) 
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9.3.2. Changes in resting HRV due to exercise training. 
Mixed ANOV A showed no significant overall effect of exercise training and no 
group interaction for any ofthe selected HRV measures (see table 9-3). Post hoc 
analysis (LSD) showed no differences between SU, HB and CT groups at 
baseline for any HRV measure. Further within-group, post hoc analysis over 
time revealed no significant effects of exercise in any group. 
9.3.2.1. Changes during exercise at equal absolute exercise intensity. 
This analysis was carried out on the SU group only (n = 14). The three HRV 
measures used differed from those analysed in previous sections. Due to the 
differences in chosen spectral parameters, it was first necessary to assess the 
changes these effects had on resting HRV measures. One-way ANOVA revealed 
no significant effects of exercise training on the resting HRV measures: TP, 
(0.003 - 0.1 Hz) HF, (0.1 - 1.0 Hz), or LF:TP ratio. 
Data from HRV measured during exercise are displayed in figures 9-1 - 9-4. 
When measured at the same absolute exercise intensity, rm-ANOV A revealed a 
significant change in RR interval over time (F = 4.30, P = 0.028). Post hoc 
analysis revealed an increase in RR interval from baseline to week six (t = 2.19, 
P = 0.079) and a significant difference between baseline and week 12 (t =3.58, P 
= 0.004). There was a significant effect of exercise on TP (F = 4.44, P = 0.024). 
Post-hoc analysis (rm t-test) revealed significant differences in TP from baseline 
at weeks six (t = 2.62, P = 0.021) and 12 (t = 3.32, P = 0.006). 
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Table 9-3. Heart rate variability measures at baseline, six and twelve weeks. 
Group HF (In) LFnu LF:HF (In) RR interval 
SU 1 4.1 ± 1.3 64.4 ± 22.0 0.73 ± 1.22 756.6 ± 154.3 
SU 6 4.4 ± 1.6 70.3 ± 21.2 0.99 ± 1.00 766.3 ± 114.5 
SU 12 3.9 ± 1.2 68.4 ± 14.3 0.91 ± 0.94 799.8 ± 144.6 
HB1 3.6 ± 1.3 67.7 ± 21.2 0.73 ± 1.02 773.0 ± 213.0 
HB6 3.3 ± 1.4 75.9 ± 15.3 1.28 ± 0.82 748.1 ±201.8 
HB12 3.9 ± 1.3 66.3 ± 14.3 0.76 ± 0.71 808.4 ± 177.0 
CT 1 4.0 ± 1.4 79.6 ± 20.0 1.50 ± 0.68 840.5 ± 118.2 
CT6 4.4 ± 1.4 72.5 ± 18.8 1.14±0.77 824.4 ± 136.7 
CT12 4.2 ± 1.3 68.7 ± 24.8 1.51 ± 1.19 836.6 ± 146.7 
1 - week one, baseline, 6 - week six, 12 - week 12, SU - Supervised exercise, HB - Home based, CT- Control, HF(1n) - High frequency spectral power in log transformed 
units, LFnu - Low frequency power in normalised units, LF:HF - the ratio of low to high frequency power 
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High frequency power during exercise was increased by exercise training (F = 
3.22. P = 0.053). Post hoc analysis (rm t-test) showed significant differences in 
HF from baseline at weeks six (t = 3.22, P = 0.007) and 12 (t = 2.50, P = 0.030). 
The ratio of LF:TP showed no significant effect over time (F = 1.15 P = 0.336) 
Post hoc analysis revealed a significant increase in LF:TP from baseline to 12 
weeks (t = 2.36, P = 0.036). 
9.3.2.2. Changes during exercise at equal relative exercise intensity. 
When measured at equal relative exercise intensity (75% V02 peak) there were no 
significant changes from baseline in RR interval, TP, HF or LF:TP in the SU 
group at week six or week 12. 
9.3.3. Predictors of baseline maximal walking time. 
Ranges for maximal walking times are shown in table 9-2. When anthropometric, 
clinical, exercise test and HRV measures were used to predict MWT in all 
subjects tested at baseline V02 peak was found to be the only significant predictor 
(See equation 9-1). 
L1MWT = (39.3 x V02 peak) - 199.5 
R2 = 0.51 and SEE = 167.8 
Equation 9-1 
9.3.4. Predictors of change in maximal walking time in SU group. 
With the SU group's L1MWT scores as the dependent variable, stepwise 
regression revealed that baseline V02 peak and HF(ln) were both significant 
independent predictors (See equation 9-2). 
L1MWT = (23.2 V02 peak) + (63.3 HF(ln)) - 511.4 
R2 = 0.74, SEE 90.9 
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Equation 9-2 
9.3.5. Predictors of change in maximal walking time in all patients. 
With the all patient's i'1MWT scores as the dependent variable, stepwise 
regression revealed that baseline V02 peak and HF(1n) were both significant 
independent predictors (See equation 9-3). 
i'1MWT = (24.2 V02 peak) + (52.1 HF(1n» - 511.4 Equation 9-3 
R2 = 0.27, SEE = 219.3 
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Figure 9-1. Mean RR interval during exercise at the same absolute exercise intensity at weeks one, six and twelve. 
RR mean RR interval (ms), RR I - baseline, RR 6 - week six, RR 12 - week twelve. * - significantly (P < 0.05) different from baseline. 
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Figure 9-2. Total spectral power during exercise at the same absolute exercise intensity at weeks one, six and twelve. 
TP - mean total spectral power (ms2), TP 1 - baseline, TP 6 - week six, TP 12 - week twelve. * - significantly (P < 0.05) different from baseline. 
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Figure 9-3 High frequency spectral power (log units) during exercise at the same absolute exercise intensity at weeks one, six and twelve. 
HF (In) - mean high frequency spectral power (log units), HF 1 - baseline, HF 6 - week six, HF 12 - week twelve. * - significantly (P < 0.05) different from baseline 
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Figure 9-4 Ratio of low frequency to total spectral power during exercise at the same absolute exercise intensity at weeks one, six and twelve. 
LF/TP- mean ratio of low frequency to total spectral power (arbitrary units), LF/TP 1 - baseline, LF/TP 6 - week six, LF/TP 12 - week twelve. * - significantly (P < 0.05) 
different from baseline. 
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9.4. Discussion. 
9.4.1. Exercise test and HRV data. 
Values for MWT and V02 peak in the present PAD patient cohort were similar to 
those reported previously for incremental treadmill testing in clinically similar 
patient groups (Regen steiner et al. 1993; Hiatt et al. 1994; Gardner 2002). These 
data support statements made in several review articles which conclude that exercise 
performance and functional capacity are severely attenuated in PAD patients 
(Gardner and Poehlman 1995; Regensteiner and Hiatt 1995). 
To date, no data are available concerning the cardioneuroregulatory status of PAD 
patients. In ischaemic conditions such as angina, 24-hour monitoring has shown that 
when compared to controls, angina patients have significantly reduced mean RR 
interval, SDNN, the route mean square of successive RR intervals (RMSSD), the 
number of adjacent beats differing by more than 50 ms in length (PNN50), TP, LF, 
HF (Wennerblom et al. 2000). Some measures are also reduced when calculated 
form short-term ECG traces. When calculated from 24-hour monitoring, HF, LF 
and VLF all predict cardiac death in stable angina patients (Forslund et al. 2002) 
and the LF:HF ratio is also known to be a powerful predictor of cardiac event in 
unstable angina (Lanza et al. 1997). Wennerblom et al. (2000) found that 
Percutaneous trans luminal coronary angioplasty (PTCA) aided the recovery of 
attenuated vagal measures of HRV (HF) calculated from short-telID ECG 
measurement under controlled respiration. This medical procedure, however, failed 
to normalise all HRV measures, indicating that ischaemia itself, was one, but not the 
only cause of the disturbed HRV in stable angina. 
Short-term values for SDNN were similar to those repOlted previously (Faber et al. 
1996) in a subgroup of post-MI patients, identified as being at high risk of three 
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year, all cause mortality. Additionally, values for HF were similar in PAD patients 
and high risk post-MI patients. Finally, when compared with values derived from 
similar short-tetlli ECG measurements in subjects of similar age (Barnett et al. 
1999), PAD patients had greatly reduced values for all HRV measures, but 
patiicularly global (SDNN) and vagal (HF) measures (Faber et al. 1996; Fei et al. 
1996). These findings indicate that the PAD patients studied here may be at 
increased risk of future cardiac event and overall mortality compared with the 
normal population. 
9.4.2. Changes due to exercise training. 
The CT group in the present study were given no specific exercise therapy and only 
instruction of the effects of exercise on PAD other than that provided by their 
general practitioner and their hospital consultant. No differences were found in any 
of the measures recorded in the study and therefore the discussion will be limited to 
data from the SU and HB groups. 
9.4.2.1. Changes in walking performance and VOz ~ in SU and HB groups. 
The efficacy of supervised walking exercise in increasing walking capacity in PAD 
patients has been demonstrated in numerous studies and reviewed thoroughly 
(Regensteiner and Hiatt 1995). The large improvements over the 12 weeks of 
exercise training in the SU group agree with findings from previous randomised 
controlled trials (Hiatt et al. 1990; Hiatt et al. 1994). Data from community-based 
exercise programmes demonstrate them to be less efficacious. Overall, however, 
they still bring about increases in walking performance. The present data agree with 
these findings, they also agree in pati, with previous data suggesting that changes in 
MWT are not always associated with any significant change in VOz peak (Kugler and 
Rudofsky 2003). This has not always been shown to be the case however, as 
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significant increases in central cardiopulmonary capacity have been demonstrated 
(Regensteiner and Hiatt 1995). 
9.4.2.2. Changes in resting HRV in SU and HB groups. 
No previous data were available concerning the effectiveness of exercise training as 
an intervention to alter the HRV profiles of PAD patients. Based on the low values 
recorded at baseline and the risk associated with such values in other populations it 
seems logical to argue that increases in global and especially vagal measures of 
HRV would be advantageous to these patients. It is known that exercise training can 
positively affect the HRV profiles ofpost-MI patients (La Rovere et ai. 1992; Stahle 
et ai. 1999), and even heart failure patients (Coats et ai. 1992). Typical effects 
appear to be increases in global measures of HRV such as TP in the frequency 
domain and SDNN in the time domain. Additionally, a shift toward increased 
parasympathetic modulation of HR has been demonstrated (Mazzuero et at. 1992). 
These changes are similar to those observed in healthy individuals who undetiake 
exercise training (See Chapters four and five for full reviews). 
In the present study, the HB group showed no significant effects of exercise training 
on HRV. This was expected as no increases in either exercise performance (MWT) 
or cardiopulmonary function (V02 peak) were detected. In the majority of studies 
where alterations in HRV are demonstrated this is commonly observed in 
conjunction with significant alterations in other physiological measures. Data from 
post-MI patients suggest evidence of a threshold effect in the ability of exercise to 
alter HRV significantly (Pardo et ai. 2000). These authors found no effect of 
exercise rehabilitation in post-MI patients when analysed by group (home-based 
group and supervised exercise group). In their study, Pardo et at. (2000) originally 
utilised the home-based exercise group as a control group. When it was discovered 
that several 'controls' had made significant > 1.5 MET increases in maximal 
exercise capacity their data were pooled with those of subjects in the experimental 
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ann of the study. These 'responders' as they are tenned were then compared with 
the 'non-responders'; defined as those subjects improving by < 1.5 METS maximal 
exercise capacity. There are several methodological issues associated with such post 
hoc data pooling techniques especially in analysing pooled data from different 
subject groups who have received different interventions. Therefore, although these 
researchers found differences in HRV measures between responders and non-
responders it is difficult to infer causality from such findings. 
Interestingly, in the present study, several HB group subjects and one CT group 
subject showed large increases in exercise capacity and indeed 1702 peak. On this 
basis it was decided that two analyses 'without intention to treat' be perfonned. The 
first was to detennine if any differences were evident at baseline between responders 
and non-responders. By dividing subjects according to improvement in MWT « 
280 s = non responder or > 280 s = responder) on all patient data to determine 
factors which may predict improvement in MWT independent t-test showed those 
who responded to exercise training (in HB and SU groups) had higher levels of 
HF(ln) recorded at baseline (data not shown). These findings are in agreement with 
data from studies in healthy individuals (Boutcher and Stein 1995; Hedelin et at. 
2001; Hautala et at. 2003). Boutcher and Stein (1995) studied the absolute and 
relative 1702 peak of 15 controls and 19 subjects who trained for 24 sessions. These 
two values increased 12% and 11% respectively, no increase was observed in the 
control group. As in the present study, HRV remained unchanged. However, when 
the trained subjects were further categorised into high (n = 5) and low (n = 5) HRV 
at baseline groups improvements in both absolute and relative V02 peak were 
significantly greater (P > 0.005) in the high HRV group (17% and 20% respectively) 
compared to the low HRV group (6% and 1 % respectively). The authors concluded 
that HRV was a significant predictor of response to exercise training in sedentary 
adults. It is of note that the tetID HRV is used in this case to represent the amplitude 
of heali rate variability from peak to trough during respiratory-mediated sinus 
arrhythmia. Prior to automated data processing techniques, this amplitude was 
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commonly reported in studies (Maciel et at. 1985; Maciel et al. 1986; De Meersman 
1993). It was used as a simple measure of vagal modulation (Reiling and Seals 1988; 
De Meersman 1992). This simple time domain measure is not dissimilar to HF 
power measured from short-term recordings measured in the frequency domain. 
Hedelin et al. (2001) studied changes in peripheral (peak torque) and central 
(V02 max) measures of response to exercise training in elite athletes. Amongst other 
associations, these authors found, that athletes who increased their V02 max following 
training had significantly higher baseline values for HF(ln) than the equal number 
who showed a decrease in V02 max. In common with the design of the study by 
Boutcher and Stein, Hedelin et al. did not intend to show such an effect. The 
intention to treat analysis of these data was to show changes in HRV profiles due to 
training and relationships between change in peak torque, V02 max and HRV. On 
this basis, as with the work of Pardo et at. no causative link between baseline HRV 
and response to training should be made. To date, only one study has set out with 
the express intention of demonstrating a causative link between an HRV measure at 
baseline and subject response to a standardised exercise training regimen. Hautala et 
al. (2003) trained 39 sedentary males six times per week for 8 weeks and assessed 
their change in V02 peak over the course of the training period. When subjects were 
divided into quartiles based on response (L1 V02 peak) there were no differences in 
baseline measures of: V02 peak , age, or BMI. Heatt rate and heart rate variability 
measures were calculated from 24-hour Holter monitoring. Neither 24-hour, day 
time or night time HR were not different between response groups, all HRV 
measures (SDNN, LF, VLF, ULF) were similar except HF(ln). When calculated for 
the entire 24-hour period HF(ln) was significantly lower in the low response group 
(4th quartile) than the high response group. When calculated from EeG recorded 
from midnight to 6 AM the average-low response and the low response (3rd and 4th 
quartiles) were both significantly lower then the high response group. 
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9.4.3. Linear regression analysis 
9.4.3.1. Predictors of MWT at baseline. 
At baseline, V02 peak was the only significant predictor of MWT. This finding is 
concordant with data from healthy individuals, and at first sight seems discordant 
with the assertion that IC limits exercise tolerance in the PAD patient. The fact that 
disease severity (ABI) was not predictive of MWT opposes the view of many 
previous data. Two reasons can be given to explain this finding. 
Firstly, ABI may be a poor measure of muscle blood flow during exercise (Green 
2002). Previous data have shown increased exercise tolerance due to training 
without change in ABI. Conversely, increases in ABI due to surgical intervention 
have been found to be unrelated to changes in pain free walking and exercise 
capacity (Regensteiner et al. 1993). It is not in doubt that IC limits walking in PAD 
patients, all patients in the present study reported leg pain during exercise. It may 
not, therefore, be the case that exercise induced IC does not impact on MWT but 
merely that in the present study a suitable measure of muscle blood flow was not 
made. 
Secondly, it may be that V02 peak and ABI are in some way related or at least 
dependent. In the general population, V02 peak is dependent on levels of habitual 
physical activity. This is undoubtedly, also tme in patients with PAD. The greater 
the level of physical activity the higher the V02 peak will be in each patient. In 
addition to this, walking economy may be higher for the same reasons. If, ABI and 
therefore, IC, have any impact on physical activity it is likely that they will be 
related to MWT. Although these measures were entered into the regression 
equation, none significantly predicted MWT. Collinearity diagnostics revealed that 
ABI was, to a degree, collinear with V02 peak. It seems therefore, that the above 
324 
argument holds, insofar as V02 peak and ABI may be intrinsically linked via physical 
activity levels and that the fOlmer acts at least partially, as a surrogate for the latter 
in the present regression analysis. 
9.4.3.2. Prediction of l'1MWT over 12 weeks of training. 
From an experimental and clinical point of view the prediction of MWT is 
interesting and useful. From a clinical standpoint, factors that can predict change in 
MWT are of greater importance. When anthropometric, physiological and HRV 
measures were used to predict l'1MWT, V02 peak and HF(ln) were both significant 
independent predictors. 
The above analysis was performed on the whole patient population, it is difficult to 
make causative conclusions based on such data as patients received different 
treatments. Therefore, an identical analysis was performed on the SU group only. 
Separate analysis of the SU group data confilmed V02 peak and HF(ln) again, to be 
significant independent predictors of l'1MWT. It seems, therefore, that subject levels 
of peak oxygen utilising capacity may be important in determining response to 
rehabilitation. It is of note here that initial MWT was not a predictor of l'1MWT. In 
fact, no significant relationship between these variables was evident. This may 
suggest the some patients may have had lower walking economy at the beginning of 
the trial. As walking economy is known to improve with training (Gardner et ai. 
2002) these subjects may have shown large improvements in MWT. Alternatively, 
it could be that patients with initially higher V02 peak levels could better tolerate the 
treadmill walking exercise, perfonning longer walking bouts at higher intensities. 
This would result in greater gains for these patients. An initial V02 peak value above 
a certain threshold may have aided these patients in gaining greater benefit from the 
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training programme. Finally, it could be that patients with initially higher V02 peak 
values were simply those patients willing to 'push themselves' during the initial 
treadmill testing protocol. It follows that someone who puts in maximal effort at the 
initial test is likely to also try hard during the training programme. It has been 
demonstrated that walking programmes that encourage PAD patients to exercise at 
near maximal levels of pain produce the biggest gains in walking improvement 
(Gardner and Poehlman 1995). Further analysis of the exercise test data, especially 
calculations of change in walking economy and V02 peak values may provide more 
definite answers to the tentative explanations put forward here. Analysis of patterns 
of exercise (duration and number of stops per session), and effort (RPE and pain 
scale scores) may also provide further valuable information. These analyses are, 
however, beyond the scope of this chapter. 
The fact that HF power, a marker of vagal modulation of the SA node is also an 
independent predictor of training response warrants further investigation. Again, 
only very tentative explanations regarding possible causative relationships between 
training response and HF can be made based on the present data due to the small 
sample size. 
One possible explanation is that as HRV was measured at rest where vagal 
modulation predominates that HF, actually more closely represents the global 
autonomic control system. Such a system will allow greater exercise tolerance via 
acute adaptation (e.g. ability to raise heart rate) which may in tum facilitate higher 
intensity exercise and create enhanced chronic adaptation. Another explanation may 
be related to evidence of increased vagal modulation per se. Enhanced vagal 
modulation of the SA node will enhance acute exercise recovery and HF has been 
shown to be related to heati rate recovery in a number of populations. Faster 
recovery means shorter rest intervals between bouts of walking within training 
seSSIOns, which would in theory, create an enhanced training response. Again 
fmiher research into this area is required to support such a notion. 
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A final reason for the predictive power of HF may be that it is a marker of disease 
severity. Those patients with the most severe fmID of PAD are likely to be those who 
are most limited in their daily activity by PAD. These are likely to be the patients 
with lowest HF and V02 peak for that matter. Therefore, patients with higher HF 
power at baseline may have represented a subpopulation of PAD patients. However, 
only resting ABI was available as a measure of disease severity and given the 
shortcomings of this measure described above, little inference regarding this notion 
can be made here. However, prior to any attempt to utilise either V02 peak or HF as 
markers of potential training response, factors which determine levels of these two 
measures at baseline require further investigation. 
Potential covariates in this population which could not be controlled for due to small 
subject numbers may include; pharmacological therapy such as beta blockade 
(Malfatto et al. 1998), antecedent related illnesses and medical interventions such as 
prior MI (Bonnemeier et al. 2000) or revascularising surgery (Tseng et al. 1996; 
Osterhues et al. 1998; Ozcan et al. 1999; Wennerblom et al. 2000) and any other 
accompanying illnesses such as diabetes (Malpas and Maling 1990). All of the 
above conditions or treatments were represented in the present PAD patient 
population and all are known to affect HRV in other populations. However, a much 
larger sample size would be necessary to make any comparison or inference about 
the effect each had on HRV and especially HF. 
9.4.4. Changes in HRV at equal absolute exercise intensity. 
Numerous pathological conditions are diagnosed routinely today by the use of 
exercise 'stress' testing. To determine if any change in the autonomic function of 
P AD patients was evident during exercise, HRV analysis was carried out in the SU 
group at weeks one, six and twelve of the exercise programme. This analysis was 
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calTied out based on the assumption that exercise HRV may reveal changes in 
autonomic function despite no changes being evident at rest. This has been shown 
previously in healthy subjects of a similar age to the PAD patients studies here 
(Myslivecek et al. 2002). 
Significant changes in RR interval and HF(ln) were evident. The increases in both 
these measures demonstrating a lower heal1 rate, accompanied as expected by 
increased vagal modulation. These findings represent a preservation of vagal tone 
during exercise. This has been shown previously in healthy populations. Levels of 
HF power are commonly higher during equal absolute intensity exercise in trained 
than untrained subjects (Gregoire et al. 1996) and may be increased by exercise 
training (Leicht et al. 2003; Leicht et al. 2003). It has previously been stated that 
preserved vagal modulation of the SA node during exercise may create a more 
electrically stable environment. On this basis, it has been argued that by 
demonstrating increased preservation of HF during exercise following a training 
intervention subjects also demonstrate a safer exercise HRV profile. Previously, this 
has only been shown in healthy subjects, who were not at risk of problematic cardiac 
electrical events. The low HRV values as well as attenuated exercise capacities, and 
historically poor prognosis for PAD patients places them in a high risk category for 
future cardiac event (Dormandy et al. 1999). The finding of increased HF at equal 
absolute exercise intensity may be of some importance. This is also the first time 
that increases in this measure have been demonstrated empirically in any clinical 
population. 
The findings of an increase in LF:TP ratio (sympathetic marker) may seem 
somewhat contradictory. This is especially true when it is considered that while HF 
remained stable from week six to week twelve and LF:TP increased, there was 
actually a concomitant increase in RR interval. 
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This finding can be explained by paying attention to the nature of HRV recordings 
made here. First of all, it is not uncommon for both LF and HF spectral powers to 
increase post-training when measured at rest and during exercise (Leicht et at. 2003; 
Leicht et at. 2003). Such findings and the increase in LF:TP in the present study are 
due to the fact that the HRV measures (LF, HF and LF:TP) all measure modulation 
of the SA node. They are not measures of sympathetic or parasympathetic tone and 
do not measure mean firing rates of either branch of the ANS (Goldberger et at. 
1994; Goldberger 1999). It therefore follows that if increased vagal modulation is 
present (as implied by increased HF) during exercise, then a greater level of 
sympathetic modulation will be required to elicit a similar HR response. What, it 
seems, is happening during exercise in the trained patients is that a preserved vagal 
modulation is maintained but that an increase in sympathetic modulation is also 
present. The latter may be necessary to facilitate adequate excitation of the SA node 
to maintain heart rate, cardiac output and therefore, exercise capacity. 
Of interest when observing the changes in RR interval, HF and LF:TP are the 
differences in the time course of their adaptation. Initially there were significant 
increases in RR interval and HF (weeks one to six) with no change in LF:TP. 
Between weeks six and twelve, HF remained relatively constant while significant 
increases in LF:TP were observed. The meaning of and reasons for the different 
adaptive behaviours of these measures also requires further investigation. 
9.5. Conclusions. 
The findings of the present study agree with previous data showing significant 
Increases in MWT in PAD patients undertaking supervised treadmill walking 
exercise. Increased exercise capacity was not accompanied by increased VOz peak 
during treadmill testing or measures of HRV made at rest. These findings together 
suggest that the training stimulus provided by treadmill walking exercise was 
insufficient to produce central physiological and autonomic adaptation. One reason 
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for this may have been the discontinuous nature of the walking exercise performed. 
This is a feature common to all studies in PAD patients. 
Heart rate variability measures designed for use during exercise showed significant 
alterations in levels of sympathetic and parasympathetic modulation resulting in a 
net overall decrease in exercise heart rate. It seems, therefore, that HRV measured 
during exercise may be able to illustrate changes in autonomic function which 
cannot be observed when the nervous system is assessed at rest. 
In common with findings in healthy subjects and other clinical populations, it was 
shown that responders and non-responders to exercise training differed from each 
other at baseline in terms of HF spectral power. The fact that baseline HF was 
higher in those who consequently showed the biggest increases in maximal walk 
time is of particular interest, especially when taken with the fact that the baseline HF 
was a significant independent predictor of ~MWT in the SU group. The nature of 
the relationship between training response and baseline HF requires further 
investigation with a larger subject population. 
9.6. References. 
ACSM (2000). ACSM's Guidlines for Exercise Testing and Prescription. 
Philadelphia, Lippincott Williams and Wilkins. 
Aubert, A., B. Seps and F. Beckers (2003). "Heart rate variability in athletes." Sports 
Medicine 33(12): 889-919. 
Barnett, S. R., R. J. Morin, D. K. Kiely, M. Gagnon, G. Azhar, E. L. Knight, J. C. 
Nelson and L. A. Lipsitz (1999). "Effects of age and gender on autonomic control of 
blood pressure dynamics." Hypeliension 33(5): 1195-1200. 
Bonnemeier, H., F. Hartmann, U. K. Wiegand, C. hmer, T. Kurz, R. Tolg, H. A. 
Katus and G. Richardt (2000). "Hem1 rate variability in patients with acute 
330 
myocardial infarction undergoing primary coronary angioplasty." American Joumal 
of Cardiology 85(7): 815-820. 
Boutcher, S. H. and P. Stein (1995). "Association between heat1 rate variability and 
training response in sedentary middle-aged men." European Joumal of Applied 
Physiology and Occupational Physiology 70(1): 75-80. 
Brass, E. P. and W. R. Hiatt (2000). "Acquired skeletal muscle metabolic myopathy 
in atherosclerotic peripheral at1erial disease." Vascular Medicine 5(1): 55-59. 
Coats, A. J., S. Adamopoulos, A. Radaelli, A. McCance, T. E. Meyer, L. Bemardi, 
P. L. Solda, P. Davey, O. OlIDerod, C. Forfar and et al. (1992). "Controlled trial of 
physical training in chronic heart failure. Exercise performance, hemodynamics, 
ventilation, and autonomic function." Circulation 85(6): 2119-2131. 
Criqui, M. H. (2001). "Peripheral arterial disease--epidemiological aspects." 
Vascular Medicine 6(3 Suppl): 3-7. 
De Meersman, R. E. (1992). "Respiratory sinus alThythmia alteration following 
training in endurance athletes." European Joumal of Applied Physiology and 
Occupational Physiology 64(5): 434-436. 
De Meersman, R. E. (1993). "Heat1 rate variability and aerobic fitness." American 
Heart Journal 125(3): 726-731. 
Dormandy, J., L. Heeck and S. Vig (1999). "The natural history of claudication: risk 
to life and limb." Seminars in Vascular Surgery 12(2): 123-137. 
Eldridge, J. E. and K. F. Hossack (1987). "Patterns of oxygen consumption during 
exercise testing in peripheral vascular disease." Cardiology 74(3): 236-240. 
England, J. D., J. G. Regensteiner, S. P. Ringel, M. R. CalTY and W. R. Hiatt (1992). 
"Muscle denervation in peripheral arterial disease." Neurology 42: 994-999. 
Faber, T. S., A. Staunton, K. Hnatkova, A. J. Camm and M. Malik (1996). "Stepwise 
strategy of using short- and long-telID heart rate variability for risk stratification after 
myocardial infarction." Pacing and Clinical Electrophysiology 19(11 Pt 2): 1845-
1851. 
Falcone, R. A., A. T. Hirsch, J. G. Regensteiner, D. Treat-Jacobson, M. A. Williams, 
W. R. Hiatt and K. J. Stewat1 (2003). "Peripheral arterial disease rehabilitation: a 
review." Joumal of Cardiopulmonary Rehabilitation 23(3): 170-175. 
Fei, L., X. Copie, M. Malik and A. J. Camm (1996). "Short- and long-term 
assessment of heat1 rate variability for risk stratification after acute myocardial 
infarction." American Joumal of Cardiology 77(9): 681-684. 
331 
Forslund, L., I. Bjorkander, M. Ericson, C. Held, T. Kahan, N. Rehnqvist and P. 
Hjemdahl (2002). "Prognostic implications of autonomic function assessed by 
analyses of catecholamines and heat1 rate variability in stable angina pectoris." Heat1 
87(5): 415-422. 
Gardner, A. W. (2002). "Sex differences in claudication pain in subjects with 
peripheral arterial disease." Medicine and Science in Sports and Exercise 34(11): 
1695-1698. 
Gardner, A. W., L. I. Katzel, 1. D. Sorkin and A. P. Goldberg (2002). "Effects of 
long-term exercise rehabilitation on claudication distances in patients with 
peripheral arterial disease: a randomized controlled trial." Journal of 
Cardiopulmonary Rehabilitation 22(3): 192-198. 
Gardner, A. W. and E. T. Poehlman (1995). "Exercise rehabilitation programs for 
the treatment of claudication pain. A meta-analysis." JAMA : the journal of the 
American Medical Association. 274(12): 975-980. 
Gardner, A. W., J. S. Skinner, B. W. Cantwell and L. K. Smith (1991). "Progressive 
vs single-stage treadmill tests for evaluation of claudication." Medicine and Science 
in Sports and Exercise 23(4): 402-408. 
Gardner, A. W., J. S. Skinner, B. W. Cantwell and L. K. Smith (1992). "Prediction 
of claudication pain from clinical measurements obtained at rest." Medicine and 
Science in Sports and Exercise 24(2): 163-170. 
Goldberger, 1. 1. (1999). "Sympathovagal balance: how should we measure it?" 
American Journal of Physiology 276(4 Pt 2): HI273-1280. 
Goldberger, J. J., M. W. Ahmed, M. A. Parker and A. H. Kadish (1994). 
"Dissociation of heat1 rate variability from parasympathetic tone." American Journal 
of Physiology 266(5 Pt 2): H2152-2157. 
Green, S. (2002). "Haemodynamic limitations and exercise performance in 
peripheral arterial disease." Clinical Physiology and Functional Imaging 22(2): 81-
91. 
Green, S. and J. Mehlsen (1999). Peripheral arterial disease. Exercise and circulation 
in Health and Disease. B. Sahltin, R. Boushel, N. Secher and J. Mitchel. Champaign, 
Illinois, Human Kinetics: 283-290. 
Gregoire, J., S. Tuck, Y. Yamamoto and R. L. Hughson (1996). "Heat1 rate 
variability at rest and exercise: influence of age, gender, and physical training." 
Canadian Journal of Applied Physiology 21(6): 455-470. 
332 
Haouzi, P., J. J. Hirsch, F. Marchal and A. Huszczuk (1997). "Ventilatory and gas 
exchange response during walking in severe peripheral vascular disease." 
Respiration Physiology 107(2): 181-190. 
Hautala, A. J., T. H. Makikallio, A. Kiviniemi, R. T. Laukkanen, S. Nissila, H. V. 
Huikuri and M. P. Tulppo (2003). "Cardiovascular autonomic function correlates 
with the response to aerobic training in healthy sedentary subjects." American 
Journal of Physiology: Heart and Circulatory Physiology 285(4): H1747-1752. 
Hedelin, R., P. Bjerle and K. Hemiksson-Larsen (2001). "Heart rate variability in 
athletes: relationship with central and peripheral performance." Medicine and 
Science in Sports and Exercise 33(8): 1394-1398. 
Hiatt, W. R. (2001). "Medical treatment of peripheral arterial disease and 
claudication." New England Journal of Medicine 344(21): 1608-1621. 
Hiatt, W. R., D. Nawaz and E. P. Brass (1987). "Carnitine metabolism during 
exercise in patients with peripheral vascular disease." Journal of Applied Physiology 
62(6): 2383-2387. 
Hiatt, W. R., J. G. Regensteiner, M. E. Hargarten, E. E. Wolfel and E. P. Brass 
(1990). "Benefit of exercise conditioning for patients with peripheral arterial 
desease." Circulation 81: 602-609. 
Hiatt, W. R., E. E. Wolfel, R. H. Meier and J. G. Regensteiner (1994). "Superiority 
of treadmill walking exercise versus strength training for patients with peripheral 
arterial disease. Implications for the mechanism of the training response. " 
Circulation 90(4): 1866-1874. 
Hiatt, W. R., E. E. Wolfel, J. G. Regensteiner and E. P. Brass (1992). "Skeletal 
muscle carnitine metabolism in patients with unilateral peripheral atierial disease." 
Journal of Applied Physiology 73(1): 346-353. 
Kugler, C. F. and G. Rudofsky (2003). "The challenges of treating peripheral atierial 
disease." Vascular Medicine 8(2): 109-114. 
La Rovere, M. T., A. Mortara, G. Sandrone and F. Lombardi (1992). "Autonomic 
nervous system adaptations to short-term exercise training." Chest 101(5 Suppl): 
299S-303S. 
Labs, K. H., M. R. Nehler, M. Roessner, K. A. Jaeger and W. R. Hiatt (1999). 
"Reliability of treadmill testing in peripheral arterial disease: a comparison of a 
constant load with a graded load treadmill protocol." Vascular Medicine 4(4): 239-
246. 
Lanza, G. A., P. Pedrotti, A. G. Rebuzzi, V. Pasceri, G. Quaranta and A. Maseri 
(1997). "Usefulness of the addition of heati rate variability to Holter monitoring in 
333 
predicting in-hospital cardiac events in patients with unstable angina pectoris." 
American Journal of Cardiology 80(3): 263-267. 
Leicht, A. S., G. D. Allen and A. J. Hoey (2003). "Influence of age and moderate-
intensity exercise training on heart rate variability in young and mature adults." 
Canadian Journal of Applied Physiology 28(3): 446-461. 
Leicht, A. S., G. D. Allen and A. J. Hoey (2003). "Influence of intensive cycling 
training on heart rate variability during rest and exercise." Canadian Journal of 
Applied Physiology 28(6): 898-909. 
Levy, W. C., M. D. Cerqueira, G. D. Harp, K. A. Johannessen, I. B. Abrass, R. S. 
Schwartz and J. R. Stratton (1998). "Effect of endurance exercise training on heart 
rate variability at rest in healthy young and older men." American Journal of 
Cardiology 82(10): 1236-1241. 
Lindh, V., U. Wiklund and S. Hakansson (1999). Heel lancing in term new-born 
infants: an evaluation of pain by frequency domain analysis of heart rate variability. 
Pain. 80(1-2): 143-148. 
Maciel, B. C., L. Gallo Junior, J. A. Marin Neto, E. C. Lima Filho, J. Terra Filho and 
J. C. Manco (1985). "Parasympathetic contribution to bradycardia induced by 
endurance training in man." Cardiovascular Research 19(10): 642-648. 
Maciel, B. C., L. Gallo, Jr., J. A. Marin Neto, E. C. Lima Filho and L. E. Martins 
(1986). "Autonomic nervous control of the heart rate during dynamic exercise in 
normal man." Clinical Science (London) 71(4): 457-460. 
Malfatto, G., M. Facchini, L. Sala, G. Branzi, R. Bragato and G. Leonetti (1998). 
"Effects of cardiac rehabilitation and beta-blocker therapy on heart rate variability 
after first acute myocardial infarction." American Journal of Cardiology 81(7): 834-
840. 
Malpas, S. C. and T. J. Maling (1990). "Heart-rate variability and cardiac autonomic 
function in diabetes." Diabetes 39( 1 0): 1177-1181. 
Martin, W. H., W. M. Kohrt, M. T. Malley, E. Korte and S. Stoltz (1990). "Exercise 
training enhances leg vasodilatory capacity in 65-year-old men and women." Journal 
of Applied Physiology 69(5): 1804-1809. 
Mazzuero, G., P. Lanfranchi, R. Colombo, P. Giannuzzi and A. Giordano (1992). 
"Long-term adaptation of 24-h heart rate variability after myocardial infarction. The 
EAMI Study Group. Exercise Training in Anterior Myocardial Infarction." Chest 
101(5 Suppl): 304S-308S. 
334 
Myslivecek, P. R., C. A. Brown and L. A. Wolfe (2002). "Effects of physical 
conditioning on cardiac autonomic function in healthy middle-aged women." 
Canadian Journal of Applied Physiology 27(1): 1-18. 
Nehler, M. R., M. M. McDermott, D. Treat-Jacobson, I. Chetter and J. G. 
Regensteiner (2003). "Functional outcomes and quality of life in peripheral arterial 
disease: current status." Vascular Medicine 8(2): 115-126. 
Noble, B. J., G. A. Borg, I. Jacobs, R. Ceci and P. Kaiser (1983). "A category-ratio 
perceived exertion scale: relationship to blood and muscle lactates and heat1 rate." 
Medicine and Science in Sports and Exercise 15(6): 523-528. 
Okita, K., H. Nishijima, K. Yonezawa, M. Ohtsubo, A. Hanada, T. Kohya, T. 
Murakami and A. Kitabatake (1998). "Skeletal muscle metabolism in maximal 
bicycle and treadmill exercise distinguished by using in vivo metabolic freeze 
method and phosphorus-31 magnetic resonance spectroscopy in normal men." 
American Journal of Cardiology 81(1): 106-109. 
Osterhues, H. H., M. Kochs and V. Hombach (1998). "Time-dependent changes of 
heart rate variability after percutaneous transluminal angioplasty." American Heart 
Journal 135(5 Pt 1): 755-761. 
Ozcan, M., H. Kudat, V. Akkaya, A. B. Sozen, S. Demirel and T. Tukek (1999). 
"Time-dependent changes of HRV after PTCA." American Heart Journal 137(2): 
375-376. 
Pardo, Y., C. N. Merz, I. Velasquez, M. Paul-Labrador, A. Agarwala and C. T. Peter 
(2000). "Exercise conditioning and heart rate variability: evidence of a threshold 
effect." Clinical Cardiology 23(8): 615-620. 
Perini, R., N. Fisher, A. Veicsteinas and D. R. Pendergast (2002). "Aerobic training 
and cardiovascular responses at rest and during exercise in older men and women." 
Medicine and Science in Sports and Exercise 34(4): 700-708. 
Regensteiner, J. G., M. E. Hargarten, R. B. Rutherford and W. R. Hiatt (1993). 
"Functional benefits of peripheral vascular bypass surgery for patients with 
intennittent claudication." Angiology 44(1): 1-10. 
Regensteiner, J. G. and W. R. Hiatt (1995). "Exercise rehabilitation for patients with 
peripheral arterial disease." Exercise and Sport Sciences Reviews 23: 1-24. 
Reiling, M. J. and D. R. Seals (1988). "Respiratory sinus arrhythmia and carotid 
baroreflex control of heart rate in endurance athletes and untrained controls." 
Clinical Physiology 8(5): 511-519. 
335 
Stahle, A., R. Nordlander and L. Bergfeldt (1999). "Aerobic group training improves 
exercise capacity and heart rate variability in elderly patients with a recent coronary 
event. A randomized controlled study." European Heart Journal 20(22): 1638-1646. 
Stewart, K. J., W. R. Hiatt, J. G. Regensteiner and A. T. Hirsch (2002). "Exercise 
training for claudication." New England Journal of Medicine 347(24): 1941-1951. 
Swain, D. P. and B. A. Franklin (2002). "Is there a threshold intensity for aerobic 
training in cardiac patients?" Medicine and Science in Sports and Exercise 34(7): 
1071-1075. 
Task Force (1996). "Heart rate variability: standards of measurement, physiological 
interpretation and clinical use. Task Force of the European Society of Cardiology 
and the North American Society of Pacing and Electrophysiology." Circulation 
93(5): 1043-1065. 
Tseng, C. D., T. L. Wang, J. L. Lin, K. L. Hsu, F. T. Chiang and Y. Z. Tseng (1996). 
"The cause-effect relationship of sympathovagal activity and the outcome of 
percutaneous trans luminal coronary angioplasty." Japanese Heart Journal 37(4): 
455-462. 
Warren, J. H., R. S. Jaffe, C. E. Wraa and C. L. Stebbins (1997). "Effect of 
autonomic blockade on power spectrum of heart rate variability during exercise." 
American Journal of Physiology 273(2 Pt 2): R495-502. 
Wennerblom, B., L. Lurje, J. Solem, H. Tygesen, M. Uden, R. Vahisalo and A. 
Hjalmarson (2000). "Reduced heart rate variability in ischemic heart disease is only 
partially caused by ischemia. An HRV study before and after PTCA." Cardiology 
94(3): 146-151. 
Womack, C. J., D. J. Sieminski, L. I. Katzel, A. Yataco and A. W. Gardner (1997). 
"Improved walking economy in patients with peripheral arterial occlusive disease." 
Medicine and Science in Sports and Exercise 29(10): 1286-1290. 
Zatina, M. A., H. D. Berkowitz, G. M. Gross, J. M. Maris and B. Chance (1986). 
"31P nuclear magnetic resonance spectroscopy: noninvasive biochemical analysis of 
the ischemic extremity." Journal of Vascular Surgery 3(3): 411-420. 
336 
CHAPTER 10. CHANGES IN RESTING HEART RATE VARIABILITY IN 
PATIENTS UNDERTAKING EIGHT WEEKS OF CARDIAC 
REHABILITATION. 
Abstract. 
Following myocardial infarction, alterations in the activity of the autonomic nervous 
system occur. These are characterised by a dominating sympathetic contribution to 
autonomic balance reflected in an overall reduction in heart rate variability (HRV). 
The aim of this study was therefore, to evaluate the effects of cardiac rehabilitation 
(CR) on autonomic function by heart rate variability. 
Thirty-eight patients (21 males and 17 females, mean age 56 ± 8 years) patients 
underwent 5 min, resting ECG recording at CR entry and exit assessments. ECG 
data were automatically filtered and a time series of normal to normal RR intervals 
created. The mean (NN) and the SD of normal to normal intervals (SDNN) were 
created. A fast Fourier transform was then applied to calculate the power spectral 
density of the NN intervals. Total spectral power (TP, 0.04 - 0.40 Hz) was divided 
according to recommended guidelines into the vagally mediated high (HF, 0.15 -
0.40 Hz) and the mixed, sympathetic and vagal low frequency components of the 
power spectrum (LF, 0.04 - 0.15 Hz). The ratio of these measures (LF:HF) was 
calculated as a measure of sympathovagal interaction. Values were log transformed 
and compared using repeated measures ANOVA, t-tests and analysis of covariance 
where appropriate. 
Global (SDNN) and spectral measures (LF, HF) were all increased following CR (P 
< 0.05) using both methods of statistical analysis. There was a trend toward 
increased NN interval but no change in LF:HF. 
HRV measures (SDNN, LF and HF) are risk factors for future cardiac event 
following myocardial infaction. In the present study, these measures of autonomic 
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modulation were all increased. An increase in HRV provides protection against 
cardiac alThythmia, demonstrating that CR is an effective therapeutic intervention. 
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10.1. Introduction. 
Following myocardial infarction (MI), alterations in the activity of the autonomic 
nervous system (ANS) occur, characterised by a dominating sympathetic 
contribution to autonomic balance. In post-MI patients, this is reflected by a 
reduction in overall heart rate variability (HRV), particularly in measures associated 
with vagal modulation (Bigger et at. 1992). There are substantial time and 
frequency domain data from 24-hour Holter measurements of HRV to describe the 
autonomic balance of post-MI patients. These data suggest that severe 
derangements are evident after a myocardial infarction (Bigger et at. 1992; Bigger et 
al. 1995). There is also evidence that, to a certain degree, these derangements 
recover spontaneously in the months following MI (Bigger et al. 1991). Despite this 
spontaneous recovery, values remain well below that of the normal population 
(Bigger et al. 1995). Perhaps more importantly, reduced 24-hour HRV values after 
MI are strong, independent predictors of future cardiac event and death (Malik et al. 
1989; Malik and Camm 1990; Bigger et al. 1991; Breithardt et at. 1995; Quintana et 
al. 1997; Klingenheben et al. 1998; Liu et al. 2003). Due to its association with 
poor prognosis, HRV has been proposed as a potential therapeutic target in 
numerous populations including post-MI patients (Routledge et al. 2002). 
In previous chapters, the effects of chronic exercise on HRV measures were 
discussed. Recent reviews on this topic have drawn the common conclusion that 
HRV may be increased following exercise training. Commonly, global increases in 
HRV are accompanied by a shift in sympathovagal balance toward increased vagal 
modulation at rest. 
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10.1.1. Post-myocardial infarction changes in HRV due to rehabilitation - a 
briefreview of the literature 
Data concerning changes in HRV measures in response to cardiovascular 
rehabilitation are relatively common. However, the majority of these HRV data 
have been generated from 24-hour, ambulatory ECG measurements. What follows 
is a brief review of the literature concerning the effect of post-MI CR on HRV. 
Unless otherwise stated, all data are drawn from 24-hour ambulatory ECG 
recordings. 
Mazzuero et al. (1992) found HRV values close to those reported for healthy 
subjects 4 - 6 weeks after anterior wall MI in n = 38 patients. Patients were 
randomised into exercise or control groups and retested six months later. An 
increase in standard deviation of normal-to-normal intervals (SDNN) and a shift 
toward resting sympathetic predominance (increased LF:HF ratio) were found. The 
effect sizes for the changes observed were small, and subjects showed heterogeneous 
responses. The authors concluded that spontaneous retum to baseline autonomic 
balance was probably responsible for changes and that any conclusions made on the 
basis of this study should be cautious. 
Leitch et al. (1997) found a short (6-week) exercise programme was effective in 
increasing exercise capacity but not HRV measures when only hospital-based 
participants (n = 26) were included in the statistical analysis. When home-based 
participants (n = 23) were included there were small but significant changes in 
global HRV, (SDNN). There were no differences between HRV changes in the 
home-based (control) subject group and the experimental group. These authors also 
conceded that these data may indicate a spontaneous return toward normal HRV 
values and suggested that as only subjects with uncomplicated MI were included, 
results from this study should not be generalised beyond this population. In an 
elderly COh0l1 on a residential rehabilitation programme, Stahle et al. (1999) found 
increased global 24-hour HRV (SDNN) due mainly to increased day-time variation. 
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Increases in long-term variation of HR, measured by the standard deviation of the 
means of all normal-to-nOlmal 5-min periods of measured time period (SDANN) 
suggest this may be due to increased ambulatory activity in this group. However, 
the authors fail to recognise this and suggest a significant increase in HRV due to 
their exercise intervention. The small effect sizes for SDNN (d = 0.32) and SDANN 
(d = 0.20) are the only two statistically significant differences from a total of 38 
longitudinal comparisons made. No statistical adjustment for multiple comparisons 
was made by the authors (e.g. Bonferroni), therefore any interpretation of these data 
should be made with extreme caution. 
Malfatto et al. (1998) combined exercise and f3-blocker therapy and found an 
additive effect compared with either therapy alone in reversing derangement of 
autonomic profile after first MI. These data showed a blunted sympathetic and 
increased parasympathetic profile in patients receiving f3-blockers four weeks after 
MI. Further increases and decreases in parasympathetic and sympathetic modulation 
respectively were found after 12 weeks, only in the subjects who also exercised. 
Those subjects receiving f3-blocker therapy alone showed no fmther improvements 
in autonomic profile. Unfortunately, no follow-up data on factors such as 
reinfarction or survival rates are available. Similarly, Pardo et al. (2000) found 
small but statistically significant increases in vagal modulation measured by high 
frequency power (HF) in patients after 12 weeks of rehabilitative exercise. No pre-
and post-test differences were found for any other HRV measures, although 
differences between changes in HRV measures were evident in a subgroup analysis 
based on patient gains in exercise capacity following rehabilitation. 
Tygesen et al. (2001) found increases in exercise capacity were related to global 
measures of HRV in patients following MI and coronary artery bypass grafting 
(CABG). Frequent training (6'd-1'wk-1) increased exercise capacity and HRV more 
than less frequent (2'd-1'wk-1) training. In the former condition, changes in HRV and 
exercise capacity remained evident a year after completion of training. La Rovere et 
al. (1992) found evidence of sympathetic overactivity in post-MI patients. After four 
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weeks of either hospital based training or no exercise neither group showed 
significant alterations in autonomic profile at rest. However, during passive tilt, the 
trained group showed enhanced parasympathetic withdrawal and sympathetic 
activation. The authors concluded that training had induced restoration of 
autonomic reactivity to near-normal values. 
Using an 8-week training period and short-term analysis of HRV, Duru et al. (2000) 
found exercise capacity and time domain measures of HRV were increased, but that 
spectral measures of HRV were unaffected. Control subjects showed a significant 
decrease in global HRV measures after 12 months. The authors concluded that a 
shift in sympathovagal balance toward sympathetic predominance was evident in the 
untrained group and that training had attenuated such a shift in the trained subjects. 
The present study and those cited above all recognise the potential confounding 
effects of cardioactive pharmacologic therapies. Most studies have measured HRV 
under 'normal' pharmacologic conditions. Under current guidelines, such 
pharmacotherapy usually includes /i-blockers, ACE inhibitors and other cardioactive 
drugs (Joliffe et al. 2001). Whereas it is realised that these drugs may affect HRV, it 
should also be recognised that ethical problems issues surrounding withholding 
recommended pharmacotherapy would preclude much research in this area. 
10.1.2. Chapter aims and justification. 
The main aim of this chapter is to determine whether short-term, resting measures of 
HRV can be improved by cardiac rehabilitation as offered in a British district 
general hospital. The results and conclusions of this study, will differ distinctly 
from those reviewed above due to several factors. 
10.1.2.1. Time to entry into cardiac rehabilitation. 
In the studies mentioned above, time to rehabilitation ranges from five days to 
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'within two months' (See Table 10-1). By making some simple assumptions such as 
'within second month' being approximately six weeks the mean time from event or 
surgery to baseline assessment is approximately 37 ± 11 days. 
Table 10-1 Reported time from myocardial infarction or surgery to baseline assessment for 
entry into cardiac rehabilitation. 
Reported Time Study Country of Study 
28 days La Rovere et al. (1992) Italy 
Within second month Mazzuero et ai. (1992) Italy 
5 -7 days Leitch et al. (1997) Australia 
1 month Malfatto et ai.(1998) Italy 
6 weeks Stahle et ai. (1999) Sweden 
14 -16 days Iellamo et ai.(2000) Italy 
36 (14) days Durn et ai. (2000) Sweden 
40 (22) days Pardo et ai. (2000) USA 
One month Tygesen et ai. {200 1) USA 
Four weeks. Lucini et al. (2002) USA 
Due to economic circumstance and limited resources, initial CR assessment is often 
longer than four weeks in the United Kingdom. Although this is in many ways 
problematic for both patients and staff, it does create a unique scientific perspective 
by which to examine the effects of CR on HRV after surgery or MI. In a landmark 
study (Bigger et ai. 1991) it was shown that in 24-hour HRV values of post-MI 
patients, initially only 33 - 50% of those recorded in healthy controls showed 
significant spontaneous recovery in the first three months following MI. There 
were, however, no further increases at either 6 or 12 months. From these findings it 
can be seen that the mean (± SD) study baseline assessment period in all but a few 
subjects in a single study (Iellamo et ai. 2000) lie well within this boundary. 
Therefore, it is of interest to the scientist and rehabilitation practitioner alike to 
detelmine whether HRV, an important risk factor for future cardiac events in this 
population can be further increased beyond the time scale of this known period of 
spontaneous autonomic recovery. 
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10.1.3. The importance of control groups and appropriate statistical 
analyses. 
The majority of the studies employ some form of control group who either undertake 
home based activity (Leitch et al. 1997) or no exercise (Dum et al. 2000). Where 
control groups have been used, a statistical issue is raised. The question of whether 
a mixed analysis (group x time) with post hoc comparisons is used or whether a 
simple comparison of ~HRV between experimental and control groups becomes 
important. For instance, Dum et al. claim to have used a 2 x 4 mixed analysis of 
variance (mixed ANOV A) to observe differences in HRV between an exercise group 
and controls (two groups) at baseline, one, two and 12 months (four time points.) 
They give no account of any proposed post hoc analyses. Results of this study are 
then strewn with P values relating to change in heart rate (P < 0.01), pNN50 (P < 
0.05) and SDNN (P = 0.06). No information as to how these values were created or 
to what type of inferential statistic they relate is given. There also seem to be 
disparities in the baseline HRV characteristics of the two groups, particularly in 
frequency domain measures. For instance, normalised low frequency power (LFnu) 
in the experimental group (20.0 ± 10.1) greatly exceeded that in the control group 
(14.2 ± 4.1). Similarly, LF:HF in the experimental group (2.7 ± 2.9) was much 
greater than that of controls (1.9 ± 2.0). It would be foolhardy to assume that subject 
baseline characteristics do not influence response to rehabilitation especially in light 
of published data that suggest this to be the case (Malfatto et al. 2000). Other 
examples of poor description of data analysis methods include stating simply that 
'Student's t-test were used' (Tygesen et al. 2001). This does not allow the reader to 
determine whether these were canied out between experimental and control group 
mean values pre- and post-rehabilitation or on change in measures. This study 
(Tygesen et al. 2001) also reports a very large number of individual comparisons 
with no mention or employment of a correction factor for alpha. 
Based on previous findings (Bigger et al. 1991), it is unlikely that any spontaneous 
autonomic recovery will occur in the present study. This makes the employment of a 
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control group less important. It is of interest to note that none of the studies cited 
thus far have been based in the United Kingdom. Ethical approval committees in the 
UK for example, would not permit the randomisation of cardiac rehabilitation 
patients into control groups (Tan et al. 2003) as is clearly allowed in Sweden and the 
United States. Therefore, in certain cases where a control group has not been used 
(Pardo et al. 2000; Tygesen et al. 2001) such actions may be justified on an ethical 
basis. Some studies have used opportunistic sampling methods for subject group 
allocation, whereby those patients who decline their place in the rehabilitation 
programme are used as controls (Lucini et al. 2002). Other studies use no control 
group (La Rovere et al. 1992; Pardo et al. 2000). Both these methods are 
problematic. The latter makes any conclusions regarding causative effects of 
rehabilitation on change in HRV difficult. The process of self-selection in the former 
method may lead to significant between-group differences at baseline. In the study 
of Lucini et al. (2002) for example, controls were significantly younger, heavier and 
had worse cholesterol profiles than the experimental groups. 
In other studies, control groups have been used which are clearly different to 
intervention groups on certain HRV characteristics at baseline. Authors have failed 
to provide any statistical tests of these differences on two occasions (Mazzuero et al. 
1992; Malfatto et al. 1998). Additionally, only one study has evaluated the strength 
of the relationship between baseline scores and ~HRV (Malfatto et al. 2000); this is 
also a recommended step in pre-/post-test designs with controls that differ at 
baseline (Altman 2003). 
It is of interest to note that in the single study in the literature which has carried out 
an independent test between ~HRV for an intervention group and a control group, 
no differences in the change of any HRV measures were found (Leitch et al. 1997). 
Within this study, changes in HRV were of comparable direction and magnitude to 
those reported as significant in other investigations using paired analyses, but 
concomitant increases in HRV measures in the control group negated these findings. 
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Due to ethical restrictions and the increased time to onset of rehabilitation, the 
methods for this chapter will apply a novel approach, using age matched controls 
from the vascular outpatient clinic with conditions which are not currently referred 
for rehabilitation. In this way, the ethical concern of withholding therapy known t 
efficacious is removed. Additionally, a reasonably well matched group of subjects 
can be used to monitor any time-dependent changes in HRV measures. With this 
approach, a statistical analysis similar to that employed by Leitch et at. will also 
used. 
10.1.3.1. Baseline resting HRV measures as indicators of adaptation to 
training. 
In addition to monitoring any changes in resting HRV due to rehabilitation in the CR 
group, a further aim of this chapter is to investigate the potential of certain HRV 
measures to predict responses to exercise training. 
Knowledge of a patient's autonomic profile at entry to CR may be of use for a 
number of reasons. As well as providing information regarding cardiac risk, certain 
measures of HRV may provide additional information regarding appropriate 
exercise prescription. Firstly, patients with evidence of preserved vagal modulation 
may have a lower likelihood of a cardiac event during exercise at any given absolute 
workload. On this basis, such patients may be encouraged to exercise at greater 
relative and absolute exercise intensities, dependent on initial exercise capacity. 
A further application of resting HRV measures, may be as an aid to exerCIse 
prescription and rehabilitation goal setting. Data from healthy subjects have shown 
that celiain measures ofHRV are predictive of training response (Boutcher and Stein 
1995; Hedelin et al. 2000; Hautala et al. 2003). Some similar data from patients 
with peripheral vascular disease are presented in the previous chapter. 
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Boutcher and Stein (1995) studied the effect of exercise training on heart rate 
variability (HRV) and improvements in peak oxygen consumption (V02 peak) in 
sedentary middle-aged men. The HF power, absolute V02 peak and relative V02 peak 
of trained subjects (n = 19) and controls (n = 15) were assessed before and after a 
24-session training programme. Absolute and relative V02 peak increased (P < 0.005) 
for the training group (12% and 11% respectively); there were no changes in HF. 
This was despite a significant reduction in resting heati rate. However, when the 
trained subjects were divided according to high (n = 5) and low (n = 5) HF at 
baseline it was found that changes in V02 peak were significantly greater (P < 0.005) 
in the high HF group for both absolute (17%) and relative (20%) values. Changes 
in the low HF group were 6% and 1 % for these measures respectively. There were 
no group differences in mean age, pre-training V02 peak, or resting heart rate in the 
low and high HRV groups. The authors concluded that individual differences in 
baseline HRV could be associated with the response of V02 peak to aerobic training. 
This study demonstrated differences in training response in groups divided by HRV 
characteristics. However, no relationship between HRV and training response was 
demonstrated. Later studies examining the prognostic significance of HRV in 
relation to training response have, however, succeeded in demonstrating this. 
In the first of two studies from the same laboratory, Hedelin et al. (2001) studied a 
mixed (eight females and nine males) group of elite cross-country skiers during their 
normal training regimen. The start and end points of the data collection protocol 
were in the off-season and just prior to the start of competition respectively. Heati 
rate variability was measured using RR intervals derived from short-term 5-min 
measured in the supine position and during tilt a maneouver. Central performance 
( V02 max) and peripheral performance (peak isokinetic torque and time to peak 
torque) were used as indicators of training effect. The main methodological 
weakness with this type of opportunistic research is a lack of control concerning the 
independent variables involved. Specifically, training differed considerably between 
subjects in terms of type, intensity duration and volume. This resulted in some 
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subjects showing significant gains in central and peripheral performance while 
others showed no change or a decline inferring a negative training effect. When 
subjects were divided according to whether increases or decreases in V02 max had 
occurred, the authors found significant differences in baseline HF between groups. 
Specifically, those subjects with higher levels of HF at baseline demonstrated 
significantly (P < 0.05) greater increases in V02 max' Power in the HF band was 
unrelated to improvements in peripheral (strength) performance. However, resting 
LF power (ms2) measured at baseline was negatively related to change in maximal 
lactate accumulation. Response of LFnu to tilt (i1LFnu) was negatively related to 
improvements in peak torque and time to peak torque measured isokinetically. That 
is, performance in subjects highly reactive to orthostatic challenge (large 
sympathetic response to tilt) either became worse or improved less than those 
subjects with a small response. 
Unfortunately, this study has a weakness not addressed by the authors. A wide 
range of vales for HF, LFnu and i1LFnu were found at baseline and training response 
was heterogeneous. The subjects used were elite athletes and it seems likely that 
some subjects may have been overtrained or at least overreached at baseline. These 
conditions are associated with increased sympathetic predominance, which is known 
to manifest itself as a reduced variability in heart period, particularly those 
oscillations in the HF spectral band (Blaber et al. 1996; Scalvini et al. 1998; 
Uusitalo et al. 2000; Bosquet et al. 2003). Additionally, subjects who demonstrate 
cardiac sympathetic predominance at rest typically show reduced reactivity to 
orthostatic challenges (Blaber et at. 1996; Scalvini et al. 1998; Mourot et al. 2004). 
If those subjects who decreased their performance due to training were approaching 
or within a state of oveliraining they would display low i1LF. Healthy subjects 
would show a more favourable autonomic profile and be able to train in a manner 
that elicited increases in central and peripheral perfOlmance. Overtrained subjects 
would also be unlikely to show improvements due to training and more likely to 
show decrements in performance as indeed around half the subjects in this study did. 
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Hautala et al. (2003) trained previously sedentary males six days a week at an 
intensity of 70-80% V02 peak for 8 weeks and found that those subjects with higher 
levels of HF power at baseline demonstrated greater increases in V02 peak. The 
correlation was strongest between night-time HF and runtime (r = 0.52), 24-hour HF 
and daytime HF also con'elated significantly. Increases in performance were 
negatively associated with subject age (r = -0.48) and when this was controlled for, a 
significant relationship between increased run time and nocturnal measures of HF 
existed. The authors concluded that baseline cardiovascular autonomic function is 
an important indicator of improvement in aerobic performance due to training. 
Maximal oxygen consumption, age and HF were unrelated at rest, implying that HF 
power (especially when measured at rest) may be a true independent predictor of 
adaptation to training. 
10.1.3.2. The application of findings to clinical populations. 
The data given above relate only to healthy subjects and the generalisation of such 
findings to clinical populations requires caution. There are, however, data to suggest 
a link between baseline autonomic function and training response of the autonomic 
nervous system in post-MI patients (Carunchio et al. 2000; Malfatto et al. 2000). 
Carunchio et al. (2000) studied 122 patients undergoing 8 weeks of cardiac 
rehabilitation following MI. Of these patients, 58 were randomised into an exercise 
group, the remainder made up a group of control subjects. All subjects underwent 
24-hour monitoring at baseline. Of the exercise group, analysable data were 
available in 30 subjects after eight weeks of training It was found that pNN50, HF 
and LF:HF ratio were all favourably altered following rehabilitation, indicating 
increased cardiac vagal modulation. A positive correlation (r = 0.48) was found 
between LF:HF ratio at baseline and change in this measure after rehabilitation. 
This was found to be independent of ejection fraction, changes in creatine 
phospokinase and location of infarction. These authors concluded that 
sympathovagal balance at baseline may act as an indicator of adaptability of 
autonomic function in this population. Malfatto et at. (2000) also found a 
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significant, positive relationship between baseline LF:HF and ~LF:HF due to 
rehabilitation. 
To summarise, it seems that in healthy populations, high levels of vagal modulation 
(measured by HF) may indicate increased trainability in terms of exercise 
performance and physiological adaptation to training. In post-MI patients, higher 
vagal modulation (LF:HF ratio) may indicate an even greater potential for the 
autonomic nervous system to adapt. 
10.1.4. Hypotheses and structure of consequent sections. 
The results, and consequent discussion of findings within this chapter will therefore, 
be divided into three distinct parts to investigate three distinct hypotheses. 
i. Longitudinal data will be used to test the hypothesis 'Eight weeks of cardiac 
rehabilitation can favourably increase measures ofHRV.' 
11. Baseline measures will be used to test the hypothesis 'High frequency 
spectral power can independently predict improvements in shuttle-walking 
test performance.' 
iii. Longitudinal data will be used to test the hypothesis: 'LF:HF ratio predicts 
changes in autonomic balance as measured by change in LF:HF.' 
10.2. Methods. 
Subject sample size was estimated based on the results of previous studies and from 
effect sizes calculated in a small meta-analysis. A methodological description of the 
meta-analysis approach used can be found in Chapter eight and the analysis itself 
can be found in appendix four. 
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10.2.1. Subjects. 
Subjects were 21 males and 17 female patients refelTed for CR at the Hillingdon 
hospital between September 2003 - January 2005. Patients were recruited by 
including an infOlmation sheet and written consent form in the invitation to CR sent 
to all patients. All procedures were approved by the local research ethics committee 
and conformed to the guideline presented in the declaration of Helsinki (World 
Medical Association) for research with human subjects. Criteria for exclusion were 
coexisting valvular disease, contra indications to exercise such as frequent atrial or 
ventricular premature beats, orthopaedic limitations that prevented exercise testing 
and any other serious post-operative complaints or illnesses. 
10.2.1.1. Control group. 
Twenty-three control subjects were recruited from the vascular outpatient clinic at 
the same hospital. The descriptive characteristics of this group can be found in table 
10-2. All patients had a history of cardiac disease of ischaemic origin. The mean 
ages of the two patient groups were matched, but no attempt to match for disease 
aetiology was made. Heart rate variability analysis was carried out in a similar 
manner in both groups, although the controls did not attend a cardiac rehabilitation 
assessment or complete the shuttle-walking test. 
10.2.2. Protocol. 
All initial measurements were made during the entry consultation to CR. Patients 
completed the standard hospital anxiety and depression inventory (HAD). This was 
followed by a brief interview with the specialist cardiac rehabilitation Sister. During 
this time details on family history, activity levels, and general lifestyle and quality of 
life values were assessed. 
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Patients were then fitted with a Pola?M S810 hea11 rate monitor (Polar Electro OY, 
Kempele, Finland) and if a significant number of premature atrial or ventricular 
beats were expected based on their assessment; a Cardionetics Holter monitor was 
also fitted. Patients then laid supine on a plinth with head supported on a pillow and 
were instructed to lay quietly. After two minutes of relaxation the RR interval 
recording began and continued for five minutes. Respiratory rate was not controlled 
during the measurement. After five minutes patients were asked to stand slowly, 
they were then given oral instructions regarding the completion of the modified 
shuttle-walking test. This activity took approximately four minutes, in this time RR 
interval data were recorded continuously. 
10.2.2.1. Modified shuttle-walking test procedure. 
Subjects walked on a gymnasium floor between two cones, ten metres apart in time 
to an audible beep on a tape recorder. Subjects were instructed to keep up with the 
pace but not to exceed it. The test started at a speed of 0.5 m.sec- I , at which the 
subject completed three shuttles per minute, the speed of walking was then increased 
so that an extra shuttle was completed during the same time period during each 
subsequent stage to maximum velocity of 2.4 m·sec- I . Exercise was telminated 
when the subject reached volitional exhaustion, a hea11 rate within 10% of estimated 
HR max (220-age) or when they failed to maintain a pace sufficient to reach the 
cone in time on three successive occasions. 
Following test termination patient, the walked two further shuttles at a self-selected 
pace and then sat down. Blood pressure was taken while seated and the patient was 
instructed to relax and breathe normally. Patients remained seated until heart rate 
had returned to within ten beats of their pre-exercise value. 
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10.2.2.2. Measurements of heart rate response. 
Patient heart rate was recorded at the end of each stage of the test. Heart rate 
recovery was recorded as the difference between maximal exercise heart rate and 
that recorded at I-min after exercise cessation. The changes in hemt rate in the first 
minute after the subject assumed the seated position were also recorded. 
10.2.2.3. Measurements of heart rate variability. 
Heart rate variability measures were derived from the 5-min of stationary EeG 
obtained at rest using the Polar monitor, in accordance with cunent 
recommendations (Taskforce 1996). 
The Polar Precision Performance SW 3.02 software (Polar Electro OY, Kempele, 
Finland), contains an automatic, RR interval filtering and interpolation algorithm. 
Prior to extraction of any segments the entire time series was enol' conected using a 
medium filter power and minimum beat protection zone of 6 BPM. The 
interpolation of beats via this method has only minor effects on spectral measures of 
HRV measured from stationary tachograms (Jurca et al. 2004) in which <15% of 
beats are rejected. Further technical details of the beat filtering and interpolation 
algorithms have been presented previously (Huikuri et al. 1992; Huikuri et al. 1996). 
After filtering all RR interval time series were stored as .txt files on the hard drive of 
a password protected computer for later analysis. 
10.2.2.4. Heart rate variability analysis. 
Filtered RR interval data were impOlted into the Software for advanced HRV 
analysis (Universtiy of Kuopio, Finland). This software has been developed in 
accordance with published recommendations (Taskforce 1996) and the findings of 
two validation studies using RR interval data collected using a Polar S810 or 
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analogous model (Ruha et at. 1997) and consequently analysed by the programme 
have been published (Niskanen et at. 2004). 
Within the HRV analysis software, the filtered data were detrended using the 
smoothness priors method (Gersh 1991), which behaves like a time varying finite 
impulse response high-pass filter. It is easy to apply to different occasions as it only 
has a single adjustable parameter. 
Using the smoothness priors method to detrend the time series obtained during short-
term measurements ofHRV effectively removes the large very low frequency (VLF) 
spectral component derived by the fast Fourier Transformation method of obtaining 
a power spectrum. Although this method of detrending removes the VLF 
component, power within the frequency bands of interest (LF and HF) remains 
largely unaffected (Niskanen et at. 2004). Using this method it is possible to obtain 
comparable measures of LF and HF power under a number of different physiological 
conditions (supine, standing and exercise) and to compare the absolute, and relative 
distributions of spectral power within these bandwidths. 
10.2.3. 
10.2.3.1. 
Heart rate variability measurements and statistical analysis for each 
comparison. 
Changes in autonomic function due to cardiac rehabilitation. 
To compare resting pre- and post-CR measurements taken from the 5-min, stationary 
tachogram recorded in the supine position, SDNN and RMSSD were calculated in 
the time domain. In the frequency domain, low frequency power (LF, 0.04-0.15 
Hz), high frequency power (HF, 0.15-0.40 Hz), were measured in both in raw and 
normalised units (HFnu and LFnu). Additionally the LF:HF ratio was calculated 
and used as a measure of sympathovagal balance (Pagani et al. 1986). Statistical 
analysis was only carried out on: LF, HF and LF:HF ratio in the frequency domain, 
SDNN, and rMSSD in the time domain. These measures have been investigated 
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previously in healthy and clinical populations and are relatively well defined. 
Making a priori selections of measures for analysis reduces the total number of 
comparisons made. This avoids problems similar to those mentioned in relation to 
previous studies (Stahle et al. 1999). Data were first transformed, if necessary, to 
allow parametric analysis. Effectiveness of the CR programmeme on HRV measures 
was assessed by an independent t-test of pre- and post-test differences between the 
experimental and control groups. In the case of significant differences between the 
CT and the CR group in HRV measures at baseline, initial HRV values were 
controlled for using analysis of covariance (ANCOVA). The assumptions of 
homogeneity of variances and homogeneity of regression were both checked prior to 
the use of this test. 
10.2.3.2. High frequency spectral power as a predictor of change in shuttle 
walking test performance. 
Baseline high frequency spectral power (HF) was derived from the five minute 
tachogram, as described above and natural logarithms of this measure were taken to 
give HF(ln). The relationship between HF(ln) and change in shuttle-walking test 
performance measured as a percentage (6SWT%) and measured in metres 
(6SWTm) were assessed using a Pearson's product moment correlation coefficient. 
Other potential predictors were also assessed by correlation analysis. Those 
showing significant or close-to significant relationships with 6SWTm were entered 
into a stepwise regression analysis. 
10.2.3.3. The LF:HF ratio as a predictor of ANS adaptation. 
The relationship between initial vales of autonomic balance and changes in these 
values was assessed similarly to that described above but using initial LF:HF and 
6LF:HF. This analysis was performed only on data from the experimental group. 
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10.3. Results. 
10.3.1. Patient baseline descriptive characteristics. 
Table 10-2 shows the baseline descriptive characteristics of the cardiac rehabilitation 
(CR) and the control (CT) groups. The two groups were broadly similar in terms of 
age and sex distributions and were of similar weights. The CT group contained a 
lower proportion of diabetics than the CR group and as expected, the disease states 
and reasons for attending the outpatients clinic or rehabilitation programme were 
dissimilar between the groups. Reasons for not using a more exactly matched 
control group and the possible bearing this may have had on results of this study will 
be discussed later. 
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Table 10-2 Descriptive characteristics of cardiac rehabilitation and control group subjects at 
baseline. 
(Age years) 
Sex 
Mass (kg) 
Diabetic 
Disease state or reason for 
CR(%) 
Time from procedure or 
event (weeks) 
Time to retest (weeks) 
Cardiac Rehabilitation Control Group 
Group (n = 38) (n = 23) 
65.6 (11.6) 
Males 
21 (57%) 
Females 
17 (43%) 
83.5 (20.2) 
Yes 
n = 6 (17%) 
No 
N = 30 (83%) 
MI 
n = 17 (47%) 
Surgical procedure 
n = 19 (53%) 
MI and no procedure 
n = 11 (31%) 
MI with procedure 
n = 6 (16%) 
16.5 (11.3) 
9.8 (1.9) 
64.9 (9.0) 
Males 
14 (61%) 
Females 
9 (39%) 
78.7 (20) 
Yes 
n = 1 (4%) 
No 
n = 22 (96%) 
Ischaemic cardiovascular 
disease 
n = 23 (100%) 
Previous MI (> 1 year) 
n = 2 (8%) 
Previous cardiac surgical 
procedure (>1 year) 
N=7(31%) 
N/A 
10.2 (3.8) 
I3-Blockers Yes n = Yes 
23 (64%) 18 (64%) 
No No 
13 (36%) n = 5 (36%) 
Statin Yes 6 Yes 
30 (83%) n = 14 (61%) 
No No 
6 (17%) n = 9 (39%) 
Calcium channel antagonist Yes Yes 
n = 17 (45%) n = 6 (26%) 
No No 
n = 19 (55%) n = 17 (74%) 
Aspirin Yes Yes 
n = 29 (83%) n = 12 (52%) 
No No 
n = 6 (17%) n = 11 (48%) 
Other Yes Yes 
n = 6 (17%) n = 15 (64%) 
No No 
n = 29 (83%) n = 8 (36%) 
All values are mean (± SD) for continuous measures and number of cases (percent) for categorical 
measures. 
Table 10-3 shows changes in the standard physiological and psychological 
measurements taken at entry into the cardiac rehabilitation programmeme (risk 
analysis) and again at each patient's exit assessment. There were statistically 
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significant increases in 10m shuttle-walking test performance and maximal exercise 
heart rate (P < 0.05), but not heat1 rate recovery. Other physiological variables such 
as blood pressure and subject mass also remained unchanged. Both measured 
psychological parameters (Anxiety and Depression) were significantly reduced post-
rehabilitation. 
Table 10-3 Physiological and psychological effects of cardiac rehabilitation. 
Pre-rehabilitation Post- Significance. 
rehabilitation. 
Shuttle test score (m) 488 ± 214 597 ± 235 P = 0.001 
Maximal heart rate (bpm) 119±21 128 ± 27 P = 0.037 
Heart rate recovery (bpm) 24.2 ± 12 30.0 ± 24 P = 0.148 
SBP (mm/hg) 133 ± 19 134 ± 19 P = 0.808 
DBP (mm/hg) 76 ± 7 78 ± 12 P = 0.309 
Weight (kg) 83.5 ± 20 83 ± 20 P = 0.251 
Anxiety 6.5 ± 3.9 4.6 ± 3.8 P = 0.001 
Depression 5.6 ± 2.4 4.4 ± 3.5 P = 0.019 
SBP - Systolic blood pressure, DBP - diastolic blood pressure, Anxiety and Deptression are in 
arbitrary units measured by the hospital anxiety and depression inventory (HAD). 
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Table 10-4 Change in HRV measures of heart rate variability for cardiac rehabilitation and control groups. 
HRV 
Measure 
LF (In) 
HF (In) 
LF:HF 
SDNN (ms) 
RMSSD 
(ms) 
RR (ms) 
L1HRV CR. 
Mean (C.I.) 
0.586* (0.264 - 0.908) 
0.464 (0.137 - 0.790) 
-0.102* (-0.282 - 0.007) 
6.785* (2.831 -10.73) 
7.035 (3.319 -10.75) 
52.46* (17.97 - 87.05) 
F -value for 
L1HRV CT. 
ANOVAor 
Mean (C.I.) 
ANCOVAt 
-0.140 (-0.577 - 0.296) 6.433t 
0.054 (-0.485 - 0.381) 3.388 
0.121 (-0.116 - 0.358) 2.225t 
-1.853 (-0.723 - 3.516) 4.698t 
-0.210 (-5.143 -4.724) 4.656 
52.46 (-100.9 -7.074) 12.48t 
P-value for 
ANOVAor 
ANCOVAt 
0.014t 
0.071 
0.142t 
0.015t 
0.035 
0.001t 
* Indicates use of mean and C.1. adjusted for baseline values. t Indicates use of ANCOV A to adjust for baseline values. 
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Significance of 
baseline 
measure as 
covariate 
0.001 
0.189 
0.001 
0.035 
0.344 
0.001 
10.3.2. Change in heart rate variability measures due to cardiac rehabilitation. 
Table 10-4 shows the change in all HR and HRV measures over time in the CR and CT 
groups. Due to known associations between baseline HRV measurements and 
alterations, where appropriate, the baseline measure has been used as a covariate to 
control for its possible confounding effects. Where no relationship (P > 0.05 for 
ANCOVA covariate value) was found, ANOVA between .6.HRV measures was 
performed (HF and RMSSD). All other measures (LF, LF:HF, SDNN, RR) were 
analysed by ANCOV A. 
All HRV measures displayed favourable shifts in their values in the CR group and none 
were evident in the CT group. The differences between change in HRV measures in CR 
was statistically significant for LF, SDNN, RMSSD and RR interval, changes in HF and 
LF:HF were not significantly greater in CR than in CT. 
With the exception of LF:HF, the confidence intervals for .6.HRV in the CR group 
showed a relative homogeneity of response to the intervention. All c.1. s are positive for 
the remaining measures. In contrast the C.1. s for the CT group were much larger and 
contained both positive and negative values for .6.HRV. 
10.3.3. High frequency power as a predictor of change in shuttle walking test 
pelformance. 
To determine the capacity of HF(ln) to predict change in walking, Pearson's product 
moment correlation coefficients for baseline physiological variables and .6.SWT were 
calculated. In this instance .6.SWT was defined as the % change in total walking 
distance shown by each patient (.6.SWT%). Due to a significant positive skew these data 
were logarithmically transformed prior to analysis in keeping with the assumptions 
underlying the use of Pearson's correlation (In.6.SWT%). Several measures were found 
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to be associated with In~SWT%, including: baseline SWT performance, subject weight, 
subject sex, use of ~-blocker therapy, presence of diabetes, InHF, LF:HF, SDNN and 
RR interval. When these measures were entered into a stepwise regression analysis 
HF(1n) was found to be the only independent predictor of In~SWT% (See Equation 10-1 
and Table 10-5). 
In~SWT% 0.4141nHF + 1.498 Equation 10-1 
Table 10-5 Summary of stepwise multiple regression analysis for In~SWT%. 
In~SWT% 
B R2 p 
HF(1n) 0.463 0.215 0.017 
To ascertain the robustness of the predictive capacity of HFln, the regression analysis 
was repeated, this time using the logarithm of change in shuttle test performance in 
metres (1n~SWTm). Repeating the process described above resulted in the identification 
of three significant predictor measures (See equation 10-2 and table 10-6) 
In~SWTm = 0.874Sex + 0.372lnHF + 0.0137Mass Equation 10-2 
Table 10-6 Summary of stepwise multiple regression analysis for In~SWTm. 
Sex 
InHF 
Weight 
In~SWTm 
fJ 
0.530 
0.438 
-0.368 
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R2 
0.224 
0.453 
0.585 
p 
0.015 
0.005 
0.001 
10.3.4. Low to high frequency power ratio as predictor of change in heart rate 
variability. 
Pearson's product moment correlation between baseline LF:HF ratio and the change in 
the measured over the course of rehabilitation revealed that these measures were 
unrelated in the CR group (r = 0.009, P = 0.985) 
10.3.5. Paired group analysis. 
For reasons of comparability, the secondary analysis of pre- and post-test HRV data was 
carried out using the statistical analyses more commonly reported in the literature 
(paired t-test, CR and CT groups). First, no changes between any pre- and post-test 
HRV measures were evident in the CT group (P> 0.05). In comparison, analysis of the 
CR group data, paired t-tests revealed significantly (P < 0.05) increased: LF(ln) and 
HF(ln) in the frequency domain and SDNN and rMSSD in the time domain. Only the 
LF:HF ratio remained unchanged from test to retest. 
10.3.6. Pre- and post-test analysis by patient subgroup. 
The final analysis was a subgroup analysis between groups based on reason for 
attending CR. The first group split was into patients who had/had not had an MI, 
regardless of any surgical intervention, elective or otherwise. Independent t-tests 
revealed that the MI group (n = 18) and the non-MI group (n = 20) did not differ on any 
HRV measure at baseline nor was there any difference in the changes of any HRV 
measure (L\HRV) between groups from pre- to post-test. 
Dividing the patients into groups according to whether any revascularising surgery had 
been received, regardless of the occurrence of a previous MI showed that LF:HF was 
significantly higher at baseline in the patients who had undergone a surgical procedure 
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compared with the those who had not (LF:HF = 0.274 vs 0.981, t = 3.09, P = 0.004). 
This difference remained statistically significant when controlling for the presence or 
absence or previous MI (P = 0.014). There were, however, no differences in ~LF:HF 
between these groups regardless of whether, previous MI, and/or baseline LF:HF were 
controlled for. 
10.4. Discussion. 
The findings of this chapter will be subdivided into discreet sections and addressed with 
reference to previous data separately. Within each section, the unique nature of each 
finding and the methodology used to elicit it will be briefly reviewed and justified. 
Lastly, each section will contain a brief conclusion and recommendations for future 
possible empirical research related to the findings presented. 
10.4.1. Changes in routinely assessed riskfactors due to cardiac rehabilitation. 
Analysing the effectiveness of the CR was not the primary aim of this study. However, 
to ensure comparability with previous data, it is necessary to ascertain whether the CR 
programmeme has had similar effects on its patients to those expected and previously 
repOlted. Of those most commonly reported, which were recorded in the present study 
four were chosen for analysis here: exercise capacity, percentage improvement and 
improvement in metres walked on the 10-m shuttle walking test, heart rate recovery, and 
the psychological measures of anxiety and depression. These factors were only 
measured in the CR group and analysis of differences between pre- and post-
rehabilitation measures showed significant improvements in all scores. This 
demonstrates change in these measures over the course of the present CR programme. 
However, as these measures were not made in the control group the degree to which the 
CR programme is responsible for these changes cannot be assessed. It is difficult 
therefore to provide a quantitative assessment of the effictiveness of the CR programme 
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in reducing these risk factors and fulfilling the criteria for outcomes set nationally 
(Jolliffe et al. 2000). 
10.4.2. Changes in resting heart rate variability. 
The primary aim of the present study was to determine whether cardiac rehabilitation 
was able to significantly, positively modify autonomic function measured by sholt-term 
HRV. The present data show significant changes in numerous HRV measures made at 
rest and for simplicity, these will be addressed separately. 
10.4.2.1. Changes in spectral measures. 
High frequency spectral power (HF) is modulated almost uniquely by the action of the 
vagus on the SA node (Taskforce 1996). Increased HF, demonstrating increased vagal 
modulation of heatt rate, is commonly observed in conjunction with bradycardia 
following exercise training (chapter eight). It has previously been suggested that this 
may be a beneficial response to exercise training (Davy et ai. 1996; Davy et at. 1997) 
and has even been described as 'a non-pharmacolgical, antialThythmic intervention' 
(Billman 2002). Animal data support this description by showing a significantly 
reduced OCCUlTence of fibrillation in exercise trained dogs with higher vagal modulation 
evidenced by higher HF (Billman et al. 1984). 
In the present study HF(ln) increased by about 10% in the CR group. Although this 
change was not statistically significant when compared to changes in the CT group, this 
was due mainly to a wide distribution of scores in the latter. When analysed by the 
more commonly used method of paired t-test, HF(1n) showed a significant increase over 
the course of rehabilitation programmeme in the CR group. Previous studies using 24-
hour ambulatory recordings have failed to show any such change in HF (Leitch et at. 
1997; Stahle et al. 1999; Tygesen et al. 2001). However, the lack of control afforded by 
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this method of HRV analysis may be a confounding factor. Using short-term data 
collection techniques and controlled conditions as simple as lying supine in a quiet 
room, will give a better indication of HF power. Under such resting conditions HF will 
be optimised and may be easier to study. 
It can be argued that taking one 5-min measure of RR intervals under standardised, 
controlled condition gives a more accurate picture of autonomic control in that condition 
than the average of 480 separate 5-min epochs recorded under many different 
physiological conditions. Oddly, no studies which have used short-term analysis of 
HRV have attempted to demonstrate an increase in HF following CR and have instead 
relied on the use of normalised units. (La Rovere et al. 1992; Duru et al. 2000; Malfatto 
et al. 2001; Lucini et al. 2002). This is a phenomenon worth mentioning as HF power 
(expressed as both logarithmic (In) and raw (ms2) units) is known to be a predictor of 
future cardiac risk in this population, whereas HFnu has not been assessed. The 
information provided by HFnu also duplicates to some degree that given by reporting 
the LF:HF ratio, which is common in all of the above studies. With no quantitative pre-
and post-cardiac rehabilitation data to compare with the present values, the present study 
is unique in this finding using short-term HRV data collection. The effects of 
rehabilitation on HF must, therefore, be assessed in terms of impact on future risk. Low 
HF power is a known risk factor when derived from 24-hour ambulatory measures 
(Bigger et al. 1992; Bigger et al. 1993; Lanza et al. 1998) and short-term measures of 
HF (Bigger et al. 1993). Positive predictive accuracy for all cause mortality and sudden 
cardiac death similar to other HRV measures such as VLF, LF, and LF:HF has been 
demonstrated, although data are limited (Bigger et al. 1993; Faber et al. 1996). Bigger et 
al. (1993) found that post-MI patients with HF < 20 ms2, derived from a 5-min resting 
ECG, were 1.9 times more likely to die (all causes) than those above this cut point. This 
risk was slightly higher for cardiac death (risk ratio = 2.3). Unfoliunately, operator-
receiver characteristics of the survival curves for HRV measures in this study were not 
calculated and values were instead, based upon previous research. This and the fact that 
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values were dichotomised and not continuous makes interpreting the findings of the 
present study difficult. It seems justifiable, however, to state that any increase in HF 
power due to cardiac rehabilitation is likely to decrease risk of mortality, particularly 
due to cardiac death. The magnitude of such an effect is difficult to establish due to the 
paucity of data concerning sh011-term HRV as a risk factor following MI. Faber et at. 
(1996) simply used short-term measures as a 'pre-screening' tool for 24-hour 
recordings. This provided greater sensitivity in the latter but again makes it impossible 
to quantify the real usefulness of shol1-term measures in risk stratification. 
In the present study, changes in low frequency spectral power were greater in the CR 
group compared with the CT group. These values also increased in the CR group when 
compared with their own baseline measures. Again, LF in raw units has not been 
specifically investigated previously by authors using short-term recording methods. 
This is probably due to the lack of knowledge concerning the exact physiological 
meaning of LF oscillations at rest, although the reflection of Meyer waves (oscillations 
in blood pressure) has been put forward. However, LF is more commonly expressed in 
the literature in normalised units (nu). Due to its rise in response to orthostatic and 
pharmacological sympathetic stressors, it is a well established measure of sympathetic 
activation (Pagani et at. 1986). Due to the association of LFnu with sympathetic 
modulation of HR, a reduction in LF has become a proposed therapeutic target and a 
commonly hypothesised, beneficial effect of exercise training in post-MI patients (La 
Rovere et at. 1992; Malfatto et at. 1998). Both these authors demonstrated significant 
decreased in LFnu during CR. Malfatto et al. also showed an additive effect of p-
blocker therapy and exercise training on reducing LFnu. Again, in the present study 
LFnu was not assessed as it, and it's inversely related measure HFnu, are more easily 
represented and interpreted when given as the LF:HF ratio. This value is usually 
provided as a measure of sympathovagal interaction and balance, although the semantics 
and physiological underpinnings of any such phenomena as sympathovagal balance are 
debatable (Goldberger 1999). 
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Despite the lack of research into LF power using short-term HRV recordings, it is also a 
known risk factor for future cardiac event in a number of pathologies such as heali 
failure (La Rovere et al. 2003) and again, following MI (Bigger et ai. 1993). The data in 
these risk stratification studies suffer the same shortcomings described in terms of HF 
power. Only one study has provided evidence that low LF « 35 ms2) derived from 
short-term recordings is associated with increased risks or all cause mortality with (RR 
= 2.8) and cardiac death (RR = 3.0). Again, therefore, only a general statement that 
increased LF power in raw units (ms2) is a likely beneficial effect of rehabilitation in 
reducing risk can be made. It can also be stated however, that the risk ratios for LF are 
greater than those for HF. One ambulatory study has shown no significant differences in 
HF power between surviving and non-surviving post-MI patients despite large 
statistically significant differences in LF (Quintana et ai. 1997). On this basis, it seems 
that increasing LF may be a more beneficial therapeutic target for CR. 
Previous data regarding the ability of CR to alter LF show no significant effects of 
therapeutic exercise on this measure. Using 24-hour ambulatory recordings, Mazzuero 
et al. (1992) found no discemable change in LF (ms2) from test to retest. Pardo et ai. 
(2000) found a mean change of 0.4 log units for LF over the course of CR, but this 
failed to reach statistical significance. Niether of these studies utilised a control group. 
Leicht et ai. (1997) compared ~LF(ln) in controls and CR patients but found no 
difference. This was despite a mean 0.32 (± 0.18) log unit increase in the CR group. 
The lack of statistical significance may have been due to the relatively large (0.17 ± 0.13 
In) increase observed in the controls. In the present study the value of ~LF(ln) in the 
CR group was 0.59 log units, larger than both previous values and the change in the CT 
group was very small and actually negative (-0.14, C.l. -0.577 - 0.269). Statistically, it 
should be noted that the value given here was conected by ANCOV A to account for the 
influence of baseline LF(ln) values. Therefore, a combination of the larger subject 
numbers, due to a priori power calculations and the method of statistical analysis used, 
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may be responsible for this unique finding. Other factors related to the intervention and 
the HRV sampling methodology may also be at work here and these will be highlighted 
in the more general discussion of the study findings. 
The LF:HF ratio, a measure of sympathovagal balance, has repeatedly been shown to be 
a predictor of adverse outcome in post-MI patients (Bigger et al. 1993; Lanza et al. 
1998; Huikuri et al. 2000). However, somewhat counterintuitively, a high LF:HF ratio, 
which is indicative of predominant sympathetic modulation of the SA node has not been 
found to be a risk factor. Instead, increased risk of adverse event is associated with a 
lower LF:HF ratio. Optimal cut points of 1.6 (Bigger et al. 1993; Huikuri et al. 2000) 
and 0.95 (Bigger et al. 1993; Lanza et al. 1998) from 24-hour recordings have both 
demonstrated significant association with numerous adverse clinical endpoints. The fact 
that LF:HF ratio remained unchanged in the present study can therefore be seen as a 
positive outcome of CR. 
A point worthy of mention here is that in the data concerning exercise intervention in 
healthy subjects, there is a common conception that decreasing LF:HF (tipping the 
balance of SA node modulation toward vagal predominance) is a beneficial outcome. 
Cross-sectional comparisons show a lower LF:HF ratio in athletes compared with 
controls, (Bonaduce et al. 1998) described previously as a 'parasympathetic 
cardioprotective balance' (Gallagher et al. 1992). Additionally, longitudinal data have 
shown that exercise can decrease LF:HF ratio (Portier et al. 2001). 
This paradox walTants a brief explanation. It seems that in the general population, where 
there is significant power in both LF and HF bands (> 1 00 ms2), that a balance between 
the two is indicative of healthy autonomic control and therefore, desirable. In chronic 
sympathetic predominance at the SA node the overall oscillation in heart period is 
greatly reduced. This has been demonstrated experimentally in heart failure patients 
(van de Borne et al. 1997; Notarius et al. 1999). The predominant sympathetic 
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modulation heart period leads to reduced oscillations of nervous genesis, (in all 
frequency bands) but there is a slight preservation of HF oscillations due to other inputs 
such as mechanical stimuli. These are similar in nature to those observed in the 
denervated transplant hearts (Ordway et al. 1982; Smith et al. 1989; Bernardi et al. 
1990). 
This preservation of HF power, simultaneous with reductions in total and especially LF 
power produces a low LF:HF ratio. This is very similar to that reported in high intensity, 
rhythmic exercise (Perini et al. 1990; Casadei et al. 1995; Perini et al. 2000) and 
represents a parabolic relationship between level of sympathetic modulation and the 
LF:HF ratio. Such a relationship makes interpretation of this ratio and indeed 
normalised values for LF and HF very difficult in clinical populations with sympathetic 
overactivity problematic. 
Cardiac rehabilitation did not significantly increase subjects' LF:HF in the present 
study; the ratio instead, tended to decrease in the CR group and remain unchanged in 
controls. This can be explained by both the timing of the tests and to a degree, the 
conditions under which they were made. At rest, in the supine condition, vagal 
modulation of the SA node is the predominant influence on heart period. Therefore, any 
increase in vagal modulation, which manifests itself as HF oscillations will become 
obviated in this type of test compared with the mean HF power of all the 5-min periods 
in a 24-hour, ambulatory electrocardiogram. A further justification to support the 
beneficial role for decreased LF:HF ratio in this population is the test timing. The long 
duration from MI and/or surgery to entry into CR means that the acute phase of 
sympathetic ANS activation, which is well documented following MI (Bigger et al. 
1991; Bigger et al. 1992; Bigger et al. 1992; Bigger et al. 1995) would have occurred 
weeks and in some cases months prior to the test. This, coupled with the high 
percentage of patients receiving ~-blockade therapy which decreases sympathetic ANS 
activity and increases global and vagal HRV measures (Malfatto et at. 1998) means that 
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they are a somewhat different population from those studied previously. Any 
meaningful, comparison of LF:HF ratios in acute MI patients, MI patients months after 
their event and revascularised CAD patients is impossible. However, mean values for 
LF and indeed HF in the present study were higher than those gained from 5-min 
recordings previously (Bigger et al. 1993), indicating that the reversal of sympathetic 
activation which occurs spontaneously after MI may have already occurred in the 
present population. This fact and the lack of any change in the CT group means that any 
alterations in autonomic profile evidenced here by increased HRV are due to CR. The 
findings of this study are therefore, unique in this respect. 
It must be taken into account, however, that in the present study the subject group was a 
mixture ofpost-MI patients and patients who have had elective surgery (CABO, PTCA). 
The majority of previous studies have dealt exclusively with post-MI patients. Indeed 
many of the patients in the present study with previous MI had also received some fOlm 
of surgical intervention. It may be that CR offers more beneficial effects on the 
autonomic profile of patients who have undergone elective cardiac surgery than post-MI 
patients. The results of this post hoc, subgroup analysis will be discussed later. 
10.4.2.2. Changes in time domain indices ofHRV. 
The standard deviation of normal-to-normal intervals (SDNN) is the most widely 
investigated measure of HRV in post-MI patients, due probably to the simplicity of its 
calculation and the fact that valid measures can be obtained from both long and short-
term recordings (Taskforce 1996). 
A number of previous studies have shown increases in 24-hour SDNN due to CR 
(Mazzuero et al. 1992; Tygesen et al. 2001; Lucini et al. 2002) although the data are not 
entirely homogenous (Pardo et al. 2000; Lucini et al. 2002). Leitch et al. (1997) found a 
large (36 ± 6 ms) increase in SDNN from test to retest in their CR group. This change 
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was however, not significantly different from that of their control group (40 ± 9 ms). 
This is a clear illustration of the spontaneous recovery of HRV following MI first 
demonstrated by Bigger et at. (1991). Patients in the study of Leitch et at. were all 
investigated on days 5 - 7 following MI. The values obtained in this study can 
unfortunately not be compared with those of the present study due to the use of 24-hour 
Holter monitoring in the former. What the study of Leitch et at. clearly demonstrates, is 
the importance of using some sort of control group in such a study, particularly if 
patients are to be studied in the acute phase after MI. 
Using short-term data collection, Dum et at. (2000) found no statistically significant 
increase in SDNN during the training period. This was despite mean values increasing 
from 30 ± 25 at baseline to 36 ± 21 at one month and 45 ± 38 at two months. This 
represents a 50% mean increase but the SD values show a degree of heterogeneity in 
this response. Unfortunately, the parametric analysis used in this study (2 x 3 repeated 
measures ANOVA) may have been inappropriate due to these homogeneous variances 
and a type two error may have occurred. Notwithstanding this, the authors provide no 
details about which post hoc statistical comparisons were used, making it difficult to 
discern why such a large mean difference did not result in a statistically significant 
result. What can be discerned from these data however is an effect size of d = 0.48 
(Cohen 1988) which represents a moderate effect of rehabilitation on SDNN. 
In the present study, the CR group showed significantly greater improvements in SDNN 
than the CT group. Using a paired analysis, there was also a significant increase in 
SDNN in the CR group from baseline to post-CR. These data therefore agree with the 
majority of previous studies which have also reported either significant or moderate 
effect size changes in SDNN calculated from either short-term or ambulatory ECG 
measurements. 
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Perhaps more importantly, SDNN is also the most investigated HRV measure in terms 
ofpost-MI risk. Ambulatory data have repeatedly confirmed that SDNN is a significant 
risk factor for all cause mortality, (sudden) cardiac death and reinfarction in post-MI 
patients (Bigger et al. 1993; Faber et al. 1996; Fei et al. 1996; Reinhardt et al. 1996; 
1996; Zuanetti et at. 1996; La Rovere et al. 1998; Lanza et al. 1998; Poulsen et al. 2001; 
Liu et al. 2003). Data in disagreement with this supposition are rare (Huikuri et al. 
2000; Manfrini et al. 2003) and in one case at least (Manfrini et al. 2003) are almost 
cet1ainly due to the very small number of events recorded in the population studied. 
Of interest within this large cumulative data set are three studies which have used both 
24-hour and short-term measures of SDNN in risk analyses (Faber et al. 1996; Fei et al. 
1996; Reinhardt et al. 1996). 
Faber et al. (1996) used 5-min SDNN to pre-select patients for risk analysis by 24-hour 
HRV index (HRVi), a geometric ratio derived from the dimensions of a histogram of all 
RR intervals in an ambulatory tachogram. These authors found that prediction of all 
cause mortality, sudden cardiac death and arrhythmic death could be improved by 
systematically selecting patients with lower values for 5-min SDNN. These authors did 
not calculate relative risk scores for 5-min SDNN. However, they did calculate 
differences between patients with or without the above adverse events were larger for 5-
min recordings than for the entire 24-hour data strip. For ease of interpretation here, 
these differences have been transformed into effect sizes (d) (Cohen 1988). 
For two year overall mortality the effect size for 5-min SDNN was d = 0.91 whereas for 
24-hour HRVi it was d = 0.86. Differences between subjects suffering/not suffering 
cardiac death over the same period were almost identical between 5-min SDNN (d = 
0.69) and 24-hour HRVi (d = 0.70) as was the case in predicting 2-year arrhythmic 
death (5-min SDNN, d = 0.81 vs 24 - hour HRV, d = 0.82). These data show that 
SDNN derived from a simple 5-min recording is as sensitive a diagnostic tool as HRVi 
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derived from a 24-hour tachograms. These authors suggested that short-term 
measurement of SDNN may be a powerful screening tool when used to reduce the 
number of 'expensive and cumbersome' HRV measurements made. 
Reinhardt et al. (1996) directly compared the standard deviations of RR intervals 
recorded over a 5-min period with those recorded over a 24-hour. When comparing 
these values in patients with or without arrhythmic events over the follow up period, 24-
hour SDNN (and as reported by Faber et at., HRVi) did not differ between groups 
(effect size, d = 0.07). However, when the SD of intervals from a 5-min stationary ECG 
recording was analysed the effect size was larger (d = 0.63) and statistically significant 
(P = 0.02). Unfortunately, neither of these measures was a significant independent 
predictor of arrhythmic event in the multivariate analysis performed as another time 
domain variable (RMSSD) was a powerful predictor (see discussion of this measure 
below). Fei et at. (1996) quantified the relationship between 24-hour HRVi and 5-min 
SDNN and found only a moderate correlation coefficient (r = 0.51). In risk analysis, 5-
min SDNN was found to be a significant prognosticator of all cause mortality in 700 
post-MI patients. However, sensitivity and specificity of 24-hour HRVi were greater 
than 5-min SDNN. The authors concluded again that short-term recordings of SDNN 
could not replace 24-hour recordings but that they may be used as a pre-screening tool 
to improve cost effectiveness. 
One major problem with two studies (Faber et at. 1996; Fei et at. 1996), which 
coincidentally use the same retrospective data set of 24-hour tapes, is the data collection 
method for short-telID SDNN. For example, in the present study, and throughout the 
scientific literature, short-term data recordings are made at rest, under controlled 
laboratory conditions. This ensures the stationarity of the ECG signal and reduces the 
impact of external influences such as mental and physical stress, movement, breathing 
rate and even temperature. In both the above studies, the 5-min segments were extracted 
from the same 24-hour tachogram with which they were later compared. 
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Notwithstanding the statistical problems associated with comparing data that are not 
derived under conditions of mutual exclusivity, this data collection method does not 
conform with the recommendations put forward by the 1996 Taskforce for collection of 
short-term HRV data. This is not mentioned in the studies of Fei et at. or Faber et al. 
despite the fact that two authors, common to both papers are lead members of the 
aforementioned Taskforce. No study to date has compared the prognostic power of 
short-term HRV measures, recorded under controlled conditions with 24-hour 
ambulatory data. 
Despite differences in the prognostic power of 24-hour and short-term SDNN, the latter 
is still a significant predictor of risk in post-MI patients. The optimal cut-point produced 
in the study by Fei et at. was < 23 ms. Of interest here is that at baseline, this value 
represented the median (50th) percentile of SDNN values in the CR group. Post-CR, the 
median value had increased to 27 ms and 23 ms was now representative of the 40th 
percentile in the distribution. This change represents a positive influence of CR on the 
risk of a future cardiac event in the present population. 
As mentioned previously, the vagally mediated time domain measure of RMSSD is a 
significant predictor of risk in post-MI patients (Reinhardt et at. 1996). An optimal cut-
off point of < 36 ms was found for 24-hour RMSSD and in a separate analysis it was 
demonstrated that an increment of 10 ms in RMSSD produced a > 5% decrease in risk 
of adverse cardiac event in the 6-months following MI. These data are from 24-hour 
ambulatory measurement; few others are available for comparison and none are from 
short-term measures. Mean values of RMSSD in the present study increased from 20 to 
27 ms due to CR. Values for RMSSD are smaller when derived fOlID shOlt-term 
measures and therefore an accurate assessment of the impact on future risk is not 
possible except to say that it is probably larger than the same magnitude increase in 24-
hour measures. As 7 ms would have decreased the risk by approximately 4% according 
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to the previous values (Reinhardt et at. 1996), it can be assumed that the effect on future 
risk here is probably >5%. 
10.5. Conclusions. 
Previous studies using both 24-hour and short-term HRV recording methodolgies have 
shown mixed effects of CR on HRV measures. The majority of studies report 
favourable changes in at least some of the many measures made but in all cases there are 
problems with these data. A common problem is the failure to employ any form of 
control group. A second problem lies in the forms of statistical analyses undertaken; 
using paired analysis of pre- vs. post-test scores alone does not account for any changes 
in HRV measures that may occur spontaneously. Where analysis of differences in 
magnitude of change between a rehabilitation and a control group have been used, 
failure to control for the possible confounding effects of baseline HRV measures may 
previously have resulted in failure to detect change. 
This study is, therefore, unique in a number of respects. First, the present data were 
gathered on patients entering rehabilitation a typically longer time after MI and/or 
surgery than those patients studied previously. This is likely to have reduced the effects 
that any spontaneous return to recovery after MI or surgery may have had on the present 
results. 
Second, a control group of outpatients was used, and although not identical in disease 
aetiology to the CR group, they were similar in age, underlying cause of disease, 
(ischaemic) and use of pharmacotherapy. For the reason above (time to entry to cardiac 
rehabilitation) it can be argued that it was not necessary to use closely matched control 
population. 
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Third, it appears that this is the only study concerning the effects of CR on HRV in 
which power analysis has been used to calculate the necessary sample sizes to detect a 
significant difference. Although this calculation was at best, coarse, it was based on the 
mean effect sizes of a number of previous studies and therefore reasonably robust. 
Notwithstanding the accuracy of this calculation, the presence of any estimation of 
sample size is a methodological advance on all previous data. 
Fourthly, the statistical analysis undertaken in this study is rare in the existing literature 
(Leitch et al. 1997). By using a control group and examining differences in L1HRV 
between CR and CT groups it was possible to control for differences in baseline HRV 
between and within groups. This analysis revealed that for certain measures, baseline 
values are significant covariates which should be controlled for in such comparisons. It 
is of note, that for purposes of comparability with previous data, a paired comparison 
was also made. This showed significant (or very near to significant) differences in all 
the HRV measures that were expected to be altered by rehabilitation. The significance 
of these results is probably due to the rigorous planning of this investigation. 
Therefore, using precise, rigorous methodology, it was possible to demonstrate that an 
eight week cardiac rehabilitation programme, significantly altered all standard short-
term HRV measures with the exception of the LF:HF ratio. These differences were 
significantly greater than those of the control group, who undertook no rehabilitative 
exercise. The 95% confidence intervals for the changes in these HRV measures were all 
positive indicating that response to rehabilitation was homogeneous. 
Many positive psychological and physiological changes are known to occur in response 
to cardiac rehabilitation programmes such as reduced anxiety, increased exercise 
capacity, reduced heart rate, and blood pressure. All of these measures have also been 
identified as risk factors for future cardiac events. Low levels of many of the HRV 
measures recorded in the present study have also been identified as significant 
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independent risk factors for future adverse cardiac events. The present data demonstrate 
the ability of cardiac rehabilitation to increase all these identified measures, showing a 
further beneficial effect of rehabilitation in reducing further risk. 
10.5.1. Limitations. 
The major limitation of the present study is the nature of the control group employed. 
Ideally a control group should be as identical as possible to the experimental group to 
which they are being compared. This matching should include physiological 
characteristics and in clinical populations, disease aetiology and previous treatments and 
interventions. Due to ethical constraints, it is not possible to randomise patients to CR 
and CT groups as defined here. Therefore, we feel that by using outpatients with 
ischaemic complaints, a common underlying aetiology to that which results in MI and 
the need for CABG and PTCA surgical interventions, a fair comparison has been made. 
This is especially true due to the long time course from surgery and/or MI to onset of 
rehabilitation. 
A second limitation is the heterogeneity of the CR group themselves. Due in part to the 
geographical proximity of the CR centre to a national centre for cardiovascular 
treatment, a larger proportion of CR patients in the present study had undergone surgical 
interventions than reported in previous studies. Due to small subgroup numbers and the 
post hoc nature of any analysis, no meaningful assessment of the impact of antecedent 
subject characteristics in terms of disease statement and treatments was possible here. 
This is true at least if statistics comparable to those used in the main body of the study 
are to be used. However, appendix five contains results of a post hoc comparison made 
using visual analysis of means and 95% C.I.s. It should be noted that these data are 
preliminary only, they were not a planned comparison in this study, no power analysis 
was performed and therefore, are meant as only a demonstration of any potential 
differences with the possibility of some future work examining any effects shown. 
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CHAPTER 11. SUMMARY. 
The body of this thesis is a series of nine chapters which consists of systematic reviews, 
meta-analytical and empirical work undertaken over two and a half years. These 
chapters are deliberately diverse in their methods of data collection, data treatment, 
analysis and most of all, in terms of the populations they represent. There is, however, a 
clear underlying theme running through these works concerning levels and changes in 
measures of heart rate variability. 
From a philosophical viewpoint the use of such generalised nomenclature as heart rate 
variability to describe the methods employed in this thesis is wholly inadequate. The 
reader will realise that the multitude of measurements which can be derived from a 
single, short recording of heart period intervals make discussion of heart rate variability 
conceptually impossible. To avoid discussing each of the possible measurements (of 
which there are over twenty) which have been mentioned in this thesis, it is necessary to 
generalise to some degree. To do this, the HRV measures which have been used will be 
classified in two ways. 
11.1. Absolute measures of heart rate variability. 
The first categorisation is absolute measures, examples of which are SDNN (ms) in the 
time domain and LF or HF (ms2) in the frequency domain. When studying these 
measures and their behaviours, a simple, 'more is better' viewpoint can be assumed. 
Low levels of these values are risk factors for numerous adverse outcomes in various 
clinical populations; there is no evidence to suggest increases in these values are 
associated with any risk or adverse event. 
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In tenns of the effects of exercise on this category of HRV measurement, patterns are 
clear. Chapters six and seven showed that acutely during exercise as heart rate 
increases, all these measures decrease almost linearly as a function of exercise intensity. 
Longitudinally, the literature reviewed in chapter four gave mixed results concerning the 
efficacy of exercise training to increase absolute measures. For this reason it was felt 
necessary to meta-analyse these data in chapter seven. The meta-analysis of these data 
(chapter seven) showed large and significant effects for cross-sectional differences for 
SDNN and HF between active and inactive subjects. This analysis also showed that 
exercise interventions can significantly increase both SDNN and HF with a consequent 
increase in RR interval. The findings of this study were original, clarifying the debate 
within the published literature. 
From the observed relationship between absolute measures and RR interval, especially 
under conditions of ph anna co logical blockade, it is clear that the majority of variation in 
heart rate, which these measures represent, is vag ally mediated. Even low frequency 
spectral power, originally promoted as a sympathetic indicator, is clearly strongly 
influenced by the vagus. Given this relationship, it seems unsurprising that low levels of 
vagal activity and/or increased levels of sympathetic modulation (which reduce absolute 
measures) are risk factors. 
On this basis, it can be argued that increasing these measures is beneficial in reducing 
risk and that such an effect would be particularly beneficial in subjects with attenuated 
levels of absolute HRV measures. 
Chapters nine and ten both used exercise interventions in an attempt to promote 
increases in absolute measures of HRV. Patients with peripheral vascular disease 
(chapter nine) were found to have greatly attenuated levels of absolute HRV measures. 
Although large between-subject variation was evident, many subjects were found to be 
below previously quantified, high risk values. Exercise intervention in these patients 
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was not able to produce a significant increase in any measure ofHRV despite significant 
improvements in walking capacity due to supervised exercise. Comparing these 
findings with those from previous clinical exercise interventions, it was proposed that 
the intelmittent nature of the exercise may have been the reason for the lack of change 
observed. 
In chapter ten, post-MI and CAD patients entering cardiac rehabilitation were also found 
to have low levels of HRV. Eight weeks of cardiac rehabilitation was successful in 
creating large and statistically significant changes in absolute HRV measures. The 
findings from this study were unique in that data were recorded in subjects entering 
rehabilitation much longer after either MI or surgery than previously reported in the 
literature. The homogeneity of changes in HRV measures shown is as yet, unrivalled in 
the literature. Almost all seleted measures in this study increased significantly, where 
commonly only a small percent of the often numerous HRV measures reported show a 
significant change. 
11.2. Normalised measures and ratios in heart rate variability. 
Due to large interindividual differences in total spectral power (TP) and both the low 
and high frequency bands when they are expressed in raw units (ms2), it is common 
practice to normalise spectral power in the LF and HF bands for total power. This has 
led to the creation of indices of vagal or sympathetic predominance and ratios. These 
indices represent what has now been termed sympathovagal balance (Goldberger 1999). 
It should be noted, as discussed previously in the literature and throughout this thesis, 
that no physiological evidence for any such 'balance' between the branches of the ANS 
exists and this term may be an example of misleading nomenclature bom more out of 
convenience than of any physiological meaning (Eckberg 1997). 
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In the now seminal paper (Pagani et al. 1986) it was eloquently shown that 
'sympathovagal interaction' could be described with accuracy by using frequency 
domain analysis of HRV. In particular, increases in LF:HF ratio due to sympathetic 
stimulation, and decreases under conditions designed to promote vagal firing led to the 
conclusions that LF:HF and the expression of LF and HF in normalised units could 
adequately describe changes in activity levels of both cardiac ANS branches. 
These values were obtained largely under resting conditions in healthy humans and 
animals. What should be noted from studies in which subjects exercise, and when very 
high levels of sympathetic ANS activity are present (such as acutely following MI or 
during intense exercise), is that nearly all spectral power disappears. By its very nature, 
HRV relies on variation in the length of cardiac cycles; where no variation is present, no 
spectral power exists. 
In chapters two and three it was concluded that more reliable measures ofHRV could be 
obtained when normalised units were used. However, in consequent chapters (four, six 
and seven) it was found that recommended normalised units (Taskforce 1996) reflected 
poorly the expected changes in sympathetic and vagal contributions to SA node 
regulation during exercise. Additionally, between-study differences in the 
methodologies used to calculate normalised units made meta-analysis of either LFnu or 
HFnu impossible. 
In chapters nine and ten, raw values for LF and HF power were found to be attenuated. 
This led to highly heterogeneous values for LF:HF power and spectral power expressed 
in normalised units. The risk factors identified in the literature in patients with CAD 
and post-MI tend to be raw spectral power and time domain measures. Normalised units 
and the LF:HF ratio rarely show multivariate associations with risk in these populations. 
No significant changes in any HRV measure were shown in the PVD patients 
investigated in chapter eight. LF:HF ratio was the only measure not to show significant 
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change in chapter nine (cardiac rehabilitation). Interestingly, low levels of LF and HF 
power (in raw units) have both been identified as risk factors following MI. Both these 
measures increased during the intervention. However, it seems that as these measures 
increased by broadly similar magnitudes, LF:HF remained unaffected. 
Analysis of the published data for measures of LF:HF in clinical patients produces a 
paradox which can be related back to data from previous chapters. Firstly, many of the 
studies examining exercise interventions outlined in chapter four, expected to show a 
decrease in LF:HF ratio especially when measured at rest. Such a lowering of this 
measure of sympathovagal balance has been proposed by numerous authors to show a 
beneficial 'tipping of the balance' between branches of the ANS towards vagal 
predominance. This is also proposed to bring with it myocardial electrical stability and a 
decreased risk of arrhythmia. On this basis, lowering of LF:HF has been a hypothesised 
outcome of exercise interventions in healthy subjects which has been successfully 
demonstrated on a number of occasions. 
Somewhat paradoxically, in clinical populations it is not a high LF:HF ratio which tends 
to predict increased risk of arrhythmia, sudden death or indeed any cause of mortality. 
It is in fact a low LF:HF ratio, which according to data from the healthy populations in 
which this ratio was originally validated should be indicative of predominant vagal 
modulation of the SA node. 
The problem underlying this paradox is created by generalising findings from validation 
studies in healthy subjects to clinical populations. In both populations, the value of the 
LF:HF ratio is the product of LF and HF power. However, in the former, these values 
often mn into the hundreds or even thousands of milliseconds. In the clinical 
populations, recorded values are commonly in tens or even single figures. In this 
situation a small variation in one band can give a misrepresentative or wholly erroneous 
value for LF:HF. It can even be argued that below a celiain level of total spectral 
390 
power, the LF:HF ratio and of course values for normalised spectral units at best, do not 
represent what they may do in healthy subjects or at worst have little or no physiological 
meanmg. 
11.3. Recommendations. 
Despite such problems and despite the lack of significant associations between risk and 
LFnu, HFnu or LF:HF these values continue to be calculated in many clinical 
populations where global HRV is greatly attenuated. Further work should focus on the 
nature of the relationship between LF:HF and sympathovagal balance in subjects with 
varied levels of total spectral power. In addition, identification of a lower ceiling for 
TP, below which any such relationship fails to retain a physiological association, should 
be identified. 
In addition to and related to this recommendation, agreed normal, expected values for 
short-term HRV measures would be an invaluable resource for future research. Large, 
population-based studies, typically use 24-hour, Holter monitoring and are based in 
clinical populations (Bigger et at. 1995). Where short-term monitoring has been used, 
findings for raw and indeed normalised HRV values are heterogeneous. The large 
interindividuality in HRV measures can be viewed as advantageous, giving the measure 
high discriminant power. However, this same property also means that very small 
variations in data collection protocols create highly heterogeneous values (Fagard 2001; 
Kuch et al. 2001). This is paI1icularly true when raw spectral powers are measured. As 
these are the best predictors of risk and appear to be more sensitive to change due to 
intervention than nOlmalised measures, the importance of establishing population based 
nOlms should be a high priority for those researchers working in the field of heart rate 
variability. 
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11.4. Conclusions. 
The overall theme of this thesis is that heat1 rate variability is a measurement with great 
potential to identify risk in a number of populations. This measure is also dynamic, in 
that it may be acutely altered, particularly by exercise. Chronic adaptation to prolonged 
aerobic type exercise can also cause significant alterations in certain HRV measures 
known to be risk factors in healthy subjects and in clinical populations. Finally, 
although the exact physiological meanings of certain HRV measures remain ambiguous, 
the fact that they predict risk makes them invaluable due to their strong associations and 
the simplicity and non-invasive nature of their acquisition. The fact that known HRV 
measurements which are known risk factors can be modulated successfully via exercise 
intervention and other disease management strategies means heart rate variability should 
be viewed as an important therapeutic target. 
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APPENDIX I. List of standard heart rate variability abbreviations, definitions and explanations of variables. 
Abbreviation 
RR interval 
NN interval 
SDNN 
SDANN 
RMSSD 
NN50 (NN50 
count) 
pNN50 
SDNN 
HRV triangular 
index 
TINN 
Description 
Time domain measures. 
The time (ms) between the fiducial points of successive R waves from the 
original ECG trace. 
The time (ms) between the fiducial points of successive R waves from data 
which has been filtered and/or beats removed and interpolated. 
The standard deviation of all the normal-to-normal (NN) intervals. 
The standard deviation of the average NN intervals calculated over 5 min. 
The root of the mean squared differences of successive NN intervals. 
The number of successive intervals which differ by more than 50 ms. 
The proportion of successive intervals which differ by more than 50 ms 
derived by dividing NN50 by the total number ofNN counts. This may also 
be expressed as a percentage PNN50%). 
The standard deviation of all the normal-to-normal (NN) intervals. 
Geometric measures. 
The integral of the density distribution divided by the maximum of the 
density distribution. 
The width of the base of a triangle fitted to the histogram of duration of all 
NN intervals. 
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What the measure represents. 
The duration of each cardiac cycle including all 
beats. 
The duration of each normal cardiac cycle. 
All the cyclic components responsible for 
variability in the period of the recording. 
All the cyclic components responsible for 
variability during cycles longer than 5 min. 
Parasympathetic activity. 
Parasympathetic activity. 
Parasympathetic activity. 
All the cyclic components responsible for 
variability in the period of the recording. 
All the cyclic components responsible for 
variability in the period of the recording. 
All the cyclic components responsible for 
variability in the period of the recording. 
Poincare Plots 
Total Power 
LF 
HF 
LF (nu) 
HF (nu) 
LF:HF ratio 
VLF 
ULF 
A scattergram of each NN-interval of a tachogram plotted as a function of the 
previous NN-interval. 
Frequency domain measures. 
Variation in NN interval below 0.15Hz. The lower band may be altered 
depending on duration of recording. 
Variation in NN interval 0.04-15 Hz. 
Variation in NN interval 0.15-0.4 Hz. 
The proportion of spectral power from 0.04 - 0.4 Hz which is in the LF 
frequency calculated by LF! (TP - (ULHVLF)) 
The proportion of spectral power from 0.04 - 0.4 Hz which is in the HF 
frequency calculated by HF! (TP - (ULHVLF)) 
The ratio of LF power to HF power. 
Variation in NN interval <0.04 Hz 
Variation in NN interval below 0.0033 Hz. 
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All the cyclic components responsible for 
variability in the period of the recording. 
All the cyclic components responsible for 
variability in the period of the recording. 
Sympathetic and parasympathetic activity. 
Parasympathetic activity. 
Sympathetic activity or sympathovagal balance. 
Parasympathetic activity or sympathovagal 
balance. 
Sympathetic activity or sympathovagal balance. 
All the cyclic components responsible for 
variability during cycles longer than 25 seconds. 
Possibly variations in thermal control or the 
rennin-angiotensin system 
All the cyclic components responsible for 
variability during cycles longer than 5 min. Origin: 
unkown. 
APPENDIX II. Expanded descriptions and definitions of HRV terminology -
including those used for HRV measurement during exercise. 
Time domain parameters: 
Statistics derived directly from either the NN interbeat intervals or the differences 
between successive NN intervals. 
Frequency domain parameters 
A mathematically complex analysis which gives information about the amount of 
variance (power) in the heart's rhythm explained by periodic oscillations of the heati 
rate at various frequencies. 
Autoregressive modelling (ARM) 
A method by which the time series of the NN intervals can be decomposed into the 
frequency domain. This method requires no a priori decisions about the spectral 
bands as it identifies peaks in the power spectrum. 
Fast Fourier transformation (FFT) 
A method by which the time series of the NN intervals can be decomposed into the 
frequency domain. This method requires a priori decisions about the spectral bands 
as it identifies peaks in the power spectrum. 
High frequency power (HF) 
The amount of variance of power in the heati's rhythm explained by periodic 
oscillations of heart rate at a frequency of O.lS-0AHz. 
Low frequency power (LF) 
The amount of variance of power in the heart's rhythm explained by periodic 
oscillations of heati rate at a frequency of O.04-0.1SHz. 
Very low frequency power (VLF) 
The amount of variance of power in the heart's rhythm explained by periodic 
oscillations of heart rate at a frequency ofO.0033-0.04Hz. 
Ultra low frequency power (ULF) 
The amount of variance of power in the heart's rhythm explained by periodic 
oscillations ofheati rate at frequencies below O.0033Hz. 
Poincare plots 
A graphical analysis ofNN data in which each NN interval from a tachogram is 
plotted as a function of the previous interval. 
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Two-dimensional vector analysis of Poincare plots. 
A statistical method by which an elipse is fitted to the Poincare plot. This elipse is 
then fitted with a both a longitudinal axis (axis 2) and an axis perpendicular to this 
(axis 1) which defines the transverse slope. The plot is then rotated anticlockwise 
and clockwise in tum to give the measures SDI and SD2. 
SDI 
A representation of the beat-to-beat variability in HR. 
After the clockwise rotation of a Poincare plot the SD of the points is calculated on 
the horizontal axis (2) which passes through the data centre SD 1. 
SD2 
The standard deviation of long-term NN intervals. 
After the anticlockwise rotation of the Poincare plot the SD of the data points is 
calculaed around the horizontal axis (1) which passes through the centre of the data 
SD2. 
LF (nu) 
The proportion of LF to HF power in the total power spectra of the LF and HF 
bands. 
TP - VLF = LF and HF. LF I (LF+HF) * 100. 
HF (nu) 
The proportion of LF to HF power in the total power spectra of the LF and HF 
bands. 
LF% 
The spectral power in the LF band as expressed as a percentage ofVLF, LF and HF. 
HF% 
The spectral power in the HF band as expressed as a percentage ofVLF, LF and HF. 
HF CCV% (coefficient of component variance) 
The square root of HF power divided by mean NN interval. 
GSA - General spectral analysis 
A term used by some authors to describe the decomposition ofNN interval data into 
the frequency domain using either FFT or ARM. 
CGSA - Coarse graining spectral analysis 
An alternate method of decomposing the NN interval data into the frequency domain 
which separates the harmonic from the nonharmonic (llf) HRV component 
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Low or PNS indicator 
Harmonic spectral power in the frequency of 0 - 0.15Hz. 
High or SNS indicator 
Harmonic spectral power in the frequency of 0.15 - 1.0Hz 
Low:High 
The ratio of LO to HI, indicative of syrnpathovagal balance when CGSA is used. 
fJ 
See 11/ 
Lyapunov Exponent 
Derived from the time series. The Lyapunov exponent is given by averaging the 
exponential rate of divergence of short segments of delay reconstructed orbit. It is 
positive for chaotic behaviour, zero or negative for periodic behaviour. 
11/ 
A plot used to estimate the complexity of a given time series. 1If' is a regression line 
of the inverse relationship between amplitude (or power) and frequency, known to 
exist all fractal processes. x is the exponent of the line, sometimes reported in the 
literature as beta (P). 
Df 
The fractal dimension of the non-harmonic component ofHRV and is derived from 
the values of beta. Df= 2/b-l for values of 1 <b<3. When b<1 Df=l. When O<b<1 
DF = infinity. 
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APPENDIX III. Example sample size calculations based on reliability coefficients 
in chapter two. 
The Taskforce (Taskforce 1996) states that a general consensus concerning the 
practical use of HRV in adult medicine has been reached only in the following two 
areas: 
1. Depressed HRV as risk predictor following MI 
2. As an early sign of diabetic neuropathy. 
Recently the role of HRV in prognosis of patients suffering heart failure has also 
been identified (Stys and Stys 1998) 
111.1. Sample size calculations. 
All the sample sizes below are calculated using the formula provided by Lehr 
(1992). Quintana et al. (1996) list the differences found between survivors and non-
survivors, 3-years post-MI. From the list of variables provided LF and SDNN have 
been selected to represent frequency and time domain measures of HRV. Below is a 
sample size table based on the CV s reported for all three instruments in the present 
study. It should be noted that these results are drawn from 24-hour ambulatory data 
and are here only as an example. 
Table III-I. Sample size calculations for LF and SDNN in post-MI patients 
Measure Instrument CV(%) % Difference Sample size for 
to be detected fJ = 0.8, P = 0.05, 
two sided. 
LF TF5 64.7 20.2 3244 
LF CT 46.9 20.2 1742 
LF CP 59.5 20.2 2851 
SDNN TF5 6.5 17.2 36 
SDNN CT 30.0 17.2 847 
SDNN CP 25.7 17.2 621 
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The ability of 5-min measures of HRV to predict sudden cardiac death in a post-MI 
population has been canied out (Faber et al. 1996) but only data concerning SDNN 
are available in a fonn which allows the constmction of a sample size table. 
Table 111-2 Sample sizes for SDNN in post-MI patients. 
Measure Instmment CV(%) % Difference Sample Slze for 
to be detected ~=0.8, p =0.05, 
two sided. 
SDNN TF5 6.5 16.4 41 
SDNN CT 30.0 16.4 878 
SDNN CP 25.7 16.4 644 
In chronic heart failure patients a highly significant absence of LF has been found 
(van de Borne et al. 1997). The table below shows necessary sample sizes to 
detennine differences between heart failure and healthy controls. 
Table 111-3 Sample sizes for LF in heart failure patients. 
Measure Instmment CV(%) % Difference Sample Slze for 
to be detected ~=0.8, p =0.05, 
two sided. 
LF TF5 64.7 93.7 688 
LF CT 46.9 93.7 361 
LF CP 59.5 93.7 582 
The above tables are examples and are not designed for use in research design. What 
they are intended to do is to illustrate the profound effect that reliability has on the 
necessary sample size in order to achieve the desired statistical power. Of pat1icular 
note is the effect a low CV (such as the TF5, SDNN) has on the number of subjects 
needed in a research study. 
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APPENDIX IV. Meta-Analysis of effect sizes for changes in global HRV and 
measures of sympathovagal balance. 
IV.I. Study selection. 
Based on a search of the PubMed and Ovid databases seven studies were identified 
for possible meta-analysis. The entry criteria for analysis were as follows. 
Subjects in each study were required either to have been diagnosed as having MI 
or be postoperative (CABG or PTCA) patients treated due to the presence of 
ischaemic heart disease. Each study was required to have measured SDNN, HF or 
LF:HF ratio and supplied data in a form suitable for the calculation of effect size. 
Studies were not required to have employed a control group as it was deemed that 
this criterion would eliminate too many published papers. On this basis 7 papers 
were entered into the meta-analysis for SDNN and 6 for LF:HF ratio. 
IV.II. Statistical analysis. 
Effect size (d) was calculated using the formula described by Cohen (1982). 
Pooled standard deviation was drawn from the standard deviations from the 
experimental group's pre and post-test values. 
A fixed effects model for Hedge's g was then calculated using the effect sizes 
presented. A significance of P < 0.05 wad deemed statistically significant. In 
addition to calculating the overall fixed effect the data were divided on the basis of 
the type of ECG recording carried out on which the HRV data were calculated. 
These data were divided into two broad categories based on previous 
recommendations (Taskforce. 1996), 24-hour, ambulatory data collected using 
Holter monitoring (24-hour) or short-term data collected while the subject is under 
resting conditions with a relatively stable heart rate (short-term). To observe the 
effect of data collection method on each measure of interest the Q statistic was 
calculated by dividing the Chi2 value within each group by the Chi2 value between 
groups. This gives a measure of within and between-group variance analogous to 
that derived from ANOV A and provides a quantitative measure of heterogeneity. 
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Due to the low statistical power of this test a value of P < 0.10 was regarded as 
statistically significant. 
IV.III. Meta-analysis results. 
Duration Citation -4.00 -2.00 0.00 2.00 4.00 
Long Pardo et al. 
Long Stahle et al. 
--+---
Long Tygesen et al. 
Fixed Long (3) I-+--
Short Duru et al. 
Short lellamo et al. -----+---
Short La Rovere et al. 
Short Malfatto et al. 
Fixed Short (4) 
--
Fixed Combined (7) --+---
Decreased Increased 
Figure IV.l Changes in SDNN due to cardiac rehabilitation. 
In total, seven trials (n=114 cases) were compared pre- and post-rehabilitation. 
The overall effect of rehabilitation created an adjusted Hedge's g value of 1.17, (P 
< 0.001). 
Changes in SDNN remained significant regardless of whether it was derived from 
24-hour ECG recordings (g = 0.82, P = 0.002) or short-term recordings (g = 1.38, 
P < 0.00001). The difference between these two effect sizes was found to be 
statistically significant (Q = 2.96, P= 0.08). 
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Duration Citation -4.00 -2.00 0.00 2.00 4.00 
Long Mazzuero et al. 
Long Stahle et al. 
Fixed Long (2) 
Short Duru et al. 
Short La Rovere et al. 
Short Lucini et al. 
Short Malfatlo et al. 
Short Malfatlo et al. (b) 1---
Fixed Short (5) 
Fixed Combined (7) 
Increased Decreased 
Figure IV-2 Changes in LF:HF due to CR. 
Overall effect size for changes in LF:HF ratio were not statistically significant (g = 
0.18, P = 0.22). When analysed separately, effect size for 24-hour recordings was 
actually g = 0.00, P = 1.0; short-term recordings the effect size was also 
nonsignificant (g = 0.25, P = 0.15). Calculation of the heterogeneity statistic 
revealed that this latter value was not significantly different to zero (Q = 0.58, P = 
0.44) showing no significant between-group heterogeneity. However, findings 
from studies using short-term data collection displayed significant within group 
heterogeneity (Q = 11.0, P = 0.02) 
IV.IV. Discussion. 
The results of the present meta-analysis show the large variation in outcomes 
regarding changes in HRV measures during CR. Global measures ofHRV such as 
SDNN are generally shown to be significantly increased. This is as expected as 
longer RR intervals (slower HR) that commonly accompany exercise training are 
often associated with greater variation. As the heart spends the majority of its time 
at rest under continual down-regulation from its intrinsic rate by the vagal nerve, 
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an increase in vagal modulation, should increase variation and therefore SDNN. 
This should be true for both short-term and 24-hour monitoring. 
The significant heterogeneity of results between these methods may be explained 
by their differing sensitivities. Under short-term, resting conditions the heart rate 
is low, and under greatest influence from the vagus, this gives the PNS the 
opportunity to express its action and for this action to be manifested as increased 
HRV. Stress, both mental and physical accompanied by changes in behaviour and 
activities may be the reason for decreased sensitivity of SDNN when it is derived 
form 24-hour readings. 
Similarly, when LF:HF ratio is derived from 24-hour recordings a mean value for 
each five minute period is given. The lack of any significant changes in LF:HF is 
therefore unsurprising as the continual modulation of the ANS between PNS and 
SNS dominance through daily activities is likely to obscure any change in the 
overall balance of the two branches. A greater effect size for shift in autonomic 
balance was found when short-term resting measures were used. Although not 
statistically significant (P = 0.15) it does show a trend towards an increase in 
LF:HF ratio in patients undergoing rehabilitation. This is however problematic as 
increased LF:HF is indicative sympathetic predominance at rest. Such conditions 
are commonly found in post-MI patients as well as those with other forms of heart 
disease, however, LF:HF has been reported to be higher in healthy individuals 
when compared with CHF and post-MI patients (Bigger et ai. 1995). Additionally 
increased LF:HF is not indicative of poor prognosis in patients with heart disease 
(Forslund et at. 2002) when taken from 24-hour recordings. Where short-term 
assessment of LF:HF ratio is used it has been found that using a cut off point of 
0.95, those patients with higher values for LF:HF (e.g. sympathetic predominance) 
had significantly increased mortality than those with < 0.95 values (Bigger et ai. 
1993). 
It therefore seems that the goal of cardiac rehabilitation should be to decrease 
stable, resting measures of LF:HF to demonstrate an increased vagal predominance 
in patients. However, pooled data from existing studies show this value to be 
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increased. The underlying factors determining this could be methodological in 
nature and the neural and non-neural genesis of LF and HF have been discussed 
previously (see Chapter 3). It may be that the very small values for both spectral 
bands observed in this population give rise to discrepant findings. Alternatively, it 
is known that vagal influences contribute to the LF spectral component and the 
increase in LF:HF may be a consequence of this. 
The reasons why LF:HF, a known risk factor for 1-year mortality should be 
increased by CR are not known by should be resolved. The effect is in the 
opposing to direction to that which would be expected, this means that sample size 
equations based on these findings are not possible at this time. 
Based on previous data and the mini meta-analysis performed here it is possible to 
make the following power calculations (Table IV). The values for each part of the 
study are different from one another 
Table IV-l Sample Sizes 
Variables to be tested. 
Correlation between HF power 
and change in aerobic 
performance 
Correlation between LF:HF 
and change in autonomic 
function 
Change in SDNN 
Changes in HF 
Changes in LF:HF 
Sample size calculation based Number of subjects required at 
on: (P < 0.05, f3 = 0.8) 
Based on previous data (n = 22) 
(Hautala et al. (2003) 
Based on previous data (n = 31) 
(Mazzuero et al. 1992) 
Based on effect size (n = 18) 
calculations from meta analysis 
(7 based on Lucini et at. 3 
based on Illemo et at. 44 based 
on Malfatto et al.) 
Based on mean effect size (n = 43) 
calculations from meta 
analysis2 based on Lucini et at. 
21 ,Mazzuero et al., Pardo et 
al .. 
Based on previous data (n = 21) 
(Malfatto et at.). 
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APPENDIX V. Subgroup analysis for chapter tell. 
Baseline HRV characteristics of patients in subgroup 1 - those who's primary 
reason for attending CR was due to myocardial infarction either with or without 
resultant surgical procedure and subgroup 2 - those patients who's primary reason 
for attending CR was due to surgical procedure regardless of previous history of 
MI. All graphs are mean (bar), 25th, 75th percentiles (solid box), 5th and 95th 
percentiles (t-bars). 
Box and whisker plots have been used to illustrate the following data as they 
provide simple presentation of mean changes and changes in dispersion from test 
to retest. The small patient numbers in each group negate any meaningful 
statistical analysis. 
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Figures V- 1- V-7. Differences in baseline HRV values for MI and non-MI subgroups. 
On the basis of above figures it is difficult to draw any strong conclusions 
concerning differences in the baseline characteristics of MI and non-MI patients. 
One general observation is that vagal measures such as RMSSD and HF power are 
lower and equal between the two groups respectively. Additionally, the LF:HF 
ratio which takes into account both vagal and sympathetic modulation, shows a 
tendency toward greater sympathetic and/or lesser vagal modulation in the MI 
group compared with the non-MI group. 
Regardless of any differences observed, the distribution of scores for all measures 
in the non-MI group is uniformly larger compared with the MI group. This 
indicates a greater heterogeneity in autonomic control in this group. Further work 
is required to elucidate the possible effects the differences in baseline 
sympathovagal balance have on response to CR as highlighted previously 
(Malfatto et at. 2000). 
All graphs are mean (bar), 25th, 75th percentiles (solid box), 5th and 95th percentiles 
(t-bars). 
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Figures V-8 - V-14. Differences in ~HRV values for MI and non-MI subgroups. 
V.1. Differences in illIRV between subgroups. 
What can be seen from the above figures is that values for the frequency domain 
measures (LF and HF) increased to a greater extent in the no MI group. The 
LF:HF ratio which was originally lower in this group, also increased by a greater 
amount which resulted in a somewhat paradoxical increase in RR interval. This 
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increase was also of much greater magnitude in the non-MI group. It is of interest 
to note that, in addition to baseline values, the vales for change in spectral 
measures of HRV were also more heterogeneous in the non-MI group compared 
with post-MI patients. The reasons for this pattern of change and the impact it 
may have on changes in HRV during CR require further investigation. Changes in 
time domain measures were almost identical between groups. 
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